data_1kpp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kpp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -50.98 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.584 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.11 -31.28 70.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.23 -44.37 92.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -57.95 -44.5 87.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.186 0.517 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.38 -30.67 71.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtm -79.28 -31.54 43.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.825 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.21 20.18 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.027 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -78.54 -31.14 47.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.859 0.362 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -31.35 71.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.49 156.18 8.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -54.17 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.48 66.13 4.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -61.83 -52.38 64.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.35 -29.55 48.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.23 -26.94 17.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.7 m -80.71 -30.45 36.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.18 -28.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -82.1 -33.32 29.79 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.151 0.501 . . . . 0.0 110.848 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -68.93 -42.29 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.0 m -69.03 -55.07 11.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -52.35 -46.89 46.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 3.2 m-80 -51.69 -37.01 48.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.9 t -82.9 -63.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.465 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 pt -52.27 -26.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -85.54 -26.49 26.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.01 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.74 -39.02 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.668 0.271 . . . . 0.0 111.202 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -93.14 11.46 27.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.659 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 14.33 61.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.38 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.75 121.77 14.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.02 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? -100.13 128.05 31.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.123 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.53 139.39 37.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.3 2.0 . . . . 0.0 112.608 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.19 162.11 39.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.8 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.82 103.83 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.797 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -123.78 127.12 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.385 0.612 . . . . 0.0 110.534 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.72 139.64 30.53 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -108.85 160.23 16.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.96 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 179.682 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.396 0.141 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.88 140.23 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.551 0.532 . . . . 0.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.33 128.51 35.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.085 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.8 tp -136.11 136.27 39.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.4 ttp -105.26 149.75 25.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.229 0.538 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.17 163.53 36.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.892 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -127.54 123.85 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -119.45 131.12 55.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.65 -174.06 41.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.604 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -121.06 151.61 39.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.714 0.292 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pt -130.97 114.84 16.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.273 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.28 167.37 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.434 2.089 . . . . 0.0 112.141 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 p -173.39 127.01 0.48 Allowed Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.347 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.78 115.83 4.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.255 1.97 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.61 137.18 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 60.13 20.88 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.524 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.56 5.16 82.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.672 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.19 175.51 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.87 0.366 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 100.49 10.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.43 159.56 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -114.33 125.07 53.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.62 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.0 95.47 21.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.226 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.11 144.37 99.18 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.156 1.904 . . . . 0.0 112.221 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -155.47 138.97 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.9 m -99.6 162.43 13.02 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.35 134.88 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.15 148.33 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.774 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 mp -133.44 155.63 49.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.805 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -135.11 158.86 43.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -73.8 -30.95 63.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.05 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.37 154.02 68.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.76 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.99 -45.01 0.46 Allowed 'Cis proline' 0 C--N 1.347 0.448 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.433 0.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -105.09 -59.81 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 166.45 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.38 143.52 15.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.677 2.251 . . . . 0.0 112.455 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 149.99 50.3 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.491 2.127 . . . . 0.0 112.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.85 154.61 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.71 142.46 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -151.97 154.44 36.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.7 m -117.19 139.09 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.117 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -135.49 79.4 48.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.09 176.52 6.15 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.413 2.075 . . . . 0.0 112.572 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -91.84 170.35 9.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.8 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -58.72 -28.63 66.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -76.33 -29.56 57.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.06 177.03 7.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.33 -173.52 3.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.613 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.1 mm -126.13 92.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -66.47 103.72 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.867 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -58.47 134.42 56.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.71 -131.11 1.62 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.557 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 0.5 OUTLIER -99.99 -32.42 10.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.789 0.328 . . . . 0.0 111.014 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.452 ' CG ' ' CD2' ' A' ' 111' ' ' LEU . 23.1 m-70 -111.44 -34.82 6.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.981 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.05 79.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.27 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -69.25 -173.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.39 5.26 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.356 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -112.9 24.9 11.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 56.49 27.89 54.84 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.99 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.4 160.24 15.57 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.436 -0.449 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.55 38.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.284 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 30.1 p90 -60.77 102.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.989 0.423 . . . . 0.0 110.625 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.452 ' CD2' ' CG ' ' A' ' 102' ' ' HIS . 2.1 mt -108.74 144.68 30.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.073 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.72 -40.36 84.97 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.491 2.127 . . . . 0.0 112.04 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.77 -30.33 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.52 -32.51 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.51 -49.55 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.83 33.26 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.779 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 t90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.108 0.48 . . . . 0.0 110.747 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.847 0.356 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.16 -0.93 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 123' ' ' ASP . 0.9 OUTLIER 87.66 -26.45 0.08 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.62 0.368 . . . . 0.0 111.322 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.92 -38.23 90.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.452 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.96 -31.18 54.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.016 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.97 -30.5 61.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.593 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.1 mm -88.08 -28.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.037 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -67.9 -41.26 82.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.215 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 131' ' ' MET . 6.8 p -52.4 -46.58 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.981 0.419 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.441 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.1 mtt -66.94 -35.38 79.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.389 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.13 -27.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.771 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.2 t -91.43 -48.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.22 -39.94 82.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.48 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -85.21 -15.89 42.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.075 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.0 -14.77 81.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.434 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -97.98 -38.01 9.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -164.8 89.31 1.02 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.86 126.54 22.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.569 2.179 . . . . 0.0 112.412 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.83 -13.42 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.71 2.273 . . . . 0.0 112.561 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.9 t -72.45 -3.72 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.148 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.055 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.701 0.286 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -46.68 17.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -40.01 80.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.85 -37.53 79.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.268 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -62.47 -50.23 72.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.727 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -63.54 -31.12 72.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.56 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.1 mtp -74.65 -30.6 61.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.02 19.45 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.805 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -65.35 -29.86 70.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.21 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -27.24 58.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.872 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 21.2 m-85 -56.06 130.64 44.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -66.98 -42.54 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' CG2' ' A' ' 79' ' ' THR . 16.0 m-85 -103.62 60.77 0.75 Allowed 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -59.02 -35.4 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.73 -51.12 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -33.31 63.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.672 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -66.47 -39.08 88.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.02 -30.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -46.79 35.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -59.29 -42.33 91.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.979 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 m -63.71 -59.57 4.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -47.4 -47.59 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.069 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.418 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -58.02 -29.48 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.5 t -83.33 -37.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.256 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.37 -27.97 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.954 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.8 m -80.55 -29.06 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.693 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -88.73 -30.24 19.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.895 0.379 . . . . 0.0 110.977 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -106.92 127.2 53.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 35.24 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.98 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -152.06 24.75 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.026 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.07 160.74 21.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -149.28 130.14 7.03 Favored Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.32 131.74 15.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.365 2.043 . . . . 0.0 112.316 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.47 161.79 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.64 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -130.9 115.06 16.03 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.076 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.58 120.75 18.91 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.3 p -82.16 146.07 29.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -139.35 134.67 32.82 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.352 179.753 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -117.26 132.31 56.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.501 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -75.32 110.4 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -106.09 134.93 48.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -86.31 146.82 26.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 0.0 110.776 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -147.3 143.86 28.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.985 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.91 105.07 17.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -94.72 132.82 39.07 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.78 -155.23 15.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.503 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 p -150.72 150.75 31.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.569 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.43 149.44 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.677 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.04 116.73 4.63 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.331 2.021 . . . . 0.0 112.503 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.45 84.52 52.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.51 165.07 10.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.285 1.99 . . . . 0.0 112.351 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -69.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.246 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.29 46.77 1.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.089 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.06 -16.73 59.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.579 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.97 -168.22 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 110.447 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -155.96 128.71 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.757 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.24 -170.62 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.666 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.41 67.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mm -57.65 108.09 1.15 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.239 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 155.61 65.23 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.447 2.098 . . . . 0.0 112.226 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -155.88 153.82 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.0 m -122.17 103.32 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.11 129.09 34.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.742 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.92 147.52 29.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.934 0.397 . . . . 0.0 111.108 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.67 142.29 46.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.33 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -112.8 -178.87 3.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 111.481 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.31 39.42 1.5 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.605 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 17' ' ' TYR . 4.9 m 75.04 25.69 1.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 178.0 142.18 0.27 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.043 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.83 -40.11 0.82 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.467 0.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -82.85 65.96 8.23 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -32.8 -55.42 0.57 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 122.95 0.5 . . . . 0.0 111.377 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.65 131.48 24.19 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.404 2.069 . . . . 0.0 112.166 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.81 134.1 46.99 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.459 2.106 . . . . 0.0 112.329 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 29.1 mt -104.13 148.56 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 26.2 p -134.95 125.25 26.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 22.6 m-85 -133.48 142.08 48.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -95.57 145.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.781 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.0 123.95 31.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.1 -172.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.477 2.118 . . . . 0.0 112.237 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -170.63 2.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.1 -37.79 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.91 -29.37 14.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.073 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -94.72 -168.4 1.82 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.911 0.386 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.4 t -146.33 -156.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.85 142.85 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 110.897 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.83 145.52 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.8 p -114.89 134.48 55.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.82 -115.78 0.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.472 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -71.43 0.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.472 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -142.23 62.88 1.42 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 111.532 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.0 t -135.17 -7.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.867 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.403 ' OD2' ' CD2' ' A' ' 110' ' ' TYR . 16.6 m-20 45.7 -167.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.286 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.09 -46.81 6.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.129 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.69 -17.23 60.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.184 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.84 20.87 5.56 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.762 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -83.07 115.49 21.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.759 -0.259 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.46 107.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.661 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -95.73 41.58 1.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' CD2' ' CD2' ' A' ' 102' ' ' HIS . 4.0 mt -60.42 119.74 45.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.14 -21.13 27.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.438 2.092 . . . . 0.0 112.225 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -56.64 -62.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.834 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.4 tp -46.56 -39.47 11.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -59.21 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.532 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.1 35.07 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.91 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.2 t90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.932 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.54 -173.41 3.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.41 -40.4 96.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.57 -53.78 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.75 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.89 -29.66 74.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.21 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.44 -31.87 64.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.648 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -82.81 -25.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.978 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -51.48 16.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 131' ' ' MET . 5.8 p -47.11 -45.62 8.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.442 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 3.6 mtm -60.35 -38.71 84.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -25.78 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.04 -53.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.67 -29.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.49 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.441 ' CE2' ' CG ' ' A' ' 140' ' ' PRO . 2.8 m-85 -86.41 -27.86 23.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.541 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.2 -14.55 80.51 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.802 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -96.47 -30.57 13.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.382 . . . . 0.0 110.958 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.59 109.19 1.48 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.65 123.16 12.69 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.441 ' CG ' ' CE2' ' A' ' 135' ' ' PHE . 94.2 Cg_endo -89.63 25.67 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.3 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.83 -12.94 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.74 0.305 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -40.93 82.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -36.9 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.909 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.67 -55.49 34.37 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.569 0.543 . . . . 0.0 110.831 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -58.21 -30.33 66.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.89 -41.04 75.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.5 mtp -58.22 -36.32 72.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.588 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' CG2' ' CZ ' ' A' ' 18' ' ' ARG . 22.6 m -112.27 19.65 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.186 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -67.99 -29.13 68.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.908 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -28.44 65.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 5.2 m-85 -55.73 124.07 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -67.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.0 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -64.47 -49.19 72.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' CZ ' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER 64.63 -65.97 0.13 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.33 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 17' ' ' TYR . 36.7 t0 -48.05 -43.91 30.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.052 0.453 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' C ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -53.03 -36.18 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.4 ' CG2' ' NH2' ' A' ' 18' ' ' ARG . 95.6 m -83.66 -35.58 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.843 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.415 ' CG2' ' NH1' ' A' ' 18' ' ' ARG . 60.7 t -52.08 -35.11 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.761 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -83.52 -40.64 18.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.845 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -66.54 -32.65 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.907 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 t -73.6 -41.63 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -72.16 -47.43 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.021 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.7 m-80 -50.15 -46.52 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.27 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.57 -61.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.28 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 pt -59.32 -23.5 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.403 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.7 m -82.58 -28.75 30.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -18.84 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.93 164.28 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 0.0 110.602 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -18.52 8.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -96.87 28.63 3.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.718 0.294 . . . . 0.0 111.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.7 154.51 31.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.44 104.43 2.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.02 140.9 38.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.22 1.947 . . . . 0.0 112.588 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -127.61 161.82 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.109 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.48 122.93 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.728 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -157.05 138.9 14.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -87.07 154.02 21.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.24 124.91 28.21 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.22 -179.831 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.31 134.89 12.59 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.88 115.75 3.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.043 0.449 . . . . 0.0 110.797 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.02 158.36 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.008 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.9 ttp -130.71 147.23 52.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.912 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -136.61 177.31 7.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.055 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mt -139.6 104.01 4.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 m -99.96 157.41 16.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.879 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.62 -149.4 14.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.42 142.0 31.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.5 mt -112.21 123.76 33.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.83 112.63 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.3 2.0 . . . . 0.0 112.219 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.8 t -134.74 94.86 16.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.058 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.75 152.96 69.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.565 2.177 . . . . 0.0 112.325 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -179.14 -36.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -97.53 45.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.451 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 17.34 79.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.368 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -177.43 165.21 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.509 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.29 129.23 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 -165.57 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.776 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -147.32 86.44 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.013 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.7 mm -79.51 129.29 72.19 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.957 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.63 145.95 33.67 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.664 2.243 . . . . 0.0 112.286 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 pp -158.13 171.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.449 . . . . 0.0 111.042 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.7 m -148.36 161.83 40.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.92 144.86 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -120.47 147.28 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.77 -178.7 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.025 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.61 146.21 34.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.192 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -35.56 80.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.415 ' CA ' ' CD2' ' A' ' 77' ' ' LEU . 0.8 OUTLIER 166.54 -26.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.151 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 79' ' ' THR . 39.6 m-85 -160.62 161.76 24.32 Favored Pre-proline 0 C--N 1.334 -0.086 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.789 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -88.52 -26.22 5.68 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.512 0.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -76.68 60.67 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.3 m120 -41.21 -52.77 7.14 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 54.2 Cg_exo -51.14 146.1 24.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 112.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.23 127.1 14.52 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mt -89.22 151.34 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.011 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 14.4 m -122.9 161.82 23.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CE2' ' CG ' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -162.13 159.64 26.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.679 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.37 137.65 56.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.161 0.505 . . . . 0.0 111.208 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.04 92.79 28.49 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.79 158.26 58.06 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.446 2.097 . . . . 0.0 112.187 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -84.68 176.49 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.25 0.547 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 m -65.37 -25.15 67.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -57.44 -59.03 5.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.057 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -111.25 -179.01 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -115.01 -157.27 0.63 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.519 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.84 121.67 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.159 0.504 . . . . 0.0 110.797 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -81.72 133.69 35.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.8 p -102.45 131.21 49.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.75 -120.31 0.72 Allowed Glycine 0 C--N 1.322 -0.227 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.671 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -99.79 -57.93 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.861 0.363 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -80.79 -41.01 24.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -92.1 75.39 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.087 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -52.98 -178.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.39 -13.98 59.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.815 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.15 23.75 5.48 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 51.01 30.19 22.34 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.705 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.434 ' CG ' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -111.26 115.37 29.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.634 0.254 . . . . 0.0 110.99 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.2 mp -60.94 94.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.015 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.46 75.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mt -84.02 136.0 41.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.804 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.39 -28.31 18.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 0.0 112.246 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -79.61 -54.29 6.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.804 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.99 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.73 -35.82 71.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.1 25.59 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 t90 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.865 0.364 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.62 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.4 tp -66.59 -33.98 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.02 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.48 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -29.49 75.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.2 -31.53 63.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.9 mm -78.98 -29.61 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -26.73 68.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.3 p -76.27 -36.81 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.552 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 37.0 mtt -77.86 -42.63 32.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.1 tt -58.25 -26.5 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 t -91.2 -58.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.0 t -53.55 -50.8 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -71.83 -27.3 62.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.472 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.04 -12.93 69.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.608 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.06 -47.71 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.55 126.95 2.45 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.83 107.6 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.451 2.101 . . . . 0.0 112.808 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -88.64 23.85 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.663 2.242 . . . . 0.0 111.956 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.9 t -121.99 -4.27 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.928 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.739 -179.301 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -60.71 -44.88 96.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -32.59 73.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.95 -25.22 60.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.136 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.44 -24.52 50.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.391 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -22.61 33.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.167 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.9 ptp -89.98 -34.05 16.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -91.31 -1.84 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -69.65 -31.4 69.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.181 0.515 . . . . 0.0 111.105 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -72.35 -26.37 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.16 169.02 0.43 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.994 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -91.87 -38.7 12.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -122.35 68.33 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.1 0.476 . . . . 0.0 110.937 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -34.81 71.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.859 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.52 -46.45 90.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -33.09 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -70.96 -48.18 54.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.25 -27.32 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.362 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -48.4 24.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.68 -42.48 88.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.973 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 m -59.81 -58.97 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.82 -46.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.658 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.1 t-20 -58.46 -22.37 54.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.224 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 t -93.19 -22.52 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.48 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.03 -28.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.148 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -80.42 -42.62 22.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.98 -23.64 62.24 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -116.97 161.61 19.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 80.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.956 0.408 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 174.99 -33.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 mp -62.46 134.77 56.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.796 0.331 . . . . 0.0 110.925 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 106.03 21.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.936 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.5 150.37 11.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.384 2.056 . . . . 0.0 112.594 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 t -151.51 161.85 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.605 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -129.85 116.97 19.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -149.54 132.88 16.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.964 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -84.38 158.04 21.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.43 149.21 49.54 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.163 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.71 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.87 128.86 0.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.087 0.47 . . . . 0.0 110.546 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -86.88 108.14 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.696 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 3.0 mm? -123.2 178.95 4.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.012 0.434 . . . . 0.0 111.061 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.83 145.68 46.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -130.5 153.1 49.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 111.078 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mt -108.87 101.89 10.95 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.857 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.5 m -85.49 132.95 34.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.56 -177.44 42.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.505 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.8 p -143.8 130.33 20.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 pt -115.53 154.35 47.79 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.53 163.07 4.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.616 2.211 . . . . 0.0 112.568 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.4 t -158.24 106.16 1.7 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.684 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.67 92.43 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.335 2.024 . . . . 0.0 112.19 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -132.72 140.34 48.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 mtp85 61.09 18.55 9.12 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 20.45 61.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.566 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.02 176.97 8.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.338 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.24 104.8 16.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.752 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.12 167.33 12.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.744 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -123.48 111.75 16.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.0 mm -108.93 109.5 61.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.92 141.83 49.9 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.361 2.041 . . . . 0.0 112.251 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -147.43 136.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.036 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 118.26 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.699 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.59 149.68 25.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.57 142.99 50.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.832 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.92 167.4 13.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.608 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -149.5 150.91 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.469 0.652 . . . . 0.0 111.065 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.28 -38.4 90.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.3 t 179.57 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -87.47 159.54 49.84 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.46 -45.55 0.45 Allowed 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.588 -1.422 . . . . 0.0 111.977 0.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.92 -59.92 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 166.03 -53.75 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.78 145.14 4.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.733 2.289 . . . . 0.0 112.632 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.94 143.06 22.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.668 2.245 . . . . 0.0 112.427 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.1 160.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.409 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -134.51 141.41 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 9.7 m-85 -147.73 144.33 28.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.08 117.69 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.035 0.445 . . . . 0.0 111.365 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -81.08 121.25 80.44 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.77 137.87 67.81 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.463 2.108 . . . . 0.0 112.219 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -115.2 -167.11 1.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.642 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m -86.98 -56.2 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.81 -29.7 67.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -135.88 -169.47 2.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.4 p -150.0 -80.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 179.69 109.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.66 116.71 28.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.8 p -53.25 131.82 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.53 -96.46 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -60.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 111.032 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.457 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 22.5 m-70 -127.47 48.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.31 -17.88 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 108' ' ' LYS . 7.9 p-10 40.56 -158.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.335 0.254 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 5.27 48.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -131.26 28.62 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 51.07 25.36 10.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.013 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.452 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -85.96 136.6 33.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 1.4 mp -68.99 88.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 110.523 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.09 62.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.847 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.457 ' CD2' ' CD2' ' A' ' 102' ' ' HIS . 9.8 mt -95.23 109.25 43.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.83 -29.44 82.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.457 2.105 . . . . 0.0 112.131 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -54.08 50.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.41 -33.34 72.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.48 -44.44 89.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.602 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.87 24.53 6.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.8 t90 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.944 179.923 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.882 0.372 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.37 -164.25 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.76 -28.12 14.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.97 -55.0 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.07 -35.99 92.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.345 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.7 tp -55.72 -31.7 62.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.7 mm -79.7 -21.74 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.809 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -33.67 28.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 131' ' ' MET . 11.3 p -72.75 -47.37 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.424 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.6 mtm -66.8 -42.82 85.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.14 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.0 tt -53.84 -30.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.0 t -85.81 -51.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.464 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 135' ' ' PHE . 1.2 p -54.76 -51.14 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.865 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 134' ' ' VAL . 2.1 p90 -87.31 -9.15 55.69 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.38 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.82 -24.67 75.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.77 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.18 -30.69 15.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.541 0.21 . . . . 0.0 110.601 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -162.84 118.99 1.21 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.93 110.93 1.08 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.537 2.158 . . . . 0.0 112.155 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.06 -15.97 7.66 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.418 2.079 . . . . 0.0 112.561 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.1 t -57.04 -19.34 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -36.87 71.22 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.531 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -24.99 38.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.12 -50.92 71.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.01 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.91 -31.68 68.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.114 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -65.26 -28.06 69.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -31.2 35.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 111.063 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -103.15 20.22 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.735 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.8 -29.65 45.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.8 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -99.06 -18.89 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.428 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -55.58 146.11 21.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -56.09 -24.73 42.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -140.32 128.44 22.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.699 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.5 ttp85 -101.09 -64.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -50.59 63.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.43 -50.79 68.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.222 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.1 m -62.25 -34.5 76.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.67 -23.47 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.378 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -30.36 21.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 0.0 111.001 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -31.44 64.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.421 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 2.2 t -69.65 -47.43 63.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.498 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 25' ' ' THR . 1.4 t -61.13 -55.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -40.27 11.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.74 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 t -76.47 -63.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 pt -51.9 -34.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.306 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -73.17 -29.09 62.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.08 -33.56 59.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.011 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' CE1' ' CG2' ' A' ' 59' ' ' ILE . 4.2 m-85 -93.73 -0.27 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.794 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.85 37.15 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.224 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -169.34 47.88 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.9 151.1 38.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.25 96.08 25.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.06 129.05 17.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.435 2.09 . . . . 0.0 111.992 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 t -125.27 162.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.287 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -128.36 98.93 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.731 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.67 126.97 48.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -84.62 128.45 34.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -97.16 104.22 16.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.602 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.234 0.281 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.289 179.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.058 0.456 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -96.67 118.52 33.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -64.67 106.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.71 131.99 56.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.154 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.1 tmm? -92.91 147.39 22.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -141.71 159.61 41.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.937 0.399 . . . . 0.0 111.082 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 mt -126.7 103.92 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.713 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -101.34 140.67 35.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.4 169.18 37.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -116.28 144.48 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 110.935 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.464 ' CG2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.43 139.9 21.56 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.9 60.52 5.38 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.535 2.157 . . . . 0.0 112.21 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.7 t -90.56 133.39 32.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.443 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.9 143.56 33.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.144 1.896 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -83.46 -77.01 0.26 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -110.82 -61.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.92 14.15 3.1 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.449 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -175.27 3.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.81 143.2 27.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.7 174.37 10.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -128.66 103.02 6.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.72 102.68 10.78 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.98 154.4 70.85 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.313 2.009 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 pt -155.78 156.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.238 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 130.19 53.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.42 137.84 43.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.79 145.95 50.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.686 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.49 165.26 18.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.64 165.55 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.98 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -27.79 15.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -173.35 -40.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -102.01 161.93 21.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.22 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.757 -0.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -105.45 -58.04 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 165.57 -53.93 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.967 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -42.91 119.14 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.803 2.335 . . . . 0.0 112.807 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.0 164.46 10.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.598 2.199 . . . . 0.0 112.301 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.8 mm -104.02 159.54 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.31 157.11 47.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.083 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG ' ' A' ' 108' ' ' LYS . 37.1 m-85 -146.62 170.24 17.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 m -124.76 77.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.732 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -49.01 105.13 0.47 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.52 -178.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.24 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.29 179.41 8.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.253 0.549 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 p -88.11 6.92 34.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.5 m -95.22 -58.87 2.02 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -178.57 3.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.2 t -109.87 -163.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.87 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 110.998 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.28 147.47 23.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.48 136.18 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.973 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.4 -166.24 36.04 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.788 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -26.29 48.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.152 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.455 ' CE1' ' CG2' ' A' ' 109' ' ' ILE . 2.4 t-80 -94.27 -28.17 15.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.083 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -134.34 68.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.058 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 103' ' ' VAL . 1.2 p-10 -47.56 -105.82 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.104 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.45 -54.42 2.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.703 0.287 . . . . 0.0 111.479 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -95.71 38.64 1.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.584 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.14 53.76 29.39 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.533 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.458 ' CG ' ' CE2' ' A' ' 88' ' ' PHE . 3.1 mtmm -102.78 133.72 47.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.455 ' CG2' ' CE1' ' A' ' 102' ' ' HIS . 5.3 mp -87.46 106.01 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.97 48.34 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.19 121.98 84.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.63 -19.15 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.53 2.153 . . . . 0.0 112.606 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -56.33 -54.33 46.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.0 111.082 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -30.86 71.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.012 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.57 -41.47 84.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.18 27.39 7.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.073 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.12 -172.38 2.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -57.44 -34.26 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.36 -53.38 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.806 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.42 -38.55 95.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.1 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.3 tp -54.21 -28.76 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mm -84.33 -29.01 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.802 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -40.51 95.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 131' ' ' MET . 2.1 p -59.92 -42.93 91.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.414 . . . . 0.0 110.496 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.412 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 10.4 mtt -65.98 -34.4 78.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.315 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mt -60.08 -30.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.514 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.03 -52.81 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 44.2 t -52.1 -49.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -80.38 -27.2 38.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.94 -24.86 68.84 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.512 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.96 -44.45 12.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.991 0.424 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -177.08 123.64 0.28 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.81 144.09 56.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.361 2.041 . . . . 0.0 112.35 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.75 -39.66 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.607 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 m -63.24 117.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.969 -179.881 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 121.352 0.596 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -51.96 51.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.785 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -59.19 -41.59 88.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.197 0.522 . . . . 0.0 111.312 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.01 -28.49 68.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -58.79 -48.43 81.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.966 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -61.85 -35.96 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.75 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mtp -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.0 m -108.3 19.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.705 0.288 . . . . 0.0 111.561 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.3 p -71.89 -29.14 64.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -74.12 -29.08 61.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.045 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.423 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 4.6 m-85 -58.59 127.58 32.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -31.51 69.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.092 0.473 . . . . 0.0 111.307 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . 5.1 m-85 -90.44 -55.18 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 66.67 -68.35 0.14 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.6 t0 -58.67 -53.16 61.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.102 0.477 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.32 -30.79 68.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.756 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.41 ' CG2' ' CD2' ' A' ' 76' ' ' LEU . 7.1 m -74.96 -53.03 9.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.011 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.5 -36.15 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.304 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -62.8 -52.25 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -63.05 -35.53 80.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 m -70.1 -35.66 74.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -81.56 -47.12 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.425 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.5 m-80 -53.23 -30.28 37.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.588 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.5 t -84.5 -61.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 pt -53.56 -38.98 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.557 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 t -68.55 -36.96 79.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 mp -77.54 -52.7 8.63 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.368 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 34' ' ' ASP . 20.4 m-85 -76.45 -17.93 59.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.034 0.445 . . . . 0.0 111.815 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 65.92 -61.57 0.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.318 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 32' ' ' TYR . 1.9 p30 -53.73 -37.03 62.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.849 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.05 129.07 38.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.778 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.72 145.28 52.87 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.18 155.45 22.48 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.673 2.249 . . . . 0.0 112.738 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 t -147.74 161.63 7.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.928 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -134.13 102.21 5.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.218 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -117.76 128.61 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.343 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -77.53 145.91 36.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.66 104.25 3.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 -179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.506 0.193 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -91.07 126.82 36.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.223 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -88.84 91.08 8.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 110.567 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.01 153.94 21.16 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.211 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.4 mtp -105.36 145.74 30.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.392 . . . . 0.0 110.574 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -136.61 132.78 35.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.1 mt -101.49 116.13 32.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -117.68 143.79 45.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.802 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.71 164.09 31.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.444 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.5 p -113.97 140.0 48.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.859 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -121.48 156.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.356 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.44 136.73 60.82 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.839 2.359 . . . . 0.0 112.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -152.67 95.67 3.04 Favored Pre-proline 0 C--O 1.223 -0.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.002 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.59 130.43 29.9 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.067 1.845 . . . . 0.0 112.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -127.95 -74.78 0.57 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.07 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -96.5 38.77 1.19 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 -23.3 35.81 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.512 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -112.64 164.89 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 110.786 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -72.88 135.49 45.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.59 -169.01 1.46 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -138.18 94.64 2.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.987 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.0 mm -92.39 106.64 18.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.66 156.93 56.78 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.001 1.801 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.3 pt -158.18 178.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -146.0 160.21 42.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.72 162.44 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.774 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.86 145.69 52.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.41 ' CD2' ' CG2' ' A' ' 21' ' ' THR . 1.4 tp -136.84 160.88 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.11 167.37 16.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.342 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.1 m-20 -93.84 -40.76 10.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.2 p -159.88 -48.49 0.05 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.748 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.95 168.12 9.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.777 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -91.47 -33.5 0.99 Allowed 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.925 -1.281 . . . . 0.0 113.699 0.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 73.1 m-85 -82.36 -71.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.488 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 7.1 t30 129.79 -48.71 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 123.788 0.68 . . . . 0.0 111.069 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 60.5 Cg_endo -75.51 133.58 16.01 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.173 1.915 . . . . 0.0 112.334 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 138.75 41.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.725 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -99.75 159.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.501 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.3 m -126.36 141.72 51.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.935 0.398 . . . . 0.0 111.281 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.437 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 10.4 m-85 -142.33 -177.25 5.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.551 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -119.77 171.71 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 111.129 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -138.69 99.98 8.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 164.95 31.97 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.525 2.15 . . . . 0.0 112.162 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.79 177.11 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 0.0 110.996 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.4 t -83.75 -31.21 26.1 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -29.55 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.758 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -113.44 -178.47 3.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 5.5 t -125.1 -166.43 1.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.675 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.441 ' N ' ' OG1' ' A' ' 96' ' ' THR . 4.2 tt -115.39 120.85 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -76.16 127.38 32.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.014 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.2 p -98.69 129.86 45.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.63 -123.49 0.73 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.617 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -51.22 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.926 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -70.79 -46.3 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.284 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.04 77.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.107 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -50.58 175.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.361 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.35 -26.38 63.07 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.406 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -94.25 20.94 7.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.246 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.96 43.76 49.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.763 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.437 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 19.1 mtmt -106.12 124.79 50.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.738 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.407 ' CD1' ' CE ' ' A' ' 131' ' ' MET . 59.7 mt -66.02 110.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 111.081 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -123.96 94.34 4.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 mt -107.77 133.68 20.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.166 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.51 -32.48 96.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.38 2.053 . . . . 0.0 112.038 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.32 -52.39 64.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.68 -32.66 71.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.57 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -61.29 -43.78 98.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.547 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -98.41 25.7 6.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.6 t90 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.875 0.369 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.72 162.7 32.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -37.92 48.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mp -57.37 -51.75 68.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.753 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.09 -29.61 73.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.0 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 tp -56.98 -30.79 64.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.615 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mm -82.9 -26.7 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -64.82 -45.96 84.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 131' ' ' MET . 4.2 p -47.45 -45.63 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.443 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.3 mtt -62.97 -42.9 99.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.09 -27.12 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 111.032 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 t -94.21 -52.93 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.58 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.47 -36.46 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.495 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -81.53 -28.78 33.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.653 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.32 -11.75 62.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.637 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -45.82 7.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.678 0.239 . . . . 0.0 111.055 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.96 109.03 2.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.43 116.47 3.24 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.516 2.144 . . . . 0.0 112.199 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.83 44.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.091 2.527 . . . . 0.0 112.244 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.1 t -124.95 -7.19 6.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.862 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.345 0 O-C-N 122.277 -0.264 . . . . 0.0 111.129 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -36.3 83.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.41 . . . . 0.0 110.529 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.7 -30.82 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.696 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.89 -31.07 62.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -72.04 -46.76 55.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -31.27 67.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.7 ttm -63.49 -48.75 76.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.726 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.53 19.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.66 -42.96 39.96 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -70.78 -25.28 62.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.652 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.78 121.69 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.305 0.378 . . . . 0.0 111.149 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 tptt -60.13 -36.68 78.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.4 44.55 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -51.04 -52.42 43.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 111.018 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -54.04 -32.22 53.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.75 -29.03 18.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -78.05 -47.0 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.78 -38.16 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -45.67 53.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -62.5 -39.39 93.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.8 m -63.31 -59.15 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.39 -47.43 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.487 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.427 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 4.1 t-20 -57.58 -26.2 61.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.5 t -85.96 -27.86 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.377 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.19 -29.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.88 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.7 m -69.7 -46.45 65.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.505 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -40.81 67.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.953 0.406 . . . . 0.0 110.725 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -103.36 116.31 32.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.826 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 31.02 3.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.02 23.12 5.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.07 165.88 12.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.84 121.93 9.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 127.96 16.3 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.393 2.062 . . . . 0.0 112.428 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.6 t -123.76 162.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.771 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -146.84 110.06 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.56 141.36 52.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.37 116.39 28.94 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.381 0.425 . . . . 0.0 111.18 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -91.4 135.17 34.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.656 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.155 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.797 0.332 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.62 150.3 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.454 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -83.82 111.08 18.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.881 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.74 116.21 23.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.151 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -81.97 147.56 29.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -148.11 143.87 27.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 mt -108.75 116.51 32.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.75 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.6 m -116.38 145.53 43.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.61 175.83 32.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -100.31 147.24 26.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.1 mt -107.34 114.52 60.86 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.046 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.43 70.1 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.301 2.0 . . . . 0.0 112.1 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 m -89.96 144.68 31.8 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.454 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.34 153.89 76.12 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.188 1.925 . . . . 0.0 112.345 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -154.49 105.69 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 60.43 29.1 18.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.989 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.05 3.52 67.77 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.784 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -120.75 178.35 4.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.692 0.246 . . . . 0.0 110.87 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.54 131.57 44.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.726 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.21 163.08 22.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.829 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -121.74 123.5 41.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.7 mm -123.07 103.22 36.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.93 133.16 24.58 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.092 1.862 . . . . 0.0 112.305 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.95 167.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -131.0 134.62 46.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.45 137.85 44.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.979 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.52 144.44 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.777 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -138.51 160.06 40.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.68 163.83 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -43.41 23.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 80' ' ' TYR . 4.4 t 179.97 33.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 79' ' ' THR . 1.8 m-85 -153.91 151.31 24.53 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.649 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.7 -44.0 0.58 Allowed 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.173 -1.595 . . . . 0.0 112.357 0.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.409 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 72.2 m-85 -103.92 -60.81 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.557 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.428 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 5.8 t-20 162.88 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.58 0.55 . . . . 0.0 110.833 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 81.5 Cg_exo -45.34 108.65 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.497 2.132 . . . . 0.0 112.607 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.57 145.08 30.77 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.498 2.132 . . . . 0.0 112.211 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.5 mt -91.51 160.02 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.8 p -143.5 137.66 28.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 0.0 110.886 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -140.97 143.4 34.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.22 146.14 7.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.066 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.08 72.29 76.54 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.34 170.82 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.588 2.192 . . . . 0.0 112.312 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.22 176.99 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -72.77 -27.13 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -5.8 50.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.7 mtm -145.81 -174.79 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.65 0.262 . . . . 0.0 110.983 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.4 t -134.18 -164.68 1.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.266 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.445 ' CD1' ' CA ' ' A' ' 107' ' ' GLY . 11.3 tt -111.3 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -75.29 114.31 13.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 p -72.64 134.98 45.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.34 -118.66 1.26 Allowed Glycine 0 CA--C 1.515 0.083 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.672 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -31.69 11.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -118.26 -29.69 5.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.8 t -57.23 -27.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.566 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 56.55 -152.94 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.679 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 -40.9 5.97 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -93.46 3.66 55.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' CA ' ' CD1' ' A' ' 97' ' ' ILE . . . 91.5 4.85 67.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.134 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -60.18 108.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.768 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.65 66.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.205 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.409 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -92.38 57.57 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 110.856 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 mt -53.19 151.71 9.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.417 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.58 -45.83 31.24 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.573 2.182 . . . . 0.0 111.987 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -66.54 -39.58 88.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.99 -52.32 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.453 ' CD2' ' N ' ' A' ' 116' ' ' GLU . 2.8 p-80 -64.87 -35.86 82.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.669 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.453 ' N ' ' CD2' ' A' ' 115' ' ' HIS . 1.4 tt0 -95.95 26.0 4.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.5 t90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.067 0.461 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -177.85 146.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -46.48 88.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.6 tp -51.81 -46.13 64.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.91 -31.34 35.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.632 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.13 -31.78 63.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp -86.73 -28.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.56 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.93 -38.65 82.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 131' ' ' MET . 1.9 p -61.65 -42.65 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.518 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.42 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 52.8 mtt -65.37 -42.73 92.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.05 -26.77 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.644 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 t -95.03 -54.89 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.668 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.3 -37.08 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.727 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -83.22 -28.08 29.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.403 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.21 -13.02 61.64 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.716 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -99.85 -45.24 5.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 0.217 . . . . 0.0 111.195 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.3 100.63 4.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.91 119.73 7.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.386 2.057 . . . . 0.0 112.166 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.62 -0.64 10.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.449 2.1 . . . . 0.0 112.847 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.6 t -93.21 -2.71 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.525 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 111.459 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.907 0.384 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -54.19 -38.24 65.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.77 -45.83 73.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -59.32 -33.06 70.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.142 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.5 -50.95 71.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -32.7 73.94 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.488 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmm -70.14 -36.92 75.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.51 16.76 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.174 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -69.97 -35.67 74.63 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 111.129 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -29.08 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.644 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 4.2 m-30 -57.12 117.84 4.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -44.02 90.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CE1' ' OG1' ' A' ' 21' ' ' THR . 0.7 OUTLIER -95.55 33.93 1.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -49.18 -31.0 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.959 0.409 . . . . 0.0 109.996 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.65 -43.56 93.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.181 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -80.81 -25.45 37.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 0.0 110.144 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.456 ' OG1' ' CE1' ' A' ' 17' ' ' TYR . 18.7 m -74.15 -54.81 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.596 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.15 -30.0 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.054 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -44.67 18.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.076 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.17 -40.11 71.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.8 m -61.44 -47.86 83.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.481 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -60.87 -47.08 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.422 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 4.7 t-20 -57.53 -25.65 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.08 -58.26 7.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.212 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -19.48 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.454 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.65 -42.61 95.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.833 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.456 ' CD1' ' CD2' ' A' ' 32' ' ' TYR . 1.2 pp -88.04 -43.15 11.92 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 10.6 m-85 -107.93 109.16 20.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -89.71 64.8 6.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.423 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -145.65 -45.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.79 140.03 58.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 106.09 37.9 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.87 128.46 17.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.234 1.956 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -130.24 161.94 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.89 91.63 3.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.48 117.57 34.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 p -82.04 138.52 34.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -115.35 136.34 53.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.927 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.428 0.156 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.06 160.32 15.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.805 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -94.95 99.23 11.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.436 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.2 mm? -104.43 139.07 39.9 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.7 ttp -89.87 146.12 24.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.832 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -139.29 130.94 27.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.4 92.3 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -95.3 135.25 37.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.68 -148.37 7.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.02 128.59 7.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 pt -107.09 151.13 40.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.53 132.73 27.94 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.432 2.088 . . . . 0.0 112.197 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.92 106.29 7.44 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.201 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.11 120.65 7.51 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.66 2.24 . . . . 0.0 112.208 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -131.28 113.21 13.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.979 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 66.4 11.34 7.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.52 -7.74 34.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.272 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.38 -177.44 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.131 0.466 . . . . 0.0 110.912 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.61 111.12 21.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.392 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -110.48 141.97 42.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -99.22 109.36 22.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.3 mm -97.77 100.3 8.2 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.051 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.41 146.68 63.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.282 1.988 . . . . 0.0 112.419 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 pt -157.2 156.39 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.5 m -116.16 145.7 42.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.58 91.2 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.999 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.29 144.73 56.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.19 173.44 6.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.705 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -139.44 -177.61 5.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' A' ' 79' ' ' THR . 2.4 p30 -107.91 -35.73 6.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.076 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 2.2 m 178.98 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.579 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.69 165.11 14.31 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.507 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.45 -39.75 1.38 Allowed 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.465 -0.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -103.01 -63.84 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.406 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 11.3 t-20 165.13 -51.36 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 33.3 Cg_endo -67.69 153.01 77.18 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.204 1.936 . . . . 0.0 112.508 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 162.83 40.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.609 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.12 105.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 58.6 m -62.49 149.41 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.39 148.38 26.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.639 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.0 m -103.33 127.35 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -107.01 87.4 2.95 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.089 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.41 -167.83 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.611 2.207 . . . . 0.0 112.296 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -131.8 177.13 7.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -28.66 69.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -30.94 15.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.75 137.02 32.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.754 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.21 -166.97 1.69 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 97' ' ' ILE . 1.3 tt -136.96 61.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 111.149 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.68 133.13 3.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.818 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.0 p -98.31 132.68 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.76 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.4 -118.76 1.74 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.582 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -100.05 -33.21 10.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -117.05 -38.69 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 t -55.09 -24.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.246 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.02 -155.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.177 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.16 -26.36 12.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.062 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.4 -2.06 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.697 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.27 39.12 52.84 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.613 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -88.58 2.69 52.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 111.559 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.0 mp 45.7 73.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.839 0.352 . . . . 0.0 111.691 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -85.74 55.53 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 mt -58.01 110.09 2.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.13 -36.17 54.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.396 2.064 . . . . 0.0 112.308 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -60.09 -53.32 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.09 -34.04 77.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.82 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.98 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.777 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 23.84 8.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.008 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.469 ' CE2' ' CB ' ' A' ' 122' ' ' SER . 2.8 t90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.752 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.469 ' CB ' ' CE2' ' A' ' 117' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.928 0.394 . . . . 0.0 110.869 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -117.76 -179.51 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.92 -36.65 77.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.853 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.0 mp -63.35 -46.52 86.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.52 -26.81 53.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.339 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.35 -29.99 59.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 0.0 110.747 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.94 -32.58 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -58.59 -35.01 71.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 131' ' ' MET . 5.0 p -56.03 -46.18 80.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.45 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 6.0 mtt -66.77 -40.1 88.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.986 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.24 -23.55 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.899 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.09 -56.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.68 -38.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 140' ' ' PRO . 5.1 m-85 -85.81 -28.64 24.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.502 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.83 -24.49 66.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.44 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.69 -39.38 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.655 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.98 128.18 0.52 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.43 134.21 59.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 112.147 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.41 ' CG ' ' CE2' ' A' ' 135' ' ' PHE . 82.6 Cg_endo -79.8 -1.4 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.44 2.094 . . . . 0.0 112.49 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.3 m -105.72 118.29 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 110.599 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.2 t80 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.992 -179.818 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -38.49 76.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.197 0.522 . . . . 0.0 110.75 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -42.24 47.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.372 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 tp -59.08 -40.51 85.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.05 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -55.46 -62.44 1.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.38 58.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.999 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -45.97 63.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.77 17.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.454 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.2 t -72.69 -28.76 62.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.054 0.454 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -26.93 68.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -51.97 130.91 30.74 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -56.41 -64.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 19' ' ' ASP . 40.7 m-85 -60.15 -58.48 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.675 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 66.84 -68.43 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.828 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' TYR . 2.6 m-20 -50.23 -47.15 55.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 mt -71.0 -36.4 72.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 m -70.13 -34.73 73.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.071 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.8 t -87.57 -28.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.396 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -80.11 -45.44 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -63.49 -37.76 88.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.7 m -64.56 -59.14 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.92 -47.65 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.5 m-20 -59.04 -27.64 65.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.35 -25.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.407 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -28.64 6.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.077 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -70.0 -43.61 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.021 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 tp -77.07 -31.61 56.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -114.37 116.17 28.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -9.24 58.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.579 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -97.3 25.0 5.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.605 0.24 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.98 141.56 48.32 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.99 126.26 12.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.43 155.34 63.94 Favored 'Trans proline' 0 C--O 1.222 -0.316 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 t -151.09 162.68 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -136.49 119.87 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.94 162.02 30.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.505 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.2 t -103.66 135.8 44.55 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.168 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -108.76 111.13 22.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.987 -179.743 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.36 144.85 18.7 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.794 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 112.03 6.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.736 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -117.92 128.91 55.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.878 0.371 . . . . 0.0 111.05 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.9 ttp -96.38 150.32 20.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.23 149.27 34.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.0 mt -113.56 112.26 23.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.9 m -109.0 134.86 51.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.729 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.2 -156.25 9.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.489 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.23 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.8 136.51 29.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.29 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.76 80.36 3.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.827 2.351 . . . . 0.0 112.558 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.62 148.2 34.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 128.29 16.01 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.451 2.101 . . . . 0.0 112.432 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.5 108.46 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 80.18 -10.96 1.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.78 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.16 -17.02 3.4 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.12 172.93 7.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -65.64 150.04 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 148.89 29.4 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.732 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.76 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.819 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.0 mm -108.27 104.91 55.43 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.053 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.58 140.3 51.51 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.303 2.002 . . . . 0.0 112.505 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 pt -148.86 173.46 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 11.0 m -132.54 170.59 14.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.19 145.03 38.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.3 145.72 48.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 111.195 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 2.7 mm? -127.28 171.3 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.72 162.55 31.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.249 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.96 -30.9 10.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.13 -41.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -127.9 106.59 20.31 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.181 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.85 167.85 33.23 Favored 'Cis proline' 0 C--N 1.351 0.691 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.12 -0.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 25.99 9.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.3 OUTLIER 175.15 -61.31 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 83' ' ' ASN . 17.0 Cg_endo -61.18 109.83 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.6 2.2 . . . . 0.0 112.458 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.54 143.26 13.48 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.618 2.212 . . . . 0.0 112.701 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mt -84.65 161.39 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.7 m -141.59 155.42 45.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -157.89 143.38 16.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.457 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.06 -175.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.547 . . . . 0.0 111.266 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 5.6 tttm -158.42 51.86 0.49 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 56.1 Cg_endo -69.35 -167.16 0.2 Allowed 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.1 p -124.0 151.28 43.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -17.14 62.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.809 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -93.58 -15.09 25.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.869 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.441 ' O ' ' CG2' ' A' ' 96' ' ' THR . 3.6 tmm? -118.57 -8.56 10.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 95' ' ' MET . 13.8 t 46.98 -163.45 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.065 0.46 . . . . 0.0 111.306 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tt -135.54 132.69 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.26 133.11 41.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.689 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.5 p -85.58 131.4 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.966 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.5 -152.98 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -56.8 4.51 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.807 0.337 . . . . 0.0 110.648 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -85.66 -34.28 21.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.0 t -95.86 72.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.128 0.489 . . . . 0.0 111.047 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -176.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.27 -23.88 67.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.439 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.39 27.06 9.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.97 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 40.87 55.3 3.38 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.967 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 2.6 tttp -81.82 11.48 4.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.851 -0.205 . . . . 0.0 111.51 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 108' ' ' LYS . 0.6 OUTLIER 44.96 45.66 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -68.18 72.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.679 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.77 158.83 47.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.48 -36.03 4.29 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.623 2.216 . . . . 0.0 112.43 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -65.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -29.6 61.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.699 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.82 -43.15 89.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -96.81 24.08 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.977 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.426 ' NE1' ' CB ' ' A' ' 122' ' ' SER . 6.2 t90 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.426 ' CB ' ' NE1' ' A' ' 117' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.024 0.44 . . . . 0.0 111.374 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -139.4 175.22 9.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.543 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.01 -38.55 73.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mp -57.8 -47.17 83.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.619 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.48 -24.83 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.2 -30.54 64.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 110.741 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.74 -30.8 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.61 97.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 131' ' ' MET . 2.7 p -58.09 -43.04 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.428 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 0.1 OUTLIER -63.59 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.368 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -27.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.616 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.08 -51.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.677 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.54 -41.91 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.639 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -81.26 -27.91 34.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.455 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.9 -23.34 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.46 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -30.76 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.039 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -146.27 83.86 8.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.27 152.44 61.35 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.78 2.32 . . . . 0.0 112.101 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.3 -31.79 13.71 Favored 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.278 1.985 . . . . 0.0 112.154 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 142' ' ' PHE . 84.0 t -59.45 162.35 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.01 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.414 ' N ' ' CG1' ' A' ' 141' ' ' VAL . 11.1 t80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.654 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.606 0.241 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -60.13 -37.79 81.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -71.14 -31.9 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -46.39 86.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.972 0.415 . . . . 0.0 111.029 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.06 -51.02 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.841 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -61.33 -30.88 70.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.3 mtp -67.74 -30.74 70.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.39 20.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.0 p -67.98 -24.59 65.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -58.08 -44.8 87.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -61.75 175.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.49 -31.05 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -62.99 -69.72 0.25 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 66.68 -69.43 0.12 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -44.72 95.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.051 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.3 mt -68.0 -36.46 80.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.995 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.5 m -62.89 -31.32 72.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.1 t -90.56 -27.14 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -45.23 19.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -67.68 -43.71 79.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.858 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.8 t -58.43 -48.02 82.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.18 0.514 . . . . 0.0 110.793 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG2' ' A' ' 25' ' ' THR . 0.4 OUTLIER -60.4 -47.08 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.422 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -51.78 -29.96 21.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.338 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.04 -63.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pt -56.68 -25.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.339 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.7 m -80.29 -31.08 38.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.75 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mt -86.54 -20.11 28.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -126.91 136.56 52.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.35 27.11 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 111.191 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.47 8.68 3.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.348 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.11 130.41 56.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.532 0.206 . . . . 0.0 110.717 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -129.81 146.13 60.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.97 146.63 32.99 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.967 2.445 . . . . 0.0 112.706 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -135.54 162.2 37.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.717 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -132.16 123.8 27.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -139.21 129.64 25.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 p -91.3 148.2 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.63 147.48 48.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.982 0.42 . . . . 0.0 110.652 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 111.155 179.722 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.28 153.38 47.04 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.93 95.01 7.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.83 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tp -96.67 161.32 13.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.817 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.2 ttp -121.11 158.22 28.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -154.17 150.71 28.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mt -123.51 134.6 53.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -121.05 156.76 31.51 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.153 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.25 173.28 33.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.487 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.6 p -133.8 128.0 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -86.75 111.45 40.03 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.399 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.52 96.88 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.662 2.241 . . . . 0.0 112.409 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.45 141.36 27.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.275 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.26 157.34 50.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.294 1.996 . . . . 0.0 112.37 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -157.56 110.07 2.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 58.87 28.22 17.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.227 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.55 5.75 66.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.9 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -116.08 -168.45 1.43 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 110.618 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.02 123.78 50.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 7.6 t80 -121.51 162.75 19.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.711 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -140.18 123.86 17.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.439 ' CD1' ' CE2' ' A' ' 68' ' ' TYR . 5.2 mm -101.94 100.86 15.98 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.03 109.55 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.163 1.909 . . . . 0.0 112.105 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 pp -123.35 143.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -107.17 167.87 9.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.29 137.98 47.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.406 ' CD1' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -114.63 145.95 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.17 158.12 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.07 174.67 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -97.38 39.95 1.17 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.592 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 72.24 10.61 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.97 158.77 58.37 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.775 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.57 -44.28 0.55 Allowed 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.193 -1.586 . . . . 0.0 112.158 0.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.524 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 47.2 m-85 -78.78 -71.52 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 23.0 p30 146.13 -30.91 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.639 0.776 . . . . 0.0 112.185 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 48.0 Cg_exo -57.24 135.47 70.54 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.912 1.741 . . . . 0.0 112.243 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.96 133.76 18.73 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.402 2.068 . . . . 0.0 112.358 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.24 147.68 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.7 t -139.98 131.28 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' CE2' ' CD1' ' A' ' 75' ' ' TRP . 20.7 m-30 -116.5 -176.19 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.16 87.17 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 109.47 1.73 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.54 -167.97 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.251 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.5 p -149.05 173.85 12.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.089 0.471 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -67.37 -24.6 65.71 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.035 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -47.63 80.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.184 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -167.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.063 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -126.93 -146.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.588 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -123.62 123.01 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.875 0.369 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -85.12 162.29 19.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.768 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 p -141.1 132.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.39 -86.5 0.13 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.942 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -71.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -162.95 63.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.25 0.548 . . . . 0.0 111.021 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.57 -7.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.708 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.82 -153.86 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.16 -29.51 10.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.463 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -104.95 27.21 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.76 45.35 52.92 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.704 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.38 142.19 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.743 -0.269 . . . . 0.0 110.954 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.84 98.45 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -99.63 40.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.63 139.07 68.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.974 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.17 -25.01 10.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.49 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -48.69 76.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.96 -31.66 59.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.794 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.7 -35.8 79.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.79 20.02 12.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.5 t90 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 110.799 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.794 0.331 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -136.31 178.29 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.1 mt -84.05 -19.47 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mp -67.11 -43.09 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.41 -36.91 8.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 tp -54.93 -27.97 47.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.26 -31.04 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.4 -33.15 65.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.647 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 131' ' ' MET . 4.2 p -57.54 -45.53 86.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.446 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 31.2 mtt -67.94 -38.46 82.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.072 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -55.12 -25.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.4 t -95.07 -53.1 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.676 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.99 -44.54 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -83.3 -23.16 32.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.268 0.556 . . . . 0.0 110.987 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.12 -28.61 73.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.359 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.96 -38.76 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -176.58 113.09 0.25 Allowed Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.895 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.08 136.5 67.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.194 1.929 . . . . 0.0 112.135 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.75 -21.71 5.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.63 2.22 . . . . 0.0 112.345 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.653 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 6.4 t -50.52 171.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.653 ' CB ' ' O ' ' A' ' 141' ' ' VAL . 4.5 t80 . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.032 0.444 . . . . 0.0 110.375 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.834 0.35 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -60.04 -46.94 87.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 0.0 110.815 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.26 -42.54 99.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.239 0.542 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.23 -51.09 60.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.145 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -58.86 -24.24 61.89 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.192 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -21.42 42.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.016 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.0 mtt -73.93 -43.37 58.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 m -91.99 0.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.701 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -60.14 -31.95 70.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -26.17 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.977 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 10.9 m-85 -56.75 156.35 6.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -85.53 -54.54 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 23.2 m-30 -90.25 69.03 7.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -56.44 11.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.226 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.53 -58.67 7.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 111.048 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.58 -26.45 43.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.352 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.6 m -86.0 -55.09 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.243 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.65 -33.54 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.324 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.37 -47.49 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.702 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -67.33 -29.66 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.1 m -78.37 -30.8 48.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -84.16 -46.65 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.218 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.404 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 7.6 t-20 -52.32 -36.52 53.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.378 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.8 t -74.83 -62.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.192 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -57.5 -43.42 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.8 m -58.99 -42.71 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tt -73.8 -41.66 62.04 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 121.173 0.511 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -104.95 104.91 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.781 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.1 61.86 6.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -142.78 -44.34 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.801 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.61 168.13 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.828 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 143.23 18.91 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.63 134.46 26.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.639 2.226 . . . . 0.0 112.18 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.5 t -127.16 162.45 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.01 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -138.2 128.14 25.5 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -153.4 129.16 10.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.324 0.583 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -74.05 157.6 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.07 103.74 3.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.587 0.232 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -167.43 135.47 2.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.77 111.69 18.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.29 138.23 46.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.315 0.579 . . . . 0.0 110.555 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -85.45 142.37 29.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -135.28 148.71 49.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.039 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.32 120.82 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 m -115.95 158.91 22.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.1 -179.35 28.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.342 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.4 p -124.32 152.8 42.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.935 0.397 . . . . 0.0 111.007 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mt -123.47 137.02 27.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.072 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.75 104.1 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.22 1.947 . . . . 0.0 112.0 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.1 121.65 17.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.94 146.78 55.48 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.368 2.046 . . . . 0.0 112.29 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -106.01 -75.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.087 0.47 . . . . 0.0 110.897 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 26.0 2.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.05 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.28 3.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.79 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -123.1 174.02 7.5 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -91.8 123.67 35.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -120.35 161.77 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -112.34 99.97 8.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.63 110.21 20.93 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.21 145.08 43.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.262 1.975 . . . . 0.0 112.298 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 pt -155.69 153.06 7.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.9 m -113.52 169.18 9.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.624 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 146.81 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.2 155.92 49.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.07 174.58 8.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.099 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -96.31 39.55 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.418 ' OG1' ' CE2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER 76.63 6.85 3.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -152.94 150.81 25.07 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.927 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.77 -37.74 1.36 Allowed 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.409 0.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.603 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 88.3 m-85 -60.9 -80.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.603 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 8.7 t-20 135.89 -51.89 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 123.395 0.678 . . . . 0.0 111.052 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 67.9 Cg_endo -75.59 128.54 11.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.395 2.063 . . . . 0.0 112.34 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 135.94 71.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.456 2.104 . . . . 0.0 112.529 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.73 160.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.729 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.09 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 111.296 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.454 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 6.5 m-85 -130.83 143.33 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.1 p -97.67 138.72 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.956 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -130.36 68.94 81.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.53 -178.68 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.471 2.114 . . . . 0.0 112.256 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -82.81 165.41 19.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -86.28 -13.71 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.461 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -95.07 -27.92 15.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 0.0 110.586 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 13.5 ttm -89.53 -25.07 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.98 149.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.823 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tt -95.18 109.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.05 130.86 37.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.19 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.8 p -75.2 136.56 41.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.981 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.68 -157.37 7.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.562 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -35.48 70.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -105.77 -39.25 6.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 m -84.38 85.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.406 ' OD2' ' CD2' ' A' ' 110' ' ' TYR . 15.3 m-20 -60.76 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.13 5.14 31.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -131.84 30.11 4.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 0.0 111.173 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 51.53 51.21 38.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.8 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.454 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -119.21 93.0 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.033 0.444 . . . . 0.0 110.768 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.29 108.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.016 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 1.3 m-85 -101.72 51.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.5 mt -59.49 119.02 36.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.806 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 -27.43 27.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.426 2.084 . . . . 0.0 112.296 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -58.83 -29.43 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 tp -91.81 -34.32 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -67.21 -37.5 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -98.44 28.32 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.421 ' NE1' ' N ' ' A' ' 122' ' ' SER . 1.8 t90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.421 ' N ' ' NE1' ' A' ' 117' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.047 0.451 . . . . 0.0 111.483 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 179.95 -177.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.587 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mt -84.57 -34.49 23.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -47.46 57.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.65 -25.77 55.64 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.366 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.37 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -90.48 -27.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.709 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.17 -33.2 75.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.701 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 131' ' ' MET . 2.7 p -66.5 -41.86 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 0.0 110.653 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.419 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.3 mmt -67.48 -44.38 78.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.2 tt -52.77 -26.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.03 -54.1 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.53 -38.32 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -83.86 -26.7 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.05 -18.74 65.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.534 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -48.93 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.56 111.19 1.65 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.0 139.07 79.67 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.991 . . . . 0.0 112.192 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.78 1.62 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.698 2.265 . . . . 0.0 112.658 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.9 -47.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.409 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.274 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -49.76 75.75 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.524 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.95 -49.34 68.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -58.73 -29.67 66.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.927 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -55.2 36.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -70.15 -29.56 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.426 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmm -62.56 -49.18 76.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.044 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -101.35 19.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.487 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -67.09 -29.75 69.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.822 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -31.22 68.08 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 3.4 m-30 -56.91 129.73 42.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -62.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 19' ' ' ASP . 2.8 m-85 -63.63 -55.25 25.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.829 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 66.97 -67.41 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -49.38 -49.62 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -48.31 79.89 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.512 0.507 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -66.97 -31.93 72.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -79.94 -25.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.131 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -79.01 -47.02 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -67.13 -43.46 82.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.7 t -58.44 -47.46 83.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -62.44 -46.99 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.776 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.418 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -51.72 -32.58 30.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.274 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.85 -66.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.9 -28.33 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.384 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.0 m -70.25 -33.53 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.62 -34.43 15.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -102.11 122.63 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.88 3.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.6 15.75 2.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.416 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 167.64 11.24 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.832 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -152.4 137.03 10.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.12 159.7 40.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.601 2.201 . . . . 0.0 112.115 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 t -150.6 161.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.058 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -129.42 122.35 29.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -138.03 161.45 36.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.401 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.09 152.15 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.72 88.44 2.68 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.142 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.947 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.053 0.454 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -123.53 120.15 32.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -59.73 142.08 53.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 tp -147.01 141.54 26.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.251 0.548 . . . . 0.0 110.997 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.7 ttp -107.21 139.57 41.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.769 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.77 157.46 46.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mt -124.58 128.4 48.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.5 m -124.24 134.31 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.15 169.57 37.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.71 139.39 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.07 156.43 48.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.45 134.96 34.87 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.489 2.126 . . . . 0.0 112.211 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 70' ' ' ILE . 98.1 t -143.27 106.22 5.16 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.74 134.71 41.76 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.794 2.329 . . . . 0.0 112.252 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -167.85 116.27 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER 81.21 -10.24 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.039 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.06 -6.99 7.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.573 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.77 175.13 6.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 114.63 28.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -94.18 148.15 22.47 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.17 104.3 16.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 ' CG1' ' CG2' ' A' ' 61' ' ' VAL . 31.6 mm -102.45 98.88 11.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.44 153.55 73.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.469 2.113 . . . . 0.0 112.189 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 pp -159.21 154.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.403 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 43.2 t -105.13 150.01 25.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.68 142.67 51.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -127.62 139.95 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -128.22 170.4 13.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.15 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.68 165.75 18.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.08 -39.42 75.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.794 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.42 ' O ' ' CG ' ' A' ' 80' ' ' TYR . 1.5 t 173.37 -34.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.181 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 79' ' ' THR . 11.8 m-85 -166.07 163.39 12.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.771 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -92.78 -0.59 54.19 Favored 'Cis proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.237 -1.151 . . . . 0.0 112.647 0.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -87.2 51.7 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.631 0.253 . . . . 0.0 111.062 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -40.99 -51.63 7.26 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.68 115.52 4.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.217 1.945 . . . . 0.0 112.105 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.97 167.67 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.0 112.591 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.438 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 3.6 mp -104.07 159.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.6 p -133.53 126.08 30.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.051 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.438 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 21.7 m-85 -131.72 161.63 32.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.78 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -133.54 129.78 56.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.0 110.879 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 80.49 50.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.52 164.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.448 2.098 . . . . 0.0 112.588 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.0 p -87.23 172.57 9.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.824 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -59.83 -20.78 58.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 m -54.42 -58.93 5.53 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.032 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.02 177.03 5.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.048 0.451 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 t -94.19 -137.74 0.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.592 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.493 ' CG2' ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -152.1 111.25 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.317 0.58 . . . . 0.0 111.382 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -101.78 133.83 45.89 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.142 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -173.48 -177.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 111.487 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' A' ' 99' ' ' THR . . . 153.63 -17.92 0.67 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.302 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -54.89 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.551 0.215 . . . . 0.0 111.279 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -129.96 -34.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.7 t -77.46 -16.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.454 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.422 ' N ' ' OG1' ' A' ' 99' ' ' THR . 2.5 m-20 53.01 170.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.84 0.352 . . . . 0.0 111.455 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.47 -19.09 62.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.609 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.43 24.63 4.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.24 23.53 18.19 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.066 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.47 125.7 37.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.546 -0.385 . . . . 0.0 110.481 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.34 108.73 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 111.291 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -104.31 31.66 4.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.115 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mt -51.72 152.01 5.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.599 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.82 -32.12 67.32 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -31.51 66.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.684 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -86.97 -42.71 12.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.13 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.33 -36.26 83.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.059 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.99 37.01 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.422 ' NE1' ' CB ' ' A' ' 122' ' ' SER . 1.6 t90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.575 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.422 ' CB ' ' NE1' ' A' ' 117' ' ' TRP . 23.3 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.879 0.371 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 177.49 153.87 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -43.8 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.48 -42.37 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.766 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.46 56.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.254 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.2 tp -56.54 -36.58 69.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.717 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.2 -23.99 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.653 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -69.3 -33.41 73.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.676 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 131' ' ' MET . 3.6 p -63.51 -42.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.428 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 4.6 mtt -64.77 -43.76 92.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -53.77 -25.05 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.39 -52.69 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.503 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.09 -36.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.375 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -83.3 -26.1 30.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.244 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.22 -15.07 72.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.61 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.4 -36.14 11.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.803 0.335 . . . . 0.0 110.642 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -153.39 85.8 4.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.45 111.11 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.652 2.235 . . . . 0.0 112.727 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.9 50.0 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.857 2.371 . . . . 0.0 112.082 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.15 -7.66 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.404 0.145 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -81.5 -32.92 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.937 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -70.67 -42.07 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.633 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -59.88 -44.57 94.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.457 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.2 66.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.801 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -72.93 -29.01 62.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.97 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -88.62 -35.86 16.61 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.0 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -88.54 8.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.632 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 p -79.22 -29.55 42.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.912 0.387 . . . . 0.0 110.809 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -69.81 -17.89 63.43 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.533 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -51.17 167.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.821 0.343 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -47.85 8.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -84.24 -58.08 2.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 66.54 -68.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 17' ' ' TYR . 21.6 t70 -52.78 -29.9 30.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.195 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.9 -39.44 18.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -47.73 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.9 t -61.68 -39.62 83.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -63.31 -50.57 69.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.269 0.557 . . . . 0.0 111.173 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.68 -47.04 88.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.944 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -58.8 -50.65 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -58.78 -47.37 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.423 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -53.31 -33.22 52.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.446 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.95 -58.98 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 pt -59.83 -34.54 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -67.52 -38.01 83.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.831 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.39 -30.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.35 124.99 50.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.302 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.95 68.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -168.62 -41.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.56 129.39 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.803 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.85 101.44 53.49 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.883 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.05 139.71 33.64 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.453 2.102 . . . . 0.0 112.385 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 t -132.18 162.08 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -118.75 124.07 46.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -149.2 127.33 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.866 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -90.91 159.26 16.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -112.3 104.77 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 110.727 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -179.843 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.733 0.302 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 134.14 41.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.78 123.73 24.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.36 155.08 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.5 ttp -118.44 149.93 40.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.41 160.7 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mt -127.08 118.72 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.958 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.9 155.84 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 161.04 172.0 27.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.481 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.52 124.82 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.0 111.248 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 pt -104.0 150.91 38.78 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.189 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.83 149.46 66.46 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 112.257 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -155.7 107.57 2.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.199 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -52.23 111.78 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.151 1.9 . . . . 0.0 112.293 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -110.45 97.43 6.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 57.49 24.97 10.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.68 -15.97 28.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.815 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.94 177.89 5.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -114.14 111.25 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.064 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.12 -173.7 2.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.097 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -146.98 87.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.063 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 3.2 mp -89.09 107.51 18.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.18 160.24 50.66 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.556 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 pp -159.22 163.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 158.88 28.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.737 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.83 135.18 45.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -121.35 134.17 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mt -133.13 156.75 46.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.06 162.77 24.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' A' ' 79' ' ' THR . 4.8 p-10 -60.3 -44.11 95.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.676 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 3.0 m -177.39 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.56 157.74 55.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.86 -47.37 0.31 Allowed 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.307 -1.539 . . . . 0.0 112.569 0.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 80.3 m-85 -87.91 -67.66 0.81 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 4.6 m-20 156.82 -52.44 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.779 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 87.2 Cg_exo -44.52 143.49 3.87 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.744 2.296 . . . . 0.0 112.774 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.25 138.56 10.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.0 112.445 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mp -83.38 160.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.4 t -134.97 141.71 46.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.028 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -138.76 -179.86 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 p -128.25 149.19 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.36 87.83 14.41 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.7 148.46 15.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.527 2.152 . . . . 0.0 112.398 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.65 -176.71 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.0 t -77.88 -31.83 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.688 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -73.56 -56.97 4.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.7 mtm -91.54 179.3 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -130.09 -98.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.41 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.3 OUTLIER -175.5 126.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.29 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.15 116.08 29.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.5 p -86.27 134.07 33.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.43 -63.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.43 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -100.03 -71.31 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.45 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -120.71 -15.67 8.37 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.48 70.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.661 0.267 . . . . 0.0 111.583 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.415 ' OD2' ' CD1' ' A' ' 110' ' ' TYR . 70.6 m-20 -52.04 -176.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.25 68.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.19 19.64 10.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.99 29.39 43.24 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -83.87 113.31 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.805 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.2 mp -69.78 110.19 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.21 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 3.8 p90 -132.92 46.98 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.481 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 102' ' ' HIS . 1.3 mp -44.67 148.95 0.84 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.644 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -30.85 10.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.564 2.176 . . . . 0.0 112.017 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -60.34 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.98 -30.91 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.418 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -58.86 -55.64 32.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.02 31.02 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.495 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.589 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.415 ' N ' ' NE1' ' A' ' 117' ' ' TRP . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.042 0.449 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -93.17 168.89 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 tp -57.76 -39.68 77.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mp -49.28 -43.16 42.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.54 -26.86 49.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.256 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.87 -31.74 67.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -88.02 -28.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.564 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -61.34 -35.86 78.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 131' ' ' MET . 2.3 p -65.19 -39.94 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.402 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 10.0 mtt -68.74 -44.59 73.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.858 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.2 tt -52.65 -24.53 6.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.204 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -92.98 -56.48 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.529 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.63 -46.95 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.543 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -74.9 -27.79 60.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.53 -15.54 64.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.592 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -89.78 -48.66 7.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.81 137.35 7.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.74 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -55.66 105.97 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 112.338 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.62 -12.85 37.54 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.227 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.56 -13.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.605 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.68 0.276 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -72.27 -35.35 68.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.73 -32.66 57.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -28.39 70.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -29.47 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.292 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -73.65 -28.13 61.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.988 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 ptm -85.62 -35.22 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.87 11.57 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.561 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -23.19 63.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.055 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -26.67 25.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.409 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 8.5 m-85 -54.52 134.19 46.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -67.5 -49.41 63.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -90.7 66.44 6.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -60.73 3.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.325 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -51.45 -53.28 38.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.094 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.03 -41.24 99.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.0 m -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.31 -31.74 10.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -72.27 -48.42 42.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.39 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.6 m -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.078 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -85.78 -47.81 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 2.4 m-20 -55.42 -28.72 56.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.474 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.82 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.427 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.9 pt -57.38 -33.76 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.567 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 t -75.47 -32.69 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.04 -38.91 51.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.858 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -99.26 -20.56 16.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.1 mttp 67.31 -59.88 0.39 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.639 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' TYR . 3.1 m-20 -45.69 -35.88 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.885 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.38 132.52 51.75 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 111.059 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -129.95 117.97 18.4 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.7 140.68 91.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.401 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 t -131.34 162.81 38.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -133.4 95.18 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.862 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.24 118.6 35.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.08 145.52 49.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.296 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -117.67 119.93 36.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.596 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 111.188 -179.742 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.662 0.267 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.07 127.99 55.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.421 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -74.49 101.09 4.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -108.65 138.99 44.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.556 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 65.8 ttp -84.85 149.2 25.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -149.98 117.8 6.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.982 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.37 107.65 17.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.522 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 m -108.5 149.73 28.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.4 165.42 20.5 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -107.29 120.63 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.604 0.24 . . . . 0.0 110.752 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.76 126.35 37.35 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.456 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.11 126.61 22.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.417 2.078 . . . . 0.0 111.952 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.84 136.69 28.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.215 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.16 150.98 62.28 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.433 2.089 . . . . 0.0 112.094 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -176.76 116.46 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 58.48 25.1 12.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.27 3.18 75.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.75 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -124.74 176.9 6.28 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 133.91 47.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -165.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -143.53 98.04 3.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.995 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 mm -100.92 101.8 17.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.23 136.25 24.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.486 2.124 . . . . 0.0 112.53 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.5 pt -134.81 167.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 108.62 10.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.935 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mt -85.44 98.66 10.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.086 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.66 146.9 32.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.569 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -126.97 170.87 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.69 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.44 166.25 25.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.38 0.61 . . . . 0.0 110.715 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -39.27 24.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.77 163.11 27.14 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.62 -62.58 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.187 -0.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 25.4 m-85 -105.03 -56.09 2.23 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.619 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.572 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.9 p-10 161.83 -34.37 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.369 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 28.5 Cg_exo -62.09 116.99 3.83 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.968 1.778 . . . . 0.0 112.269 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.17 166.94 23.35 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.39 2.06 . . . . 0.0 112.199 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.417 ' CG2' ' CE1' ' A' ' 88' ' ' PHE . 1.2 mp -103.95 164.03 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.066 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.67 53.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.814 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CE1' ' CG2' ' A' ' 86' ' ' ILE . 30.6 m-85 -48.73 125.42 10.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.182 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.5 m -81.6 127.0 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.253 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -127.44 89.83 50.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.33 -158.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.644 2.23 . . . . 0.0 112.147 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -128.6 173.95 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 t -68.4 -25.73 65.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -29.22 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.294 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.439 ' CB ' ' CG1' ' A' ' 141' ' ' VAL . 2.0 mpp? -127.2 -169.17 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.0 t -135.62 -162.7 1.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.3 tt -122.89 104.29 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.152 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -81.43 102.28 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.5 p -57.56 141.37 48.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.905 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.33 -100.44 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.557 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -95.96 -64.53 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -107.53 -24.34 11.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.422 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.1 t -55.28 -27.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.4 -166.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -103.81 -20.57 13.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.513 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.65 22.2 7.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.488 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 51.52 44.27 53.41 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.781 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.445 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 1.5 tttm -124.05 90.82 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.785 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 109' ' ' ILE . 2.0 pp -46.79 108.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.874 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 108' ' ' LYS . 33.5 m-85 -95.61 30.9 2.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.713 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt -49.17 106.56 0.64 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.35 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.5 -14.73 46.01 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.463 2.109 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -58.56 -71.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.318 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -60.63 -19.64 58.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.151 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.434 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 24.2 t60 -64.62 -46.55 82.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 110.332 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.02 26.79 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.736 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CD1' ' CB ' ' A' ' 122' ' ' SER . 2.2 t90 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.497 ' CB ' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -174.27 179.78 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.0 mt -59.68 -31.2 69.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -47.6 81.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -83.94 -40.72 8.54 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 tt -54.02 -27.4 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.994 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.0 mt -90.54 -28.54 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.666 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -57.47 -33.06 67.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 131' ' ' MET . 4.3 p -59.79 -45.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.38 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.449 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 12.8 mtm -69.89 -40.58 75.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.087 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 63.4 mt -54.6 -26.25 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.741 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.9 t -91.87 -54.39 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.437 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.42 -47.82 80.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.279 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.66 -15.87 67.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.696 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -104.12 -42.83 5.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -151.0 90.53 4.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.253 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.99 129.23 33.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.487 2.125 . . . . 0.0 112.306 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.1 -19.03 46.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.175 1.917 . . . . 0.0 111.871 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 95' ' ' MET . 1.6 t -75.06 152.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.25 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 t80 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.043 -179.346 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.074 0.464 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -60.41 -31.76 70.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -84.31 -22.88 30.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.103 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.34 -50.72 68.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.219 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -31.8 40.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.924 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.49 68.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.651 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -86.28 -33.0 20.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -100.45 20.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -26.51 68.36 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.561 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -21.86 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.339 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -51.54 134.48 29.28 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -64.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.832 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -86.5 63.73 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -63.76 -53.7 46.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.278 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -35.03 56.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 111.449 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.59 -40.19 16.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.8 m -66.49 -49.82 65.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.086 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.67 -39.59 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -48.4 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.381 0.61 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -43.42 88.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.852 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 m -65.02 -59.02 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.94 -48.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.183 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.2 t-20 -55.99 -28.04 55.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.08 -27.18 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -27.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -68.77 -48.15 64.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -41.89 66.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.35 117.31 34.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -95.7 21.13 8.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.216 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.0 17.65 13.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.04 159.86 22.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -149.35 124.58 4.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.686 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 133.84 21.27 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.252 1.968 . . . . 0.0 112.344 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.15 162.15 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.068 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.55 114.8 22.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.804 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -134.1 115.46 14.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 110.89 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 p -72.99 141.88 47.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.09 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.48 120.51 41.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.495 179.766 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 138.94 46.84 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.488 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.54 107.08 0.14 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.82 131.03 56.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 110.544 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.04 146.08 24.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.211 0.529 . . . . 0.0 110.912 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -143.86 140.7 29.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.915 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.5 mt -100.32 101.67 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -102.55 152.96 20.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.694 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.19 -172.41 32.79 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.411 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.6 p -121.53 156.5 32.73 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -131.87 134.28 25.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 116.18 4.56 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.562 2.175 . . . . 0.0 112.104 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.15 102.1 46.47 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.522 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -42.61 129.7 5.13 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.211 2.607 . . . . 0.0 112.688 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -135.56 87.17 2.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 63.01 42.77 7.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.14 -16.58 55.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.1 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.65 -147.47 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.857 -0.202 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 t -176.24 41.95 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 121.547 0.689 . . . . 0.0 109.906 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -31.27 148.33 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.524 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -105.66 106.11 16.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.682 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mm -99.58 108.25 49.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.16 147.53 93.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.494 2.129 . . . . 0.0 111.853 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 pt -149.57 149.82 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 111.215 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 116.71 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 138.4 32.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.35 145.92 40.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 mp -141.22 146.4 36.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.37 166.24 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.16 0.505 . . . . 0.0 110.85 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.84 -39.57 79.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.723 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t 174.43 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.843 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.59 163.54 38.15 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.65 -31.69 3.89 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.421 -1.491 . . . . 0.0 112.108 0.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 52.0 m-85 -59.55 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.101 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 64.6 t-20 117.67 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 89.5 Cg_endo -84.21 141.25 9.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.433 2.089 . . . . 0.0 112.399 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.36 127.42 26.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.473 2.115 . . . . 0.0 112.248 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.474 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 2.5 mp -93.35 160.03 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.2 t -155.16 123.19 5.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.474 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 19.7 m-85 -134.6 121.64 21.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.581 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.71 130.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 125.86 68.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.04 165.89 22.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.119 . . . . 0.0 112.41 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.41 -176.66 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.914 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.93 -33.96 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 p -93.48 -32.78 14.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.766 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.3 ttp -99.01 -12.14 20.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.528 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 142' ' ' PHE . 8.9 t 44.59 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.39 127.14 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 111.473 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.01 145.61 29.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -79.34 131.35 36.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.22 -121.13 1.65 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.635 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 -39.07 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.132 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.409 ' O ' ' N ' ' A' ' 104' ' ' ASP . 0.1 OUTLIER -108.74 -48.49 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -68.11 67.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.573 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 102' ' ' HIS . 71.5 m-20 -49.89 -100.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.18 -54.7 2.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -106.94 39.59 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.037 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.83 51.89 56.24 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.391 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -93.11 90.0 6.7 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.041 0.448 . . . . 0.0 110.406 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.2 mt -47.89 109.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.089 0.471 . . . . 0.0 111.435 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.38 39.48 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.668 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.3 mt -54.59 118.98 18.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.18 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.75 -35.32 87.5 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.0 112.122 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.97 -29.83 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.403 ' CD1' ' CD1' ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.47 -30.11 17.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -57.35 -37.7 72.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.23 22.75 8.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 t90 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.652 179.989 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.03 -84.51 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tp 176.78 -36.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.42 -44.81 95.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.779 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.63 -36.45 92.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.108 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.403 ' CD1' ' CD1' ' A' ' 114' ' ' LEU . 20.6 tp -57.12 -34.14 68.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.979 0.418 . . . . 0.0 110.513 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.75 -24.32 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.006 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -68.9 -40.87 78.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 131' ' ' MET . 1.9 p -61.76 -41.31 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.472 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.407 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 2.5 mtt -63.81 -40.3 96.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -28.34 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.964 0.411 . . . . 0.0 111.022 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.19 -52.22 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.86 -36.0 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.989 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.18 -21.93 20.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -21.53 61.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -28.89 13.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.734 0.302 . . . . 0.0 111.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -161.3 95.79 1.35 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.28 117.83 3.78 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.6 2.2 . . . . 0.0 112.076 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -88.55 45.84 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.621 2.214 . . . . 0.0 112.737 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.497 ' O ' ' C ' ' A' ' 142' ' ' PHE . 1.4 m -136.9 -40.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.842 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' C ' ' O ' ' A' ' 141' ' ' VAL . 21.8 t80 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 113.214 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.725 0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.81 66.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.349 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -73.34 -175.88 2.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.137 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -59.38 -38.29 80.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -50.98 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.584 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.11 -31.28 70.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.23 -44.37 92.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -57.95 -44.5 87.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.186 0.517 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.38 -30.67 71.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtm -79.28 -31.54 43.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.825 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.21 20.18 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.027 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -78.54 -31.14 47.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.859 0.362 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -31.35 71.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.49 156.18 8.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -54.17 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.48 66.13 4.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -61.83 -52.38 64.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.35 -29.55 48.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.23 -26.94 17.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.7 m -80.71 -30.45 36.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.18 -28.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -82.1 -33.32 29.79 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.151 0.501 . . . . 0.0 110.848 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -68.93 -42.29 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.0 m -69.03 -55.07 11.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -52.35 -46.89 46.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 3.2 m-80 -51.69 -37.01 48.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.9 t -82.9 -63.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.465 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 pt -52.27 -26.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -85.54 -26.49 26.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.01 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.74 -39.02 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.668 0.271 . . . . 0.0 111.202 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -93.14 11.46 27.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.659 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 14.33 61.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.38 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.75 121.77 14.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.02 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? -100.13 128.05 31.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.123 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.53 139.39 37.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.3 2.0 . . . . 0.0 112.608 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.19 162.11 39.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.8 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.82 103.83 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.797 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -123.78 127.12 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.385 0.612 . . . . 0.0 110.534 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.72 139.64 30.53 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -108.85 160.23 16.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.96 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.74 151.18 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -98.9 80.04 2.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 60.78 37.65 18.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.4 21.49 12.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.061 0.458 . . . . 0.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.01 -17.47 16.2 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.361 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.64 133.18 0.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.687 -0.302 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m -100.26 177.75 4.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.88 140.23 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.551 0.532 . . . . 0.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.33 128.51 35.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.085 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.8 tp -136.11 136.27 39.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.4 ttp -105.26 149.75 25.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.229 0.538 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.17 163.53 36.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.892 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -127.54 123.85 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -119.45 131.12 55.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.65 -174.06 41.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.604 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -121.06 151.61 39.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.714 0.292 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pt -130.97 114.84 16.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.273 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.28 167.37 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.434 2.089 . . . . 0.0 112.141 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 p -173.39 127.01 0.48 Allowed Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.347 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.78 115.83 4.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.255 1.97 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.61 137.18 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 60.13 20.88 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.524 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.56 5.16 82.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.672 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.19 175.51 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.87 0.366 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 100.49 10.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.43 159.56 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -114.33 125.07 53.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.62 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.0 95.47 21.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.226 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.11 144.37 99.18 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.156 1.904 . . . . 0.0 112.221 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -155.47 138.97 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.9 m -99.6 162.43 13.02 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.35 134.88 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.15 148.33 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.774 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 mp -133.44 155.63 49.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.805 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -135.11 158.86 43.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -73.8 -30.95 63.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.05 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.37 154.02 68.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.76 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.99 -45.01 0.46 Allowed 'Cis proline' 0 C--N 1.347 0.448 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.433 0.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -105.09 -59.81 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 166.45 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.38 143.52 15.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.677 2.251 . . . . 0.0 112.455 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 149.99 50.3 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.491 2.127 . . . . 0.0 112.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.85 154.61 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.71 142.46 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -151.97 154.44 36.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.7 m -117.19 139.09 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.117 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -135.49 79.4 48.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.09 176.52 6.15 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.413 2.075 . . . . 0.0 112.572 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -91.84 170.35 9.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.8 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -58.72 -28.63 66.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -76.33 -29.56 57.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.06 177.03 7.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.33 -173.52 3.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.613 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.1 mm -126.13 92.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -66.47 103.72 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.867 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -58.47 134.42 56.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.71 -131.11 1.62 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.557 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 0.5 OUTLIER -99.99 -32.42 10.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.789 0.328 . . . . 0.0 111.014 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.452 ' CG ' ' CD2' ' A' ' 111' ' ' LEU . 23.1 m-70 -111.44 -34.82 6.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.981 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.05 79.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.27 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -69.25 -173.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.39 5.26 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.356 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -112.9 24.9 11.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 56.49 27.89 54.84 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.99 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.4 160.24 15.57 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.436 -0.449 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.55 38.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.284 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 30.1 p90 -60.77 102.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.989 0.423 . . . . 0.0 110.625 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.452 ' CD2' ' CG ' ' A' ' 102' ' ' HIS . 2.1 mt -108.74 144.68 30.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.073 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.72 -40.36 84.97 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.491 2.127 . . . . 0.0 112.04 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.77 -30.33 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.52 -32.51 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.51 -49.55 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.83 33.26 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.779 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.437 ' CD1' ' N ' ' A' ' 118' ' ' LYS . 2.8 t90 -90.93 136.59 32.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.108 0.48 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 16.6 pttt -149.4 133.34 17.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -45.99 169.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.304 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.16 6.81 50.4 Favored 'Cis proline' 0 C--N 1.354 0.84 0 C-N-CA 124.95 -0.854 . . . . 0.0 113.435 0.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -6.83 45.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 t -92.98 103.65 15.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.847 0.356 . . . . 0.0 111.258 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.16 -0.93 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 123' ' ' ASP . 0.9 OUTLIER 87.66 -26.45 0.08 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.62 0.368 . . . . 0.0 111.322 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.92 -38.23 90.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.452 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.96 -31.18 54.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.016 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.97 -30.5 61.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.593 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.1 mm -88.08 -28.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.037 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -67.9 -41.26 82.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.215 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 131' ' ' MET . 6.8 p -52.4 -46.58 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.981 0.419 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.441 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.1 mtt -66.94 -35.38 79.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.389 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.13 -27.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.771 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.2 t -91.43 -48.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.22 -39.94 82.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.48 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -85.21 -15.89 42.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.075 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.0 -14.77 81.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.434 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -97.98 -38.01 9.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -164.8 89.31 1.02 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.86 126.54 22.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.569 2.179 . . . . 0.0 112.412 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.83 -13.42 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.71 2.273 . . . . 0.0 112.561 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.9 t -72.45 -3.72 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.148 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.19 173.96 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.055 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 p -140.64 21.71 2.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.091 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 46.0 76.77 0.51 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.132 1.888 . . . . 0.0 112.436 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t 59.98 64.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.164 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.2 p -84.8 -177.08 6.49 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.659 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.71 -30.94 69.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -46.68 17.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -40.01 80.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.85 -37.53 79.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.268 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -62.47 -50.23 72.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.727 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -63.54 -31.12 72.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.56 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.1 mtp -74.65 -30.6 61.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.02 19.45 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.805 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -65.35 -29.86 70.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.21 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -27.24 58.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.872 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 21.2 m-85 -56.06 130.64 44.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -66.98 -42.54 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' CG2' ' A' ' 79' ' ' THR . 16.0 m-85 -103.62 60.77 0.75 Allowed 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -59.02 -35.4 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.73 -51.12 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -33.31 63.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.672 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -66.47 -39.08 88.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.02 -30.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -46.79 35.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -59.29 -42.33 91.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.979 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 m -63.71 -59.57 4.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -47.4 -47.59 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.069 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -58.02 -29.48 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.5 t -83.33 -37.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.256 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.37 -27.97 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.954 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.8 m -80.55 -29.06 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.693 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -88.73 -30.24 19.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.895 0.379 . . . . 0.0 110.977 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -106.92 127.2 53.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 35.24 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.98 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -152.06 24.75 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.026 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.07 160.74 21.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -149.28 130.14 7.03 Favored Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.32 131.74 15.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.365 2.043 . . . . 0.0 112.316 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.47 161.79 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.64 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -130.9 115.06 16.03 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.076 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.58 120.75 18.91 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.3 p -82.16 146.07 29.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -139.35 134.67 32.82 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.5 158.58 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.352 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -106.59 -175.02 2.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.218 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.21 -23.97 64.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.255 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -85.85 -28.53 24.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.296 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.15 -27.98 4.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.657 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -58.42 162.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -115.59 122.95 47.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.205 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -117.26 132.31 56.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.501 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -75.32 110.4 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -106.09 134.93 48.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -86.31 146.82 26.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 0.0 110.776 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -147.3 143.86 28.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.985 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.91 105.07 17.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -94.72 132.82 39.07 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.78 -155.23 15.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.503 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 p -150.72 150.75 31.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.569 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.43 149.44 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.677 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.04 116.73 4.63 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.331 2.021 . . . . 0.0 112.503 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.45 84.52 52.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.51 165.07 10.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.285 1.99 . . . . 0.0 112.351 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -69.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.246 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.29 46.77 1.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.089 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.06 -16.73 59.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.579 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.97 -168.22 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 110.447 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -155.96 128.71 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.757 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.24 -170.62 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.666 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.41 67.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mm -57.65 108.09 1.15 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.239 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 155.61 65.23 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.447 2.098 . . . . 0.0 112.226 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -155.88 153.82 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.0 m -122.17 103.32 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.11 129.09 34.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.742 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.92 147.52 29.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.934 0.397 . . . . 0.0 111.108 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.67 142.29 46.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.33 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -112.8 -178.87 3.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 111.481 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.31 39.42 1.5 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.605 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 17' ' ' TYR . 4.9 m 75.04 25.69 1.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 178.0 142.18 0.27 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.043 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.83 -40.11 0.82 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.467 0.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -82.85 65.96 8.23 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -32.8 -55.42 0.57 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 122.95 0.5 . . . . 0.0 111.377 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.65 131.48 24.19 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.404 2.069 . . . . 0.0 112.166 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.81 134.1 46.99 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.459 2.106 . . . . 0.0 112.329 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 29.1 mt -104.13 148.56 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 26.2 p -134.95 125.25 26.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 22.6 m-85 -133.48 142.08 48.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 p -95.57 145.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.781 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.0 123.95 31.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.1 -172.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.477 2.118 . . . . 0.0 112.237 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -170.63 2.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.1 -37.79 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.91 -29.37 14.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.073 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -94.72 -168.4 1.82 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.911 0.386 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.4 t -146.33 -156.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.85 142.85 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 110.897 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.83 145.52 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.8 p -114.89 134.48 55.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.82 -115.78 0.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.472 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -71.43 0.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.472 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -142.23 62.88 1.42 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 111.532 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.0 t -135.17 -7.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.867 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.403 ' OD2' ' CD2' ' A' ' 110' ' ' TYR . 16.6 m-20 45.7 -167.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.286 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.09 -46.81 6.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.129 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.69 -17.23 60.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.184 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.84 20.87 5.56 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.762 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -83.07 115.49 21.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.759 -0.259 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.46 107.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.661 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -95.73 41.58 1.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' CD2' ' CD2' ' A' ' 102' ' ' HIS . 4.0 mt -60.42 119.74 45.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.14 -21.13 27.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.438 2.092 . . . . 0.0 112.225 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -56.64 -62.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.834 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.4 tp -46.56 -39.47 11.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -59.21 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.532 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.1 35.07 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.91 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -101.94 122.98 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.932 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.55 9.87 2.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.57 160.42 0.36 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.73 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.15 -19.24 22.9 Favored 'Cis proline' 0 C--N 1.345 0.358 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.691 0.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -131.09 54.76 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.8 t -70.5 68.61 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.903 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.54 -173.41 3.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.41 -40.4 96.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.57 -53.78 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.75 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.89 -29.66 74.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.21 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.44 -31.87 64.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.648 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -82.81 -25.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.978 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -51.48 16.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 131' ' ' MET . 5.8 p -47.11 -45.62 8.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.442 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 3.6 mtm -60.35 -38.71 84.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -25.78 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.04 -53.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.67 -29.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.49 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.441 ' CE2' ' CG ' ' A' ' 140' ' ' PRO . 2.8 m-85 -86.41 -27.86 23.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.541 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.2 -14.55 80.51 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.802 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -96.47 -30.57 13.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.382 . . . . 0.0 110.958 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.59 109.19 1.48 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.65 123.16 12.69 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.441 ' CG ' ' CE2' ' A' ' 135' ' ' PHE . 94.2 Cg_endo -89.63 25.67 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.3 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.83 -12.94 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -162.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.7 57.84 0.96 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.24 86.17 0.15 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.789 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 122.788 2.325 . . . . 0.0 112.416 179.811 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 p -97.88 -39.59 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.51 143.08 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.787 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -59.44 -35.16 73.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -40.93 82.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -36.9 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.909 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.67 -55.49 34.37 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.569 0.543 . . . . 0.0 110.831 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -58.21 -30.33 66.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.89 -41.04 75.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.5 mtp -58.22 -36.32 72.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.588 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' CG2' ' CZ ' ' A' ' 18' ' ' ARG . 22.6 m -112.27 19.65 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.186 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -67.99 -29.13 68.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.908 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -28.44 65.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 5.2 m-85 -55.73 124.07 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -67.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.0 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -64.47 -49.19 72.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' CZ ' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER 64.63 -65.97 0.13 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.33 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 17' ' ' TYR . 36.7 t0 -48.05 -43.91 30.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.052 0.453 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' C ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -53.03 -36.18 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.4 ' CG2' ' NH2' ' A' ' 18' ' ' ARG . 95.6 m -83.66 -35.58 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.843 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' CG2' ' NH1' ' A' ' 18' ' ' ARG . 60.7 t -52.08 -35.11 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.761 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -83.52 -40.64 18.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.845 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -66.54 -32.65 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.907 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 t -73.6 -41.63 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -72.16 -47.43 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.021 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.7 m-80 -50.15 -46.52 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.27 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.57 -61.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.28 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 pt -59.32 -23.5 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.403 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.7 m -82.58 -28.75 30.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -18.84 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.93 164.28 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 0.0 110.602 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -18.52 8.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -96.87 28.63 3.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.718 0.294 . . . . 0.0 111.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.7 154.51 31.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.44 104.43 2.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.02 140.9 38.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.22 1.947 . . . . 0.0 112.588 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -127.61 161.82 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.109 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.48 122.93 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.728 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -157.05 138.9 14.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -87.07 154.02 21.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.24 124.91 28.21 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.18 151.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.22 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.19 38.36 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.25 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 69.31 -64.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -125.66 18.51 8.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.56 22.11 12.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.168 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 p 64.07 175.95 0.18 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.744 0.307 . . . . 0.0 111.384 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 t -80.27 168.73 18.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.471 . . . . 0.0 111.285 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.31 134.89 12.59 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.88 115.75 3.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.043 0.449 . . . . 0.0 110.797 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.02 158.36 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.008 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.9 ttp -130.71 147.23 52.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.912 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -136.61 177.31 7.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.055 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mt -139.6 104.01 4.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 m -99.96 157.41 16.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.879 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.62 -149.4 14.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.42 142.0 31.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.5 mt -112.21 123.76 33.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.83 112.63 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.3 2.0 . . . . 0.0 112.219 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.8 t -134.74 94.86 16.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.058 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.75 152.96 69.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.565 2.177 . . . . 0.0 112.325 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -179.14 -36.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -97.53 45.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.451 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 17.34 79.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.368 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -177.43 165.21 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.509 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.29 129.23 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 -165.57 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.776 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -147.32 86.44 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.013 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.7 mm -79.51 129.29 72.19 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.957 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.63 145.95 33.67 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.664 2.243 . . . . 0.0 112.286 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 pp -158.13 171.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.449 . . . . 0.0 111.042 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.7 m -148.36 161.83 40.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.92 144.86 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -120.47 147.28 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.77 -178.7 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.025 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.61 146.21 34.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.192 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -35.56 80.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.415 ' CA ' ' CD2' ' A' ' 77' ' ' LEU . 0.8 OUTLIER 166.54 -26.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.151 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 79' ' ' THR . 39.6 m-85 -160.62 161.76 24.32 Favored Pre-proline 0 C--N 1.334 -0.086 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.789 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -88.52 -26.22 5.68 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.512 0.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -76.68 60.67 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.3 m120 -41.21 -52.77 7.14 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 54.2 Cg_exo -51.14 146.1 24.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 112.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.23 127.1 14.52 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mt -89.22 151.34 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.011 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 14.4 m -122.9 161.82 23.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CE2' ' CG ' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -162.13 159.64 26.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.679 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.37 137.65 56.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.161 0.505 . . . . 0.0 111.208 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.04 92.79 28.49 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.79 158.26 58.06 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.446 2.097 . . . . 0.0 112.187 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -84.68 176.49 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.25 0.547 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 m -65.37 -25.15 67.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -57.44 -59.03 5.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.057 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -111.25 -179.01 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.451 ' CG2' ' CB ' ' A' ' 143' ' ' SER . 8.9 t -115.01 -157.27 0.63 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.519 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.84 121.67 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.159 0.504 . . . . 0.0 110.797 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -81.72 133.69 35.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.8 p -102.45 131.21 49.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.75 -120.31 0.72 Allowed Glycine 0 C--N 1.322 -0.227 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.671 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -99.79 -57.93 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.861 0.363 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -80.79 -41.01 24.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -92.1 75.39 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.087 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -52.98 -178.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.39 -13.98 59.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.815 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.15 23.75 5.48 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 51.01 30.19 22.34 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.705 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.434 ' CG ' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -111.26 115.37 29.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.634 0.254 . . . . 0.0 110.99 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.2 mp -60.94 94.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.015 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.46 75.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mt -84.02 136.0 41.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.804 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.39 -28.31 18.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 0.0 112.246 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -79.61 -54.29 6.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.804 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.99 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.73 -35.82 71.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.1 25.59 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' NE1' ' O ' ' A' ' 119' ' ' HIS . 6.4 t90 -107.47 120.61 42.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 24.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.191 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' O ' ' NE1' ' A' ' 117' ' ' TRP . 0.3 OUTLIER 178.37 151.26 0.44 Allowed Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.064 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.77 -30.33 4.02 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.378 -1.509 . . . . 0.0 112.485 -0.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -120.42 57.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.129 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.2 p -76.18 62.98 1.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.751 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.62 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.4 tp -66.59 -33.98 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.02 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.48 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -29.49 75.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.2 -31.53 63.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.9 mm -78.98 -29.61 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -26.73 68.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.3 p -76.27 -36.81 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.552 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 37.0 mtt -77.86 -42.63 32.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.1 tt -58.25 -26.5 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 t -91.2 -58.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.0 t -53.55 -50.8 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -71.83 -27.3 62.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.472 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.04 -12.93 69.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.608 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.06 -47.71 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.55 126.95 2.45 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.83 107.6 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.451 2.101 . . . . 0.0 112.808 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -88.64 23.85 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.663 2.242 . . . . 0.0 111.956 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.9 t -121.99 -4.27 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.928 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' N ' ' A' ' 143' ' ' SER . 17.3 t80 -46.13 -92.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.739 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.463 ' N ' ' CG ' ' A' ' 142' ' ' PHE . 42.0 t -175.92 35.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.996 0.426 . . . . 0.0 111.601 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 63.18 143.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.992 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 m -76.5 68.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.41 -175.56 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.12 -35.97 74.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -60.71 -44.88 96.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -32.59 73.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.95 -25.22 60.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.136 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.44 -24.52 50.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.391 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -22.61 33.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.167 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.9 ptp -89.98 -34.05 16.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -91.31 -1.84 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -69.65 -31.4 69.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.181 0.515 . . . . 0.0 111.105 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -72.35 -26.37 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.16 169.02 0.43 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.994 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -91.87 -38.7 12.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -122.35 68.33 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.1 0.476 . . . . 0.0 110.937 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -34.81 71.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.859 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.52 -46.45 90.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -33.09 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -70.96 -48.18 54.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.25 -27.32 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.362 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -48.4 24.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.68 -42.48 88.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.973 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 m -59.81 -58.97 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.82 -46.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.658 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.1 t-20 -58.46 -22.37 54.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.224 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 t -93.19 -22.52 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.48 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.03 -28.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.148 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -80.42 -42.62 22.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.98 -23.64 62.24 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -116.97 161.61 19.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 80.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.956 0.408 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 174.99 -33.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 mp -62.46 134.77 56.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.796 0.331 . . . . 0.0 110.925 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 106.03 21.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.936 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.5 150.37 11.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.384 2.056 . . . . 0.0 112.594 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 t -151.51 161.85 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.605 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -129.85 116.97 19.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -149.54 132.88 16.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.964 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -84.38 158.04 21.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.43 149.21 49.54 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.163 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -126.52 140.12 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.71 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -91.63 170.45 9.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.969 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.26 -3.16 44.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.111 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.65 -30.12 22.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.974 0.416 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.9 -27.12 4.67 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.613 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.63 126.37 33.3 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.717 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.9 p -101.81 -168.01 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.87 128.86 0.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.087 0.47 . . . . 0.0 110.546 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -86.88 108.14 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.696 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 3.0 mm? -123.2 178.95 4.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.012 0.434 . . . . 0.0 111.061 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.83 145.68 46.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -130.5 153.1 49.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 111.078 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mt -108.87 101.89 10.95 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.857 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.5 m -85.49 132.95 34.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.56 -177.44 42.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.505 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.8 p -143.8 130.33 20.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 pt -115.53 154.35 47.79 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.53 163.07 4.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.616 2.211 . . . . 0.0 112.568 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.4 t -158.24 106.16 1.7 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.684 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.67 92.43 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.335 2.024 . . . . 0.0 112.19 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -132.72 140.34 48.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 mtp85 61.09 18.55 9.12 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 20.45 61.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.566 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.02 176.97 8.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.338 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.24 104.8 16.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.752 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.12 167.33 12.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.744 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -123.48 111.75 16.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.0 mm -108.93 109.5 61.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.92 141.83 49.9 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.361 2.041 . . . . 0.0 112.251 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -147.43 136.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.036 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 118.26 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.699 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.59 149.68 25.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.57 142.99 50.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.832 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.92 167.4 13.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.608 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -149.5 150.91 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.469 0.652 . . . . 0.0 111.065 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.28 -38.4 90.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.3 t 179.57 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -87.47 159.54 49.84 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.46 -45.55 0.45 Allowed 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.588 -1.422 . . . . 0.0 111.977 0.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.92 -59.92 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 166.03 -53.75 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.78 145.14 4.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.733 2.289 . . . . 0.0 112.632 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.94 143.06 22.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.668 2.245 . . . . 0.0 112.427 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.1 160.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.409 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -134.51 141.41 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 9.7 m-85 -147.73 144.33 28.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.08 117.69 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.035 0.445 . . . . 0.0 111.365 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -81.08 121.25 80.44 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.77 137.87 67.81 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.463 2.108 . . . . 0.0 112.219 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -115.2 -167.11 1.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.642 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m -86.98 -56.2 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.81 -29.7 67.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -135.88 -169.47 2.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.4 p -150.0 -80.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 179.69 109.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.66 116.71 28.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.8 p -53.25 131.82 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.53 -96.46 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -60.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 111.032 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.457 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 22.5 m-70 -127.47 48.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.31 -17.88 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 108' ' ' LYS . 7.9 p-10 40.56 -158.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.335 0.254 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 5.27 48.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -131.26 28.62 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 51.07 25.36 10.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.013 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -85.96 136.6 33.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 1.4 mp -68.99 88.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 110.523 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.09 62.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.847 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.457 ' CD2' ' CD2' ' A' ' 102' ' ' HIS . 9.8 mt -95.23 109.25 43.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.83 -29.44 82.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.457 2.105 . . . . 0.0 112.131 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -54.08 50.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.41 -33.34 72.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.48 -44.44 89.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.602 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.87 24.53 6.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -112.99 121.84 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.9 27.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.11 158.33 0.37 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.95 4.49 65.8 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 123.342 -1.524 . . . . 0.0 112.73 0.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 28.66 0.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.872 0.368 . . . . 0.0 111.073 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.0 t -54.43 117.95 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.37 -164.25 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.76 -28.12 14.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.97 -55.0 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.07 -35.99 92.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.345 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.7 tp -55.72 -31.7 62.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.7 mm -79.7 -21.74 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.809 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -33.67 28.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 131' ' ' MET . 11.3 p -72.75 -47.37 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.424 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.6 mtm -66.8 -42.82 85.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.14 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.0 tt -53.84 -30.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.0 t -85.81 -51.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.464 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 135' ' ' PHE . 1.2 p -54.76 -51.14 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.865 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 134' ' ' VAL . 2.1 p90 -87.31 -9.15 55.69 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.38 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.82 -24.67 75.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.77 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.18 -30.69 15.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.541 0.21 . . . . 0.0 110.601 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -162.84 118.99 1.21 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.93 110.93 1.08 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.537 2.158 . . . . 0.0 112.155 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.06 -15.97 7.66 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.418 2.079 . . . . 0.0 112.561 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.1 t -57.04 -19.34 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -41.37 2.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t 65.79 57.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.621 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -109.43 97.09 25.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.81 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 122.313 2.009 . . . . 0.0 112.424 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.045 0.45 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -120.76 37.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.477 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -163.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.817 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -27.44 6.52 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.567 0.542 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -36.87 71.22 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.531 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -24.99 38.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.12 -50.92 71.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.01 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.91 -31.68 68.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.114 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -65.26 -28.06 69.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -31.2 35.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 111.063 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -103.15 20.22 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.735 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.8 -29.65 45.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.8 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -99.06 -18.89 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.428 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -55.58 146.11 21.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -56.09 -24.73 42.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -140.32 128.44 22.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.699 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.5 ttp85 -101.09 -64.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -50.59 63.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.43 -50.79 68.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.222 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.1 m -62.25 -34.5 76.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.67 -23.47 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.378 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -30.36 21.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 0.0 111.001 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -31.44 64.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.421 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 2.2 t -69.65 -47.43 63.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.498 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 25' ' ' THR . 1.4 t -61.13 -55.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -40.27 11.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.74 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 t -76.47 -63.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 pt -51.9 -34.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.306 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -73.17 -29.09 62.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.08 -33.56 59.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.011 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' CE1' ' CG2' ' A' ' 59' ' ' ILE . 4.2 m-85 -93.73 -0.27 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.794 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.85 37.15 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.224 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -169.34 47.88 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.9 151.1 38.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.25 96.08 25.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.06 129.05 17.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.435 2.09 . . . . 0.0 111.992 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 t -125.27 162.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.287 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -128.36 98.93 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.731 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.67 126.97 48.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -84.62 128.45 34.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -97.16 104.22 16.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.602 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -60.06 137.03 23.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.289 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -84.23 -175.97 6.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.96 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.59 -11.83 60.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -85.88 -30.93 22.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.572 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.5 -30.5 4.01 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.271 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.24 165.99 1.8 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.158 0.504 . . . . 0.0 110.632 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -122.68 120.07 32.6 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.058 0.456 . . . . 0.0 111.026 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -96.67 118.52 33.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -64.67 106.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.71 131.99 56.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.154 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.1 tmm? -92.91 147.39 22.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -141.71 159.61 41.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.937 0.399 . . . . 0.0 111.082 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 mt -126.7 103.92 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.713 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -101.34 140.67 35.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.4 169.18 37.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -116.28 144.48 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 110.935 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.464 ' CG2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.43 139.9 21.56 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.9 60.52 5.38 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.535 2.157 . . . . 0.0 112.21 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.7 t -90.56 133.39 32.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.443 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.9 143.56 33.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.144 1.896 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -83.46 -77.01 0.26 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -110.82 -61.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.92 14.15 3.1 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.449 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -175.27 3.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.81 143.2 27.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.7 174.37 10.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -128.66 103.02 6.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.72 102.68 10.78 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.98 154.4 70.85 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.313 2.009 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 pt -155.78 156.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.238 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 130.19 53.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.42 137.84 43.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.79 145.95 50.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.686 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.49 165.26 18.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.64 165.55 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.98 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -27.79 15.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -173.35 -40.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -102.01 161.93 21.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.22 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.757 -0.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -105.45 -58.04 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 165.57 -53.93 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.967 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -42.91 119.14 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.803 2.335 . . . . 0.0 112.807 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.0 164.46 10.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.598 2.199 . . . . 0.0 112.301 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.8 mm -104.02 159.54 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.31 157.11 47.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.083 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG ' ' A' ' 108' ' ' LYS . 37.1 m-85 -146.62 170.24 17.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 m -124.76 77.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.732 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -49.01 105.13 0.47 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.52 -178.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.24 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.29 179.41 8.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.253 0.549 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 p -88.11 6.92 34.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.5 m -95.22 -58.87 2.02 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -178.57 3.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.2 t -109.87 -163.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.87 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 110.998 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.28 147.47 23.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.48 136.18 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.973 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.4 -166.24 36.04 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.788 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -26.29 48.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.152 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.455 ' CE1' ' CG2' ' A' ' 109' ' ' ILE . 2.4 t-80 -94.27 -28.17 15.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.083 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -134.34 68.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.058 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 103' ' ' VAL . 1.2 p-10 -47.56 -105.82 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.104 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.45 -54.42 2.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.703 0.287 . . . . 0.0 111.479 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -95.71 38.64 1.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.584 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.14 53.76 29.39 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.533 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.458 ' CG ' ' CE2' ' A' ' 88' ' ' PHE . 3.1 mtmm -102.78 133.72 47.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.455 ' CG2' ' CE1' ' A' ' 102' ' ' HIS . 5.3 mp -87.46 106.01 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.97 48.34 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.19 121.98 84.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.63 -19.15 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.53 2.153 . . . . 0.0 112.606 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -56.33 -54.33 46.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.0 111.082 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -30.86 71.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.012 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.57 -41.47 84.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.18 27.39 7.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -89.55 115.56 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 86.13 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.73 158.53 0.15 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -89.8 9.65 63.54 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.999 0.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.82 30.23 1.86 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.9 t -66.17 78.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.12 -172.38 2.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -57.44 -34.26 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.36 -53.38 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.806 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.42 -38.55 95.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.1 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.3 tp -54.21 -28.76 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mm -84.33 -29.01 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.802 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -40.51 95.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 131' ' ' MET . 2.1 p -59.92 -42.93 91.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.414 . . . . 0.0 110.496 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.412 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 10.4 mtt -65.98 -34.4 78.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.315 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mt -60.08 -30.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.514 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.03 -52.81 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 44.2 t -52.1 -49.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -80.38 -27.2 38.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.94 -24.86 68.84 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.512 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.96 -44.45 12.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.991 0.424 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -177.08 123.64 0.28 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.81 144.09 56.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.361 2.041 . . . . 0.0 112.35 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.75 -39.66 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.607 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 m -63.24 117.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.2 t80 176.64 -176.26 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.969 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.2 p -143.72 24.29 1.71 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.89 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -177.03 80.99 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.999 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.504 2.136 . . . . 0.0 112.384 179.862 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.656 0.265 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -122.64 70.81 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -72.83 164.03 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.421 . . . . 0.0 110.687 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.1 -31.26 69.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 111.085 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -51.96 51.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.785 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -59.19 -41.59 88.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.197 0.522 . . . . 0.0 111.312 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.01 -28.49 68.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -58.79 -48.43 81.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.966 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -61.85 -35.96 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.75 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mtp -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.0 m -108.3 19.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.705 0.288 . . . . 0.0 111.561 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.3 p -71.89 -29.14 64.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -74.12 -29.08 61.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.045 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.423 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 4.6 m-85 -58.59 127.58 32.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -31.51 69.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.092 0.473 . . . . 0.0 111.307 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . 5.1 m-85 -90.44 -55.18 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 66.67 -68.35 0.14 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.6 t0 -58.67 -53.16 61.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.102 0.477 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.32 -30.79 68.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.756 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.41 ' CG2' ' CD2' ' A' ' 76' ' ' LEU . 7.1 m -74.96 -53.03 9.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.011 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.5 -36.15 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.304 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -62.8 -52.25 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -63.05 -35.53 80.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 m -70.1 -35.66 74.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -81.56 -47.12 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.5 m-80 -53.23 -30.28 37.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.588 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.5 t -84.5 -61.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 pt -53.56 -38.98 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.557 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 t -68.55 -36.96 79.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 mp -77.54 -52.7 8.63 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.368 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 34' ' ' ASP . 20.4 m-85 -76.45 -17.93 59.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.034 0.445 . . . . 0.0 111.815 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 65.92 -61.57 0.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.318 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 32' ' ' TYR . 1.9 p30 -53.73 -37.03 62.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.849 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.05 129.07 38.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.778 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.72 145.28 52.87 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.18 155.45 22.48 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.673 2.249 . . . . 0.0 112.738 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 t -147.74 161.63 7.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.928 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -134.13 102.21 5.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.218 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -117.76 128.61 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.343 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -77.53 145.91 36.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.66 104.25 3.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -63.11 172.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -124.87 90.3 3.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.692 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.72 -72.59 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.845 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.84 37.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.78 -24.31 6.43 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.62 -167.51 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 0.0 110.788 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.3 m -127.47 105.34 8.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -91.07 126.82 36.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.223 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -88.84 91.08 8.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 110.567 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.01 153.94 21.16 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.211 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.4 mtp -105.36 145.74 30.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.392 . . . . 0.0 110.574 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -136.61 132.78 35.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.1 mt -101.49 116.13 32.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -117.68 143.79 45.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.802 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.71 164.09 31.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.444 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.5 p -113.97 140.0 48.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.859 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -121.48 156.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.356 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.44 136.73 60.82 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.839 2.359 . . . . 0.0 112.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -152.67 95.67 3.04 Favored Pre-proline 0 C--O 1.223 -0.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.002 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.59 130.43 29.9 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.067 1.845 . . . . 0.0 112.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -127.95 -74.78 0.57 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.07 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -96.5 38.77 1.19 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 -23.3 35.81 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.512 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -112.64 164.89 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 110.786 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -72.88 135.49 45.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.59 -169.01 1.46 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -138.18 94.64 2.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.987 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.0 mm -92.39 106.64 18.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.66 156.93 56.78 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.001 1.801 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.3 pt -158.18 178.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -146.0 160.21 42.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.72 162.44 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.774 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.86 145.69 52.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.41 ' CD2' ' CG2' ' A' ' 21' ' ' THR . 1.4 tp -136.84 160.88 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.11 167.37 16.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.342 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.1 m-20 -93.84 -40.76 10.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.2 p -159.88 -48.49 0.05 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.748 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.95 168.12 9.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.777 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -91.47 -33.5 0.99 Allowed 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.925 -1.281 . . . . 0.0 113.699 0.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 73.1 m-85 -82.36 -71.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.488 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 7.1 t30 129.79 -48.71 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 123.788 0.68 . . . . 0.0 111.069 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 60.5 Cg_endo -75.51 133.58 16.01 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.173 1.915 . . . . 0.0 112.334 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 138.75 41.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.725 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -99.75 159.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.501 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.3 m -126.36 141.72 51.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.935 0.398 . . . . 0.0 111.281 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.437 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 10.4 m-85 -142.33 -177.25 5.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.551 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -119.77 171.71 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 111.129 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -138.69 99.98 8.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 164.95 31.97 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.525 2.15 . . . . 0.0 112.162 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.79 177.11 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 0.0 110.996 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.4 t -83.75 -31.21 26.1 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -29.55 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.758 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -113.44 -178.47 3.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 5.5 t -125.1 -166.43 1.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.675 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.441 ' N ' ' OG1' ' A' ' 96' ' ' THR . 4.2 tt -115.39 120.85 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -76.16 127.38 32.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.014 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.2 p -98.69 129.86 45.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.63 -123.49 0.73 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.617 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -51.22 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.926 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -70.79 -46.3 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.284 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.04 77.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.107 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -50.58 175.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.361 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.35 -26.38 63.07 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.406 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -94.25 20.94 7.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.246 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.96 43.76 49.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.763 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.437 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 19.1 mtmt -106.12 124.79 50.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.738 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.407 ' CD1' ' CE ' ' A' ' 131' ' ' MET . 59.7 mt -66.02 110.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 111.081 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -123.96 94.34 4.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 mt -107.77 133.68 20.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.166 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.51 -32.48 96.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.38 2.053 . . . . 0.0 112.038 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.32 -52.39 64.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.68 -32.66 71.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.57 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -61.29 -43.78 98.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.547 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -98.41 25.7 6.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -98.56 129.47 45.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.88 103.78 5.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -52.37 178.08 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.55 4.0 5.1 Favored 'Cis proline' 0 C--N 1.356 0.968 0 N-CA-C 114.517 0.929 . . . . 0.0 114.517 1.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -1.8 14.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.1 t -93.49 155.18 17.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.875 0.369 . . . . 0.0 111.097 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.72 162.7 32.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -37.92 48.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mp -57.37 -51.75 68.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.753 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.09 -29.61 73.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.0 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 tp -56.98 -30.79 64.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.615 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mm -82.9 -26.7 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -64.82 -45.96 84.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 131' ' ' MET . 4.2 p -47.45 -45.63 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.443 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.3 mtt -62.97 -42.9 99.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.09 -27.12 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 111.032 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 t -94.21 -52.93 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.58 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.47 -36.46 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.495 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -81.53 -28.78 33.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.653 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.32 -11.75 62.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.637 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -45.82 7.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.678 0.239 . . . . 0.0 111.055 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.96 109.03 2.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.43 116.47 3.24 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.516 2.144 . . . . 0.0 112.199 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.83 44.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.091 2.527 . . . . 0.0 112.244 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.1 t -124.95 -7.19 6.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.862 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.39 -61.01 1.77 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.277 -0.264 . . . . 0.0 111.129 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 73.37 53.37 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.86 0.362 . . . . 0.0 110.856 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.98 88.66 17.68 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.103 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--O 1.248 0.979 0 C-N-CA 122.694 2.263 . . . . 0.0 112.469 179.747 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.764 0.316 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.5 44.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -59.46 166.05 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 110.799 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -33.32 74.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -36.3 83.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.41 . . . . 0.0 110.529 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.7 -30.82 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.696 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.89 -31.07 62.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -72.04 -46.76 55.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -31.27 67.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.7 ttm -63.49 -48.75 76.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.726 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.53 19.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.66 -42.96 39.96 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -70.78 -25.28 62.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.652 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.78 121.69 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.305 0.378 . . . . 0.0 111.149 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 tptt -60.13 -36.68 78.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.4 44.55 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -51.04 -52.42 43.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 111.018 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -54.04 -32.22 53.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.75 -29.03 18.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -78.05 -47.0 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.78 -38.16 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -45.67 53.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -62.5 -39.39 93.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.8 m -63.31 -59.15 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.39 -47.43 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.487 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.427 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 4.1 t-20 -57.58 -26.2 61.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.5 t -85.96 -27.86 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.377 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.19 -29.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.88 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.7 m -69.7 -46.45 65.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.505 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -40.81 67.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.953 0.406 . . . . 0.0 110.725 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -103.36 116.31 32.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.826 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 31.02 3.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.02 23.12 5.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.07 165.88 12.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.84 121.93 9.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 127.96 16.3 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.393 2.062 . . . . 0.0 112.428 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.6 t -123.76 162.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.771 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -146.84 110.06 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.56 141.36 52.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.37 116.39 28.94 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.381 0.425 . . . . 0.0 111.18 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -91.4 135.17 34.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.656 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -85.58 167.24 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.155 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' ASP . 48.6 m-85 -136.84 148.77 47.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.255 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.89 -63.44 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.073 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' PHE . 5.1 p30 176.3 -24.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.679 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.34 23.4 2.54 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.018 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.7 t -99.71 175.26 5.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 162.72 38.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.797 0.332 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.62 150.3 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.454 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -83.82 111.08 18.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.881 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.74 116.21 23.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.151 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -81.97 147.56 29.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -148.11 143.87 27.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 mt -108.75 116.51 32.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.75 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.6 m -116.38 145.53 43.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.61 175.83 32.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -100.31 147.24 26.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.1 mt -107.34 114.52 60.86 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.046 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.43 70.1 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.301 2.0 . . . . 0.0 112.1 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 m -89.96 144.68 31.8 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.454 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.34 153.89 76.12 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.188 1.925 . . . . 0.0 112.345 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -154.49 105.69 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 60.43 29.1 18.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.989 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.05 3.52 67.77 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.784 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -120.75 178.35 4.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.692 0.246 . . . . 0.0 110.87 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.54 131.57 44.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.726 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.21 163.08 22.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.829 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -121.74 123.5 41.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.7 mm -123.07 103.22 36.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.93 133.16 24.58 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.092 1.862 . . . . 0.0 112.305 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.95 167.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -131.0 134.62 46.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.45 137.85 44.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.979 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.52 144.44 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.777 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -138.51 160.06 40.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.68 163.83 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -43.41 23.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 80' ' ' TYR . 4.4 t 179.97 33.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 79' ' ' THR . 1.8 m-85 -153.91 151.31 24.53 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.649 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.7 -44.0 0.58 Allowed 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.173 -1.595 . . . . 0.0 112.357 0.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.409 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 72.2 m-85 -103.92 -60.81 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.557 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.428 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 5.8 t-20 162.88 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.58 0.55 . . . . 0.0 110.833 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 81.5 Cg_exo -45.34 108.65 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.497 2.132 . . . . 0.0 112.607 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.57 145.08 30.77 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.498 2.132 . . . . 0.0 112.211 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.5 mt -91.51 160.02 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.8 p -143.5 137.66 28.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 0.0 110.886 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -140.97 143.4 34.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.22 146.14 7.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.066 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.08 72.29 76.54 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.34 170.82 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.588 2.192 . . . . 0.0 112.312 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.22 176.99 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -72.77 -27.13 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -5.8 50.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.7 mtm -145.81 -174.79 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.65 0.262 . . . . 0.0 110.983 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.4 t -134.18 -164.68 1.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.266 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.445 ' CD1' ' CA ' ' A' ' 107' ' ' GLY . 11.3 tt -111.3 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -75.29 114.31 13.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 p -72.64 134.98 45.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.34 -118.66 1.26 Allowed Glycine 0 CA--C 1.515 0.083 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.672 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -31.69 11.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -118.26 -29.69 5.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.8 t -57.23 -27.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.566 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 56.55 -152.94 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.679 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 -40.9 5.97 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -93.46 3.66 55.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' CA ' ' CD1' ' A' ' 97' ' ' ILE . . . 91.5 4.85 67.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.134 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -60.18 108.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.768 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.65 66.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.205 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.409 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -92.38 57.57 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 110.856 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 mt -53.19 151.71 9.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.417 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.58 -45.83 31.24 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.573 2.182 . . . . 0.0 111.987 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -66.54 -39.58 88.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.99 -52.32 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.453 ' CD2' ' N ' ' A' ' 116' ' ' GLU . 2.8 p-80 -64.87 -35.86 82.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.669 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.453 ' N ' ' CD2' ' A' ' 115' ' ' HIS . 1.4 tt0 -95.95 26.0 4.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 118' ' ' LYS . 2.5 t90 -94.79 -71.12 0.68 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 2.6 tptt 80.29 -165.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.645 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.446 ' CB ' ' CA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -154.32 -175.9 0.55 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.241 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.446 ' CA ' ' CB ' ' A' ' 119' ' ' HIS . 17.0 Cg_endo -57.21 -16.98 1.43 Allowed 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 124.837 -0.901 . . . . 0.0 114.051 1.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -32.4 -49.17 0.2 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.3 t -46.25 158.27 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.067 0.461 . . . . 0.0 111.696 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -177.85 146.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -46.48 88.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.6 tp -51.81 -46.13 64.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.91 -31.34 35.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.632 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.13 -31.78 63.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp -86.73 -28.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.56 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.93 -38.65 82.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 131' ' ' MET . 1.9 p -61.65 -42.65 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.518 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.42 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 52.8 mtt -65.37 -42.73 92.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.05 -26.77 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.644 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 t -95.03 -54.89 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.668 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.3 -37.08 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.727 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -83.22 -28.08 29.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.403 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.21 -13.02 61.64 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.716 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -99.85 -45.24 5.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 0.217 . . . . 0.0 111.195 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.3 100.63 4.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.91 119.73 7.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.386 2.057 . . . . 0.0 112.166 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.62 -0.64 10.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.449 2.1 . . . . 0.0 112.847 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.6 t -93.21 -2.71 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.525 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 143' ' ' SER . 0.5 OUTLIER -39.42 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 111.459 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.465 ' N ' ' CG ' ' A' ' 142' ' ' PHE . 29.5 t -173.21 31.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.222 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -78.89 110.41 14.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.304 2.003 . . . . 0.0 112.361 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.938 0.399 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.2 t 66.17 42.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.982 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t 66.04 159.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.482 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.79 -29.31 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.989 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -54.19 -38.24 65.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.77 -45.83 73.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -59.32 -33.06 70.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.142 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.5 -50.95 71.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -32.7 73.94 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.488 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmm -70.14 -36.92 75.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.51 16.76 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.174 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -69.97 -35.67 74.63 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 111.129 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -29.08 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.644 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 4.2 m-30 -57.12 117.84 4.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -44.02 90.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CE1' ' OG1' ' A' ' 21' ' ' THR . 0.7 OUTLIER -95.55 33.93 1.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -49.18 -31.0 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.959 0.409 . . . . 0.0 109.996 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.65 -43.56 93.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.181 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -80.81 -25.45 37.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 0.0 110.144 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.456 ' OG1' ' CE1' ' A' ' 17' ' ' TYR . 18.7 m -74.15 -54.81 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.596 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.15 -30.0 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.054 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -44.67 18.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.076 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.17 -40.11 71.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.8 m -61.44 -47.86 83.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.481 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -60.87 -47.08 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.422 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 4.7 t-20 -57.53 -25.65 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.08 -58.26 7.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.212 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -19.48 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.454 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.65 -42.61 95.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.833 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' CD1' ' CD2' ' A' ' 32' ' ' TYR . 1.2 pp -88.04 -43.15 11.92 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 10.6 m-85 -107.93 109.16 20.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -89.71 64.8 6.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.423 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -145.65 -45.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.79 140.03 58.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 106.09 37.9 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.87 128.46 17.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.234 1.956 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -130.24 161.94 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.89 91.63 3.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.48 117.57 34.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 p -82.04 138.52 34.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -115.35 136.34 53.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -90.94 134.62 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.06 30.1 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.737 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 63.88 -77.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.5 -15.71 16.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 111.805 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 31.01 7.03 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.32 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.25 -170.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.6 p -121.57 130.25 53.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.06 160.32 15.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.805 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -94.95 99.23 11.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.436 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.2 mm? -104.43 139.07 39.9 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.7 ttp -89.87 146.12 24.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.832 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -139.29 130.94 27.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.4 92.3 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -95.3 135.25 37.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.68 -148.37 7.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.02 128.59 7.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 pt -107.09 151.13 40.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.53 132.73 27.94 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.432 2.088 . . . . 0.0 112.197 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.92 106.29 7.44 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.201 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.11 120.65 7.51 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.66 2.24 . . . . 0.0 112.208 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -131.28 113.21 13.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.979 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 66.4 11.34 7.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.52 -7.74 34.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.272 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.38 -177.44 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.131 0.466 . . . . 0.0 110.912 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.61 111.12 21.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.392 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -110.48 141.97 42.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -99.22 109.36 22.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.3 mm -97.77 100.3 8.2 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.051 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.41 146.68 63.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.282 1.988 . . . . 0.0 112.419 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 pt -157.2 156.39 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.5 m -116.16 145.7 42.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.58 91.2 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.999 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.29 144.73 56.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.19 173.44 6.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.705 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -139.44 -177.61 5.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' A' ' 79' ' ' THR . 2.4 p30 -107.91 -35.73 6.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.076 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 2.2 m 178.98 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.579 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.69 165.11 14.31 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.507 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.45 -39.75 1.38 Allowed 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.465 -0.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -103.01 -63.84 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.406 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 11.3 t-20 165.13 -51.36 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 33.3 Cg_endo -67.69 153.01 77.18 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.204 1.936 . . . . 0.0 112.508 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 162.83 40.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.609 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.12 105.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 58.6 m -62.49 149.41 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.39 148.38 26.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.639 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.0 m -103.33 127.35 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -107.01 87.4 2.95 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.089 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.41 -167.83 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.611 2.207 . . . . 0.0 112.296 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -131.8 177.13 7.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -28.66 69.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -30.94 15.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.75 137.02 32.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.754 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.21 -166.97 1.69 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 97' ' ' ILE . 1.3 tt -136.96 61.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 111.149 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.68 133.13 3.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.818 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.0 p -98.31 132.68 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.76 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.4 -118.76 1.74 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.582 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -100.05 -33.21 10.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -117.05 -38.69 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 t -55.09 -24.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.246 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.02 -155.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.177 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.16 -26.36 12.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.062 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.4 -2.06 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.697 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.27 39.12 52.84 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.613 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -88.58 2.69 52.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 111.559 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.0 mp 45.7 73.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.839 0.352 . . . . 0.0 111.691 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -85.74 55.53 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 mt -58.01 110.09 2.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.13 -36.17 54.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.396 2.064 . . . . 0.0 112.308 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -60.09 -53.32 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.09 -34.04 77.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.82 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.98 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.777 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 23.84 8.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.008 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.469 ' CE2' ' CB ' ' A' ' 122' ' ' SER . 2.8 t90 -115.82 -76.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.752 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.73 82.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.667 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 m80 62.44 170.56 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.046 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.91 3.76 69.46 Favored 'Cis proline' 0 C--N 1.351 0.699 0 C-N-CA 124.044 -1.232 . . . . 0.0 112.948 -0.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -104.58 -16.08 15.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.515 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.469 ' CB ' ' CE2' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -87.4 104.56 16.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.869 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -117.76 -179.51 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.92 -36.65 77.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.853 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.0 mp -63.35 -46.52 86.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.52 -26.81 53.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.339 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.35 -29.99 59.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 0.0 110.747 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.94 -32.58 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -58.59 -35.01 71.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 131' ' ' MET . 5.0 p -56.03 -46.18 80.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.45 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 6.0 mtt -66.77 -40.1 88.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.986 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.24 -23.55 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.899 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.09 -56.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.68 -38.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 140' ' ' PRO . 5.1 m-85 -85.81 -28.64 24.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.502 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.83 -24.49 66.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.44 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.69 -39.38 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.655 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.98 128.18 0.52 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.43 134.21 59.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 112.147 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.41 ' CG ' ' CE2' ' A' ' 135' ' ' PHE . 82.6 Cg_endo -79.8 -1.4 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.44 2.094 . . . . 0.0 112.49 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.3 m -105.72 118.29 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 110.599 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -177.51 164.63 2.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.6 t -92.82 62.84 3.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.33 87.85 0.34 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.36 2.04 . . . . 0.0 112.337 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.077 0.465 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p -110.15 -26.83 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.449 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t 65.39 142.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.219 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.11 -31.22 69.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 110.759 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -38.49 76.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.197 0.522 . . . . 0.0 110.75 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -42.24 47.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.372 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 tp -59.08 -40.51 85.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.05 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -55.46 -62.44 1.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.38 58.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.999 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -45.97 63.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.77 17.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.454 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.2 t -72.69 -28.76 62.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.054 0.454 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -26.93 68.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -51.97 130.91 30.74 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -56.41 -64.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 19' ' ' ASP . 40.7 m-85 -60.15 -58.48 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.675 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 66.84 -68.43 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.828 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' TYR . 2.6 m-20 -50.23 -47.15 55.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 mt -71.0 -36.4 72.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 m -70.13 -34.73 73.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.071 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.8 t -87.57 -28.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.396 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -80.11 -45.44 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -63.49 -37.76 88.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.7 m -64.56 -59.14 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.92 -47.65 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.5 m-20 -59.04 -27.64 65.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.35 -25.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.407 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -28.64 6.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.077 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -70.0 -43.61 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.021 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 tp -77.07 -31.61 56.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -114.37 116.17 28.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -9.24 58.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.579 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -97.3 25.0 5.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.605 0.24 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.98 141.56 48.32 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.99 126.26 12.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.43 155.34 63.94 Favored 'Trans proline' 0 C--O 1.222 -0.316 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 t -151.09 162.68 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -136.49 119.87 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.94 162.02 30.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.505 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.2 t -103.66 135.8 44.55 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.168 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -108.76 111.13 22.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.82 143.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.987 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -94.04 78.46 4.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.352 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 p30 46.33 43.29 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.373 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 65.68 22.72 11.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.084 0.469 . . . . 0.0 111.104 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.59 -13.85 8.51 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.526 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.0 t -178.14 -165.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.737 0.304 . . . . 0.0 111.198 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -158.56 165.76 33.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.593 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.36 144.85 18.7 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.794 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 112.03 6.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.736 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -117.92 128.91 55.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.878 0.371 . . . . 0.0 111.05 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.9 ttp -96.38 150.32 20.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.23 149.27 34.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.0 mt -113.56 112.26 23.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.9 m -109.0 134.86 51.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.729 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.2 -156.25 9.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.489 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.23 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.8 136.51 29.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.29 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.76 80.36 3.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.827 2.351 . . . . 0.0 112.558 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.62 148.2 34.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 128.29 16.01 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.451 2.101 . . . . 0.0 112.432 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.5 108.46 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 80.18 -10.96 1.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.78 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.16 -17.02 3.4 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.12 172.93 7.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -65.64 150.04 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 148.89 29.4 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.732 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.76 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.819 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.0 mm -108.27 104.91 55.43 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.053 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.58 140.3 51.51 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.303 2.002 . . . . 0.0 112.505 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 pt -148.86 173.46 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 11.0 m -132.54 170.59 14.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.19 145.03 38.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.3 145.72 48.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 111.195 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 2.7 mm? -127.28 171.3 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.72 162.55 31.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.249 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.96 -30.9 10.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.13 -41.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -127.9 106.59 20.31 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.181 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.85 167.85 33.23 Favored 'Cis proline' 0 C--N 1.351 0.691 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.12 -0.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 25.99 9.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.3 OUTLIER 175.15 -61.31 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 83' ' ' ASN . 17.0 Cg_endo -61.18 109.83 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.6 2.2 . . . . 0.0 112.458 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.54 143.26 13.48 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.618 2.212 . . . . 0.0 112.701 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mt -84.65 161.39 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.7 m -141.59 155.42 45.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -157.89 143.38 16.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.457 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.06 -175.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.547 . . . . 0.0 111.266 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 5.6 tttm -158.42 51.86 0.49 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 56.1 Cg_endo -69.35 -167.16 0.2 Allowed 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.1 p -124.0 151.28 43.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -17.14 62.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.809 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -93.58 -15.09 25.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.869 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.441 ' O ' ' CG2' ' A' ' 96' ' ' THR . 3.6 tmm? -118.57 -8.56 10.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 95' ' ' MET . 13.8 t 46.98 -163.45 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.065 0.46 . . . . 0.0 111.306 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tt -135.54 132.69 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.26 133.11 41.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.689 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.5 p -85.58 131.4 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.966 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.5 -152.98 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -56.8 4.51 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.807 0.337 . . . . 0.0 110.648 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -85.66 -34.28 21.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.0 t -95.86 72.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.128 0.489 . . . . 0.0 111.047 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -176.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.27 -23.88 67.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.439 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.39 27.06 9.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.97 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 40.87 55.3 3.38 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.967 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.401 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 2.6 tttp -81.82 11.48 4.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.851 -0.205 . . . . 0.0 111.51 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 108' ' ' LYS . 0.6 OUTLIER 44.96 45.66 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -68.18 72.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.679 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.77 158.83 47.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.48 -36.03 4.29 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.623 2.216 . . . . 0.0 112.43 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -65.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -29.6 61.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.699 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.82 -43.15 89.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -96.81 24.08 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.977 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.426 ' NE1' ' CB ' ' A' ' 122' ' ' SER . 6.2 t90 -80.91 120.03 24.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -131.97 10.4 4.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.624 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 118' ' ' LYS . 4.2 p80 53.21 160.24 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -98.83 12.43 29.01 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.664 0.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -59.55 -54.96 40.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.763 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.426 ' CB ' ' NE1' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -82.64 144.06 30.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 111.374 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -139.4 175.22 9.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.543 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.01 -38.55 73.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mp -57.8 -47.17 83.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.619 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.48 -24.83 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.2 -30.54 64.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 110.741 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.74 -30.8 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.61 97.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 131' ' ' MET . 2.7 p -58.09 -43.04 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.428 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 0.1 OUTLIER -63.59 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.368 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -27.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.616 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.08 -51.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.677 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.54 -41.91 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.639 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -81.26 -27.91 34.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.455 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.9 -23.34 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.46 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -30.76 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.039 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -146.27 83.86 8.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.27 152.44 61.35 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.78 2.32 . . . . 0.0 112.101 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.3 -31.79 13.71 Favored 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.278 1.985 . . . . 0.0 112.154 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 142' ' ' PHE . 84.0 t -59.45 162.35 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.01 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.414 ' N ' ' CG1' ' A' ' 141' ' ' VAL . 11.1 t80 179.85 -80.01 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.654 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 53.46 23.57 3.49 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.68 88.21 0.12 Allowed Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.01 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.246 0.913 0 C-N-CA 122.578 2.185 . . . . 0.0 112.338 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.984 0.421 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.45 66.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.393 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 m -110.73 -170.02 1.56 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.528 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.74 -36.46 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -60.13 -37.79 81.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -71.14 -31.9 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -46.39 86.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.972 0.415 . . . . 0.0 111.029 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.06 -51.02 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.841 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -61.33 -30.88 70.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.3 mtp -67.74 -30.74 70.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.39 20.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.0 p -67.98 -24.59 65.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -58.08 -44.8 87.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -61.75 175.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.49 -31.05 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -62.99 -69.72 0.25 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 66.68 -69.43 0.12 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -44.72 95.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.051 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.3 mt -68.0 -36.46 80.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.995 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.5 m -62.89 -31.32 72.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.1 t -90.56 -27.14 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -45.23 19.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -67.68 -43.71 79.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.858 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.8 t -58.43 -48.02 82.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.18 0.514 . . . . 0.0 110.793 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG2' ' A' ' 25' ' ' THR . 0.4 OUTLIER -60.4 -47.08 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.422 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -51.78 -29.96 21.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.338 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.04 -63.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pt -56.68 -25.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.339 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.7 m -80.29 -31.08 38.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.75 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mt -86.54 -20.11 28.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -126.91 136.56 52.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.35 27.11 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 111.191 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.47 8.68 3.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.348 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.11 130.41 56.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.532 0.206 . . . . 0.0 110.717 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -129.81 146.13 60.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.97 146.63 32.99 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.967 2.445 . . . . 0.0 112.706 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -135.54 162.2 37.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.717 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -132.16 123.8 27.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -139.21 129.64 25.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 p -91.3 148.2 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.63 147.48 48.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.982 0.42 . . . . 0.0 110.652 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.5 m -106.86 150.08 9.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 111.155 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -93.08 73.99 4.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.97 41.06 21.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.966 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 61.44 24.24 14.38 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.35 8.96 12.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.796 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.46 -170.96 0.14 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.92 131.76 12.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.643 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.28 153.38 47.04 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.93 95.01 7.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.83 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tp -96.67 161.32 13.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.817 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.2 ttp -121.11 158.22 28.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -154.17 150.71 28.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mt -123.51 134.6 53.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -121.05 156.76 31.51 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.153 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.25 173.28 33.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.487 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.6 p -133.8 128.0 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -86.75 111.45 40.03 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.399 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.52 96.88 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.662 2.241 . . . . 0.0 112.409 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.45 141.36 27.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.275 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.26 157.34 50.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.294 1.996 . . . . 0.0 112.37 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -157.56 110.07 2.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 58.87 28.22 17.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.227 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.55 5.75 66.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.9 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -116.08 -168.45 1.43 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 110.618 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.02 123.78 50.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 7.6 t80 -121.51 162.75 19.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.711 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -140.18 123.86 17.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.439 ' CD1' ' CE2' ' A' ' 68' ' ' TYR . 5.2 mm -101.94 100.86 15.98 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.03 109.55 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.163 1.909 . . . . 0.0 112.105 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 pp -123.35 143.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -107.17 167.87 9.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.29 137.98 47.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.406 ' CD1' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -114.63 145.95 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.17 158.12 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.07 174.67 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -97.38 39.95 1.17 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.592 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 72.24 10.61 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.97 158.77 58.37 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.775 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.57 -44.28 0.55 Allowed 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.193 -1.586 . . . . 0.0 112.158 0.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 47.2 m-85 -78.78 -71.52 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 23.0 p30 146.13 -30.91 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.639 0.776 . . . . 0.0 112.185 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 48.0 Cg_exo -57.24 135.47 70.54 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.912 1.741 . . . . 0.0 112.243 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.96 133.76 18.73 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.402 2.068 . . . . 0.0 112.358 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.24 147.68 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.7 t -139.98 131.28 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' CE2' ' CD1' ' A' ' 75' ' ' TRP . 20.7 m-30 -116.5 -176.19 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.16 87.17 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 109.47 1.73 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.54 -167.97 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.251 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.5 p -149.05 173.85 12.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.089 0.471 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -67.37 -24.6 65.71 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.035 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -47.63 80.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.184 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -167.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.063 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -126.93 -146.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.588 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -123.62 123.01 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.875 0.369 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -85.12 162.29 19.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.768 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 p -141.1 132.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.39 -86.5 0.13 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.942 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -71.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -162.95 63.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.25 0.548 . . . . 0.0 111.021 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.57 -7.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.708 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.82 -153.86 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.16 -29.51 10.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.463 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -104.95 27.21 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.76 45.35 52.92 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.704 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.38 142.19 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.743 -0.269 . . . . 0.0 110.954 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.84 98.45 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -99.63 40.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.63 139.07 68.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.974 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.17 -25.01 10.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.49 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -48.69 76.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.96 -31.66 59.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.794 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.7 -35.8 79.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.79 20.02 12.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -117.3 121.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 110.799 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.81 126.88 44.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.629 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -52.42 160.16 1.4 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.334 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' GLN . 1.2 Cg_endo -83.22 142.08 43.67 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.208 0.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 120' ' ' PRO . 3.1 mt-30 141.92 -31.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -76.91 120.84 22.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.984 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -136.31 178.29 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.1 mt -84.05 -19.47 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mp -67.11 -43.09 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.41 -36.91 8.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 tp -54.93 -27.97 47.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -90.26 -31.04 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.4 -33.15 65.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.647 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 131' ' ' MET . 4.2 p -57.54 -45.53 86.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.446 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 31.2 mtt -67.94 -38.46 82.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.072 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -55.12 -25.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.4 t -95.07 -53.1 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.676 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.99 -44.54 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -83.3 -23.16 32.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.268 0.556 . . . . 0.0 110.987 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.12 -28.61 73.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.359 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.96 -38.76 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -176.58 113.09 0.25 Allowed Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.895 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.08 136.5 67.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.194 1.929 . . . . 0.0 112.135 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.75 -21.71 5.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.63 2.22 . . . . 0.0 112.345 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.653 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 6.4 t -50.52 171.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.653 ' CB ' ' O ' ' A' ' 141' ' ' VAL . 4.5 t80 102.44 176.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.032 0.444 . . . . 0.0 110.375 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -94.12 50.35 1.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 63.8 88.74 0.11 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.67 2.246 . . . . 0.0 112.393 179.802 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.891 0.377 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.89 -63.11 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 63.47 143.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.762 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -31.95 73.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -60.04 -46.94 87.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 0.0 110.815 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.26 -42.54 99.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.239 0.542 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.23 -51.09 60.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.145 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -58.86 -24.24 61.89 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.192 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -21.42 42.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.016 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.0 mtt -73.93 -43.37 58.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 m -91.99 0.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.701 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -60.14 -31.95 70.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -26.17 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.977 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 10.9 m-85 -56.75 156.35 6.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -85.53 -54.54 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 23.2 m-30 -90.25 69.03 7.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -56.44 11.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.226 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.53 -58.67 7.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 111.048 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.58 -26.45 43.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.352 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.6 m -86.0 -55.09 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.243 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.65 -33.54 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.324 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.37 -47.49 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.702 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -67.33 -29.66 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.1 m -78.37 -30.8 48.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -84.16 -46.65 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.218 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.404 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 7.6 t-20 -52.32 -36.52 53.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.378 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.8 t -74.83 -62.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.192 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -57.5 -43.42 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.8 m -58.99 -42.71 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tt -73.8 -41.66 62.04 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 121.173 0.511 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -104.95 104.91 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.781 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.1 61.86 6.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -142.78 -44.34 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.801 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.61 168.13 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.828 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 143.23 18.91 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.63 134.46 26.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.639 2.226 . . . . 0.0 112.18 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.5 t -127.16 162.45 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.01 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -138.2 128.14 25.5 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -153.4 129.16 10.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.324 0.583 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -74.05 157.6 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.07 103.74 3.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.93 137.24 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -82.89 162.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.537 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -80.42 -1.76 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.42 -28.85 24.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.616 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.41 -35.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -92.96 164.96 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -124.95 -178.1 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.138 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -167.43 135.47 2.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.77 111.69 18.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.29 138.23 46.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.315 0.579 . . . . 0.0 110.555 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -85.45 142.37 29.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -135.28 148.71 49.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.039 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.32 120.82 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 m -115.95 158.91 22.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.1 -179.35 28.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.342 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.4 p -124.32 152.8 42.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.935 0.397 . . . . 0.0 111.007 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mt -123.47 137.02 27.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.072 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.75 104.1 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.22 1.947 . . . . 0.0 112.0 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.1 121.65 17.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.94 146.78 55.48 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.368 2.046 . . . . 0.0 112.29 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -106.01 -75.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.087 0.47 . . . . 0.0 110.897 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 26.0 2.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.05 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.28 3.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.79 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -123.1 174.02 7.5 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -91.8 123.67 35.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -120.35 161.77 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -112.34 99.97 8.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.63 110.21 20.93 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.21 145.08 43.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.262 1.975 . . . . 0.0 112.298 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 pt -155.69 153.06 7.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.9 m -113.52 169.18 9.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.624 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 146.81 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.2 155.92 49.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.07 174.58 8.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.099 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -96.31 39.55 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.418 ' OG1' ' CE2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER 76.63 6.85 3.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -152.94 150.81 25.07 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.927 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.77 -37.74 1.36 Allowed 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.409 0.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.603 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 88.3 m-85 -60.9 -80.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.603 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 8.7 t-20 135.89 -51.89 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 123.395 0.678 . . . . 0.0 111.052 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 67.9 Cg_endo -75.59 128.54 11.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.395 2.063 . . . . 0.0 112.34 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 135.94 71.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.456 2.104 . . . . 0.0 112.529 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.73 160.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.729 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.09 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 111.296 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.454 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 6.5 m-85 -130.83 143.33 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.1 p -97.67 138.72 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.956 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -130.36 68.94 81.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.53 -178.68 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.471 2.114 . . . . 0.0 112.256 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -82.81 165.41 19.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -86.28 -13.71 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.461 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -95.07 -27.92 15.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 0.0 110.586 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 13.5 ttm -89.53 -25.07 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.98 149.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.823 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tt -95.18 109.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.05 130.86 37.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.19 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.8 p -75.2 136.56 41.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.981 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.68 -157.37 7.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.562 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -35.48 70.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -105.77 -39.25 6.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 m -84.38 85.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.406 ' OD2' ' CD2' ' A' ' 110' ' ' TYR . 15.3 m-20 -60.76 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.13 5.14 31.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -131.84 30.11 4.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 0.0 111.173 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 51.53 51.21 38.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.8 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -119.21 93.0 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.033 0.444 . . . . 0.0 110.768 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.29 108.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.016 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 1.3 m-85 -101.72 51.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.5 mt -59.49 119.02 36.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.806 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 -27.43 27.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.426 2.084 . . . . 0.0 112.296 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -58.83 -29.43 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 tp -91.81 -34.32 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -67.21 -37.5 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -98.44 28.32 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.421 ' NE1' ' N ' ' A' ' 122' ' ' SER . 1.8 t90 -96.71 -80.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 75.6 120.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.201 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -45.75 179.39 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.688 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.442 ' CA ' ' CB ' ' A' ' 119' ' ' HIS . 61.3 Cg_endo -91.0 37.53 5.11 Favored 'Cis proline' 0 C--N 1.357 0.974 0 C-N-CA 125.035 -0.819 . . . . 0.0 113.864 0.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -21.7 12.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.831 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.421 ' N ' ' NE1' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -64.24 160.49 18.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 111.483 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 179.95 -177.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.587 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mt -84.57 -34.49 23.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -47.46 57.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.65 -25.77 55.64 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.366 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.37 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -90.48 -27.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.709 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.17 -33.2 75.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.701 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 131' ' ' MET . 2.7 p -66.5 -41.86 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 0.0 110.653 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.419 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.3 mmt -67.48 -44.38 78.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.2 tt -52.77 -26.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.03 -54.1 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.53 -38.32 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -83.86 -26.7 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.05 -18.74 65.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.534 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -48.93 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.56 111.19 1.65 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.0 139.07 79.67 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.991 . . . . 0.0 112.192 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.78 1.62 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.698 2.265 . . . . 0.0 112.658 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.9 -47.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.409 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 51.35 172.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.274 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 142' ' ' PHE . 1.1 p -173.34 38.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.845 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 43.92 89.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.358 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo . . . . . 0 C--O 1.25 1.089 0 C-N-CA 122.66 2.24 . . . . 0.0 112.291 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -95.61 -28.59 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.5 145.34 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.793 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.62 72.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -49.76 75.75 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.524 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.95 -49.34 68.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -58.73 -29.67 66.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.927 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -55.2 36.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -70.15 -29.56 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.426 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmm -62.56 -49.18 76.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.044 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -101.35 19.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.487 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -67.09 -29.75 69.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.822 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -31.22 68.08 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 3.4 m-30 -56.91 129.73 42.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -62.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 19' ' ' ASP . 2.8 m-85 -63.63 -55.25 25.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.829 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 66.97 -67.41 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -49.38 -49.62 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -48.31 79.89 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.512 0.507 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -66.97 -31.93 72.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -79.94 -25.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.131 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -79.01 -47.02 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -67.13 -43.46 82.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.7 t -58.44 -47.46 83.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -62.44 -46.99 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.776 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -51.72 -32.58 30.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.274 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.85 -66.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.9 -28.33 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.384 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.0 m -70.25 -33.53 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.62 -34.43 15.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -102.11 122.63 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.88 3.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.6 15.75 2.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.416 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 167.64 11.24 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.832 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -152.4 137.03 10.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.12 159.7 40.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.601 2.201 . . . . 0.0 112.115 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 t -150.6 161.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.058 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -129.42 122.35 29.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -138.03 161.45 36.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.401 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.09 152.15 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.72 88.44 2.68 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.142 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.47 163.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.947 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.39 76.91 1.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 57.22 54.68 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 44.95 32.14 0.79 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.403 0.62 . . . . 0.0 110.885 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.71 -19.23 7.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.449 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.8 -167.79 0.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.192 0.52 . . . . 0.0 110.477 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -153.41 123.08 6.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -123.53 120.15 32.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -59.73 142.08 53.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 tp -147.01 141.54 26.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.251 0.548 . . . . 0.0 110.997 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.7 ttp -107.21 139.57 41.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.769 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.77 157.46 46.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mt -124.58 128.4 48.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.5 m -124.24 134.31 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.15 169.57 37.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.71 139.39 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.07 156.43 48.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.45 134.96 34.87 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.489 2.126 . . . . 0.0 112.211 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 70' ' ' ILE . 98.1 t -143.27 106.22 5.16 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.74 134.71 41.76 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.794 2.329 . . . . 0.0 112.252 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -167.85 116.27 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER 81.21 -10.24 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.039 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.06 -6.99 7.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.573 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.77 175.13 6.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 114.63 28.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -94.18 148.15 22.47 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.17 104.3 16.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 ' CG1' ' CG2' ' A' ' 61' ' ' VAL . 31.6 mm -102.45 98.88 11.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.44 153.55 73.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.469 2.113 . . . . 0.0 112.189 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 pp -159.21 154.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.403 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 43.2 t -105.13 150.01 25.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.68 142.67 51.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -127.62 139.95 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -128.22 170.4 13.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.15 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.68 165.75 18.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.08 -39.42 75.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.794 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.42 ' O ' ' CG ' ' A' ' 80' ' ' TYR . 1.5 t 173.37 -34.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.181 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 79' ' ' THR . 11.8 m-85 -166.07 163.39 12.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.771 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -92.78 -0.59 54.19 Favored 'Cis proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.237 -1.151 . . . . 0.0 112.647 0.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -87.2 51.7 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.631 0.253 . . . . 0.0 111.062 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -40.99 -51.63 7.26 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.68 115.52 4.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.217 1.945 . . . . 0.0 112.105 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.97 167.67 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.0 112.591 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.438 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 3.6 mp -104.07 159.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.6 p -133.53 126.08 30.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.051 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 21.7 m-85 -131.72 161.63 32.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.78 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -133.54 129.78 56.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.0 110.879 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 80.49 50.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.52 164.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.448 2.098 . . . . 0.0 112.588 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.0 p -87.23 172.57 9.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.824 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -59.83 -20.78 58.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 m -54.42 -58.93 5.53 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.032 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.02 177.03 5.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.048 0.451 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 t -94.19 -137.74 0.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.592 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.493 ' CG2' ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -152.1 111.25 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.317 0.58 . . . . 0.0 111.382 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -101.78 133.83 45.89 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.142 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -173.48 -177.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 111.487 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' A' ' 99' ' ' THR . . . 153.63 -17.92 0.67 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.302 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -54.89 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.551 0.215 . . . . 0.0 111.279 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -129.96 -34.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.7 t -77.46 -16.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.454 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.422 ' N ' ' OG1' ' A' ' 99' ' ' THR . 2.5 m-20 53.01 170.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.84 0.352 . . . . 0.0 111.455 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.47 -19.09 62.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.609 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.43 24.63 4.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.24 23.53 18.19 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.066 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.47 125.7 37.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.546 -0.385 . . . . 0.0 110.481 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.34 108.73 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 111.291 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -104.31 31.66 4.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.115 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mt -51.72 152.01 5.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.599 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.82 -32.12 67.32 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -31.51 66.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.684 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -86.97 -42.71 12.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.13 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.33 -36.26 83.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.059 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.99 37.01 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.422 ' NE1' ' CB ' ' A' ' 122' ' ' SER . 1.6 t90 -80.44 114.96 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.575 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -149.38 111.1 4.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -50.69 159.68 0.88 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.023 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -87.76 -14.13 31.61 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.9 -1.291 . . . . 0.0 112.874 0.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -26.93 5.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.079 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.422 ' CB ' ' NE1' ' A' ' 117' ' ' TRP . 23.3 p -74.57 156.41 36.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 177.49 153.87 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -43.8 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.48 -42.37 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.766 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.46 56.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.254 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.2 tp -56.54 -36.58 69.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.717 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.2 -23.99 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.653 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -69.3 -33.41 73.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.676 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 131' ' ' MET . 3.6 p -63.51 -42.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.428 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 4.6 mtt -64.77 -43.76 92.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -53.77 -25.05 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.39 -52.69 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.503 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.09 -36.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.375 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -83.3 -26.1 30.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.244 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.22 -15.07 72.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.61 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.4 -36.14 11.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.803 0.335 . . . . 0.0 110.642 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -153.39 85.8 4.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.45 111.11 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.652 2.235 . . . . 0.0 112.727 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.9 50.0 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.857 2.371 . . . . 0.0 112.082 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.15 -7.66 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.37 -159.33 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.3 p -57.07 -125.89 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.8 tpt85 67.54 61.55 0.78 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.644 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.783 2.322 . . . . 0.0 111.922 -179.831 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.641 0.257 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 m -110.91 66.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.759 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -22.69 11.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -82.36 -34.67 28.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -81.5 -32.92 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.937 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -70.67 -42.07 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.633 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -59.88 -44.57 94.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.457 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.2 66.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.801 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -72.93 -29.01 62.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.97 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -88.62 -35.86 16.61 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.0 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -88.54 8.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.632 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 p -79.22 -29.55 42.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.912 0.387 . . . . 0.0 110.809 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -69.81 -17.89 63.43 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.533 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -51.17 167.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.821 0.343 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -47.85 8.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -84.24 -58.08 2.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 66.54 -68.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 17' ' ' TYR . 21.6 t70 -52.78 -29.9 30.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.195 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.9 -39.44 18.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -47.73 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.9 t -61.68 -39.62 83.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -63.31 -50.57 69.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.269 0.557 . . . . 0.0 111.173 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.68 -47.04 88.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.944 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -58.8 -50.65 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -58.78 -47.37 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -53.31 -33.22 52.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.446 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.95 -58.98 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 pt -59.83 -34.54 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -67.52 -38.01 83.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.831 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.39 -30.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.35 124.99 50.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.302 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.95 68.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -168.62 -41.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.56 129.39 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.803 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.85 101.44 53.49 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.883 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.05 139.71 33.64 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.453 2.102 . . . . 0.0 112.385 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 t -132.18 162.08 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -118.75 124.07 46.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -149.2 127.33 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.866 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -90.91 159.26 16.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -112.3 104.77 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 110.727 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.61 158.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -114.33 74.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.4 p30 44.74 52.09 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.543 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.86 23.5 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.919 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.77 -14.1 14.74 Favored Glycine 0 N--CA 1.459 0.228 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.319 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -177.38 -169.43 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.719 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.4 107.39 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.429 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 134.14 41.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.78 123.73 24.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.36 155.08 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.5 ttp -118.44 149.93 40.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.41 160.7 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mt -127.08 118.72 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.958 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.9 155.84 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 161.04 172.0 27.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.481 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.52 124.82 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.0 111.248 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 pt -104.0 150.91 38.78 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.189 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.83 149.46 66.46 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 112.257 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -155.7 107.57 2.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.199 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -52.23 111.78 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.151 1.9 . . . . 0.0 112.293 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -110.45 97.43 6.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 57.49 24.97 10.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.68 -15.97 28.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.815 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.94 177.89 5.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -114.14 111.25 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.064 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.12 -173.7 2.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.097 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -146.98 87.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.063 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 3.2 mp -89.09 107.51 18.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.18 160.24 50.66 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.556 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 pp -159.22 163.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 158.88 28.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.737 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.83 135.18 45.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -121.35 134.17 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mt -133.13 156.75 46.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.06 162.77 24.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' A' ' 79' ' ' THR . 4.8 p-10 -60.3 -44.11 95.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.676 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 3.0 m -177.39 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.56 157.74 55.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.86 -47.37 0.31 Allowed 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.307 -1.539 . . . . 0.0 112.569 0.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 80.3 m-85 -87.91 -67.66 0.81 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 4.6 m-20 156.82 -52.44 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.779 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 87.2 Cg_exo -44.52 143.49 3.87 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.744 2.296 . . . . 0.0 112.774 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.25 138.56 10.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.0 112.445 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mp -83.38 160.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.4 t -134.97 141.71 46.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.028 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -138.76 -179.86 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 p -128.25 149.19 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.36 87.83 14.41 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.7 148.46 15.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.527 2.152 . . . . 0.0 112.398 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.65 -176.71 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.0 t -77.88 -31.83 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.688 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -73.56 -56.97 4.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.7 mtm -91.54 179.3 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -130.09 -98.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.41 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.3 OUTLIER -175.5 126.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.29 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.15 116.08 29.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.5 p -86.27 134.07 33.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.43 -63.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.43 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -100.03 -71.31 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.45 ' CD2' ' CD2' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -120.71 -15.67 8.37 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.48 70.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.661 0.267 . . . . 0.0 111.583 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' OD2' ' CD1' ' A' ' 110' ' ' TYR . 70.6 m-20 -52.04 -176.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.25 68.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.19 19.64 10.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 53.99 29.39 43.24 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -83.87 113.31 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.805 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.2 mp -69.78 110.19 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.21 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 3.8 p90 -132.92 46.98 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.481 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 102' ' ' HIS . 1.3 mp -44.67 148.95 0.84 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.644 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -30.85 10.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.564 2.176 . . . . 0.0 112.017 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -60.34 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.98 -30.91 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.418 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -58.86 -55.64 32.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.02 31.02 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.608 ' O ' ' CB ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -81.05 -64.37 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.589 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 117' ' ' TRP . 1.0 OUTLIER 109.58 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.915 0.76 . . . . 0.0 110.053 -179.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 118' ' ' LYS . 1.4 m80 -175.95 175.77 0.66 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.392 -0.193 . . . . 0.0 110.746 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.42 -2.32 57.99 Favored 'Cis proline' 0 C--N 1.354 0.83 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.049 0.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -25.3 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.381 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.415 ' N ' ' NE1' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -70.13 66.21 0.27 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.015 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -93.17 168.89 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 tp -57.76 -39.68 77.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mp -49.28 -43.16 42.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.54 -26.86 49.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.256 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.87 -31.74 67.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -88.02 -28.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.564 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -61.34 -35.86 78.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 131' ' ' MET . 2.3 p -65.19 -39.94 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.402 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 10.0 mtt -68.74 -44.59 73.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.858 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.2 tt -52.65 -24.53 6.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.204 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -92.98 -56.48 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.529 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.63 -46.95 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.543 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -74.9 -27.79 60.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.53 -15.54 64.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.592 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -89.78 -48.66 7.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.81 137.35 7.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.74 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -55.66 105.97 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 112.338 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.62 -12.85 37.54 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.227 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.56 -13.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.605 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -68.42 179.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.98 44.17 1.04 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 61.2 154.84 0.11 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.237 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.252 1.18 0 C-N-CA 122.657 2.238 . . . . 0.0 112.282 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.698 0.285 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.93 31.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -25.65 58.88 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.022 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.27 -34.42 14.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -72.27 -35.35 68.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.73 -32.66 57.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -28.39 70.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -29.47 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.292 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -73.65 -28.13 61.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.988 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 ptm -85.62 -35.22 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.87 11.57 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.561 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -23.19 63.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.055 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -26.67 25.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.409 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 8.5 m-85 -54.52 134.19 46.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -67.5 -49.41 63.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -90.7 66.44 6.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -60.73 3.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.325 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -51.45 -53.28 38.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.094 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.03 -41.24 99.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.0 m -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.31 -31.74 10.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -72.27 -48.42 42.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.39 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.6 m -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.078 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -85.78 -47.81 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 2.4 m-20 -55.42 -28.72 56.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.474 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.82 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.427 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.9 pt -57.38 -33.76 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.567 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 t -75.47 -32.69 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.04 -38.91 51.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.858 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -99.26 -20.56 16.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.1 mttp 67.31 -59.88 0.39 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.639 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' TYR . 3.1 m-20 -45.69 -35.88 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.885 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.38 132.52 51.75 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 111.059 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -129.95 117.97 18.4 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.7 140.68 91.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.401 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 t -131.34 162.81 38.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -133.4 95.18 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.862 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.24 118.6 35.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.08 145.52 49.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.296 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -117.67 119.93 36.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.596 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.0 152.38 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 111.188 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -121.17 107.95 13.19 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.355 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 46.94 29.69 1.09 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 64.09 15.82 9.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.369 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.6 -13.86 66.69 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.175 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.454 ' CB ' ' CE2' ' A' ' 44' ' ' PHE . 0.5 OUTLIER 173.77 -168.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.08 131.22 17.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.07 127.99 55.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.421 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -74.49 101.09 4.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -108.65 138.99 44.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.556 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 65.8 ttp -84.85 149.2 25.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -149.98 117.8 6.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.982 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.37 107.65 17.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.522 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 m -108.5 149.73 28.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.4 165.42 20.5 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -107.29 120.63 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.604 0.24 . . . . 0.0 110.752 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.76 126.35 37.35 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.456 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.11 126.61 22.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.417 2.078 . . . . 0.0 111.952 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.84 136.69 28.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.215 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.16 150.98 62.28 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.433 2.089 . . . . 0.0 112.094 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -176.76 116.46 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 58.48 25.1 12.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.27 3.18 75.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.75 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -124.74 176.9 6.28 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 133.91 47.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -165.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -143.53 98.04 3.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.995 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.0 mm -100.92 101.8 17.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.23 136.25 24.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.486 2.124 . . . . 0.0 112.53 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.5 pt -134.81 167.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 108.62 10.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.935 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mt -85.44 98.66 10.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.086 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.66 146.9 32.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.569 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -126.97 170.87 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.69 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.44 166.25 25.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.38 0.61 . . . . 0.0 110.715 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -39.27 24.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.77 163.11 27.14 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.62 -62.58 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.187 -0.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 25.4 m-85 -105.03 -56.09 2.23 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.619 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.572 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.9 p-10 161.83 -34.37 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.369 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 28.5 Cg_exo -62.09 116.99 3.83 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.968 1.778 . . . . 0.0 112.269 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.17 166.94 23.35 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.39 2.06 . . . . 0.0 112.199 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.417 ' CG2' ' CE1' ' A' ' 88' ' ' PHE . 1.2 mp -103.95 164.03 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.066 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.67 53.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.814 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CE1' ' CG2' ' A' ' 86' ' ' ILE . 30.6 m-85 -48.73 125.42 10.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.182 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.5 m -81.6 127.0 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.253 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -127.44 89.83 50.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.33 -158.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.644 2.23 . . . . 0.0 112.147 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -128.6 173.95 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 t -68.4 -25.73 65.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -29.22 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.294 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.439 ' CB ' ' CG1' ' A' ' 141' ' ' VAL . 2.0 mpp? -127.2 -169.17 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.0 t -135.62 -162.7 1.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.3 tt -122.89 104.29 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.152 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -81.43 102.28 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.5 p -57.56 141.37 48.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.905 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.33 -100.44 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.557 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -95.96 -64.53 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -107.53 -24.34 11.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.422 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.1 t -55.28 -27.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.4 -166.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -103.81 -20.57 13.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.513 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.65 22.2 7.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.488 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 51.52 44.27 53.41 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.781 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.445 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 1.5 tttm -124.05 90.82 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.785 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 109' ' ' ILE . 2.0 pp -46.79 108.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.874 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 108' ' ' LYS . 33.5 m-85 -95.61 30.9 2.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.713 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt -49.17 106.56 0.64 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.35 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.5 -14.73 46.01 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.463 2.109 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -58.56 -71.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.318 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -60.63 -19.64 58.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.151 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.434 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 24.2 t60 -64.62 -46.55 82.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 110.332 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.02 26.79 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.736 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CD1' ' CB ' ' A' ' 122' ' ' SER . 2.2 t90 -97.02 136.89 36.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.476 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -124.51 138.19 54.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.773 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.98 174.28 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.236 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -90.43 32.03 9.81 Favored 'Cis proline' 0 C--N 1.355 0.876 0 C-N-CA 124.661 -0.975 . . . . 0.0 113.437 0.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -113.41 -0.38 14.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.748 0.309 . . . . 0.0 111.273 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.497 ' CB ' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -90.72 120.96 32.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -174.27 179.78 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.0 mt -59.68 -31.2 69.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -47.6 81.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -83.94 -40.72 8.54 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 tt -54.02 -27.4 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.994 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.0 mt -90.54 -28.54 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.666 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -57.47 -33.06 67.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 131' ' ' MET . 4.3 p -59.79 -45.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.38 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.449 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 12.8 mtm -69.89 -40.58 75.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.087 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 63.4 mt -54.6 -26.25 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.741 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.9 t -91.87 -54.39 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.437 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.42 -47.82 80.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.279 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.66 -15.87 67.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.696 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -104.12 -42.83 5.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -151.0 90.53 4.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.253 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.99 129.23 33.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.487 2.125 . . . . 0.0 112.306 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.1 -19.03 46.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.175 1.917 . . . . 0.0 111.871 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 95' ' ' MET . 1.6 t -75.06 152.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.25 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.437 ' CG ' ' N ' ' A' ' 143' ' ' SER . 16.7 t80 -174.99 -87.65 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.043 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 142' ' ' PHE . 1.3 p 57.35 33.23 23.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.525 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.3 mtm-85 60.45 153.35 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.838 0.351 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.597 2.198 . . . . 0.0 112.632 179.605 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.633 0.254 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.9 t -100.04 36.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.6 p -107.28 -23.94 12.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -84.68 -51.31 6.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.074 0.464 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -60.41 -31.76 70.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -84.31 -22.88 30.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.103 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.34 -50.72 68.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.219 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -31.8 40.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.924 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.49 68.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.651 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -86.28 -33.0 20.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -100.45 20.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -26.51 68.36 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.561 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -21.86 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.339 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -51.54 134.48 29.28 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -64.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.832 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -86.5 63.73 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -63.76 -53.7 46.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.278 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -35.03 56.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 111.449 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.59 -40.19 16.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.8 m -66.49 -49.82 65.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.086 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.67 -39.59 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -48.4 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.381 0.61 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -43.42 88.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.852 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 m -65.02 -59.02 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.94 -48.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.183 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.2 t-20 -55.99 -28.04 55.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.08 -27.18 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -27.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -68.77 -48.15 64.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -41.89 66.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.35 117.31 34.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -95.7 21.13 8.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.216 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.0 17.65 13.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.04 159.86 22.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -149.35 124.58 4.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.686 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 133.84 21.27 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.252 1.968 . . . . 0.0 112.344 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.15 162.15 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.068 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.55 114.8 22.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.804 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -134.1 115.46 14.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 110.89 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 p -72.99 141.88 47.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.09 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.48 120.51 41.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.91 156.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -114.24 54.52 0.76 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.166 0.507 . . . . 0.0 110.964 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 55.93 68.58 0.84 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.947 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.94 22.36 12.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.26 38.1 2.67 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.463 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.6 t 69.39 169.2 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.4 p -125.47 173.92 8.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 138.94 46.84 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.488 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.54 107.08 0.14 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.82 131.03 56.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 110.544 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.04 146.08 24.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.211 0.529 . . . . 0.0 110.912 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -143.86 140.7 29.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.915 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.5 mt -100.32 101.67 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -102.55 152.96 20.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.694 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.19 -172.41 32.79 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.411 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.6 p -121.53 156.5 32.73 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -131.87 134.28 25.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 116.18 4.56 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.562 2.175 . . . . 0.0 112.104 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.15 102.1 46.47 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.522 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -42.61 129.7 5.13 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.211 2.607 . . . . 0.0 112.688 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -135.56 87.17 2.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 63.01 42.77 7.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.14 -16.58 55.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.1 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.65 -147.47 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.857 -0.202 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 t -176.24 41.95 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 121.547 0.689 . . . . 0.0 109.906 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -31.27 148.33 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.524 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -105.66 106.11 16.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.682 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mm -99.58 108.25 49.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.16 147.53 93.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.494 2.129 . . . . 0.0 111.853 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 pt -149.57 149.82 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 111.215 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 116.71 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 138.4 32.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.35 145.92 40.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 mp -141.22 146.4 36.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.37 166.24 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.16 0.505 . . . . 0.0 110.85 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.84 -39.57 79.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.723 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t 174.43 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.843 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.59 163.54 38.15 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.65 -31.69 3.89 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.421 -1.491 . . . . 0.0 112.108 0.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 52.0 m-85 -59.55 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.101 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 64.6 t-20 117.67 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 89.5 Cg_endo -84.21 141.25 9.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.433 2.089 . . . . 0.0 112.399 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.36 127.42 26.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.473 2.115 . . . . 0.0 112.248 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.474 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 2.5 mp -93.35 160.03 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.2 t -155.16 123.19 5.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.474 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 19.7 m-85 -134.6 121.64 21.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.581 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.71 130.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 125.86 68.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.04 165.89 22.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.119 . . . . 0.0 112.41 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.41 -176.66 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.914 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.93 -33.96 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 p -93.48 -32.78 14.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.766 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.3 ttp -99.01 -12.14 20.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.528 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 142' ' ' PHE . 8.9 t 44.59 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.39 127.14 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 111.473 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.01 145.61 29.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -79.34 131.35 36.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.22 -121.13 1.65 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.635 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 -39.07 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.132 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.409 ' O ' ' N ' ' A' ' 104' ' ' ASP . 0.1 OUTLIER -108.74 -48.49 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -68.11 67.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.573 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 102' ' ' HIS . 71.5 m-20 -49.89 -100.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.18 -54.7 2.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -106.94 39.59 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.037 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.83 51.89 56.24 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.391 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -93.11 90.0 6.7 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.041 0.448 . . . . 0.0 110.406 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.2 mt -47.89 109.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.089 0.471 . . . . 0.0 111.435 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.38 39.48 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.668 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.3 mt -54.59 118.98 18.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.18 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.75 -35.32 87.5 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.0 112.122 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.97 -29.83 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.403 ' CD1' ' CD1' ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.47 -30.11 17.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -57.35 -37.7 72.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.23 22.75 8.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -95.08 122.72 38.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -129.53 107.56 9.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.411 ' CB ' ' CA ' ' A' ' 120' ' ' PRO . 15.1 p80 -56.35 -179.04 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.134 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.411 ' CA ' ' CB ' ' A' ' 119' ' ' HIS . 50.4 Cg_exo -57.3 -17.63 1.52 Allowed 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 124.718 -0.951 . . . . 0.0 113.98 0.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -37.86 -59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.686 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.58 164.38 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.03 -84.51 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tp 176.78 -36.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.42 -44.81 95.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.779 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.63 -36.45 92.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.108 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' CD1' ' CD1' ' A' ' 114' ' ' LEU . 20.6 tp -57.12 -34.14 68.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.979 0.418 . . . . 0.0 110.513 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.75 -24.32 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.006 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -68.9 -40.87 78.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 131' ' ' MET . 1.9 p -61.76 -41.31 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.472 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.407 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 2.5 mtt -63.81 -40.3 96.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -28.34 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.964 0.411 . . . . 0.0 111.022 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.19 -52.22 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.86 -36.0 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.989 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.18 -21.93 20.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -21.53 61.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -28.89 13.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.734 0.302 . . . . 0.0 111.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -161.3 95.79 1.35 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.28 117.83 3.78 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.6 2.2 . . . . 0.0 112.076 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -88.55 45.84 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.621 2.214 . . . . 0.0 112.737 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.497 ' O ' ' C ' ' A' ' 142' ' ' PHE . 1.4 m -136.9 -40.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.842 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' C ' ' O ' ' A' ' 141' ' ' VAL . 21.8 t80 -0.86 -86.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 113.214 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.472 ' N ' ' CG ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER 41.28 30.45 0.12 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.834 0.454 . . . . 0.0 112.031 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.465 ' O ' ' CZ ' ' A' ' 142' ' ' PHE . 11.9 ttp85 -102.89 100.2 16.04 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.181 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo . . . . . 0 C--O 1.252 1.184 0 C-N-CA 122.601 2.201 . . . . 0.0 112.533 179.378 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -50.98 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.584 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.11 -31.28 70.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.818 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.4 tp -59.23 -44.37 92.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -57.95 -44.5 87.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.186 0.517 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.38 -30.67 71.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtm -79.28 -31.54 43.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.825 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 8' ' ' LEU . 18.3 m -102.21 20.18 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.027 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -78.54 -31.14 47.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.859 0.362 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -31.35 71.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.49 156.18 8.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -54.17 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.48 66.13 4.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.0 ttm180 -61.83 -52.38 64.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.35 -29.55 48.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.23 -26.94 17.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.887 HG23 HD23 ' A' ' 76' ' ' LEU . 97.7 m -80.71 -30.45 36.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 18' ' ' ARG . 40.3 t -87.18 -28.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -82.1 -33.32 29.79 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.151 0.501 . . . . 0.0 110.848 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.646 ' HB3' HD12 ' A' ' 124' ' ' LEU . 66.4 mt-10 -68.93 -42.29 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.833 ' CG2' HD21 ' A' ' 55' ' ' LEU . 19.0 m -69.03 -55.07 11.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -52.35 -46.89 46.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.779 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 m-80 -51.69 -37.01 48.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.889 HG21 HD22 ' A' ' 124' ' ' LEU . 23.9 t -82.9 -63.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.465 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.588 HD13 HG22 ' A' ' 25' ' ' THR . 5.6 pt -52.27 -26.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -85.54 -26.49 26.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.01 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 27' ' ' ASN . 5.6 mp -89.74 -39.02 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.668 0.271 . . . . 0.0 111.202 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' HE2' HD11 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -93.14 11.46 27.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.659 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 14.33 61.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.38 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD13 ' HA3' ' A' ' 57' ' ' GLY . 4.0 mm? -62.75 121.77 14.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.02 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? -100.13 128.05 31.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.123 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.798 ' HA ' HD23 ' A' ' 55' ' ' LEU . 56.7 Cg_endo -70.53 139.39 37.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.3 2.0 . . . . 0.0 112.608 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.5 t -134.19 162.11 39.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.8 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.697 HD11 ' HG3' ' A' ' 51' ' ' GLU . 2.1 tm? -136.82 103.83 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.797 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -123.78 127.12 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.385 0.612 . . . . 0.0 110.534 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.72 139.64 30.53 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -108.85 160.23 16.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.96 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 179.682 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.396 0.141 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.88 140.23 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.551 0.532 . . . . 0.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.697 ' HG3' HD11 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -74.33 128.51 35.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.085 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 52' ' ' LEU . 4.8 tp -136.11 136.27 39.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.4 ttp -105.26 149.75 25.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.229 0.538 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.444 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -148.17 163.53 36.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.892 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.833 HD21 ' CG2' ' A' ' 25' ' ' THR . 5.1 mt -127.54 123.85 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -119.45 131.12 55.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.553 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -174.65 -174.06 41.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.604 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -121.06 151.61 39.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.714 0.292 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.699 HG12 HD12 ' A' ' 72' ' ' ILE . 1.4 pt -130.97 114.84 16.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.273 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.28 167.37 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.434 2.089 . . . . 0.0 112.141 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 p -173.39 127.01 0.48 Allowed Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.347 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.78 115.83 4.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.255 1.97 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.61 137.18 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 60.13 20.88 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.524 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.56 5.16 82.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.672 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.19 175.51 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.87 0.366 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 100.49 10.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.43 159.56 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.5 m-20 -114.33 125.07 53.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 141' ' ' VAL . 31.0 mm -110.0 95.47 21.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.226 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 69' ' ' ASN . 32.9 Cg_exo -61.11 144.37 99.18 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.156 1.904 . . . . 0.0 112.221 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.699 HD12 HG12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -155.47 138.97 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.9 m -99.6 162.43 13.02 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.787 HD11 HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -130.35 134.88 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.538 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -115.15 148.33 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.774 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.887 HD23 HG23 ' A' ' 21' ' ' THR . 7.6 mp -133.44 155.63 49.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.805 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.741 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -135.11 158.86 43.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 79' ' ' THR . 2.4 t0 -73.8 -30.95 63.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -178.05 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.37 154.02 68.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.76 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HG2' ' CE1' ' A' ' 82' ' ' TYR . 73.7 Cg_endo -76.99 -45.01 0.46 Allowed 'Cis proline' 0 C--N 1.347 0.448 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.433 0.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -105.09 -59.81 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.686 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.4 OUTLIER 166.45 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.865 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.38 143.52 15.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.677 2.251 . . . . 0.0 112.455 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 149.99 50.3 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.491 2.127 . . . . 0.0 112.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 87' ' ' CYS . 2.9 mp -87.85 154.61 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.419 ' N ' HG22 ' A' ' 86' ' ' ILE . 5.0 p -123.71 142.46 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.454 ' C ' HD11 ' A' ' 109' ' ' ILE . 4.1 m-85 -151.97 154.44 36.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.844 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.791 HG13 HD11 ' A' ' 109' ' ' ILE . 16.7 m -117.19 139.09 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.117 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -135.49 79.4 48.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HB3' HG13 ' A' ' 141' ' ' VAL . 56.3 Cg_endo -69.09 176.52 6.15 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.413 2.075 . . . . 0.0 112.572 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -91.84 170.35 9.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.8 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -58.72 -28.63 66.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -76.33 -29.56 57.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.06 177.03 7.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -139.33 -173.52 3.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.613 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.494 ' H ' HG22 ' A' ' 96' ' ' THR . 12.1 mm -126.13 92.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.444 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 25.5 tptt -66.47 103.72 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.867 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -58.47 134.42 56.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.71 -131.11 1.62 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.557 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 0.5 OUTLIER -99.99 -32.42 10.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.789 0.328 . . . . 0.0 111.014 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.665 ' CG ' HD23 ' A' ' 111' ' ' LEU . 11.3 m80 -111.44 -34.82 6.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.981 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.868 HG21 ' HG3' ' A' ' 140' ' ' PRO . 22.0 t -91.05 79.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.27 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -69.25 -173.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.39 5.26 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.356 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -112.9 24.9 11.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.708 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 56.49 27.89 54.84 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.99 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.4 160.24 15.57 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.436 -0.449 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.791 HD11 HG13 ' A' ' 89' ' ' VAL . 3.3 mp -131.55 38.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 30.1 p90 -60.77 102.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.989 0.423 . . . . 0.0 110.625 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.665 HD23 ' CG ' ' A' ' 102' ' ' HIS . 2.1 mt -108.74 144.68 30.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.073 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.72 -40.36 84.97 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.491 2.127 . . . . 0.0 112.04 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.77 -30.33 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.684 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -90.52 -32.51 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.51 -49.55 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.83 33.26 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.779 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.457 ' NE1' ' HB2' ' A' ' 122' ' ' SER . 2.8 t90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.108 0.48 . . . . 0.0 110.747 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.457 ' HB2' ' NE1' ' A' ' 117' ' ' TRP . 39.3 t . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.847 0.356 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.16 -0.93 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER 87.66 -26.45 0.08 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.62 0.368 . . . . 0.0 111.322 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.605 HD21 HD22 ' A' ' 31' ' ' LEU . 1.3 tp -64.92 -38.23 90.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.96 -31.18 54.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.016 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 114' ' ' LEU . 28.1 tp -55.97 -30.5 61.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.593 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.1 mm -88.08 -28.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.037 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.846 ' HA ' HD12 ' A' ' 132' ' ' ILE . 1.8 tt0 -67.9 -41.26 82.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.215 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 134' ' ' VAL . 6.8 p -52.4 -46.58 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.981 0.419 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.48 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.1 mtt -66.94 -35.38 79.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.389 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 129' ' ' GLN . 52.5 mt -61.13 -27.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.771 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 129' ' ' GLN . 23.2 t -91.43 -48.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 130' ' ' VAL . 48.6 t -60.22 -39.94 82.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.48 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 131' ' ' MET . 20.0 m-30 -85.21 -15.89 42.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.075 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.0 -14.77 81.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.434 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -97.98 -38.01 9.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -164.8 89.31 1.02 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.563 ' HB3' HD11 ' A' ' 70' ' ' ILE . 33.5 Cg_exo -57.86 126.54 22.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.569 2.179 . . . . 0.0 112.412 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.868 ' HG3' HG21 ' A' ' 103' ' ' VAL . 92.7 Cg_endo -85.83 -13.42 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.71 2.273 . . . . 0.0 112.561 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.865 HG21 HG23 ' A' ' 70' ' ' ILE . 36.9 t -72.45 -3.72 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.148 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.055 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.701 0.286 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -46.68 17.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -40.01 80.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.709 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.0 tt -59.85 -37.53 79.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -62.47 -50.23 72.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.727 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -63.54 -31.12 72.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.56 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.423 ' HE3' HD23 ' A' ' 39' ' ' LEU . 11.1 mtp -74.65 -30.6 61.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 8' ' ' LEU . 32.7 m -105.02 19.45 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.805 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -65.35 -29.86 70.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.21 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -27.24 58.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.872 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 21.2 m-85 -56.06 130.64 44.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -66.98 -42.54 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' CG2' ' A' ' 79' ' ' THR . 16.0 m-85 -103.62 60.77 0.75 Allowed 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.787 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.0 ptm180 -59.02 -35.4 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.785 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.73 -51.12 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -33.31 63.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.672 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -66.47 -39.08 88.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.3 t -82.02 -30.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -46.79 35.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.863 ' O ' HG23 ' A' ' 28' ' ' VAL . 21.1 mt-10 -59.29 -42.33 91.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.979 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.931 HG23 HD21 ' A' ' 55' ' ' LEU . 9.3 m -63.71 -59.57 4.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -47.4 -47.59 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.069 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.455 ' HB3' HD13 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -58.02 -29.48 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -83.33 -37.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.256 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 25' ' ' THR . 0.6 OUTLIER -74.37 -27.97 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.954 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.8 m -80.55 -29.06 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.693 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 31' ' ' LEU . 11.2 tp -88.73 -30.24 19.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.895 0.379 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -106.92 127.2 53.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 35.24 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.98 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -152.06 24.75 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.026 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.861 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.8 mm? -118.07 160.74 21.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -149.28 130.14 7.03 Favored Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.32 131.74 15.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.365 2.043 . . . . 0.0 112.316 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.2 t -127.47 161.79 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.64 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 51' ' ' GLU . 1.1 tm? -130.9 115.06 16.03 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.076 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.58 120.75 18.91 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.3 p -82.16 146.07 29.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -139.35 134.67 32.82 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.352 179.753 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -117.26 132.31 56.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.501 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.669 ' HB2' HD11 ' A' ' 39' ' ' LEU . 3.5 pm0 -75.32 110.4 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.8 mm? -106.09 134.93 48.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.462 ' HA ' HD22 ' A' ' 39' ' ' LEU . 2.6 tmm? -86.31 146.82 26.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 0.0 110.776 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.455 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 12.1 p-10 -147.3 143.86 28.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.985 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.931 HD21 HG23 ' A' ' 25' ' ' THR . 16.1 mt -98.91 105.07 17.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -94.72 132.82 39.07 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.861 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 179.78 -155.23 15.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.503 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 p -150.72 150.75 31.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.569 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.675 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -124.43 149.44 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.677 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.04 116.73 4.63 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.331 2.021 . . . . 0.0 112.503 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' HA2' ' A' ' 136' ' ' GLY . 61.6 t -123.45 84.52 52.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 32.0 Cg_exo -59.51 165.07 10.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.285 1.99 . . . . 0.0 112.351 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -69.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.246 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.29 46.77 1.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.089 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.06 -16.73 59.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.579 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 1.2 t-20 -99.97 -168.22 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 110.447 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -155.96 128.71 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.757 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.24 -170.62 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.666 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -128.41 67.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.56 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.56 HG21 ' CD2' ' A' ' 135' ' ' PHE . 13.2 mm -57.65 108.09 1.15 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.239 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 155.61 65.23 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.447 2.098 . . . . 0.0 112.226 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -155.88 153.82 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.0 m -122.17 103.32 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.853 HD11 HD13 ' A' ' 76' ' ' LEU . 1.4 tm? -82.11 129.09 34.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.711 ' N ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -106.92 147.52 29.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.934 0.397 . . . . 0.0 111.108 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.853 HD13 HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -134.67 142.29 46.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.33 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.85 HD21 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -112.8 -178.87 3.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 111.481 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.31 39.42 1.5 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.605 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 17' ' ' TYR . 4.9 m 75.04 25.69 1.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.5 OUTLIER 178.0 142.18 0.27 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.043 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 90.3 Cg_endo -83.83 -40.11 0.82 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.467 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -82.85 65.96 8.23 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.85 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -32.8 -55.42 0.57 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 122.95 0.5 . . . . 0.0 111.377 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 73.0 Cg_exo -48.65 131.48 24.19 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.404 2.069 . . . . 0.0 112.166 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 84' ' ' PRO . 57.1 Cg_exo -51.81 134.1 46.99 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.459 2.106 . . . . 0.0 112.329 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.515 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 29.1 mt -104.13 148.56 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.486 ' HB3' HD21 ' A' ' 127' ' ' LEU . 26.2 p -134.95 125.25 26.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' HA ' HD12 ' A' ' 109' ' ' ILE . 22.6 m-85 -133.48 142.08 48.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 107' ' ' GLY . 10.8 p -95.57 145.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.781 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.0 123.95 31.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.1 -172.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.477 2.118 . . . . 0.0 112.237 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -170.63 2.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.1 -37.79 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.91 -29.37 14.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.073 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -94.72 -168.4 1.82 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.911 0.386 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.4 t -146.33 -156.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.563 HD11 ' HA2' ' A' ' 107' ' ' GLY . 1.0 OUTLIER -134.85 142.85 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 110.897 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.818 ' HD2' HG21 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -111.83 145.52 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 105' ' ' ALA . 3.8 p -114.89 134.48 55.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.82 -115.78 0.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.472 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -71.43 0.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -142.23 62.88 1.42 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 111.532 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.818 HG21 ' HD2' ' A' ' 98' ' ' LYS . 6.0 t -135.17 -7.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.867 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 99' ' ' THR . 16.6 m-20 45.7 -167.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.286 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.689 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -94.09 -46.81 6.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.129 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.69 -17.23 60.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.184 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.778 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 114.84 20.87 5.56 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.762 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG2' ' CE1' ' A' ' 88' ' ' PHE . 2.4 mptt -83.07 115.49 21.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.759 -0.259 . . . . 0.0 111.04 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.787 HG21 HD12 ' A' ' 111' ' ' LEU . 5.3 mp -73.46 107.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.661 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -95.73 41.58 1.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.787 HD12 HG21 ' A' ' 109' ' ' ILE . 4.0 mt -60.42 119.74 45.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.14 -21.13 27.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.438 2.092 . . . . 0.0 112.225 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' TRP . 87.5 m-85 -56.64 -62.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.834 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.4 tp -46.56 -39.47 11.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -59.21 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.532 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.1 35.07 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.91 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 113' ' ' TYR . 7.2 t90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.932 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.423 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 39.8 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.54 -173.41 3.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 24' ' ' GLU . 7.2 tp -62.41 -40.4 96.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 27' ' ' ASN . 4.5 tp -56.57 -53.78 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.89 -29.66 74.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.21 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 87' ' ' CYS . 7.9 tt -56.44 -31.87 64.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.648 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -82.81 -25.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.978 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.745 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -73.59 -51.48 16.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.998 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' MET . 5.8 p -47.11 -45.62 8.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 3.6 mtm -60.35 -38.71 84.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -56.15 -25.78 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.04 -53.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.67 -29.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.49 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.56 ' CD2' HG21 ' A' ' 70' ' ' ILE . 2.8 m-85 -86.41 -27.86 23.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.541 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -74.2 -14.55 80.51 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.802 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -96.47 -30.57 13.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.382 . . . . 0.0 110.958 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.59 109.19 1.48 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.65 123.16 12.69 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 135' ' ' PHE . 94.2 Cg_endo -89.63 25.67 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.3 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.83 -12.94 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.74 0.305 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -40.93 82.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -36.9 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.909 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.67 -55.49 34.37 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.569 0.543 . . . . 0.0 110.831 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -58.21 -30.33 66.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.89 -41.04 75.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.5 mtp -58.22 -36.32 72.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.588 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.64 HG11 ' SD ' ' A' ' 53' ' ' MET . 22.6 m -112.27 19.65 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.186 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -67.99 -29.13 68.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.908 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -28.44 65.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 5.2 m-85 -55.73 124.07 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HD2' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -51.77 -67.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.0 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.861 ' HB3' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -64.47 -49.19 72.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.832 ' NH1' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER 64.63 -65.97 0.13 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.33 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 17' ' ' TYR . 36.7 t0 -48.05 -43.91 30.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.052 0.453 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.876 HD13 ' H ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -53.03 -36.18 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.876 ' H ' HD13 ' A' ' 20' ' ' LEU . 95.6 m -83.66 -35.58 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.843 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.832 HG22 ' NH1' ' A' ' 18' ' ' ARG . 60.7 t -52.08 -35.11 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.761 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -83.52 -40.64 18.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.845 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.752 ' O ' HG23 ' A' ' 28' ' ' VAL . 19.7 mt-10 -66.54 -32.65 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.907 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 t -73.6 -41.63 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -72.16 -47.43 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.021 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.7 m-80 -50.15 -46.52 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.27 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.855 ' CG2' HD23 ' A' ' 124' ' ' LEU . 23.6 t -64.57 -61.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.28 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 26' ' ' VAL . 3.4 pt -59.32 -23.5 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.403 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.7 m -82.58 -28.75 30.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -18.84 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CE2' HG23 ' A' ' 59' ' ' ILE . 7.1 m-85 -125.93 164.28 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 0.0 110.602 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -18.52 8.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -96.87 28.63 3.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.718 0.294 . . . . 0.0 111.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.835 HD22 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -117.7 154.51 31.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.44 104.43 2.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' A' ' 55' ' ' LEU . 58.3 Cg_exo -51.02 140.9 38.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.22 1.947 . . . . 0.0 112.588 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.4 t -127.61 161.82 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.109 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.3 tm? -118.48 122.93 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.728 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' N ' HD13 ' A' ' 39' ' ' LEU . 20.6 t0 -157.05 138.9 14.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -87.07 154.02 21.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.24 124.91 28.21 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG12 ' CA ' ' A' ' 49' ' ' SER . 35.4 m . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.22 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.702 ' CA ' HG12 ' A' ' 43' ' ' VAL . 15.1 t . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.31 134.89 12.59 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.88 115.75 3.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.043 0.449 . . . . 0.0 110.797 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.02 158.36 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.008 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.64 ' SD ' HG11 ' A' ' 12' ' ' VAL . 35.9 ttp -130.71 147.23 52.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.912 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 13.4 p-10 -136.61 177.31 7.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.7 mt -139.6 104.01 4.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.641 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.4 m -99.96 157.41 16.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.879 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.62 -149.4 14.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.42 142.0 31.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 61' ' ' VAL . 37.5 mt -112.21 123.76 33.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.83 112.63 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.3 2.0 . . . . 0.0 112.219 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 59' ' ' ILE . 23.8 t -134.74 94.86 16.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.058 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 55.6 Cg_endo -69.75 152.96 69.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.565 2.177 . . . . 0.0 112.325 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -179.14 -36.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -97.53 45.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.451 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 17.34 79.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.368 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 12.5 t-20 -177.43 165.21 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.509 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.29 129.23 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 -165.57 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.776 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -147.32 86.44 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.013 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.7 mm -79.51 129.29 72.19 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.957 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.506 ' O ' HG23 ' A' ' 72' ' ' ILE . 70.9 Cg_endo -74.63 145.95 33.67 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.664 2.243 . . . . 0.0 112.286 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 71' ' ' PRO . 1.7 pp -158.13 171.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.449 . . . . 0.0 111.042 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 56' ' ' THR . 73.7 m -148.36 161.83 40.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.987 HD21 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -131.92 144.86 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.509 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -120.47 147.28 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.466 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.8 mm? -118.77 -178.7 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.025 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.61 146.21 34.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.192 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -62.94 -35.56 80.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.87 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.517 HG21 ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 166.54 -26.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.151 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 79' ' ' THR . 39.6 m-85 -160.62 161.76 24.32 Favored Pre-proline 0 C--N 1.334 -0.086 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.789 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -88.52 -26.22 5.68 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.512 0.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.883 ' CD1' HD11 ' A' ' 86' ' ' ILE . 6.9 p90 -76.68 60.67 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.3 m120 -41.21 -52.77 7.14 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 54.2 Cg_exo -51.14 146.1 24.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 112.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.23 127.1 14.52 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.883 HD11 ' CD1' ' A' ' 82' ' ' TYR . 2.7 mt -89.22 151.34 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.011 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.749 ' SG ' HD11 ' A' ' 127' ' ' LEU . 14.4 m -122.9 161.82 23.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.495 ' N ' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -162.13 159.64 26.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.679 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 107' ' ' GLY . 11.4 p -128.37 137.65 56.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.161 0.505 . . . . 0.0 111.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.04 92.79 28.49 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.79 158.26 58.06 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.446 2.097 . . . . 0.0 112.187 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -84.68 176.49 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.25 0.547 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 m -65.37 -25.15 67.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -57.44 -59.03 5.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.057 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -111.25 -179.01 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -115.01 -157.27 0.63 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.519 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -115.84 121.67 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.159 0.504 . . . . 0.0 110.797 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -81.72 133.69 35.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 105' ' ' ALA . 34.8 p -102.45 131.21 49.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.75 -120.31 0.72 Allowed Glycine 0 C--N 1.322 -0.227 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.671 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -99.79 -57.93 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.861 0.363 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.774 ' HB3' HD23 ' A' ' 111' ' ' LEU . 8.7 m-70 -80.79 -41.01 24.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.711 HG21 ' HB2' ' A' ' 140' ' ' PRO . 25.9 t -92.1 75.39 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.087 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -52.98 -178.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -79.39 -13.98 59.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.815 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.15 23.75 5.48 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.417 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 51.01 30.19 22.34 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.705 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -111.26 115.37 29.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.634 0.254 . . . . 0.0 110.99 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.728 HG22 ' HG ' ' A' ' 111' ' ' LEU . 2.2 mp -60.94 94.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.46 75.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.784 HD13 HG11 ' A' ' 130' ' ' VAL . 1.6 mt -84.02 136.0 41.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.804 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.39 -28.31 18.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 0.0 112.246 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -79.61 -54.29 6.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.804 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.781 ' HG ' HD12 ' A' ' 127' ' ' LEU . 1.9 tm? -62.99 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.73 -35.82 71.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.1 25.59 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 t90 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.865 0.364 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.62 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.987 HD11 HD21 ' A' ' 74' ' ' LEU . 3.4 tp -66.59 -33.98 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.48 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -29.49 75.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.781 HD12 ' HG ' ' A' ' 114' ' ' LEU . 6.5 tp -56.2 -31.53 63.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.9 mm -78.98 -29.61 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.767 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -62.43 -26.73 68.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.784 HG11 HD13 ' A' ' 111' ' ' LEU . 1.3 p -76.27 -36.81 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.552 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.421 ' HG2' ' CZ ' ' A' ' 135' ' ' PHE . 37.0 mtt -77.86 -42.63 32.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.997 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 129' ' ' GLN . 13.1 tt -58.25 -26.5 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 129' ' ' GLN . 28.6 t -91.2 -58.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.56 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 130' ' ' VAL . 88.0 t -53.55 -50.8 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.48 ' O ' HG11 ' A' ' 61' ' ' VAL . 6.8 m-30 -71.83 -27.3 62.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.66 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.04 -12.93 69.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.608 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.06 -47.71 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.55 126.95 2.45 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.83 107.6 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.451 2.101 . . . . 0.0 112.808 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.711 ' HB2' HG21 ' A' ' 103' ' ' VAL . 97.6 Cg_endo -88.64 23.85 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.663 2.242 . . . . 0.0 111.956 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 141' ' ' VAL . 22.9 t -121.99 -4.27 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.928 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.739 -179.301 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -60.71 -44.88 96.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -32.59 73.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.4 tp -72.95 -25.22 60.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.136 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.44 -24.52 50.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.391 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -22.61 33.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.167 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.427 ' HE1' ' HB2' ' A' ' 39' ' ' LEU . 15.9 ptp -89.98 -34.05 16.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 8' ' ' LEU . 28.3 m -91.31 -1.84 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -69.65 -31.4 69.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.181 0.515 . . . . 0.0 111.105 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -72.35 -26.37 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.16 169.02 0.43 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.994 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -91.87 -38.7 12.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -122.35 68.33 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.1 0.476 . . . . 0.0 110.937 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.83 -34.81 71.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.859 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.52 -46.45 90.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -33.09 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -70.96 -48.18 54.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 18' ' ' ARG . 42.4 t -71.25 -27.32 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.362 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -48.4 24.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -58.68 -42.48 88.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.973 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.885 HG22 HD11 ' A' ' 29' ' ' ILE . 26.8 m -59.81 -58.97 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.82 -46.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.658 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.1 t-20 -58.46 -22.37 54.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.224 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.018 HG21 HD23 ' A' ' 124' ' ' LEU . 27.2 t -93.19 -22.52 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.48 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.885 HD11 HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER -91.03 -28.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.148 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -80.42 -42.62 22.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 31' ' ' LEU . 7.4 tt -70.98 -23.64 62.24 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.683 ' HE2' HG21 ' A' ' 128' ' ' ILE . 35.1 m-85 -116.97 161.61 19.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 80.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.956 0.408 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 174.99 -33.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.524 HD22 HG12 ' A' ' 28' ' ' VAL . 1.7 mp -62.46 134.77 56.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.796 0.331 . . . . 0.0 110.925 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 106.03 21.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.936 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.785 ' HA ' HD23 ' A' ' 55' ' ' LEU . 76.1 Cg_exo -50.5 150.37 11.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.384 2.056 . . . . 0.0 112.594 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.5 t -151.51 161.85 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.605 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.488 ' C ' HD13 ' A' ' 39' ' ' LEU . 2.5 tm? -129.85 116.97 19.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -149.54 132.88 16.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.964 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -84.38 158.04 21.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.43 149.21 49.54 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.163 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.71 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.626 ' HB2' HD21 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -175.87 128.86 0.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.087 0.47 . . . . 0.0 110.546 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.713 ' C ' HD22 ' A' ' 52' ' ' LEU . 5.7 mt-10 -86.88 108.14 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.696 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.713 HD22 ' C ' ' A' ' 51' ' ' GLU . 3.0 mm? -123.2 178.95 4.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.012 0.434 . . . . 0.0 111.061 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.83 145.68 46.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -130.5 153.1 49.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 111.078 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.5 mt -108.87 101.89 10.95 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.857 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.5 m -85.49 132.95 34.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.56 -177.44 42.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.505 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.694 HG22 ' CA ' ' A' ' 71' ' ' PRO . 16.8 p -143.8 130.33 20.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 pt -115.53 154.35 47.79 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HB3' HG22 ' A' ' 67' ' ' THR . 51.0 Cg_exo -54.53 163.07 4.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.616 2.211 . . . . 0.0 112.568 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.742 HG21 ' CG1' ' A' ' 70' ' ' ILE . 25.4 t -158.24 106.16 1.7 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.684 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.67 92.43 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.335 2.024 . . . . 0.0 112.19 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.443 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 55.3 t80 -132.72 140.34 48.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 mtp85 61.09 18.55 9.12 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 20.45 61.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.566 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.02 176.97 8.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.338 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -96.24 104.8 16.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.752 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -91.12 167.33 12.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.744 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -123.48 111.75 16.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.742 ' CG1' HG21 ' A' ' 61' ' ' VAL . 37.0 mm -108.93 109.5 61.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.694 ' CA ' HG22 ' A' ' 58' ' ' THR . 49.9 Cg_endo -68.92 141.83 49.9 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.361 2.041 . . . . 0.0 112.251 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -147.43 136.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.036 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 118.26 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.699 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.663 HD22 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -84.59 149.68 25.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.482 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -123.57 142.99 50.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.832 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 52' ' ' LEU . 2.6 mm? -121.92 167.4 13.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.608 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.804 HD22 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -149.5 150.91 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.469 0.652 . . . . 0.0 111.065 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.28 -38.4 90.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.3 t 179.57 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 0.8 OUTLIER -87.47 159.54 49.84 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 7.5 Cg_exo -73.46 -45.55 0.45 Allowed 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.588 -1.422 . . . . 0.0 111.977 0.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.444 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -104.92 -59.92 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 0.0 110.637 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.628 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.4 OUTLIER 166.03 -53.75 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.78 145.14 4.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.733 2.289 . . . . 0.0 112.632 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.58 ' CG ' HD12 ' A' ' 124' ' ' LEU . 72.0 Cg_endo -76.94 143.06 22.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.668 2.245 . . . . 0.0 112.427 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 87' ' ' CYS . 2.9 mp -90.1 160.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.477 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -134.51 141.41 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 9.7 m-85 -147.73 144.33 28.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 107' ' ' GLY . 33.8 m -95.08 117.69 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.035 0.445 . . . . 0.0 111.365 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -81.08 121.25 80.44 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.77 137.87 67.81 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.463 2.108 . . . . 0.0 112.219 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 95' ' ' MET . 8.8 t -115.2 -167.11 1.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.642 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m -86.98 -56.2 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.81 -29.7 67.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.765 ' H ' HG23 ' A' ' 92' ' ' THR . 2.3 mpp? -135.88 -169.47 2.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.4 p -150.0 -80.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.782 HD11 HG23 ' A' ' 89' ' ' VAL . 0.4 OUTLIER 179.69 109.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.66 116.71 28.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 104' ' ' ASP . 27.8 p -53.25 131.82 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.53 -96.46 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -60.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 111.032 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.739 ' CD2' HG21 ' A' ' 134' ' ' VAL . 22.5 m-70 -127.47 48.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.31 -17.88 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.799 ' O ' HG22 ' A' ' 99' ' ' THR . 7.9 p-10 40.56 -158.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.335 0.254 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 5.27 48.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -131.26 28.62 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 51.07 25.36 10.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.013 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.452 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -85.96 136.6 33.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.881 ' CG2' HD12 ' A' ' 111' ' ' LEU . 1.4 mp -68.99 88.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 110.523 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.09 62.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.847 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.881 HD12 ' CG2' ' A' ' 109' ' ' ILE . 9.8 mt -95.23 109.25 43.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.83 -29.44 82.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.457 2.105 . . . . 0.0 112.131 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -54.08 50.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.009 HD22 HD13 ' A' ' 127' ' ' LEU . 55.5 tp -60.41 -33.34 72.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.48 -44.44 89.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.602 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.87 24.53 6.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.4 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 3.8 t90 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.4 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 6.0 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.882 0.372 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.37 -164.25 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.018 HD23 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -51.76 -28.12 14.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 125' ' ' LEU . 3.2 mm? -68.97 -55.0 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.07 -35.99 92.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.345 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 1.009 HD13 HD22 ' A' ' 114' ' ' LEU . 66.7 tp -55.72 -31.7 62.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.683 HG21 ' HE2' ' A' ' 32' ' ' TYR . 24.7 mm -79.7 -21.74 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.809 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -82.54 -33.67 28.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.26 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 131' ' ' MET . 11.3 p -72.75 -47.37 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.528 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.6 mtm -66.8 -42.82 85.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.14 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 129' ' ' GLN . 4.0 tt -53.84 -30.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 129' ' ' GLN . 30.0 t -85.81 -51.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.464 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.739 HG21 ' CD2' ' A' ' 102' ' ' HIS . 1.2 p -54.76 -51.14 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.865 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.536 ' CD1' HG22 ' A' ' 61' ' ' VAL . 2.1 p90 -87.31 -9.15 55.69 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.38 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.439 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -72.82 -24.67 75.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.77 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.18 -30.69 15.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.541 0.21 . . . . 0.0 110.601 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -162.84 118.99 1.21 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.565 ' HB3' HD11 ' A' ' 70' ' ' ILE . 24.3 Cg_exo -61.93 110.93 1.08 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.537 2.158 . . . . 0.0 112.155 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.06 -15.97 7.66 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.418 2.079 . . . . 0.0 112.561 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.468 HG21 HG23 ' A' ' 70' ' ' ILE . 98.1 t -57.04 -19.34 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -36.87 71.22 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.531 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -24.99 38.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.12 -50.92 71.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.01 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.91 -31.68 68.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.114 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -65.26 -28.06 69.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.615 ' HG2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -80.77 -31.2 35.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 111.063 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.656 HG21 ' CG2' ' A' ' 22' ' ' VAL . 29.3 m -103.15 20.22 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.735 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.8 -29.65 45.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.8 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -99.06 -18.89 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.428 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' HD2' HG21 ' A' ' 21' ' ' THR . 2.3 m-30 -55.58 146.11 21.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 79' ' ' THR . 9.7 tttm -56.09 -24.73 42.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -140.32 128.44 22.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.699 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.699 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.5 ttp85 -101.09 -64.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -50.59 63.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 20' ' ' LEU . 2.5 tm? -63.43 -50.79 68.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.222 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.483 HG21 ' HD2' ' A' ' 15' ' ' TYR . 99.1 m -62.25 -34.5 76.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.5 t -83.67 -23.47 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -30.36 21.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 0.0 111.001 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.806 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.89 -31.44 64.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.2 t -69.65 -47.43 63.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.498 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 22' ' ' VAL . 1.4 t -61.13 -55.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -46.28 -40.27 11.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.74 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 24' ' ' GLU . 35.2 t -76.47 -63.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.714 HG22 ' HB3' ' A' ' 35' ' ' LEU . 4.7 pt -51.9 -34.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.306 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -73.17 -29.09 62.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.63 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -76.08 -33.56 59.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.011 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB2' HD23 ' A' ' 35' ' ' LEU . 4.2 m-85 -93.73 -0.27 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.794 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.85 37.15 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.224 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -169.34 47.88 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.714 ' HB3' HG22 ' A' ' 29' ' ' ILE . 3.9 mm? -117.9 151.1 38.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.25 96.08 25.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.06 129.05 17.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.435 2.09 . . . . 0.0 111.992 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.8 t -125.27 162.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.287 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.846 HD11 ' HG3' ' A' ' 51' ' ' GLU . 2.6 tm? -128.36 98.93 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.731 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.67 126.97 48.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -84.62 128.45 34.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -97.16 104.22 16.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.602 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.455 HG12 ' OG ' ' A' ' 49' ' ' SER . 30.3 m . . . . . 0 C--O 1.234 0.281 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.289 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.455 ' OG ' HG12 ' A' ' 43' ' ' VAL . 19.0 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.058 0.456 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -96.67 118.52 33.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.846 ' HG3' HD11 ' A' ' 39' ' ' LEU . 5.0 tt0 -64.67 106.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.3 mm? -118.71 131.99 56.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.154 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.416 ' HA ' HD22 ' A' ' 39' ' ' LEU . 6.1 tmm? -92.91 147.39 22.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 15.2 p-10 -141.71 159.61 41.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.937 0.399 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.007 HD12 HD13 ' A' ' 74' ' ' LEU . 4.7 mt -126.7 103.92 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -101.34 140.67 35.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 176.4 169.18 37.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -116.28 144.48 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 110.935 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -109.43 139.9 21.56 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 59' ' ' ILE . 70.3 Cg_endo -74.9 60.52 5.38 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.535 2.157 . . . . 0.0 112.21 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 59' ' ' ILE . 92.7 t -90.56 133.39 32.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.9 143.56 33.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.144 1.896 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -83.46 -77.01 0.26 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -110.82 -61.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.92 14.15 3.1 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.449 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -175.27 3.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.81 143.2 27.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.7 174.37 10.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -128.66 103.02 6.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.72 102.68 10.78 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.98 154.4 70.85 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.313 2.009 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 pt -155.78 156.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.238 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 130.19 53.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.007 HD13 HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -106.42 137.84 43.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.766 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -125.79 145.95 50.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.686 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.766 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.4 mm? -125.49 165.26 18.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -125.64 165.55 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.98 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -94.85 -27.79 15.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -173.35 -40.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HB3' ' HA ' ' A' ' 81' ' ' PRO . 28.5 m-85 -102.01 161.93 21.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 55.6 Cg_endo -73.22 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.757 -0.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 22.5 m-85 -105.45 -58.04 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.763 ' O ' HD11 ' A' ' 77' ' ' LEU . 0.3 OUTLIER 165.57 -53.93 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.967 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 82' ' ' TYR . 91.0 Cg_exo -42.91 119.14 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.803 2.335 . . . . 0.0 112.807 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.746 ' HB3' HD13 ' A' ' 76' ' ' LEU . 31.5 Cg_exo -59.0 164.46 10.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.598 2.199 . . . . 0.0 112.301 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 87' ' ' CYS . 19.8 mm -104.02 159.54 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -136.31 157.11 47.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.083 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG ' ' A' ' 108' ' ' LYS . 37.1 m-85 -146.62 170.24 17.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 107' ' ' GLY . 9.6 m -124.76 77.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.732 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -49.01 105.13 0.47 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.52 -178.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.24 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.29 179.41 8.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.253 0.549 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 p -88.11 6.92 34.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.5 m -95.22 -58.87 2.02 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -178.57 3.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.2 t -109.87 -163.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.727 HD11 ' HA3' ' A' ' 107' ' ' GLY . 0.8 OUTLIER -119.87 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 110.998 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.28 147.47 23.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 104' ' ' ASP . 0.7 OUTLIER -86.48 136.18 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.973 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.4 -166.24 36.04 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.788 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -26.29 48.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.152 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.766 ' CE1' HG23 ' A' ' 109' ' ' ILE . 2.4 t-80 -94.27 -28.17 15.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.083 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.614 HG12 HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -134.34 68.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.058 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 103' ' ' VAL . 1.2 p-10 -47.56 -105.82 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.104 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.45 -54.42 2.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.703 0.287 . . . . 0.0 111.479 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -95.71 38.64 1.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.584 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.84 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 52.14 53.76 29.39 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.533 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.458 ' CG ' ' CE2' ' A' ' 88' ' ' PHE . 3.1 mtmm -102.78 133.72 47.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.815 HD11 HG13 ' A' ' 89' ' ' VAL . 5.3 mp -87.46 106.01 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.97 48.34 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 113' ' ' TYR . 11.8 mt -70.19 121.98 84.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.63 -19.15 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.53 2.153 . . . . 0.0 112.606 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.676 ' CD2' HD22 ' A' ' 111' ' ' LEU . 15.2 m-85 -56.33 -54.33 46.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.0 111.082 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -64.47 -30.86 71.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.012 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.57 -41.47 84.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.18 27.39 7.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.073 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.12 -172.38 2.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.721 HD11 HD21 ' A' ' 74' ' ' LEU . 12.6 tp -57.44 -34.26 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 27' ' ' ASN . 1.7 mm? -62.36 -53.38 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.806 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.42 -38.55 95.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.1 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 114' ' ' LEU . 32.3 tp -54.21 -28.76 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 110.649 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mm -84.33 -29.01 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.802 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.443 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -61.65 -40.51 95.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.838 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.827 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.1 p -59.92 -42.93 91.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.414 . . . . 0.0 110.496 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.42 ' HB3' ' CD2' ' A' ' 135' ' ' PHE . 10.4 mtt -65.98 -34.4 78.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.315 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 129' ' ' GLN . 2.8 mt -60.08 -30.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.514 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.03 -52.81 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 130' ' ' VAL . 44.2 t -52.1 -49.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 131' ' ' MET . 17.6 m-30 -80.38 -27.2 38.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.94 -24.86 68.84 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.512 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.96 -44.45 12.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.991 0.424 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -177.08 123.64 0.28 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.81 144.09 56.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.361 2.041 . . . . 0.0 112.35 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.75 -39.66 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.607 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 m -63.24 117.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.969 -179.881 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 121.352 0.596 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -51.96 51.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.785 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -59.19 -41.59 88.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.197 0.522 . . . . 0.0 111.312 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.519 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.2 tp -66.01 -28.49 68.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -58.79 -48.43 81.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.966 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -61.85 -35.96 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.75 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mtp -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.765 HG12 ' SD ' ' A' ' 53' ' ' MET . 25.0 m -108.3 19.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.705 0.288 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.3 p -71.89 -29.14 64.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -74.12 -29.08 61.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.045 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.6 m-85 -58.59 127.58 32.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB3' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER -59.29 -31.51 69.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.092 0.473 . . . . 0.0 111.307 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . 5.1 m-85 -90.44 -55.18 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.662 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.4 ttm180 66.67 -68.35 0.14 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.6 t0 -58.67 -53.16 61.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.102 0.477 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 20' ' ' LEU . 1.1 tt -59.32 -30.79 68.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.756 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.635 HG23 ' CD2' ' A' ' 76' ' ' LEU . 7.1 m -74.96 -53.03 9.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.011 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 18' ' ' ARG . 32.8 t -63.5 -36.15 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.304 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -62.8 -52.25 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 28' ' ' VAL . 60.7 mt-10 -63.05 -35.53 80.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.613 HG23 ' CD2' ' A' ' 55' ' ' LEU . 61.8 m -70.1 -35.66 74.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -81.56 -47.12 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.425 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -53.23 -30.28 37.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.588 -179.222 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.796 HG21 HD23 ' A' ' 124' ' ' LEU . 35.5 t -84.5 -61.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 26' ' ' VAL . 6.0 pt -53.56 -38.98 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.557 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.0 t -68.55 -36.96 79.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 125' ' ' LEU . 5.1 mp -77.54 -52.7 8.63 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.368 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -76.45 -17.93 59.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.034 0.445 . . . . 0.0 111.815 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 65.92 -61.57 0.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.318 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' OD1' HD22 ' A' ' 35' ' ' LEU . 1.9 p30 -53.73 -37.03 62.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.849 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.531 HD13 ' HA3' ' A' ' 57' ' ' GLY . 2.3 mm? -63.05 129.07 38.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.72 145.28 52.87 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.18 155.45 22.48 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.673 2.249 . . . . 0.0 112.738 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 39' ' ' LEU . 4.9 t -147.74 161.63 7.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 51' ' ' GLU . 2.2 tm? -134.13 102.21 5.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.218 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -117.76 128.61 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.343 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -77.53 145.91 36.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.66 104.25 3.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 49' ' ' SER . 29.4 m . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.426 ' HA ' HG12 ' A' ' 43' ' ' VAL . 49.3 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.506 0.193 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.461 ' HB3' HD21 ' A' ' 52' ' ' LEU . 1.6 tpp180 -91.07 126.82 36.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.223 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' HG2' HD11 ' A' ' 39' ' ' LEU . 4.2 mt-10 -88.84 91.08 8.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 110.567 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.1 mm? -87.01 153.94 21.16 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.211 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.765 ' SD ' HG12 ' A' ' 12' ' ' VAL . 2.4 mtp -105.36 145.74 30.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.392 . . . . 0.0 110.574 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 4.4 p30 -136.61 132.78 35.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' CD2' HG23 ' A' ' 25' ' ' THR . 16.1 mt -101.49 116.13 32.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -117.68 143.79 45.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.802 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -179.71 164.09 31.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.444 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.718 HG22 ' CA ' ' A' ' 71' ' ' PRO . 33.5 p -113.97 140.0 48.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.611 ' N ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -121.48 156.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.356 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.44 136.73 60.82 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.839 2.359 . . . . 0.0 112.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 70' ' ' ILE . 62.1 t -152.67 95.67 3.04 Favored Pre-proline 0 C--O 1.223 -0.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.002 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.59 130.43 29.9 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.067 1.845 . . . . 0.0 112.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -127.95 -74.78 0.57 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.07 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -96.5 38.77 1.19 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 -23.3 35.81 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.512 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -112.64 164.89 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 110.786 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -72.88 135.49 45.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.59 -169.01 1.46 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -138.18 94.64 2.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.987 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.722 HG21 ' HD2' ' A' ' 135' ' ' PHE . 24.0 mm -92.39 106.64 18.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 0.0 111.026 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.718 ' CA ' HG22 ' A' ' 58' ' ' THR . 58.3 Cg_endo -71.66 156.93 56.78 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.001 1.801 . . . . 0.0 112.523 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 71' ' ' PRO . 23.3 pt -158.18 178.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -146.0 160.21 42.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 75' ' ' TRP . 0.3 OUTLIER -129.72 162.44 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.774 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.518 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -130.86 145.69 52.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 52' ' ' LEU . 1.4 tp -136.84 160.88 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.11 167.37 16.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.342 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.1 m-20 -93.84 -40.76 10.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 16' ' ' LYS . 18.2 p -159.88 -48.49 0.05 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.748 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.507 ' HB3' ' HA ' ' A' ' 81' ' ' PRO . 5.4 m-85 -115.95 168.12 9.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.777 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 62.7 Cg_endo -91.47 -33.5 0.99 Allowed 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.925 -1.281 . . . . 0.0 113.699 0.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 73.1 m-85 -82.36 -71.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.488 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 7.1 t30 129.79 -48.71 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 123.788 0.68 . . . . 0.0 111.069 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 60.5 Cg_endo -75.51 133.58 16.01 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.173 1.915 . . . . 0.0 112.334 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 138.75 41.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.725 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 87' ' ' CYS . 5.6 mt -99.75 159.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.501 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HB3' HD12 ' A' ' 109' ' ' ILE . 5.3 m -126.36 141.72 51.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.935 0.398 . . . . 0.0 111.281 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.456 ' CE2' ' HG3' ' A' ' 108' ' ' LYS . 10.4 m-85 -142.33 -177.25 5.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.551 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 107' ' ' GLY . 36.0 m -119.77 171.71 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 111.129 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -138.69 99.98 8.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 164.95 31.97 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.525 2.15 . . . . 0.0 112.162 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.79 177.11 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 0.0 110.996 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.4 t -83.75 -31.21 26.1 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -29.55 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.758 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -113.44 -178.47 3.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 5.5 t -125.1 -166.43 1.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.675 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.556 HD11 HG21 ' A' ' 89' ' ' VAL . 4.2 tt -115.39 120.85 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -76.16 127.38 32.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.014 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.688 HG22 ' HA ' ' A' ' 105' ' ' ALA . 67.2 p -98.69 129.86 45.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.63 -123.49 0.73 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.617 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -51.22 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.926 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.737 ' HE1' HD11 ' A' ' 111' ' ' LEU . 3.9 t60 -70.79 -46.3 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.04 77.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.107 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -50.58 175.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.361 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.688 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -58.35 -26.38 63.07 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.406 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -94.25 20.94 7.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.246 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 50.96 43.76 49.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.763 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 88' ' ' PHE . 19.1 mtmt -106.12 124.79 50.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.738 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' CE ' ' A' ' 131' ' ' MET . 59.7 mt -66.02 110.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 111.081 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -123.96 94.34 4.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.737 HD11 ' HE1' ' A' ' 102' ' ' HIS . 9.7 mt -107.77 133.68 20.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.166 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.51 -32.48 96.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.38 2.053 . . . . 0.0 112.038 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.32 -52.39 64.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.484 HD12 ' CE3' ' A' ' 117' ' ' TRP . 8.3 tp -60.68 -32.66 71.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.57 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -61.29 -43.78 98.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.547 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -98.41 25.7 6.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 2.6 t90 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 30.1 t . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.875 0.369 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.72 162.7 32.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.796 HD23 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -77.71 -37.92 48.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 28' ' ' VAL . 2.4 mp -57.37 -51.75 68.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.753 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.09 -29.61 73.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.0 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.484 HD21 ' SG ' ' A' ' 87' ' ' CYS . 41.6 tp -56.98 -30.79 64.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.615 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mm -82.9 -26.7 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.761 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.1 tp60 -64.82 -45.96 84.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.713 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.2 p -47.45 -45.63 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.872 ' CE ' HD13 ' A' ' 109' ' ' ILE . 1.3 mtt -62.97 -42.9 99.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.3 OUTLIER -53.09 -27.12 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 111.032 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 t -94.21 -52.93 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.58 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 130' ' ' VAL . 43.6 t -54.47 -36.46 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.495 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.722 ' HD2' HG21 ' A' ' 70' ' ' ILE . 5.7 m-85 -81.53 -28.78 33.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.653 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.432 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -68.32 -11.75 62.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.637 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -45.82 7.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.678 0.239 . . . . 0.0 111.055 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.96 109.03 2.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.43 116.47 3.24 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.516 2.144 . . . . 0.0 112.199 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.83 44.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.091 2.527 . . . . 0.0 112.244 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 141' ' ' VAL . 15.1 t -124.95 -7.19 6.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.862 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.345 0 O-C-N 122.277 -0.264 . . . . 0.0 111.129 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -36.3 83.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.41 . . . . 0.0 110.529 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.7 -30.82 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.696 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.89 -31.07 62.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -72.04 -46.76 55.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -31.27 67.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.479 ' HE2' ' HG ' ' A' ' 39' ' ' LEU . 7.7 ttm -63.49 -48.75 76.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.726 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 22' ' ' VAL . 17.2 m -94.53 19.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.66 -42.96 39.96 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -70.78 -25.28 62.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.652 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.78 121.69 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.305 0.378 . . . . 0.0 111.149 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 tptt -60.13 -36.68 78.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.4 44.55 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.6 ttp-105 -51.04 -52.42 43.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -54.04 -32.22 53.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.75 -29.03 18.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 76' ' ' LEU . 86.3 m -78.05 -47.0 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 12' ' ' VAL . 40.3 t -64.78 -38.16 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -45.67 53.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.875 ' O ' HG23 ' A' ' 28' ' ' VAL . 48.9 mm-40 -62.5 -39.39 93.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.755 HG22 HD11 ' A' ' 29' ' ' ILE . 63.8 m -63.31 -59.15 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.39 -47.43 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.487 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.696 ' HB3' HD13 ' A' ' 125' ' ' LEU . 4.1 t-20 -57.58 -26.2 61.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -85.96 -27.86 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.377 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -91.19 -29.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.88 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.7 m -69.7 -46.45 65.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.505 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -72.19 -40.81 67.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.953 0.406 . . . . 0.0 110.725 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -103.36 116.31 32.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.826 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 31.02 3.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.02 23.12 5.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.62 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.4 mm? -117.07 165.88 12.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.84 121.93 9.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 127.96 16.3 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.393 2.062 . . . . 0.0 112.428 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.6 t -123.76 162.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.771 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HG ' ' HE2' ' A' ' 11' ' ' MET . 2.2 tm? -146.84 110.06 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.56 141.36 52.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.37 116.39 28.94 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.381 0.425 . . . . 0.0 111.18 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.448 ' H ' HD23 ' A' ' 52' ' ' LEU . 10.0 t80 -91.4 135.17 34.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.656 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.155 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.797 0.332 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HB3' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -169.62 150.3 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.454 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.561 ' C ' HD22 ' A' ' 52' ' ' LEU . 3.7 tt0 -83.82 111.08 18.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.881 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.6 mm? -122.74 116.21 23.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -81.97 147.56 29.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.427 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 15.3 p-10 -148.11 143.87 27.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 25' ' ' THR . 44.2 mt -108.75 116.51 32.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.6 m -116.38 145.53 43.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.62 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 160.61 175.83 32.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -100.31 147.24 26.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.486 HG22 HG13 ' A' ' 61' ' ' VAL . 23.1 mt -107.34 114.52 60.86 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.046 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.43 70.1 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.301 2.0 . . . . 0.0 112.1 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 59' ' ' ILE . 7.6 m -89.96 144.68 31.8 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 35.9 Cg_endo -65.34 153.89 76.12 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.188 1.925 . . . . 0.0 112.345 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 139' ' ' PRO . 57.7 t80 -154.49 105.69 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 1.3 mpt_? 60.43 29.1 18.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.989 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.05 3.52 67.77 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.784 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 1.5 t-20 -120.75 178.35 4.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.692 0.246 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.54 131.57 44.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.726 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.21 163.08 22.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.829 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.512 ' O ' HD13 ' A' ' 70' ' ' ILE . 7.9 p-10 -121.74 123.5 41.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.722 HG23 ' CG2' ' A' ' 141' ' ' VAL . 18.7 mm -123.07 103.22 36.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' A' ' 91' ' ' PRO . 55.3 Cg_endo -69.93 133.16 24.58 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.092 1.862 . . . . 0.0 112.305 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.473 ' CD1' HD11 ' A' ' 59' ' ' ILE . 2.9 pt -142.95 167.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -131.0 134.62 46.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.447 HD13 HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -107.45 137.85 44.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.979 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.514 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -115.52 144.44 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.777 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 52' ' ' LEU . 6.1 mp -138.51 160.06 40.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.68 163.83 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -43.41 23.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 80' ' ' TYR . 4.4 t 179.97 33.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.434 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 1.8 m-85 -153.91 151.31 24.53 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.649 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 72.5 Cg_endo -76.7 -44.0 0.58 Allowed 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.173 -1.595 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.433 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 72.2 m-85 -103.92 -60.81 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.557 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 5.8 t-20 162.88 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.58 0.55 . . . . 0.0 110.833 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 81.5 Cg_exo -45.34 108.65 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.497 2.132 . . . . 0.0 112.607 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.57 145.08 30.77 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.498 2.132 . . . . 0.0 112.211 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 87' ' ' CYS . 16.5 mt -91.51 160.02 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.48 ' N ' HG22 ' A' ' 86' ' ' ILE . 4.8 p -143.5 137.66 28.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.45 ' CZ ' ' HE2' ' A' ' 108' ' ' LYS . 6.5 m-85 -140.97 143.4 34.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.637 HG22 ' HA3' ' A' ' 107' ' ' GLY . 24.8 m -84.22 146.14 7.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.066 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.08 72.29 76.54 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 71' ' ' PRO . 75.7 Cg_exo -51.34 170.82 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.588 2.192 . . . . 0.0 112.312 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.22 176.99 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -72.77 -27.13 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -5.8 50.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.516 ' HB3' HG12 ' A' ' 141' ' ' VAL . 20.7 mtm -145.81 -174.79 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.65 0.262 . . . . 0.0 110.983 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.4 t -134.18 -164.68 1.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.266 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.846 HD11 ' HA2' ' A' ' 107' ' ' GLY . 11.3 tt -111.3 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.669 ' O ' HG11 ' A' ' 103' ' ' VAL . 2.7 ttpp -75.29 114.31 13.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 p -72.64 134.98 45.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.34 -118.66 1.26 Allowed Glycine 0 CA--C 1.515 0.083 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.672 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -31.69 11.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -118.26 -29.69 5.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 98' ' ' LYS . 11.8 t -57.23 -27.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.566 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 56.55 -152.94 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.679 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 -40.9 5.97 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -93.46 3.66 55.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.846 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . 91.5 4.85 67.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.134 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HE2' ' CZ ' ' A' ' 88' ' ' PHE . 8.1 tttm -60.18 108.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.768 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 109' ' ' ILE . 4.2 mp -74.65 66.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -92.38 57.57 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 110.856 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.593 HD21 HG11 ' A' ' 134' ' ' VAL . 7.1 mt -53.19 151.71 9.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.417 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.625 ' HA ' ' CD2' ' A' ' 115' ' ' HIS . 32.5 Cg_exo -57.58 -45.83 31.24 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.573 2.182 . . . . 0.0 111.987 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -66.54 -39.58 88.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.99 -52.32 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.625 ' CD2' ' HA ' ' A' ' 112' ' ' PRO . 3.5 p80 -64.87 -35.86 82.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.669 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -95.95 26.0 4.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CE2' ' HA ' ' A' ' 122' ' ' SER . 2.5 t90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 117' ' ' TRP . 33.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.067 0.461 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -177.85 146.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -59.52 -46.48 88.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' A' ' 27' ' ' ASN . 11.6 tp -51.81 -46.13 64.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.91 -31.34 35.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.632 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 130' ' ' VAL . 11.3 tp -56.13 -31.78 63.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.9 mp -86.73 -28.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.56 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.93 -38.65 82.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.9 p -61.65 -42.65 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.518 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.42 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 52.8 mtt -65.37 -42.73 92.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.674 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.2 mp -52.05 -26.77 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.644 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 t -95.03 -54.89 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.668 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 130' ' ' VAL . 38.1 t -55.3 -37.08 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.727 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.714 ' HD2' HG21 ' A' ' 70' ' ' ILE . 3.4 m-85 -83.22 -28.08 29.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.403 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.21 -13.02 61.64 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.716 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -99.85 -45.24 5.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 0.217 . . . . 0.0 111.195 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.3 100.63 4.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 50.7 Cg_exo -55.91 119.73 7.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.386 2.057 . . . . 0.0 112.166 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 88.9 Cg_endo -78.62 -0.64 10.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.449 2.1 . . . . 0.0 112.847 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.722 ' CG2' HG23 ' A' ' 70' ' ' ILE . 22.6 t -93.21 -2.71 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.525 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 111.459 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.907 0.384 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -54.19 -38.24 65.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.77 -45.83 73.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 12' ' ' VAL . 10.7 tp -59.32 -33.06 70.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.5 -50.95 71.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -32.7 73.94 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.488 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmm -70.14 -36.92 75.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 8' ' ' LEU . 27.2 m -99.51 16.76 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.174 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -69.97 -35.67 74.63 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 111.129 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -29.08 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.644 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.568 ' HD2' HG21 ' A' ' 21' ' ' THR . 4.2 m-30 -57.12 117.84 4.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -44.02 90.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CE1' ' OG1' ' A' ' 21' ' ' THR . 0.7 OUTLIER -95.55 33.93 1.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.9 ttt180 -49.18 -31.0 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.959 0.409 . . . . 0.0 109.996 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.65 -43.56 93.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.181 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -80.81 -25.45 37.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 0.0 110.144 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.568 HG21 ' HD2' ' A' ' 15' ' ' TYR . 18.7 m -74.15 -54.81 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.596 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.6 t -63.15 -30.0 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.054 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -44.67 18.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.076 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.841 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.8 mm-40 -71.17 -40.11 71.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.495 ' O ' HD13 ' A' ' 29' ' ' ILE . 89.8 m -61.44 -47.86 83.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.481 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -60.87 -47.08 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.605 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.7 t-20 -57.53 -25.65 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.8 t -67.08 -58.26 7.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.212 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -71.59 -19.48 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.454 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -64.65 -42.61 95.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.833 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.658 HD12 ' CG ' ' A' ' 32' ' ' TYR . 1.2 pp -88.04 -43.15 11.92 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CG ' HD12 ' A' ' 31' ' ' LEU . 10.6 m-85 -107.93 109.16 20.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -89.71 64.8 6.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.423 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -145.65 -45.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.3 mm? -62.79 140.03 58.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 106.09 37.9 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.87 128.46 17.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.234 1.956 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.3 t -130.24 161.94 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.641 HD11 ' HB3' ' A' ' 51' ' ' GLU . 1.7 tm? -114.89 91.63 3.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.48 117.57 34.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 p -82.04 138.52 34.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -115.35 136.34 53.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.927 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.428 0.156 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.06 160.32 15.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.805 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.641 ' HB3' HD11 ' A' ' 39' ' ' LEU . 12.4 mt-10 -94.95 99.23 11.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.436 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.714 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.2 mm? -104.43 139.07 39.9 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.7 ttp -89.87 146.12 24.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.832 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -139.29 130.94 27.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.4 92.3 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -95.3 135.25 37.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.68 -148.37 7.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.02 128.59 7.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 pt -107.09 151.13 40.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.53 132.73 27.94 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.432 2.088 . . . . 0.0 112.197 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 136' ' ' GLY . 41.0 t -138.92 106.29 7.44 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.201 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 52.2 Cg_endo -69.11 120.65 7.51 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.66 2.24 . . . . 0.0 112.208 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 139' ' ' PRO . 12.2 t80 -131.28 113.21 13.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.979 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 66.4 11.34 7.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.52 -7.74 34.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.272 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -102.38 -177.44 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.131 0.466 . . . . 0.0 110.912 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.61 111.12 21.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.392 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -110.48 141.97 42.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -99.22 109.36 22.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.768 HG21 ' HD2' ' A' ' 135' ' ' PHE . 20.3 mm -97.77 100.3 8.2 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' O ' HG23 ' A' ' 72' ' ' ILE . 51.5 Cg_endo -69.41 146.68 63.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.282 1.988 . . . . 0.0 112.419 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 71' ' ' PRO . 2.4 pt -157.2 156.39 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.5 m -116.16 145.7 42.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.831 ' CD1' HD11 ' A' ' 128' ' ' ILE . 0.5 OUTLIER -122.58 91.2 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.999 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -66.29 144.73 56.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.8 mm? -115.19 173.44 6.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.705 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.709 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -139.44 -177.61 5.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -107.91 -35.73 6.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.076 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m 178.98 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.579 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' CB ' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -102.69 165.11 14.31 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.507 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 67.4 Cg_endo -73.45 -39.75 1.38 Allowed 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.465 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 26.2 m-85 -103.01 -63.84 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 82' ' ' TYR . 11.3 t-20 165.13 -51.36 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 33.3 Cg_endo -67.69 153.01 77.18 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.204 1.936 . . . . 0.0 112.508 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.487 ' HA ' HD12 ' A' ' 77' ' ' LEU . 54.2 Cg_endo -69.75 162.83 40.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.609 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 86' ' ' ILE . 3.2 mp -104.12 105.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.671 ' SG ' HD11 ' A' ' 127' ' ' LEU . 58.6 m -62.49 149.41 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -153.39 148.38 26.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.639 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.795 HG13 HD11 ' A' ' 109' ' ' ILE . 23.0 m -103.33 127.35 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -107.01 87.4 2.95 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.089 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.448 ' HG3' HD12 ' A' ' 97' ' ' ILE . 64.9 Cg_endo -73.41 -167.83 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.611 2.207 . . . . 0.0 112.296 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -131.8 177.13 7.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -28.66 69.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -30.94 15.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.75 137.02 32.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.754 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.21 -166.97 1.69 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.3 tt -136.96 61.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 111.149 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' O ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -42.68 133.13 3.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.818 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 105' ' ' ALA . 17.0 p -98.31 132.68 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.76 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.4 -118.76 1.74 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.582 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -100.05 -33.21 10.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -117.05 -38.69 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 98' ' ' LYS . 5.6 t -55.09 -24.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 99' ' ' THR . 0.4 OUTLIER 51.02 -155.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.177 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -104.16 -26.36 12.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.062 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.4 -2.06 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.697 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.699 ' HA3' HG22 ' A' ' 89' ' ' VAL . . . 73.27 39.12 52.84 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.613 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 88' ' ' PHE . 3.0 tttt -88.58 2.69 52.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 111.559 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.795 HD11 HG13 ' A' ' 89' ' ' VAL . 3.0 mp 45.7 73.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.839 0.352 . . . . 0.0 111.691 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 63.1 m-85 -85.74 55.53 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 mt -58.01 110.09 2.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.13 -36.17 54.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.396 2.064 . . . . 0.0 112.308 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -60.09 -53.32 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 114' ' ' LEU . 2.6 tm? -66.09 -34.04 77.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.82 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.98 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.777 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 23.84 8.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.008 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.469 ' CE2' ' CB ' ' A' ' 122' ' ' SER . 2.8 t90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.752 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.469 ' CB ' ' CE2' ' A' ' 117' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.928 0.394 . . . . 0.0 110.869 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -117.76 -179.51 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.644 HD12 ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -59.92 -36.65 77.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.853 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 27' ' ' ASN . 4.0 mp -63.35 -46.52 86.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.52 -26.81 53.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.339 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.3 tm? -55.35 -29.99 59.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 0.0 110.747 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 74' ' ' LEU . 1.9 mp -91.94 -32.58 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.778 ' HA ' HD12 ' A' ' 132' ' ' ILE . 11.6 tt0 -58.59 -35.01 71.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' MET . 5.0 p -56.03 -46.18 80.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 6.0 mtt -66.77 -40.1 88.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.986 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 129' ' ' GLN . 92.9 mt -54.24 -23.55 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.899 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 129' ' ' GLN . 40.6 t -95.09 -56.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.68 -38.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.768 ' HD2' HG21 ' A' ' 70' ' ' ILE . 5.1 m-85 -85.81 -28.64 24.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.502 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.818 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.83 -24.49 66.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.44 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.69 -39.38 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.655 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.98 128.18 0.52 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 16.0 Cg_endo -58.43 134.21 59.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 112.147 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 82.6 Cg_endo -79.8 -1.4 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.44 2.094 . . . . 0.0 112.49 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 97' ' ' ILE . 3.3 m -105.72 118.29 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.2 t80 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.992 -179.818 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -38.49 76.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.197 0.522 . . . . 0.0 110.75 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -42.24 47.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.372 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 8' ' ' LEU . 8.8 tp -59.08 -40.51 85.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.05 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -55.46 -62.44 1.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.38 58.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.999 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -45.97 63.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.77 17.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.454 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.2 t -72.69 -28.76 62.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.054 0.454 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -26.93 68.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -51.97 130.91 30.74 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -56.41 -64.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.897 ' CD2' HD12 ' A' ' 20' ' ' LEU . 40.7 m-85 -60.15 -58.48 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.675 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.609 ' O ' HG23 ' A' ' 22' ' ' VAL . 12.2 ttt180 66.84 -68.43 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.828 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' TYR . 2.6 m-20 -50.23 -47.15 55.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.897 HD12 ' CD2' ' A' ' 17' ' ' TYR . 30.4 mt -71.0 -36.4 72.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 m -70.13 -34.73 73.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.071 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 18' ' ' ARG . 23.8 t -87.57 -28.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.396 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -80.11 -45.44 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.84 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.3 mt-10 -63.49 -37.76 88.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 29' ' ' ILE . 91.7 m -64.56 -59.14 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.92 -47.65 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.563 ' HB3' HD11 ' A' ' 125' ' ' LEU . 1.5 m-20 -59.04 -27.64 65.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 24' ' ' GLU . 42.5 t -85.35 -25.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.407 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.08 -28.64 6.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.077 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -70.0 -43.61 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.021 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD23 ' CE1' ' A' ' 32' ' ' TYR . 4.5 tp -77.07 -31.61 56.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.867 ' HB3' HD23 ' A' ' 35' ' ' LEU . 78.6 m-85 -114.37 116.17 28.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -9.24 58.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.579 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' C ' HD22 ' A' ' 35' ' ' LEU . 11.2 m-20 -97.3 25.0 5.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.605 0.24 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.867 HD23 ' HB3' ' A' ' 32' ' ' TYR . 4.2 mm? -117.98 141.56 48.32 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.99 126.26 12.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.607 ' HA ' HD23 ' A' ' 55' ' ' LEU . 55.4 Cg_endo -70.43 155.34 63.94 Favored 'Trans proline' 0 C--O 1.222 -0.316 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 39' ' ' LEU . 8.8 t -151.09 162.68 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.556 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.5 tm? -136.49 119.87 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.94 162.02 30.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.505 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.2 t -103.66 135.8 44.55 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.168 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -108.76 111.13 22.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.987 -179.743 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.56 ' HE ' HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -157.36 144.85 18.7 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.794 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CG ' HD11 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -70.05 112.03 6.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.736 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.56 HD13 ' HE ' ' A' ' 50' ' ' ARG . 8.0 tp -117.92 128.91 55.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.878 0.371 . . . . 0.0 111.05 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.9 ttp -96.38 150.32 20.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.438 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -145.23 149.27 34.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.866 HD21 HG23 ' A' ' 25' ' ' THR . 35.0 mt -113.56 112.26 23.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.553 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.9 m -109.0 134.86 51.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.729 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.814 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -166.2 -156.25 9.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.489 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.548 HG23 ' N ' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -148.23 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -130.8 136.51 29.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.29 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 97.9 Cg_endo -78.76 80.36 3.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.827 2.351 . . . . 0.0 112.558 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.461 HG21 HG13 ' A' ' 70' ' ' ILE . 14.9 m -99.62 148.2 34.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 128.29 16.01 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.451 2.101 . . . . 0.0 112.432 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 0.5 OUTLIER -131.5 108.46 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 80.18 -10.96 1.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.78 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.16 -17.02 3.4 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.12 172.93 7.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -65.64 150.04 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -150.3 148.89 29.4 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.732 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.76 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.819 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 61' ' ' VAL . 26.0 mm -108.27 104.91 55.43 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.053 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.548 ' N ' HG23 ' A' ' 58' ' ' THR . 41.0 Cg_endo -67.58 140.3 51.51 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.303 2.002 . . . . 0.0 112.505 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 pt -148.86 173.46 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.553 ' SG ' HG23 ' A' ' 56' ' ' THR . 11.0 m -132.54 170.59 14.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.19 145.03 38.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.764 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -123.3 145.72 48.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 111.195 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.764 HD22 ' C ' ' A' ' 75' ' ' TRP . 2.7 mm? -127.28 171.3 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.755 HD11 ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -133.72 162.55 31.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.249 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.96 -30.9 10.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.13 -41.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -127.9 106.59 20.31 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.181 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HB3' ' HG2' ' A' ' 84' ' ' PRO . 24.2 Cg_exo -62.85 167.85 33.23 Favored 'Cis proline' 0 C--N 1.351 0.691 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.12 -0.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 25.99 9.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.454 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER 175.15 -61.31 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 17.0 Cg_endo -61.18 109.83 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.6 2.2 . . . . 0.0 112.458 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.755 ' HA ' HD11 ' A' ' 77' ' ' LEU . 87.4 Cg_endo -81.54 143.26 13.48 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.618 2.212 . . . . 0.0 112.701 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.9 mt -84.65 161.39 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.526 ' CB ' HG21 ' A' ' 109' ' ' ILE . 13.7 m -141.59 155.42 45.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 9.3 m-85 -157.89 143.38 16.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.457 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.853 HG21 HD12 ' A' ' 97' ' ' ILE . 29.7 m -59.06 -175.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.547 . . . . 0.0 111.266 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HE2' HG21 ' A' ' 56' ' ' THR . 5.6 tttm -158.42 51.86 0.49 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.474 ' CD ' HG23 ' A' ' 89' ' ' VAL . 56.1 Cg_endo -69.35 -167.16 0.2 Allowed 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.1 p -124.0 151.28 43.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -17.14 62.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.809 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -93.58 -15.09 25.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.869 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.828 ' CG ' HG13 ' A' ' 141' ' ' VAL . 3.6 tmm? -118.57 -8.56 10.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 95' ' ' MET . 13.8 t 46.98 -163.45 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.065 0.46 . . . . 0.0 111.306 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.853 HD12 HG21 ' A' ' 89' ' ' VAL . 10.2 tt -135.54 132.69 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -75.26 133.11 41.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.689 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 105' ' ' ALA . 33.5 p -85.58 131.4 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.966 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.5 -152.98 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -56.8 4.51 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.807 0.337 . . . . 0.0 110.648 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -85.66 -34.28 21.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.454 HG11 ' CB ' ' A' ' 140' ' ' PRO . 13.0 t -95.86 72.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.128 0.489 . . . . 0.0 111.047 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -176.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -63.27 -23.88 67.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.439 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.39 27.06 9.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.97 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA3' ' CG2' ' A' ' 89' ' ' VAL . . . 40.87 55.3 3.38 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.967 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.493 ' O ' HG22 ' A' ' 109' ' ' ILE . 2.6 tttp -81.82 11.48 4.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.851 -0.205 . . . . 0.0 111.51 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER 44.96 45.66 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 108' ' ' LYS . 3.7 m-85 -68.18 72.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.89 HD22 HG21 ' A' ' 134' ' ' VAL . 8.8 mt -88.77 158.83 47.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.48 -36.03 4.29 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.623 2.216 . . . . 0.0 112.43 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.55 ' HB2' HG21 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -57.86 -65.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -56.46 -29.6 61.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.699 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.82 -43.15 89.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -96.81 24.08 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.977 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 6.2 t90 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.454 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.024 0.44 . . . . 0.0 111.374 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -139.4 175.22 9.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.543 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -57.01 -38.55 73.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 27' ' ' ASN . 3.8 mp -57.8 -47.17 83.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.48 -24.83 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 130' ' ' VAL . 7.5 tt -57.2 -30.54 64.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 110.741 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.4 HG22 ' CD1' ' A' ' 132' ' ' ILE . 3.4 mp -87.74 -30.8 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.61 97.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.7 p -58.09 -43.04 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.459 ' CG ' HD11 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -63.59 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.368 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.4 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.0 OUTLIER -58.3 -27.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.616 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.08 -51.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.677 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.89 HG21 HD22 ' A' ' 111' ' ' LEU . 43.2 t -53.54 -41.91 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.639 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.507 ' HZ ' HD12 ' A' ' 109' ' ' ILE . 21.8 m-30 -81.26 -27.91 34.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.455 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.9 -23.34 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.46 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -30.76 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.039 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -146.27 83.86 8.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.438 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 9.0 Cg_exo -71.27 152.44 61.35 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.78 2.32 . . . . 0.0 112.101 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CB ' HG11 ' A' ' 103' ' ' VAL . 59.2 Cg_endo -71.3 -31.79 13.71 Favored 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.278 1.985 . . . . 0.0 112.154 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.828 HG13 ' CG ' ' A' ' 95' ' ' MET . 84.0 t -59.45 162.35 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.01 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' HG12 ' A' ' 141' ' ' VAL . 11.1 t80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.654 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.606 0.241 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -60.13 -37.79 81.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -71.14 -31.9 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -58.29 -46.39 86.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.972 0.415 . . . . 0.0 111.029 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.06 -51.02 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.841 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -61.33 -30.88 70.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.486 ' HE2' HD23 ' A' ' 39' ' ' LEU . 13.3 mtp -67.74 -30.74 70.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -111.39 20.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.0 p -67.98 -24.59 65.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -58.08 -44.8 87.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' OH ' HD12 ' A' ' 52' ' ' LEU . 9.8 m-30 -61.75 175.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.49 -31.05 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 20' ' ' LEU . 4.3 m-30 -62.99 -69.72 0.25 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.55 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.9 ttt180 66.68 -69.43 0.12 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -44.72 95.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.051 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.625 HD12 ' CD2' ' A' ' 17' ' ' TYR . 46.3 mt -68.0 -36.46 80.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.995 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.66 HG21 HG11 ' A' ' 12' ' ' VAL . 16.5 m -62.89 -31.32 72.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.806 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.1 t -90.56 -27.14 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -45.23 19.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 28' ' ' VAL . 3.1 tt0 -67.68 -43.71 79.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.858 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.8 t -58.43 -48.02 82.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.18 0.514 . . . . 0.0 110.793 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG2' ' A' ' 25' ' ' THR . 0.4 OUTLIER -60.4 -47.08 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.456 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -51.78 -29.96 21.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.338 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 24' ' ' GLU . 21.8 t -85.04 -63.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pt -56.68 -25.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.339 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.7 m -80.29 -31.08 38.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.75 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.4 mt -86.54 -20.11 28.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.045 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -126.91 136.56 52.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.35 27.11 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 111.191 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.47 8.68 3.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.348 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.743 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.9 mm? -118.11 130.41 56.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.532 0.206 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -129.81 146.13 60.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.97 146.63 32.99 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.967 2.445 . . . . 0.0 112.706 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.738 ' CG2' HG22 ' A' ' 56' ' ' THR . 6.7 t -135.54 162.2 37.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD23 ' HE2' ' A' ' 11' ' ' MET . 1.8 tm? -132.16 123.8 27.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.461 ' N ' HD13 ' A' ' 39' ' ' LEU . 22.8 t70 -139.21 129.64 25.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 p -91.3 148.2 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.63 147.48 48.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.982 0.42 . . . . 0.0 110.652 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 111.155 179.722 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.28 153.38 47.04 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.93 95.01 7.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.83 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.539 HD23 ' CZ3' ' A' ' 75' ' ' TRP . 6.7 tp -96.67 161.32 13.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.817 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.645 ' HE1' HD21 ' A' ' 55' ' ' LEU . 1.2 ttp -121.11 158.22 28.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.464 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 17.7 t-20 -154.17 150.71 28.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.645 HD21 ' HE1' ' A' ' 53' ' ' MET . 2.6 mt -123.51 134.6 53.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.738 HG22 ' CG2' ' A' ' 38' ' ' VAL . 10.2 t -121.05 156.76 31.51 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.153 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.743 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 165.25 173.28 33.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.487 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 71' ' ' PRO . 13.6 p -133.8 128.0 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -86.75 111.45 40.03 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.399 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.52 96.88 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.662 2.241 . . . . 0.0 112.409 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.45 141.36 27.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.275 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.26 157.34 50.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.294 1.996 . . . . 0.0 112.37 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.436 ' CE2' ' HD2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -157.56 110.07 2.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 58.87 28.22 17.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.227 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.55 5.75 66.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.9 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -116.08 -168.45 1.43 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 110.618 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.02 123.78 50.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 7.6 t80 -121.51 162.75 19.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.711 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -140.18 123.86 17.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.838 HG21 ' CD2' ' A' ' 135' ' ' PHE . 5.2 mm -101.94 100.86 15.98 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HA ' HG22 ' A' ' 58' ' ' THR . 42.7 Cg_endo -68.03 109.55 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.163 1.909 . . . . 0.0 112.105 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 89' ' ' VAL . 2.6 pp -123.35 143.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -107.17 167.87 9.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.493 HD22 HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -132.29 137.98 47.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.705 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -114.63 145.95 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.705 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.2 mm? -120.17 158.12 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.803 HD11 ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -128.07 174.67 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 79' ' ' THR . 12.8 p-10 -97.38 39.95 1.17 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.592 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 72.24 10.61 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.97 158.77 58.37 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.775 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.57 -44.28 0.55 Allowed 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.193 -1.586 . . . . 0.0 112.158 0.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 47.2 m-85 -78.78 -71.52 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 23.0 p30 146.13 -30.91 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.639 0.776 . . . . 0.0 112.185 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 48.0 Cg_exo -57.24 135.47 70.54 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.912 1.741 . . . . 0.0 112.243 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.803 ' HA ' HD11 ' A' ' 77' ' ' LEU . 69.2 Cg_endo -73.96 133.76 18.73 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.402 2.068 . . . . 0.0 112.358 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.24 147.68 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.7 t -139.98 131.28 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 20.7 m-30 -116.5 -176.19 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 109' ' ' ILE . 4.6 m -134.16 87.17 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.899 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 109.47 1.73 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.424 ' CG ' HD11 ' A' ' 97' ' ' ILE . 73.8 Cg_endo -75.54 -167.97 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.251 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.5 p -149.05 173.85 12.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.089 0.471 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -67.37 -24.6 65.71 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.035 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -47.63 80.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.184 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -167.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.063 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -126.93 -146.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.588 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.424 HD11 ' CG ' ' A' ' 91' ' ' PRO . 22.1 mm -123.62 123.01 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.875 0.369 . . . . 0.0 110.766 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -85.12 162.29 19.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.768 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 104' ' ' ASP . 12.9 p -141.1 132.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.39 -86.5 0.13 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.942 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -54.29 -71.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CG ' ' HG ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -162.95 63.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.25 0.548 . . . . 0.0 111.021 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -133.57 -7.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.708 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.765 ' O ' HG22 ' A' ' 99' ' ' THR . 0.6 OUTLIER 51.82 -153.86 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.16 -29.51 10.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.463 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -104.95 27.21 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.786 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 70.76 45.35 52.92 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.704 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.436 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -100.38 142.19 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.743 -0.269 . . . . 0.0 110.954 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.011 HD11 HG13 ' A' ' 89' ' ' VAL . 4.5 mp -101.84 98.45 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -99.63 40.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' HD2' ' A' ' 112' ' ' PRO . 3.8 mt -55.63 139.07 68.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.974 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HD2' HD23 ' A' ' 111' ' ' LEU . 73.1 Cg_endo -76.17 -25.01 10.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.49 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -48.69 76.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.96 -31.66 59.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.794 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.7 -35.8 79.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.79 20.02 12.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 122' ' ' SER . 3.5 t90 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 110.799 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 117' ' ' TRP . 1.3 p . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.794 0.331 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -136.31 178.29 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 128' ' ' ILE . 17.1 mt -84.05 -19.47 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mp -67.11 -43.09 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.41 -36.91 8.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 130' ' ' VAL . 5.4 tp -54.93 -27.97 47.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.537 HD13 ' O ' ' A' ' 124' ' ' LEU . 1.3 mp -90.26 -31.04 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.423 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -56.4 -33.15 65.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.647 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.2 p -57.54 -45.53 86.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.446 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 31.2 mtt -67.94 -38.46 82.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.072 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -55.12 -25.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 129' ' ' GLN . 40.4 t -95.07 -53.1 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.676 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 130' ' ' VAL . 38.9 t -57.99 -44.54 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.838 ' CD2' HG21 ' A' ' 70' ' ' ILE . 18.0 m-85 -83.3 -23.16 32.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.268 0.556 . . . . 0.0 110.987 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.12 -28.61 73.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.359 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.96 -38.76 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -176.58 113.09 0.25 Allowed Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.895 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 50.1 Cg_exo -54.08 136.5 67.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.194 1.929 . . . . 0.0 112.135 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 135' ' ' PHE . 84.7 Cg_endo -81.75 -21.71 5.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.63 2.22 . . . . 0.0 112.345 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.653 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 6.4 t -50.52 171.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.653 ' CB ' ' O ' ' A' ' 141' ' ' VAL . 4.5 t80 . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.032 0.444 . . . . 0.0 110.375 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.834 0.35 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -60.04 -46.94 87.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 0.0 110.815 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.26 -42.54 99.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.239 0.542 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.23 -51.09 60.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.145 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -58.86 -24.24 61.89 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.192 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -21.42 42.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.016 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.0 mtt -73.93 -43.37 58.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.438 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 16.5 m -91.99 0.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.701 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -60.14 -31.95 70.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -26.17 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.977 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' A' ' 12' ' ' VAL . 10.9 m-85 -56.75 156.35 6.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -85.53 -54.54 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 23.2 m-30 -90.25 69.03 7.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -50.51 -56.44 11.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.226 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.53 -58.67 7.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 111.048 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -55.58 -26.45 43.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.352 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.848 HG23 HD23 ' A' ' 76' ' ' LEU . 77.6 m -86.0 -55.09 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.243 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.6 t -66.65 -33.54 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.37 -47.49 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.702 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.775 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.7 mp0 -67.33 -29.66 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.856 HG23 HD21 ' A' ' 55' ' ' LEU . 7.1 m -78.37 -30.8 48.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -84.16 -46.65 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.218 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.566 ' CG ' HD11 ' A' ' 125' ' ' LEU . 7.6 t-20 -52.32 -36.52 53.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.378 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 24' ' ' GLU . 28.8 t -74.83 -62.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.192 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -57.5 -43.42 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.8 m -58.99 -42.71 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tt -73.8 -41.66 62.04 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 121.173 0.511 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -104.95 104.91 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.781 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.1 61.86 6.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -142.78 -44.34 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.801 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.656 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.61 168.13 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.828 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 143.23 18.91 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.658 ' HA ' HD23 ' A' ' 55' ' ' LEU . 55.6 Cg_endo -70.63 134.46 26.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.639 2.226 . . . . 0.0 112.18 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' LEU . 6.5 t -127.16 162.45 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.01 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.1 tm? -138.2 128.14 25.5 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -153.4 129.16 10.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.324 0.583 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -74.05 157.6 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.07 103.74 3.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.587 0.232 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -167.43 135.47 2.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.77 111.69 18.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.8 mm? -110.29 138.23 46.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.315 0.579 . . . . 0.0 110.555 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.49 ' CE ' HG21 ' A' ' 25' ' ' THR . 2.9 tmm? -85.45 142.37 29.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.774 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 38' ' ' VAL . 12.1 p-10 -135.28 148.71 49.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 25' ' ' THR . 8.7 mt -113.32 120.82 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.413 HG23 ' SG ' ' A' ' 73' ' ' CYS . 2.5 m -115.95 158.91 22.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.1 -179.35 28.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.342 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.675 HG22 ' CA ' ' A' ' 71' ' ' PRO . 60.4 p -124.32 152.8 42.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.935 0.397 . . . . 0.0 111.007 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.462 HG23 ' HD2' ' A' ' 60' ' ' PRO . 5.3 mt -123.47 137.02 27.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.072 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 59' ' ' ILE . 19.0 Cg_endo -60.75 104.1 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.22 1.947 . . . . 0.0 112.0 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.648 HG13 ' HA2' ' A' ' 136' ' ' GLY . 42.3 t -132.1 121.65 17.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.94 146.78 55.48 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.368 2.046 . . . . 0.0 112.29 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -106.01 -75.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.087 0.47 . . . . 0.0 110.897 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 26.0 2.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.05 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.28 3.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.79 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -123.1 174.02 7.5 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -91.8 123.67 35.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -120.35 161.77 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -112.34 99.97 8.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.568 HG21 ' HD2' ' A' ' 135' ' ' PHE . 21.0 mm -82.63 110.21 20.93 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.675 ' CA ' HG22 ' A' ' 58' ' ' THR . 59.7 Cg_endo -72.21 145.08 43.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.262 1.975 . . . . 0.0 112.298 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 59' ' ' ILE . 2.9 pt -155.69 153.06 7.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' SG ' HG23 ' A' ' 56' ' ' THR . 87.9 m -113.52 169.18 9.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.624 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.558 HD21 HD21 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -138.89 146.81 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.533 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 HG23 ' A' ' 21' ' ' THR . 1.7 mp -135.2 155.92 49.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -126.07 174.58 8.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.099 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.614 ' O ' HG22 ' A' ' 79' ' ' THR . 10.1 p-10 -96.31 39.55 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 76.63 6.85 3.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.455 ' HD1' HG23 ' A' ' 79' ' ' THR . 1.6 m-85 -152.94 150.81 25.07 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.927 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 87.4 Cg_endo -82.77 -37.74 1.36 Allowed 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.409 0.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.603 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 88.3 m-85 -60.9 -80.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.766 ' O ' HD21 ' A' ' 77' ' ' LEU . 8.7 t-20 135.89 -51.89 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 123.395 0.678 . . . . 0.0 111.052 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 67.9 Cg_endo -75.59 128.54 11.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.395 2.063 . . . . 0.0 112.34 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 135.94 71.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.456 2.104 . . . . 0.0 112.529 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.1 mp -92.73 160.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.493 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -128.09 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 111.296 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 109' ' ' ILE . 6.5 m-85 -130.83 143.33 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.747 HG22 ' HD3' ' A' ' 91' ' ' PRO . 13.1 p -97.67 138.72 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.956 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -130.36 68.94 81.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.747 ' HD3' HG22 ' A' ' 89' ' ' VAL . 32.7 Cg_exo -59.53 -178.68 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.471 2.114 . . . . 0.0 112.256 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -82.81 165.41 19.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -86.28 -13.71 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.461 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -95.07 -27.92 15.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 0.0 110.586 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 13.5 ttm -89.53 -25.07 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.98 149.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.823 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 97' ' ' ILE . 10.2 tt -95.18 109.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.099 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 1.0 OUTLIER -77.05 130.86 37.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.19 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.8 p -75.2 136.56 41.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.981 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 103' ' ' VAL . . . -144.68 -157.37 7.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.562 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -35.48 70.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -105.77 -39.25 6.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 140' ' ' PRO . 1.3 m -84.38 85.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.406 ' OD2' ' CD2' ' A' ' 110' ' ' TYR . 15.3 m-20 -60.76 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.13 5.14 31.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -131.84 30.11 4.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 0.0 111.173 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . 51.53 51.21 38.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.8 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.454 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -119.21 93.0 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.033 0.444 . . . . 0.0 110.768 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 109' ' ' ILE . 3.6 mp -59.29 108.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.016 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 1.3 m-85 -101.72 51.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.733 HD13 HG11 ' A' ' 130' ' ' VAL . 19.5 mt -59.49 119.02 36.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 -27.43 27.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.426 2.084 . . . . 0.0 112.296 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -58.83 -29.43 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.486 HD22 HD23 ' A' ' 127' ' ' LEU . 6.8 tp -91.81 -34.32 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -67.21 -37.5 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -98.44 28.32 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.435 ' CE2' ' HA ' ' A' ' 122' ' ' SER . 1.8 t90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.435 ' HA ' ' CE2' ' A' ' 117' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.047 0.451 . . . . 0.0 111.483 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 179.95 -177.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.587 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.558 HD21 HD21 ' A' ' 74' ' ' LEU . 4.4 mt -84.57 -34.49 23.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.854 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.566 HD11 ' CG ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -50.48 -47.46 57.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.65 -25.77 55.64 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.366 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.663 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.4 tm? -58.37 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 128' ' ' ILE . 3.4 mp -90.48 -27.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.709 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.863 ' O ' HG22 ' A' ' 132' ' ' ILE . 2.5 tt0 -65.17 -33.2 75.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.701 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.81 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.7 p -66.5 -41.86 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 0.0 110.653 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.419 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.3 mmt -67.48 -44.38 78.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.863 HG22 ' O ' ' A' ' 129' ' ' GLN . 1.2 tt -52.77 -26.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.153 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.03 -54.1 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 130' ' ' VAL . 41.6 t -55.53 -38.32 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.568 ' HD2' HG21 ' A' ' 70' ' ' ILE . 6.0 m-85 -83.86 -26.7 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.648 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -65.05 -18.74 65.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.534 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -48.93 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.56 111.19 1.65 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.0 139.07 79.67 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.991 . . . . 0.0 112.192 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.684 ' HB2' HG11 ' A' ' 103' ' ' VAL . 91.8 Cg_endo -84.78 1.62 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.698 2.265 . . . . 0.0 112.658 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 91' ' ' PRO . 25.8 t -84.9 -47.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.409 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.274 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -49.76 75.75 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.524 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.95 -49.34 68.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.1 tp -58.73 -29.67 66.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.927 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -55.2 36.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -70.15 -29.56 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.426 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmm -62.56 -49.18 76.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.044 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 8' ' ' LEU . 17.1 m -101.35 19.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.487 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -67.09 -29.75 69.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.822 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -31.22 68.08 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CE2' HG21 ' A' ' 21' ' ' THR . 3.4 m-30 -56.91 129.73 42.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' HG21 ' A' ' 79' ' ' THR . 1.0 OUTLIER -58.27 -62.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.63 -55.25 25.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.829 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 ttp180 66.97 -67.41 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.38 -49.62 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -48.31 79.89 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.512 0.507 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 15' ' ' TYR . 5.0 m -66.97 -31.93 72.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 18' ' ' ARG . 37.8 t -79.94 -25.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.131 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -79.01 -47.02 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 28' ' ' VAL . 15.5 mt-10 -67.13 -43.46 82.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.7 t -58.44 -47.46 83.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.449 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -62.44 -46.99 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.776 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.447 ' HB3' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -51.72 -32.58 30.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.274 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.938 HG21 HD23 ' A' ' 124' ' ' LEU . 21.4 t -73.85 -66.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -56.9 -28.33 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.0 m -70.25 -33.53 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.62 -34.43 15.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -102.11 122.63 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.88 3.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.6 15.75 2.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.416 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 167.64 11.24 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.832 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -152.4 137.03 10.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.776 ' HA ' HD23 ' A' ' 55' ' ' LEU . 74.4 Cg_endo -75.12 159.7 40.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.601 2.201 . . . . 0.0 112.115 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 6.4 t -150.6 161.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.5 tm? -129.42 122.35 29.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -138.03 161.45 36.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.401 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.09 152.15 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.72 88.44 2.68 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.142 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.947 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.053 0.454 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -123.53 120.15 32.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -59.73 142.08 53.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 52' ' ' LEU . 3.9 tp -147.01 141.54 26.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.251 0.548 . . . . 0.0 110.997 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.602 ' SD ' HG11 ' A' ' 12' ' ' VAL . 5.7 ttp -107.21 139.57 41.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.492 ' ND2' ' HB ' ' A' ' 38' ' ' VAL . 5.0 p-10 -138.77 157.46 46.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.813 HD12 HD13 ' A' ' 74' ' ' LEU . 4.1 mt -124.58 128.4 48.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.5 m -124.24 134.31 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.15 169.57 37.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.71 139.39 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.733 ' O ' HD12 ' A' ' 59' ' ' ILE . 2.0 pp -117.07 156.43 48.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.763 ' HG2' HD11 ' A' ' 132' ' ' ILE . 39.8 Cg_endo -67.45 134.96 34.87 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.489 2.126 . . . . 0.0 112.211 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.71 HG21 ' CG1' ' A' ' 70' ' ' ILE . 98.1 t -143.27 106.22 5.16 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.74 134.71 41.76 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.794 2.329 . . . . 0.0 112.252 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -167.85 116.27 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER 81.21 -10.24 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.039 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.06 -6.99 7.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.573 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.77 175.13 6.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 114.63 28.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -94.18 148.15 22.47 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.17 104.3 16.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.724 HG21 ' HD2' ' A' ' 135' ' ' PHE . 31.6 mm -102.45 98.88 11.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 72' ' ' ILE . 46.0 Cg_endo -68.44 153.55 73.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.469 2.113 . . . . 0.0 112.189 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.756 ' O ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -159.21 154.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.403 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 43.2 t -105.13 150.01 25.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.813 HD13 HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -124.68 142.67 51.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.544 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -127.62 139.95 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 75' ' ' TRP . 2.6 mm? -128.22 170.4 13.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.15 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.68 165.75 18.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.08 -39.42 75.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.794 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 16' ' ' LYS . 1.5 t 173.37 -34.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.181 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 79' ' ' THR . 11.8 m-85 -166.07 163.39 12.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.771 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 68.1 Cg_endo -92.78 -0.59 54.19 Favored 'Cis proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.237 -1.151 . . . . 0.0 112.647 0.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 12.0 m-85 -87.2 51.7 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.631 0.253 . . . . 0.0 111.062 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.568 ' O ' HD11 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -40.99 -51.63 7.26 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 44.4 Cg_endo -70.68 115.52 4.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.217 1.945 . . . . 0.0 112.105 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 84' ' ' PRO . 34.5 Cg_endo -64.97 167.67 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.0 112.591 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 3.6 mp -104.07 159.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.487 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.6 p -133.53 126.08 30.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.051 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 21.7 m-85 -131.72 161.63 32.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.78 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.546 HG22 ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -133.54 129.78 56.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 80.49 50.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 89' ' ' VAL . 84.3 Cg_exo -46.52 164.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.448 2.098 . . . . 0.0 112.588 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.0 p -87.23 172.57 9.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.824 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -59.83 -20.78 58.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 m -54.42 -58.93 5.53 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.032 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.02 177.03 5.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.048 0.451 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.804 HG23 ' O ' ' A' ' 142' ' ' PHE . 8.2 t -94.19 -137.74 0.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.592 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -152.1 111.25 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.317 0.58 . . . . 0.0 111.382 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' HA ' ' A' ' 140' ' ' PRO . 3.0 ptmt -101.78 133.83 45.89 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.142 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -173.48 -177.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 111.487 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' A' ' 99' ' ' THR . . . 153.63 -17.92 0.67 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.302 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -54.89 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.551 0.215 . . . . 0.0 111.279 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.614 ' ND1' HG23 ' A' ' 103' ' ' VAL . 10.6 p80 -129.96 -34.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.614 HG23 ' ND1' ' A' ' 102' ' ' HIS . 84.7 t -77.46 -16.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.454 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 99' ' ' THR . 2.5 m-20 53.01 170.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.84 0.352 . . . . 0.0 111.455 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.47 -19.09 62.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.609 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.43 24.63 4.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 53.24 23.53 18.19 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.066 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.47 125.7 37.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.546 -0.385 . . . . 0.0 110.481 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.34 108.73 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 111.291 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -104.31 31.66 4.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.115 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.614 HD21 HG21 ' A' ' 134' ' ' VAL . 4.2 mt -51.72 152.01 5.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.599 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CD ' HD23 ' A' ' 111' ' ' LEU . 23.1 Cg_exo -63.82 -32.12 67.32 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.745 ' HB2' HG21 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -57.9 -31.51 66.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.684 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -86.97 -42.71 12.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.13 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.33 -36.26 83.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.059 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.99 37.01 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.422 ' NE1' ' CB ' ' A' ' 122' ' ' SER . 1.6 t90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.575 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.422 ' CB ' ' NE1' ' A' ' 117' ' ' TRP . 23.3 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.879 0.371 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 177.49 153.87 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -56.71 -43.8 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 27' ' ' ASN . 1.6 mp -55.48 -42.37 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.766 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.46 56.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.254 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 130' ' ' VAL . 30.2 tp -56.54 -36.58 69.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.441 HD11 HD11 ' A' ' 74' ' ' LEU . 3.8 mp -90.2 -23.99 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.653 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.922 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.2 tt0 -69.3 -33.41 73.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.676 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 113' ' ' TYR . 3.6 p -63.51 -42.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.428 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 4.6 mtt -64.77 -43.76 92.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.922 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER -53.77 -25.05 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.39 -52.69 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.503 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 130' ' ' VAL . 43.0 t -57.09 -36.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.375 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.724 ' HD2' HG21 ' A' ' 70' ' ' ILE . 4.3 m-85 -83.3 -26.1 30.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.244 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.22 -15.07 72.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.61 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.4 -36.14 11.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.803 0.335 . . . . 0.0 110.642 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -153.39 85.8 4.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.45 111.11 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.652 2.235 . . . . 0.0 112.727 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 98' ' ' LYS . 86.8 Cg_endo -83.9 50.0 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.857 2.371 . . . . 0.0 112.082 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 70' ' ' ILE . 3.8 t -125.15 -7.66 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.404 0.145 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -81.5 -32.92 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.937 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -70.67 -42.07 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.633 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.735 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.6 tp -59.88 -44.57 94.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.457 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.2 66.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.801 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -72.93 -29.01 62.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.97 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -88.62 -35.86 16.61 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.0 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 8' ' ' LEU . 26.9 m -88.54 8.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.632 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 p -79.22 -29.55 42.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.912 0.387 . . . . 0.0 110.809 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -69.81 -17.89 63.43 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.533 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 78' ' ' ASP . 1.8 m-85 -51.17 167.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.821 0.343 . . . . 0.0 111.142 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -47.85 8.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -84.24 -58.08 2.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER 66.54 -68.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -52.78 -29.9 30.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.195 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -84.9 -39.44 18.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -47.73 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 18' ' ' ARG . 22.9 t -61.68 -39.62 83.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -63.31 -50.57 69.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.269 0.557 . . . . 0.0 111.173 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 28' ' ' VAL . 9.4 mt-10 -60.68 -47.04 88.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.944 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.471 HG23 HD21 ' A' ' 55' ' ' LEU . 5.7 m -58.8 -50.65 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -58.78 -47.37 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.423 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -53.31 -33.22 52.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.446 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.847 HG21 HD23 ' A' ' 124' ' ' LEU . 21.8 t -80.95 -58.98 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.448 HD11 ' HA ' ' A' ' 26' ' ' VAL . 2.9 pt -59.83 -34.54 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.362 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.5 t -67.52 -38.01 83.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.831 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' CD2' HG23 ' A' ' 30' ' ' THR . 2.5 mm? -86.39 -30.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.35 124.99 50.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.302 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.95 68.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -168.62 -41.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.588 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.7 mm? -62.56 129.39 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.85 101.44 53.49 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.883 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.05 139.71 33.64 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.453 2.102 . . . . 0.0 112.385 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.497 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 5.2 t -132.18 162.08 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.466 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.4 tm? -118.75 124.07 46.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 39' ' ' LEU . 16.2 t70 -149.2 127.33 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.866 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -90.91 159.26 16.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -112.3 104.77 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 110.727 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -179.843 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.733 0.302 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 134.14 41.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.78 123.73 24.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 77' ' ' LEU . 6.5 tp -134.36 155.08 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.527 ' HE2' HD12 ' A' ' 76' ' ' LEU . 15.5 ttp -118.44 149.93 40.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 38' ' ' VAL . 4.4 p-10 -143.41 160.7 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.884 HD12 HD13 ' A' ' 74' ' ' LEU . 11.0 mt -127.08 118.72 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.958 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.41 HG21 ' HD3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -119.9 155.84 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.588 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 161.04 172.0 27.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.481 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.409 HG23 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -110.52 124.82 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.0 111.248 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 pt -104.0 150.91 38.78 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.189 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.83 149.46 66.46 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 112.257 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.772 HG13 ' HA2' ' A' ' 136' ' ' GLY . 97.1 t -155.7 107.57 2.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.199 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 58.2 Cg_exo -52.23 111.78 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.151 1.9 . . . . 0.0 112.293 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -110.45 97.43 6.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 57.49 24.97 10.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.68 -15.97 28.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.815 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -96.94 177.89 5.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -114.14 111.25 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.064 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.12 -173.7 2.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.097 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -146.98 87.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.063 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 70' ' ' ILE . 3.2 mp -89.09 107.51 18.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HG3' HG23 ' A' ' 92' ' ' THR . 49.5 Cg_endo -69.18 160.24 50.66 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.556 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 71' ' ' PRO . 2.7 pp -159.22 163.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 158.88 28.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.737 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.884 HD13 HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -132.83 135.18 45.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.908 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -121.35 134.17 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.908 HD23 ' O ' ' A' ' 75' ' ' TRP . 8.8 mt -133.13 156.75 46.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.06 162.77 24.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 4.8 p-10 -60.3 -44.11 95.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.676 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -177.39 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.56 157.74 55.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HG2' ' CD2' ' A' ' 82' ' ' TYR . 73.5 Cg_endo -77.86 -47.37 0.31 Allowed 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.307 -1.539 . . . . 0.0 112.569 0.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 80.3 m-85 -87.91 -67.66 0.81 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' O ' HD21 ' A' ' 77' ' ' LEU . 4.6 m-20 156.82 -52.44 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.779 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' O ' HD11 ' A' ' 77' ' ' LEU . 87.2 Cg_exo -44.52 143.49 3.87 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.744 2.296 . . . . 0.0 112.774 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.594 ' CB ' HD22 ' A' ' 76' ' ' LEU . 85.8 Cg_endo -82.25 138.56 10.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.0 112.445 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.3 mp -83.38 160.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.493 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.4 t -134.97 141.71 46.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.028 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.477 ' CA ' HD12 ' A' ' 109' ' ' ILE . 2.8 m-85 -138.76 -179.86 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 107' ' ' GLY . 13.6 p -128.25 149.19 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HD3' HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -114.36 87.83 14.41 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.7 148.46 15.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.527 2.152 . . . . 0.0 112.398 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.647 HG23 ' HG3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -105.65 -176.71 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.0 t -77.88 -31.83 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.688 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -73.56 -56.97 4.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.7 mtm -91.54 179.3 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -130.09 -98.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.484 HD11 HG11 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -175.5 126.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.29 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.15 116.08 29.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.636 HG22 ' C ' ' A' ' 104' ' ' ASP . 57.5 p -86.27 134.07 33.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.43 -63.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.43 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -100.03 -71.31 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.577 ' NE2' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -120.71 -15.67 8.37 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' THR . 21.7 t -87.48 70.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.661 0.267 . . . . 0.0 111.583 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.636 ' C ' HG22 ' A' ' 99' ' ' THR . 70.6 m-20 -52.04 -176.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.25 68.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.19 19.64 10.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.796 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 53.99 29.39 43.24 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 88' ' ' PHE . 27.8 tttp -83.87 113.31 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.578 HG22 HD12 ' A' ' 111' ' ' LEU . 2.2 mp -69.78 110.19 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.21 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 102' ' ' HIS . 3.8 p90 -132.92 46.98 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.481 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 109' ' ' ILE . 1.3 mp -44.67 148.95 0.84 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.644 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -30.85 10.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.564 2.176 . . . . 0.0 112.017 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -60.34 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.98 -30.91 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.418 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -58.86 -55.64 32.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.02 31.02 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.495 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.589 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.415 ' N ' ' NE1' ' A' ' 117' ' ' TRP . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.042 0.449 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -93.17 168.89 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 28' ' ' VAL . 4.4 tp -57.76 -39.68 77.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mp -49.28 -43.16 42.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.54 -26.86 49.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.256 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.1 tm? -57.87 -31.74 67.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.6 mp -88.02 -28.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.7 tm0? -61.34 -35.86 78.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 111' ' ' LEU . 2.3 p -65.19 -39.94 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.404 ' HG2' ' CE1' ' A' ' 135' ' ' PHE . 10.0 mtt -68.74 -44.59 73.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.858 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 129' ' ' GLN . 1.2 tt -52.65 -24.53 6.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.204 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 129' ' ' GLN . 42.0 t -92.98 -56.48 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.529 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 130' ' ' VAL . 89.6 t -56.63 -46.95 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.543 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.544 ' CD2' HG21 ' A' ' 70' ' ' ILE . 4.3 m-85 -74.9 -27.79 60.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.772 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -66.53 -15.54 64.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.592 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -89.78 -48.66 7.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -158.81 137.35 7.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.74 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 138' ' ' GLU . 48.5 Cg_exo -55.66 105.97 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 112.338 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 18.3 Cg_exo -66.62 -12.85 37.54 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.227 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 141' ' ' VAL . 42.8 t -84.56 -13.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.605 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.68 0.276 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -72.27 -35.35 68.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.73 -32.66 57.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.821 ' O ' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -63.01 -28.39 70.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -29.47 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.292 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -73.65 -28.13 61.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.988 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.66 ' CE ' HD23 ' A' ' 39' ' ' LEU . 5.6 ptm -85.62 -35.22 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.081 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 8' ' ' LEU . 29.4 m -94.87 11.57 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.561 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -23.19 63.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.055 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -26.67 25.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.409 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 8.5 m-85 -54.52 134.19 46.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -67.5 -49.41 63.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -90.7 66.44 6.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.851 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -56.92 -60.73 3.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.325 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -51.45 -53.28 38.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.094 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.03 -41.24 99.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.0 m -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 18' ' ' ARG . 39.4 t -82.31 -31.74 10.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -72.27 -48.42 42.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 28' ' ' VAL . 23.4 mt-10 -64.39 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.697 HG23 ' CD2' ' A' ' 55' ' ' LEU . 85.6 m -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.078 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -85.78 -47.81 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.598 ' O ' HD23 ' A' ' 31' ' ' LEU . 2.4 m-20 -55.42 -28.72 56.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.474 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.5 t -85.82 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.427 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 5.9 pt -57.38 -33.76 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.567 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 26' ' ' VAL . 4.8 t -75.47 -32.69 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 27' ' ' ASN . 2.7 mm? -77.04 -38.91 51.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.858 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' CB ' HD23 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -99.26 -20.56 16.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.512 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 1.1 mttp 67.31 -59.88 0.39 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.639 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -45.69 -35.88 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.885 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.674 HD21 ' CG2' ' A' ' 59' ' ' ILE . 3.6 mm? -63.38 132.52 51.75 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 111.059 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -129.95 117.97 18.4 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.699 ' HB2' HD11 ' A' ' 8' ' ' LEU . 45.4 Cg_exo -56.7 140.68 91.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.401 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 39' ' ' LEU . 8.4 t -131.34 162.81 38.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.66 HD23 ' CE ' ' A' ' 11' ' ' MET . 2.1 tm? -133.4 95.18 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.862 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.24 118.6 35.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.08 145.52 49.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.296 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -117.67 119.93 36.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.596 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 49' ' ' SER . 33.3 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 111.188 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.569 ' HB3' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.662 0.267 . . . . 0.0 111.275 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.07 127.99 55.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.421 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -74.49 101.09 4.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' O ' HD22 ' A' ' 39' ' ' LEU . 4.6 mm? -108.65 138.99 44.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.556 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 65.8 ttp -84.85 149.2 25.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.442 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 9.0 p-10 -149.98 117.8 6.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.697 ' CD2' HG23 ' A' ' 25' ' ' THR . 3.6 mt -85.37 107.65 17.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.522 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 m -108.5 149.73 28.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.498 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 163.4 165.42 20.5 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.42 HG23 ' HB3' ' A' ' 71' ' ' PRO . 1.4 p -107.29 120.63 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.604 0.24 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.674 ' CG2' HD21 ' A' ' 35' ' ' LEU . 2.2 pt -99.76 126.35 37.35 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.456 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.11 126.61 22.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.417 2.078 . . . . 0.0 111.952 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG11 ' CG1' ' A' ' 70' ' ' ILE . 14.8 p -132.84 136.69 28.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.0 Cg_exo -58.16 150.98 62.28 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.433 2.089 . . . . 0.0 112.094 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -176.76 116.46 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 58.48 25.1 12.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.27 3.18 75.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.75 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -124.74 176.9 6.28 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 133.91 47.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -165.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -143.53 98.04 3.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.995 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.701 HG21 ' CD2' ' A' ' 135' ' ' PHE . 25.0 mm -100.92 101.8 17.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB3' HG23 ' A' ' 58' ' ' THR . 61.3 Cg_endo -73.23 136.25 24.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.486 2.124 . . . . 0.0 112.53 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.409 HD12 ' SG ' ' A' ' 87' ' ' CYS . 11.5 pt -134.81 167.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 108.62 10.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.935 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.894 HD22 HD22 ' A' ' 124' ' ' LEU . 8.3 mt -85.44 98.66 10.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.086 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.778 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -79.66 146.9 32.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.569 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.778 HD22 ' C ' ' A' ' 75' ' ' TRP . 2.8 mm? -126.97 170.87 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.44 166.25 25.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.38 0.61 . . . . 0.0 110.715 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -39.27 24.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.77 163.11 27.14 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.62 -62.58 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.187 -0.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 25.4 m-85 -105.03 -56.09 2.23 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.619 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.572 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.9 p-10 161.83 -34.37 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.369 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 28.5 Cg_exo -62.09 116.99 3.83 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.968 1.778 . . . . 0.0 112.269 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.694 ' HB3' HD13 ' A' ' 76' ' ' LEU . 46.2 Cg_endo -68.17 166.94 23.35 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.39 2.06 . . . . 0.0 112.199 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.802 HG21 ' CE1' ' A' ' 88' ' ' PHE . 1.2 mp -103.95 164.03 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.066 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.774 ' H ' HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -131.67 53.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.814 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.802 ' CE1' HG21 ' A' ' 86' ' ' ILE . 30.6 m-85 -48.73 125.42 10.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.182 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.733 HG13 HG23 ' A' ' 109' ' ' ILE . 33.5 m -81.6 127.0 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.253 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -127.44 89.83 50.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 32.9 Cg_exo -60.33 -158.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.644 2.23 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -128.6 173.95 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 t -68.4 -25.73 65.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -29.22 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.294 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.685 ' HB3' HG12 ' A' ' 141' ' ' VAL . 2.0 mpp? -127.2 -169.17 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.0 t -135.62 -162.7 1.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 97' ' ' ILE . 9.3 tt -122.89 104.29 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -81.43 102.28 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 105' ' ' ALA . 15.5 p -57.56 141.37 48.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.33 -100.44 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.557 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -95.96 -64.53 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.81 ' CE1' HG11 ' A' ' 134' ' ' VAL . 4.8 p-80 -107.53 -24.34 11.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.422 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 140' ' ' PRO . 52.1 t -55.28 -27.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 99' ' ' THR . 1.0 OUTLIER 44.4 -166.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -103.81 -20.57 13.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.513 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.65 22.2 7.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.488 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.41 ' HA2' ' CD1' ' A' ' 97' ' ' ILE . . . 51.52 44.27 53.41 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.781 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 1.5 tttm -124.05 90.82 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.785 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.858 ' O ' HD12 ' A' ' 109' ' ' ILE . 2.0 pp -46.79 108.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.874 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 108' ' ' LYS . 33.5 m-85 -95.61 30.9 2.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.713 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.778 HD13 HG11 ' A' ' 130' ' ' VAL . 9.5 mt -49.17 106.56 0.64 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.35 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.5 -14.73 46.01 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.463 2.109 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -58.56 -71.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.318 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -60.63 -19.64 58.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.151 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.954 ' N ' HD13 ' A' ' 114' ' ' LEU . 24.2 t60 -64.62 -46.55 82.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 110.332 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.02 26.79 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.736 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CD1' ' CB ' ' A' ' 122' ' ' SER . 2.2 t90 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.497 ' CB ' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -174.27 179.78 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.894 HD22 HD22 ' A' ' 74' ' ' LEU . 59.0 mt -59.68 -31.2 69.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -47.6 81.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -83.94 -40.72 8.54 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 130' ' ' VAL . 9.5 tt -54.02 -27.4 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.749 HD11 HD11 ' A' ' 74' ' ' LEU . 50.0 mt -90.54 -28.54 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.666 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.875 ' HA ' HD12 ' A' ' 132' ' ' ILE . 2.2 tt0 -57.47 -33.06 67.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.778 HG11 HD13 ' A' ' 111' ' ' LEU . 4.3 p -59.79 -45.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.38 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.449 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 12.8 mtm -69.89 -40.58 75.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.087 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 129' ' ' GLN . 63.4 mt -54.6 -26.25 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.741 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 129' ' ' GLN . 39.9 t -91.87 -54.39 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.437 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.81 HG11 ' CE1' ' A' ' 102' ' ' HIS . 39.5 t -56.42 -47.82 80.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.701 ' CD2' HG21 ' A' ' 70' ' ' ILE . 7.3 m-30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.279 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 61' ' ' VAL . . . -67.66 -15.87 67.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.696 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -104.12 -42.83 5.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 28.0 mt-10 -151.0 90.53 4.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.253 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 10.7 Cg_endo -55.99 129.23 33.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.487 2.125 . . . . 0.0 112.306 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.648 ' HB3' HG21 ' A' ' 103' ' ' VAL . 37.0 Cg_exo -59.1 -19.03 46.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.175 1.917 . . . . 0.0 111.871 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 95' ' ' MET . 1.6 t -75.06 152.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.25 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 t80 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.043 -179.346 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.074 0.464 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -60.41 -31.76 70.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -84.31 -22.88 30.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.103 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.797 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.2 tp -55.34 -50.72 68.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.219 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -31.8 40.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.924 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.49 68.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.651 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.543 ' HG2' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -86.28 -33.0 20.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 8' ' ' LEU . 26.7 m -100.45 20.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -26.51 68.36 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.561 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -21.86 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.339 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -51.54 134.48 29.28 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -64.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.832 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -86.5 63.73 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 22' ' ' VAL . 12.8 ttp180 -63.76 -53.7 46.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.278 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -35.03 56.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 111.449 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.59 -40.19 16.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.738 HG23 HD23 ' A' ' 76' ' ' LEU . 81.8 m -66.49 -49.82 65.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.086 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.1 t -59.67 -39.59 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -48.4 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.381 0.61 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.4 -43.42 88.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.852 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.757 HG22 HD11 ' A' ' 29' ' ' ILE . 23.4 m -65.02 -59.02 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.94 -48.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.183 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.2 t-20 -55.99 -28.04 55.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -84.08 -27.18 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.757 HD11 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -91.12 -27.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.933 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -68.77 -48.15 64.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -41.89 66.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.35 117.31 34.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -95.7 21.13 8.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.216 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.469 ' C ' HD22 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -119.0 17.65 13.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.725 HD13 ' HA3' ' A' ' 57' ' ' GLY . 4.1 mm? -118.04 159.86 22.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -149.35 124.58 4.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.686 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 133.84 21.27 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.252 1.968 . . . . 0.0 112.344 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.543 HG23 HG22 ' A' ' 56' ' ' THR . 6.9 t -130.15 162.15 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.068 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -120.55 114.8 22.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.804 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -134.1 115.46 14.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 110.89 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 p -72.99 141.88 47.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.09 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.48 120.51 41.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.495 179.766 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.769 ' NE ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -133.12 138.94 46.84 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.488 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.54 107.08 0.14 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.769 HD13 ' NE ' ' A' ' 50' ' ' ARG . 7.6 tp -117.82 131.03 56.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 110.544 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.76 ' SD ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -92.04 146.08 24.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.211 0.529 . . . . 0.0 110.912 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.434 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 6.6 p-10 -143.86 140.7 29.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.915 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD11 HG23 ' A' ' 25' ' ' THR . 57.5 mt -100.32 101.67 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.543 HG22 HG23 ' A' ' 38' ' ' VAL . 11.7 t -102.55 152.96 20.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.694 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.725 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 154.19 -172.41 32.79 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.411 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.6 p -121.53 156.5 32.73 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.852 HD12 HG13 ' A' ' 61' ' ' VAL . 2.2 pp -131.87 134.28 25.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.036 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 116.18 4.56 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.562 2.175 . . . . 0.0 112.104 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.852 HG13 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -120.15 102.1 46.47 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.522 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 89.4 Cg_exo -42.61 129.7 5.13 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.211 2.607 . . . . 0.0 112.688 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -135.56 87.17 2.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 63.01 42.77 7.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.14 -16.58 55.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.1 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 3.1 t-20 -86.65 -147.47 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.857 -0.202 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 67' ' ' THR . 6.0 t -176.24 41.95 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 121.547 0.689 . . . . 0.0 109.906 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.459 ' O ' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -31.27 148.33 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.524 -179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -105.66 106.11 16.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.682 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.744 HG21 ' CD2' ' A' ' 135' ' ' PHE . 13.2 mm -99.58 108.25 49.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.217 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.16 147.53 93.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.494 2.129 . . . . 0.0 111.853 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 pt -149.57 149.82 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 111.215 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 116.71 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 138.4 32.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.699 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -113.35 145.92 40.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.76 HD22 ' SD ' ' A' ' 53' ' ' MET . 2.3 mp -141.22 146.4 36.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.37 166.24 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.16 0.505 . . . . 0.0 110.85 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.84 -39.57 79.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.723 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t 174.43 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.843 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -125.59 163.54 38.15 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 90.5 Cg_endo -82.65 -31.69 3.89 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.421 -1.491 . . . . 0.0 112.108 0.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 52.0 m-85 -59.55 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.101 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 64.6 t-20 117.67 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 89.5 Cg_endo -84.21 141.25 9.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.433 2.089 . . . . 0.0 112.399 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 84' ' ' PRO . 50.4 Cg_exo -55.36 127.42 26.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.473 2.115 . . . . 0.0 112.248 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.639 ' CD1' HD12 ' A' ' 77' ' ' LEU . 2.5 mp -93.35 160.03 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.637 ' C ' HD12 ' A' ' 109' ' ' ILE . 4.2 t -155.16 123.19 5.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.474 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 19.7 m-85 -134.6 121.64 21.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.581 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.496 HG11 HG12 ' A' ' 103' ' ' VAL . 14.6 p -68.71 130.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 125.86 68.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.04 165.89 22.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.119 . . . . 0.0 112.41 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.41 -176.66 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.914 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.93 -33.96 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 p -93.48 -32.78 14.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.766 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.417 ' SD ' HG21 ' A' ' 141' ' ' VAL . 21.3 ttp -99.01 -12.14 20.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.528 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 142' ' ' PHE . 8.9 t 44.59 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -139.39 127.14 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 111.473 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.01 145.61 29.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 104' ' ' ASP . 72.7 p -79.34 131.35 36.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.22 -121.13 1.65 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.635 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 -39.07 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.132 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.74 -48.49 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 140' ' ' PRO . 2.9 m -68.11 67.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 99' ' ' THR . 71.5 m-20 -49.89 -100.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.18 -54.7 2.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -106.94 39.59 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.037 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.461 ' HA3' HG13 ' A' ' 89' ' ' VAL . . . 59.83 51.89 56.24 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.391 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 4.2 mtpt -93.11 90.0 6.7 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.041 0.448 . . . . 0.0 110.406 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 87' ' ' CYS . 4.2 mt -47.89 109.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.089 0.471 . . . . 0.0 111.435 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.38 39.48 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.668 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.3 mt -54.59 118.98 18.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.18 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.75 -35.32 87.5 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.0 112.122 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.97 -29.83 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.801 ' CD1' HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.47 -30.11 17.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -57.35 -37.7 72.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.23 22.75 8.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.47 ' CD1' ' HB3' ' A' ' 122' ' ' SER . 2.8 t90 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' A' ' 117' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.03 -84.51 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 24' ' ' GLU . 5.4 tp 176.78 -36.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.42 -44.81 95.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.779 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.63 -36.45 92.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.108 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.801 HD13 ' CD1' ' A' ' 114' ' ' LEU . 20.6 tp -57.12 -34.14 68.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.979 0.418 . . . . 0.0 110.513 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.75 -24.32 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.006 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.873 ' O ' HG22 ' A' ' 132' ' ' ILE . 19.7 tt0 -68.9 -40.87 78.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.816 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.9 p -61.76 -41.31 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.472 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.407 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 2.5 mtt -63.81 -40.3 96.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -55.89 -28.34 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.964 0.411 . . . . 0.0 111.022 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.19 -52.22 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 130' ' ' VAL . 40.0 t -54.86 -36.0 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.989 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.744 ' CD2' HG21 ' A' ' 70' ' ' ILE . 5.5 m-85 -92.18 -21.93 20.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -21.53 61.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -28.89 13.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.734 0.302 . . . . 0.0 111.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -161.3 95.79 1.35 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.28 117.83 3.78 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.6 2.2 . . . . 0.0 112.076 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.552 ' O ' HG11 ' A' ' 103' ' ' VAL . 93.5 Cg_endo -88.55 45.84 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.621 2.214 . . . . 0.0 112.737 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.497 ' O ' ' C ' ' A' ' 142' ' ' PHE . 1.4 m -136.9 -40.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.842 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' C ' ' O ' ' A' ' 141' ' ' VAL . 21.8 t80 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 113.214 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.725 0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 3' ' ' VAL . 31.6 m -133.81 66.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.349 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -73.34 -175.88 2.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.137 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -59.38 -38.29 80.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -50.98 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.584 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.11 -31.28 70.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.818 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.4 tp -59.23 -44.37 92.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -57.95 -44.5 87.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.186 0.517 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.38 -30.67 71.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtm -79.28 -31.54 43.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.825 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 8' ' ' LEU . 18.3 m -102.21 20.18 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.027 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -78.54 -31.14 47.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.859 0.362 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -31.35 71.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.49 156.18 8.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -54.17 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.48 66.13 4.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.0 ttm180 -61.83 -52.38 64.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.35 -29.55 48.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.23 -26.94 17.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.887 HG23 HD23 ' A' ' 76' ' ' LEU . 97.7 m -80.71 -30.45 36.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 18' ' ' ARG . 40.3 t -87.18 -28.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -82.1 -33.32 29.79 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.151 0.501 . . . . 0.0 110.848 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.646 ' HB3' HD12 ' A' ' 124' ' ' LEU . 66.4 mt-10 -68.93 -42.29 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.833 ' CG2' HD21 ' A' ' 55' ' ' LEU . 19.0 m -69.03 -55.07 11.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -52.35 -46.89 46.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.779 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 m-80 -51.69 -37.01 48.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.889 HG21 HD22 ' A' ' 124' ' ' LEU . 23.9 t -82.9 -63.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.465 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.588 HD13 HG22 ' A' ' 25' ' ' THR . 5.6 pt -52.27 -26.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -85.54 -26.49 26.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.01 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 27' ' ' ASN . 5.6 mp -89.74 -39.02 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.668 0.271 . . . . 0.0 111.202 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' HE2' HD11 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -93.14 11.46 27.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.659 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 14.33 61.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.38 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD13 ' HA3' ' A' ' 57' ' ' GLY . 4.0 mm? -62.75 121.77 14.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.02 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? -100.13 128.05 31.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.123 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.798 ' HA ' HD23 ' A' ' 55' ' ' LEU . 56.7 Cg_endo -70.53 139.39 37.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.3 2.0 . . . . 0.0 112.608 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.5 t -134.19 162.11 39.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.8 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.697 HD11 ' HG3' ' A' ' 51' ' ' GLU . 2.1 tm? -136.82 103.83 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.797 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -123.78 127.12 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.385 0.612 . . . . 0.0 110.534 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.72 139.64 30.53 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -108.85 160.23 16.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.96 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.74 151.18 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -98.9 80.04 2.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 60.78 37.65 18.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.4 21.49 12.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.061 0.458 . . . . 0.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.01 -17.47 16.2 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.361 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.64 133.18 0.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.687 -0.302 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m -100.26 177.75 4.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.88 140.23 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.551 0.532 . . . . 0.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.697 ' HG3' HD11 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -74.33 128.51 35.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.085 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 52' ' ' LEU . 4.8 tp -136.11 136.27 39.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.4 ttp -105.26 149.75 25.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.229 0.538 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.444 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -148.17 163.53 36.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.892 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.833 HD21 ' CG2' ' A' ' 25' ' ' THR . 5.1 mt -127.54 123.85 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -119.45 131.12 55.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.553 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -174.65 -174.06 41.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.604 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -121.06 151.61 39.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.714 0.292 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.699 HG12 HD12 ' A' ' 72' ' ' ILE . 1.4 pt -130.97 114.84 16.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.273 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.28 167.37 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.434 2.089 . . . . 0.0 112.141 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 p -173.39 127.01 0.48 Allowed Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.347 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.78 115.83 4.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.255 1.97 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.61 137.18 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 60.13 20.88 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.524 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.56 5.16 82.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.672 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.19 175.51 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.87 0.366 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 100.49 10.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.43 159.56 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.5 m-20 -114.33 125.07 53.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 141' ' ' VAL . 31.0 mm -110.0 95.47 21.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.226 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 69' ' ' ASN . 32.9 Cg_exo -61.11 144.37 99.18 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.156 1.904 . . . . 0.0 112.221 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.699 HD12 HG12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -155.47 138.97 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.9 m -99.6 162.43 13.02 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.787 HD11 HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -130.35 134.88 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.538 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -115.15 148.33 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.774 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.887 HD23 HG23 ' A' ' 21' ' ' THR . 7.6 mp -133.44 155.63 49.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.805 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.741 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -135.11 158.86 43.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 79' ' ' THR . 2.4 t0 -73.8 -30.95 63.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -178.05 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.37 154.02 68.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.76 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HG2' ' CE1' ' A' ' 82' ' ' TYR . 73.7 Cg_endo -76.99 -45.01 0.46 Allowed 'Cis proline' 0 C--N 1.347 0.448 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.433 0.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -105.09 -59.81 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.686 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.4 OUTLIER 166.45 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.865 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.38 143.52 15.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.677 2.251 . . . . 0.0 112.455 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 149.99 50.3 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.491 2.127 . . . . 0.0 112.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 87' ' ' CYS . 2.9 mp -87.85 154.61 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.419 ' N ' HG22 ' A' ' 86' ' ' ILE . 5.0 p -123.71 142.46 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.454 ' C ' HD11 ' A' ' 109' ' ' ILE . 4.1 m-85 -151.97 154.44 36.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.844 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.791 HG13 HD11 ' A' ' 109' ' ' ILE . 16.7 m -117.19 139.09 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.117 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -135.49 79.4 48.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HB3' HG13 ' A' ' 141' ' ' VAL . 56.3 Cg_endo -69.09 176.52 6.15 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.413 2.075 . . . . 0.0 112.572 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -91.84 170.35 9.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.8 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -58.72 -28.63 66.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -76.33 -29.56 57.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.06 177.03 7.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -139.33 -173.52 3.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.613 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.494 ' H ' HG22 ' A' ' 96' ' ' THR . 12.1 mm -126.13 92.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.444 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 25.5 tptt -66.47 103.72 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.867 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -58.47 134.42 56.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.71 -131.11 1.62 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.557 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 0.5 OUTLIER -99.99 -32.42 10.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.789 0.328 . . . . 0.0 111.014 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.665 ' CG ' HD23 ' A' ' 111' ' ' LEU . 11.3 m80 -111.44 -34.82 6.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.981 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.868 HG21 ' HG3' ' A' ' 140' ' ' PRO . 22.0 t -91.05 79.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.27 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -69.25 -173.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.39 5.26 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.356 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -112.9 24.9 11.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.708 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 56.49 27.89 54.84 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.99 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.4 160.24 15.57 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.436 -0.449 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.791 HD11 HG13 ' A' ' 89' ' ' VAL . 3.3 mp -131.55 38.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 30.1 p90 -60.77 102.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.989 0.423 . . . . 0.0 110.625 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.665 HD23 ' CG ' ' A' ' 102' ' ' HIS . 2.1 mt -108.74 144.68 30.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.073 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.72 -40.36 84.97 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.491 2.127 . . . . 0.0 112.04 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.77 -30.33 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.684 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -90.52 -32.51 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.51 -49.55 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.83 33.26 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.779 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.532 ' HD1' ' N ' ' A' ' 118' ' ' LYS . 2.8 t90 -90.93 136.59 32.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.108 0.48 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.532 ' N ' ' HD1' ' A' ' 117' ' ' TRP . 16.6 pttt -149.4 133.34 17.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.648 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 3.8 p80 -45.99 169.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.304 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.648 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 1.9 Cg_endo -83.16 6.81 50.4 Favored 'Cis proline' 0 C--N 1.354 0.84 0 C-N-CA 124.95 -0.854 . . . . 0.0 113.435 0.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -6.83 45.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.457 ' HB2' ' NE1' ' A' ' 117' ' ' TRP . 39.3 t -92.98 103.65 15.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.847 0.356 . . . . 0.0 111.258 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.16 -0.93 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER 87.66 -26.45 0.08 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.62 0.368 . . . . 0.0 111.322 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.605 HD21 HD22 ' A' ' 31' ' ' LEU . 1.3 tp -64.92 -38.23 90.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.96 -31.18 54.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.016 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 114' ' ' LEU . 28.1 tp -55.97 -30.5 61.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.593 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.1 mm -88.08 -28.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.037 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.846 ' HA ' HD12 ' A' ' 132' ' ' ILE . 1.8 tt0 -67.9 -41.26 82.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.215 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 134' ' ' VAL . 6.8 p -52.4 -46.58 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.981 0.419 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.48 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.1 mtt -66.94 -35.38 79.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.389 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 129' ' ' GLN . 52.5 mt -61.13 -27.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.771 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 129' ' ' GLN . 23.2 t -91.43 -48.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 130' ' ' VAL . 48.6 t -60.22 -39.94 82.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.48 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 131' ' ' MET . 20.0 m-30 -85.21 -15.89 42.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.075 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.0 -14.77 81.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.434 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -97.98 -38.01 9.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -164.8 89.31 1.02 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.563 ' HB3' HD11 ' A' ' 70' ' ' ILE . 33.5 Cg_exo -57.86 126.54 22.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.569 2.179 . . . . 0.0 112.412 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.868 ' HG3' HG21 ' A' ' 103' ' ' VAL . 92.7 Cg_endo -85.83 -13.42 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.71 2.273 . . . . 0.0 112.561 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.865 HG21 HG23 ' A' ' 70' ' ' ILE . 36.9 t -72.45 -3.72 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.148 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -45.19 173.96 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.055 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 p -140.64 21.71 2.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.091 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 46.0 76.77 0.51 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.132 1.888 . . . . 0.0 112.436 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.643 HG13 ' CE ' ' A' ' 11' ' ' MET . 21.6 t 59.98 64.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.164 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.2 p -84.8 -177.08 6.49 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.659 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.71 -30.94 69.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -46.68 17.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -40.01 80.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.709 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.0 tt -59.85 -37.53 79.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -62.47 -50.23 72.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.727 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -63.54 -31.12 72.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.56 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.643 ' CE ' HG13 ' A' ' 3' ' ' VAL . 11.1 mtp -74.65 -30.6 61.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 8' ' ' LEU . 32.7 m -105.02 19.45 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.805 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -65.35 -29.86 70.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.21 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -27.24 58.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.872 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 21.2 m-85 -56.06 130.64 44.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -66.98 -42.54 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' CG2' ' A' ' 79' ' ' THR . 16.0 m-85 -103.62 60.77 0.75 Allowed 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.787 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.0 ptm180 -59.02 -35.4 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.785 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.73 -51.12 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -33.31 63.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.672 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -66.47 -39.08 88.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.3 t -82.02 -30.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -46.79 35.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.863 ' O ' HG23 ' A' ' 28' ' ' VAL . 21.1 mt-10 -59.29 -42.33 91.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.979 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.931 HG23 HD21 ' A' ' 55' ' ' LEU . 9.3 m -63.71 -59.57 4.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -47.4 -47.59 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.069 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.455 ' HB3' HD13 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -58.02 -29.48 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -83.33 -37.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.256 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 25' ' ' THR . 0.6 OUTLIER -74.37 -27.97 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.954 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.8 m -80.55 -29.06 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.693 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 31' ' ' LEU . 11.2 tp -88.73 -30.24 19.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.895 0.379 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -106.92 127.2 53.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 35.24 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.98 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -152.06 24.75 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.026 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.861 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.8 mm? -118.07 160.74 21.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -149.28 130.14 7.03 Favored Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.32 131.74 15.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.365 2.043 . . . . 0.0 112.316 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.2 t -127.47 161.79 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.64 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 51' ' ' GLU . 1.1 tm? -130.9 115.06 16.03 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.076 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.58 120.75 18.91 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.3 p -82.16 146.07 29.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -139.35 134.67 32.82 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.5 158.58 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.352 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -106.59 -175.02 2.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.218 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.21 -23.97 64.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.255 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -85.85 -28.53 24.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.296 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.15 -27.98 4.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.657 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -58.42 162.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -115.59 122.95 47.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.205 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -117.26 132.31 56.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.501 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.669 ' HB2' HD11 ' A' ' 39' ' ' LEU . 3.5 pm0 -75.32 110.4 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.8 mm? -106.09 134.93 48.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.462 ' HA ' HD22 ' A' ' 39' ' ' LEU . 2.6 tmm? -86.31 146.82 26.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 0.0 110.776 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.455 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 12.1 p-10 -147.3 143.86 28.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.985 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.931 HD21 HG23 ' A' ' 25' ' ' THR . 16.1 mt -98.91 105.07 17.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -94.72 132.82 39.07 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.861 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 179.78 -155.23 15.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.503 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 p -150.72 150.75 31.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.569 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.675 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -124.43 149.44 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.677 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.04 116.73 4.63 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.331 2.021 . . . . 0.0 112.503 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' HA2' ' A' ' 136' ' ' GLY . 61.6 t -123.45 84.52 52.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 32.0 Cg_exo -59.51 165.07 10.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.285 1.99 . . . . 0.0 112.351 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -69.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.246 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.29 46.77 1.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.089 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.06 -16.73 59.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.579 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 1.2 t-20 -99.97 -168.22 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 110.447 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -155.96 128.71 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.757 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.24 -170.62 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.666 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -128.41 67.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.56 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.56 HG21 ' CD2' ' A' ' 135' ' ' PHE . 13.2 mm -57.65 108.09 1.15 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.239 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 155.61 65.23 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.447 2.098 . . . . 0.0 112.226 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -155.88 153.82 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.0 m -122.17 103.32 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.853 HD11 HD13 ' A' ' 76' ' ' LEU . 1.4 tm? -82.11 129.09 34.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.711 ' N ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -106.92 147.52 29.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.934 0.397 . . . . 0.0 111.108 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.853 HD13 HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -134.67 142.29 46.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.33 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.85 HD21 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -112.8 -178.87 3.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 111.481 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.31 39.42 1.5 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.605 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 17' ' ' TYR . 4.9 m 75.04 25.69 1.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.5 OUTLIER 178.0 142.18 0.27 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.043 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 90.3 Cg_endo -83.83 -40.11 0.82 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.467 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -82.85 65.96 8.23 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.85 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -32.8 -55.42 0.57 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 122.95 0.5 . . . . 0.0 111.377 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 73.0 Cg_exo -48.65 131.48 24.19 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.404 2.069 . . . . 0.0 112.166 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 84' ' ' PRO . 57.1 Cg_exo -51.81 134.1 46.99 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.459 2.106 . . . . 0.0 112.329 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.515 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 29.1 mt -104.13 148.56 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.486 ' HB3' HD21 ' A' ' 127' ' ' LEU . 26.2 p -134.95 125.25 26.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' HA ' HD12 ' A' ' 109' ' ' ILE . 22.6 m-85 -133.48 142.08 48.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 107' ' ' GLY . 10.8 p -95.57 145.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.781 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.0 123.95 31.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.1 -172.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.477 2.118 . . . . 0.0 112.237 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -170.63 2.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.1 -37.79 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.91 -29.37 14.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.073 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -94.72 -168.4 1.82 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.911 0.386 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.4 t -146.33 -156.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.563 HD11 ' HA2' ' A' ' 107' ' ' GLY . 1.0 OUTLIER -134.85 142.85 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 110.897 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.818 ' HD2' HG21 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -111.83 145.52 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 105' ' ' ALA . 3.8 p -114.89 134.48 55.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.82 -115.78 0.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.472 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -71.43 0.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -142.23 62.88 1.42 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 111.532 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.818 HG21 ' HD2' ' A' ' 98' ' ' LYS . 6.0 t -135.17 -7.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.867 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 99' ' ' THR . 16.6 m-20 45.7 -167.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.286 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.689 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -94.09 -46.81 6.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.129 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.69 -17.23 60.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.184 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.778 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 114.84 20.87 5.56 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.762 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG2' ' CE1' ' A' ' 88' ' ' PHE . 2.4 mptt -83.07 115.49 21.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.759 -0.259 . . . . 0.0 111.04 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.787 HG21 HD12 ' A' ' 111' ' ' LEU . 5.3 mp -73.46 107.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.661 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -95.73 41.58 1.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.787 HD12 HG21 ' A' ' 109' ' ' ILE . 4.0 mt -60.42 119.74 45.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.14 -21.13 27.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.438 2.092 . . . . 0.0 112.225 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' TRP . 87.5 m-85 -56.64 -62.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.834 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.4 tp -46.56 -39.47 11.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -59.21 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.532 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.1 35.07 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.91 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 113' ' ' TYR . 7.2 t90 -101.94 122.98 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.932 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -140.55 9.87 2.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 119' ' ' HIS . 0.3 OUTLIER 174.57 160.42 0.36 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.73 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.426 ' N ' ' CD2' ' A' ' 119' ' ' HIS . 1.7 Cg_endo -82.15 -19.24 22.9 Favored 'Cis proline' 0 C--N 1.345 0.358 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.691 0.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -131.09 54.76 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.423 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 39.8 t -70.5 68.61 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.903 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.54 -173.41 3.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 24' ' ' GLU . 7.2 tp -62.41 -40.4 96.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 27' ' ' ASN . 4.5 tp -56.57 -53.78 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.89 -29.66 74.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.21 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 87' ' ' CYS . 7.9 tt -56.44 -31.87 64.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.648 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -82.81 -25.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.978 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.745 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -73.59 -51.48 16.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.998 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' MET . 5.8 p -47.11 -45.62 8.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 3.6 mtm -60.35 -38.71 84.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -56.15 -25.78 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.04 -53.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.67 -29.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.49 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.56 ' CD2' HG21 ' A' ' 70' ' ' ILE . 2.8 m-85 -86.41 -27.86 23.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.541 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -74.2 -14.55 80.51 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.802 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -96.47 -30.57 13.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.382 . . . . 0.0 110.958 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.59 109.19 1.48 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.65 123.16 12.69 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 135' ' ' PHE . 94.2 Cg_endo -89.63 25.67 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.3 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.83 -12.94 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -162.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.7 57.84 0.96 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.24 86.17 0.15 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.789 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 122.788 2.325 . . . . 0.0 112.416 179.811 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 p -97.88 -39.59 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.51 143.08 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.787 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -59.44 -35.16 73.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -40.93 82.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -36.9 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.909 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.67 -55.49 34.37 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.569 0.543 . . . . 0.0 110.831 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -58.21 -30.33 66.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.89 -41.04 75.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.5 mtp -58.22 -36.32 72.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.588 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.64 HG11 ' SD ' ' A' ' 53' ' ' MET . 22.6 m -112.27 19.65 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.186 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -67.99 -29.13 68.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.908 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -28.44 65.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 5.2 m-85 -55.73 124.07 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HD2' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -51.77 -67.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.0 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.861 ' HB3' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -64.47 -49.19 72.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.832 ' NH1' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER 64.63 -65.97 0.13 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.33 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 17' ' ' TYR . 36.7 t0 -48.05 -43.91 30.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.052 0.453 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.876 HD13 ' H ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -53.03 -36.18 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.876 ' H ' HD13 ' A' ' 20' ' ' LEU . 95.6 m -83.66 -35.58 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.843 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.832 HG22 ' NH1' ' A' ' 18' ' ' ARG . 60.7 t -52.08 -35.11 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.761 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -83.52 -40.64 18.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.845 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.752 ' O ' HG23 ' A' ' 28' ' ' VAL . 19.7 mt-10 -66.54 -32.65 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.907 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 t -73.6 -41.63 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -72.16 -47.43 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.021 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.7 m-80 -50.15 -46.52 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.27 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.855 ' CG2' HD23 ' A' ' 124' ' ' LEU . 23.6 t -64.57 -61.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.28 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 26' ' ' VAL . 3.4 pt -59.32 -23.5 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.403 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.7 m -82.58 -28.75 30.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -18.84 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CE2' HG23 ' A' ' 59' ' ' ILE . 7.1 m-85 -125.93 164.28 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 0.0 110.602 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -18.52 8.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -96.87 28.63 3.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.718 0.294 . . . . 0.0 111.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.835 HD22 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -117.7 154.51 31.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.44 104.43 2.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' A' ' 55' ' ' LEU . 58.3 Cg_exo -51.02 140.9 38.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.22 1.947 . . . . 0.0 112.588 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.4 t -127.61 161.82 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.109 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.3 tm? -118.48 122.93 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.728 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' N ' HD13 ' A' ' 39' ' ' LEU . 20.6 t0 -157.05 138.9 14.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -87.07 154.02 21.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.24 124.91 28.21 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG12 ' CA ' ' A' ' 49' ' ' SER . 35.4 m -91.18 151.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.22 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.41 ' HZ ' ' HH ' ' A' ' 82' ' ' TYR . 19.9 m-85 -97.19 38.36 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.25 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 69.31 -64.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -125.66 18.51 8.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.56 22.11 12.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.168 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 p 64.07 175.95 0.18 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.744 0.307 . . . . 0.0 111.384 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.702 ' CA ' HG12 ' A' ' 43' ' ' VAL . 15.1 t -80.27 168.73 18.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.471 . . . . 0.0 111.285 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.31 134.89 12.59 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.88 115.75 3.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.043 0.449 . . . . 0.0 110.797 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.02 158.36 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.008 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.64 ' SD ' HG11 ' A' ' 12' ' ' VAL . 35.9 ttp -130.71 147.23 52.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.912 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 13.4 p-10 -136.61 177.31 7.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.7 mt -139.6 104.01 4.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.641 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.4 m -99.96 157.41 16.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.879 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.62 -149.4 14.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.42 142.0 31.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 61' ' ' VAL . 37.5 mt -112.21 123.76 33.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.83 112.63 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.3 2.0 . . . . 0.0 112.219 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 59' ' ' ILE . 23.8 t -134.74 94.86 16.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.058 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 55.6 Cg_endo -69.75 152.96 69.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.565 2.177 . . . . 0.0 112.325 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -179.14 -36.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -97.53 45.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.451 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 17.34 79.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.368 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 12.5 t-20 -177.43 165.21 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.509 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.29 129.23 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 -165.57 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.776 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -147.32 86.44 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.013 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.7 mm -79.51 129.29 72.19 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.957 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.506 ' O ' HG23 ' A' ' 72' ' ' ILE . 70.9 Cg_endo -74.63 145.95 33.67 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.664 2.243 . . . . 0.0 112.286 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 71' ' ' PRO . 1.7 pp -158.13 171.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.449 . . . . 0.0 111.042 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 56' ' ' THR . 73.7 m -148.36 161.83 40.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.987 HD21 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -131.92 144.86 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.509 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -120.47 147.28 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.466 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.8 mm? -118.77 -178.7 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.025 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.61 146.21 34.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.192 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -62.94 -35.56 80.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.87 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.517 HG21 ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 166.54 -26.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.151 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 79' ' ' THR . 39.6 m-85 -160.62 161.76 24.32 Favored Pre-proline 0 C--N 1.334 -0.086 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.789 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -88.52 -26.22 5.68 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.512 0.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.883 ' CD1' HD11 ' A' ' 86' ' ' ILE . 6.9 p90 -76.68 60.67 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.3 m120 -41.21 -52.77 7.14 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 54.2 Cg_exo -51.14 146.1 24.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 112.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.23 127.1 14.52 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.883 HD11 ' CD1' ' A' ' 82' ' ' TYR . 2.7 mt -89.22 151.34 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.011 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.749 ' SG ' HD11 ' A' ' 127' ' ' LEU . 14.4 m -122.9 161.82 23.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.495 ' N ' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -162.13 159.64 26.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.679 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 107' ' ' GLY . 11.4 p -128.37 137.65 56.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.161 0.505 . . . . 0.0 111.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.04 92.79 28.49 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.79 158.26 58.06 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.446 2.097 . . . . 0.0 112.187 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -84.68 176.49 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.25 0.547 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 m -65.37 -25.15 67.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -57.44 -59.03 5.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.057 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -111.25 -179.01 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 143' ' ' SER . 8.9 t -115.01 -157.27 0.63 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.519 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -115.84 121.67 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.159 0.504 . . . . 0.0 110.797 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -81.72 133.69 35.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 105' ' ' ALA . 34.8 p -102.45 131.21 49.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.75 -120.31 0.72 Allowed Glycine 0 C--N 1.322 -0.227 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.671 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -99.79 -57.93 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.861 0.363 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.774 ' HB3' HD23 ' A' ' 111' ' ' LEU . 8.7 m-70 -80.79 -41.01 24.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.711 HG21 ' HB2' ' A' ' 140' ' ' PRO . 25.9 t -92.1 75.39 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.087 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -52.98 -178.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -79.39 -13.98 59.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.815 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.15 23.75 5.48 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.417 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 51.01 30.19 22.34 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.705 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -111.26 115.37 29.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.634 0.254 . . . . 0.0 110.99 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.728 HG22 ' HG ' ' A' ' 111' ' ' LEU . 2.2 mp -60.94 94.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.46 75.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.784 HD13 HG11 ' A' ' 130' ' ' VAL . 1.6 mt -84.02 136.0 41.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.804 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.39 -28.31 18.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 0.0 112.246 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -79.61 -54.29 6.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.804 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.781 ' HG ' HD12 ' A' ' 127' ' ' LEU . 1.9 tm? -62.99 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.73 -35.82 71.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.1 25.59 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' NE1' ' O ' ' A' ' 119' ' ' HIS . 6.4 t90 -107.47 120.61 42.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 24.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.191 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' O ' ' NE1' ' A' ' 117' ' ' TRP . 0.3 OUTLIER 178.37 151.26 0.44 Allowed Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.064 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.77 -30.33 4.02 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.378 -1.509 . . . . 0.0 112.485 -0.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -120.42 57.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.129 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.2 p -76.18 62.98 1.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.751 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.62 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.987 HD11 HD21 ' A' ' 74' ' ' LEU . 3.4 tp -66.59 -33.98 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.48 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -29.49 75.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.781 HD12 ' HG ' ' A' ' 114' ' ' LEU . 6.5 tp -56.2 -31.53 63.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.9 mm -78.98 -29.61 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.767 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -62.43 -26.73 68.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.784 HG11 HD13 ' A' ' 111' ' ' LEU . 1.3 p -76.27 -36.81 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.552 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.421 ' HG2' ' CZ ' ' A' ' 135' ' ' PHE . 37.0 mtt -77.86 -42.63 32.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.997 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 129' ' ' GLN . 13.1 tt -58.25 -26.5 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 129' ' ' GLN . 28.6 t -91.2 -58.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.56 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 130' ' ' VAL . 88.0 t -53.55 -50.8 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.48 ' O ' HG11 ' A' ' 61' ' ' VAL . 6.8 m-30 -71.83 -27.3 62.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.66 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.04 -12.93 69.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.608 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.06 -47.71 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.55 126.95 2.45 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.83 107.6 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.451 2.101 . . . . 0.0 112.808 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.711 ' HB2' HG21 ' A' ' 103' ' ' VAL . 97.6 Cg_endo -88.64 23.85 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.663 2.242 . . . . 0.0 111.956 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 141' ' ' VAL . 22.9 t -121.99 -4.27 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.928 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' N ' ' A' ' 143' ' ' SER . 17.3 t80 -46.13 -92.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.739 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.582 ' HB2' HG22 ' A' ' 96' ' ' THR . 42.0 t -175.92 35.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.996 0.426 . . . . 0.0 111.601 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.401 ' CG ' ' HD2' ' A' ' 145' ' ' PRO . 23.5 ttp180 63.18 143.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.992 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 144' ' ' ARG . 53.8 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 m -76.5 68.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.41 -175.56 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.12 -35.97 74.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -60.71 -44.88 96.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -32.59 73.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.4 tp -72.95 -25.22 60.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.136 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.44 -24.52 50.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.391 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -22.61 33.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.167 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.427 ' HE1' ' HB2' ' A' ' 39' ' ' LEU . 15.9 ptp -89.98 -34.05 16.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 8' ' ' LEU . 28.3 m -91.31 -1.84 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -69.65 -31.4 69.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.181 0.515 . . . . 0.0 111.105 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -72.35 -26.37 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.16 169.02 0.43 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.994 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -91.87 -38.7 12.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -122.35 68.33 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.1 0.476 . . . . 0.0 110.937 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.83 -34.81 71.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.859 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.52 -46.45 90.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -33.09 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -70.96 -48.18 54.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 18' ' ' ARG . 42.4 t -71.25 -27.32 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.362 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -48.4 24.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -58.68 -42.48 88.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.973 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.885 HG22 HD11 ' A' ' 29' ' ' ILE . 26.8 m -59.81 -58.97 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.82 -46.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.658 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.1 t-20 -58.46 -22.37 54.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.224 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.018 HG21 HD23 ' A' ' 124' ' ' LEU . 27.2 t -93.19 -22.52 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.48 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.885 HD11 HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER -91.03 -28.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.148 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -80.42 -42.62 22.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 31' ' ' LEU . 7.4 tt -70.98 -23.64 62.24 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.683 ' HE2' HG21 ' A' ' 128' ' ' ILE . 35.1 m-85 -116.97 161.61 19.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 80.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.956 0.408 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 174.99 -33.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.524 HD22 HG12 ' A' ' 28' ' ' VAL . 1.7 mp -62.46 134.77 56.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.796 0.331 . . . . 0.0 110.925 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 106.03 21.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.936 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.785 ' HA ' HD23 ' A' ' 55' ' ' LEU . 76.1 Cg_exo -50.5 150.37 11.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.384 2.056 . . . . 0.0 112.594 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.5 t -151.51 161.85 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.605 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.488 ' C ' HD13 ' A' ' 39' ' ' LEU . 2.5 tm? -129.85 116.97 19.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -149.54 132.88 16.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.964 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -84.38 158.04 21.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.43 149.21 49.54 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.163 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -126.52 140.12 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.71 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -91.63 170.45 9.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.969 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.26 -3.16 44.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.111 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.65 -30.12 22.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.974 0.416 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.9 -27.12 4.67 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.613 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.63 126.37 33.3 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.717 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.9 p -101.81 -168.01 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.626 ' HB2' HD21 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -175.87 128.86 0.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.087 0.47 . . . . 0.0 110.546 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.713 ' C ' HD22 ' A' ' 52' ' ' LEU . 5.7 mt-10 -86.88 108.14 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.696 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.713 HD22 ' C ' ' A' ' 51' ' ' GLU . 3.0 mm? -123.2 178.95 4.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.012 0.434 . . . . 0.0 111.061 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.83 145.68 46.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -130.5 153.1 49.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 111.078 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.5 mt -108.87 101.89 10.95 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.857 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.5 m -85.49 132.95 34.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.56 -177.44 42.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.505 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.694 HG22 ' CA ' ' A' ' 71' ' ' PRO . 16.8 p -143.8 130.33 20.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 pt -115.53 154.35 47.79 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HB3' HG22 ' A' ' 67' ' ' THR . 51.0 Cg_exo -54.53 163.07 4.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.616 2.211 . . . . 0.0 112.568 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.742 HG21 ' CG1' ' A' ' 70' ' ' ILE . 25.4 t -158.24 106.16 1.7 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.684 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.67 92.43 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.335 2.024 . . . . 0.0 112.19 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.443 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 55.3 t80 -132.72 140.34 48.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 mtp85 61.09 18.55 9.12 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 20.45 61.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.566 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.02 176.97 8.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.338 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -96.24 104.8 16.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.752 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -91.12 167.33 12.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.744 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -123.48 111.75 16.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.742 ' CG1' HG21 ' A' ' 61' ' ' VAL . 37.0 mm -108.93 109.5 61.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.694 ' CA ' HG22 ' A' ' 58' ' ' THR . 49.9 Cg_endo -68.92 141.83 49.9 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.361 2.041 . . . . 0.0 112.251 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -147.43 136.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.036 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 118.26 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.699 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.663 HD22 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -84.59 149.68 25.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.482 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -123.57 142.99 50.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.832 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 52' ' ' LEU . 2.6 mm? -121.92 167.4 13.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.608 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.804 HD22 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -149.5 150.91 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.469 0.652 . . . . 0.0 111.065 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.28 -38.4 90.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.3 t 179.57 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 0.8 OUTLIER -87.47 159.54 49.84 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 7.5 Cg_exo -73.46 -45.55 0.45 Allowed 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.588 -1.422 . . . . 0.0 111.977 0.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.444 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -104.92 -59.92 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 0.0 110.637 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.628 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.4 OUTLIER 166.03 -53.75 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.78 145.14 4.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.733 2.289 . . . . 0.0 112.632 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.58 ' CG ' HD12 ' A' ' 124' ' ' LEU . 72.0 Cg_endo -76.94 143.06 22.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.668 2.245 . . . . 0.0 112.427 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 87' ' ' CYS . 2.9 mp -90.1 160.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.477 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -134.51 141.41 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 9.7 m-85 -147.73 144.33 28.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 107' ' ' GLY . 33.8 m -95.08 117.69 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.035 0.445 . . . . 0.0 111.365 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -81.08 121.25 80.44 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.77 137.87 67.81 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.463 2.108 . . . . 0.0 112.219 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 95' ' ' MET . 8.8 t -115.2 -167.11 1.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.642 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m -86.98 -56.2 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.81 -29.7 67.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.765 ' H ' HG23 ' A' ' 92' ' ' THR . 2.3 mpp? -135.88 -169.47 2.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.4 p -150.0 -80.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.782 HD11 HG23 ' A' ' 89' ' ' VAL . 0.4 OUTLIER 179.69 109.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.66 116.71 28.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 104' ' ' ASP . 27.8 p -53.25 131.82 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.53 -96.46 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -60.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 111.032 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.739 ' CD2' HG21 ' A' ' 134' ' ' VAL . 22.5 m-70 -127.47 48.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.31 -17.88 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.799 ' O ' HG22 ' A' ' 99' ' ' THR . 7.9 p-10 40.56 -158.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.335 0.254 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 5.27 48.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -131.26 28.62 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 51.07 25.36 10.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.013 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -85.96 136.6 33.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.881 ' CG2' HD12 ' A' ' 111' ' ' LEU . 1.4 mp -68.99 88.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 110.523 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.09 62.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.847 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.881 HD12 ' CG2' ' A' ' 109' ' ' ILE . 9.8 mt -95.23 109.25 43.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.83 -29.44 82.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.457 2.105 . . . . 0.0 112.131 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -54.08 50.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.009 HD22 HD13 ' A' ' 127' ' ' LEU . 55.5 tp -60.41 -33.34 72.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.48 -44.44 89.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.602 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.87 24.53 6.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.4 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 3.8 t90 -112.99 121.84 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.944 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.9 27.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.448 ' CG ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER 175.11 158.33 0.37 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.448 ' HA ' ' CG ' ' A' ' 119' ' ' HIS . 93.0 Cg_endo -85.95 4.49 65.8 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 123.342 -1.524 . . . . 0.0 112.73 0.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 28.66 0.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.872 0.368 . . . . 0.0 111.073 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.4 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 6.0 t -54.43 117.95 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.37 -164.25 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.018 HD23 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -51.76 -28.12 14.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 125' ' ' LEU . 3.2 mm? -68.97 -55.0 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.07 -35.99 92.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.345 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 1.009 HD13 HD22 ' A' ' 114' ' ' LEU . 66.7 tp -55.72 -31.7 62.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.683 HG21 ' HE2' ' A' ' 32' ' ' TYR . 24.7 mm -79.7 -21.74 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.809 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -82.54 -33.67 28.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.26 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 131' ' ' MET . 11.3 p -72.75 -47.37 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.528 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.6 mtm -66.8 -42.82 85.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.14 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 129' ' ' GLN . 4.0 tt -53.84 -30.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 129' ' ' GLN . 30.0 t -85.81 -51.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.464 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.739 HG21 ' CD2' ' A' ' 102' ' ' HIS . 1.2 p -54.76 -51.14 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.865 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.536 ' CD1' HG22 ' A' ' 61' ' ' VAL . 2.1 p90 -87.31 -9.15 55.69 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.38 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.439 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -72.82 -24.67 75.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.77 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.18 -30.69 15.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.541 0.21 . . . . 0.0 110.601 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -162.84 118.99 1.21 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.565 ' HB3' HD11 ' A' ' 70' ' ' ILE . 24.3 Cg_exo -61.93 110.93 1.08 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.537 2.158 . . . . 0.0 112.155 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.06 -15.97 7.66 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.418 2.079 . . . . 0.0 112.561 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.468 HG21 HG23 ' A' ' 70' ' ' ILE . 98.1 t -57.04 -19.34 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -41.37 2.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t 65.79 57.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.621 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -109.43 97.09 25.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.81 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 122.313 2.009 . . . . 0.0 112.424 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.045 0.45 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 3' ' ' VAL . 14.6 t -120.76 37.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.477 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -163.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.817 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -27.44 6.52 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.567 0.542 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -36.87 71.22 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.531 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -24.99 38.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.12 -50.92 71.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.01 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.91 -31.68 68.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.114 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -65.26 -28.06 69.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.615 ' HG2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -80.77 -31.2 35.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 111.063 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.656 HG21 ' CG2' ' A' ' 22' ' ' VAL . 29.3 m -103.15 20.22 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.735 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.8 -29.65 45.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.8 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -99.06 -18.89 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.428 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' HD2' HG21 ' A' ' 21' ' ' THR . 2.3 m-30 -55.58 146.11 21.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 79' ' ' THR . 9.7 tttm -56.09 -24.73 42.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -140.32 128.44 22.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.699 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.699 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.5 ttp85 -101.09 -64.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -50.59 63.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 20' ' ' LEU . 2.5 tm? -63.43 -50.79 68.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.222 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.483 HG21 ' HD2' ' A' ' 15' ' ' TYR . 99.1 m -62.25 -34.5 76.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.5 t -83.67 -23.47 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -30.36 21.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 0.0 111.001 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.806 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.89 -31.44 64.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.2 t -69.65 -47.43 63.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.498 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 22' ' ' VAL . 1.4 t -61.13 -55.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -46.28 -40.27 11.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.74 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 24' ' ' GLU . 35.2 t -76.47 -63.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.714 HG22 ' HB3' ' A' ' 35' ' ' LEU . 4.7 pt -51.9 -34.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.306 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -73.17 -29.09 62.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.63 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -76.08 -33.56 59.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.011 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB2' HD23 ' A' ' 35' ' ' LEU . 4.2 m-85 -93.73 -0.27 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.794 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.85 37.15 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.224 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -169.34 47.88 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.714 ' HB3' HG22 ' A' ' 29' ' ' ILE . 3.9 mm? -117.9 151.1 38.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.25 96.08 25.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.06 129.05 17.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.435 2.09 . . . . 0.0 111.992 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.8 t -125.27 162.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.287 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.846 HD11 ' HG3' ' A' ' 51' ' ' GLU . 2.6 tm? -128.36 98.93 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.731 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.67 126.97 48.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -84.62 128.45 34.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -97.16 104.22 16.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.602 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.455 HG12 ' OG ' ' A' ' 49' ' ' SER . 30.3 m -60.06 137.03 23.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.289 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -84.23 -175.97 6.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.96 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.59 -11.83 60.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -85.88 -30.93 22.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.572 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.5 -30.5 4.01 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.271 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.24 165.99 1.8 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.158 0.504 . . . . 0.0 110.632 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.455 ' OG ' HG12 ' A' ' 43' ' ' VAL . 19.0 m -122.68 120.07 32.6 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.058 0.456 . . . . 0.0 111.026 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -96.67 118.52 33.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.846 ' HG3' HD11 ' A' ' 39' ' ' LEU . 5.0 tt0 -64.67 106.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.3 mm? -118.71 131.99 56.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.154 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.416 ' HA ' HD22 ' A' ' 39' ' ' LEU . 6.1 tmm? -92.91 147.39 22.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 15.2 p-10 -141.71 159.61 41.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.937 0.399 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.007 HD12 HD13 ' A' ' 74' ' ' LEU . 4.7 mt -126.7 103.92 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -101.34 140.67 35.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 176.4 169.18 37.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -116.28 144.48 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 110.935 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -109.43 139.9 21.56 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 59' ' ' ILE . 70.3 Cg_endo -74.9 60.52 5.38 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.535 2.157 . . . . 0.0 112.21 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 59' ' ' ILE . 92.7 t -90.56 133.39 32.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.9 143.56 33.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.144 1.896 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -83.46 -77.01 0.26 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -110.82 -61.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.92 14.15 3.1 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.449 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -175.27 3.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.81 143.2 27.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.7 174.37 10.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -128.66 103.02 6.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.72 102.68 10.78 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.98 154.4 70.85 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.313 2.009 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 pt -155.78 156.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.238 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 130.19 53.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.007 HD13 HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -106.42 137.84 43.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.766 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -125.79 145.95 50.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.686 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.766 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.4 mm? -125.49 165.26 18.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -125.64 165.55 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.98 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -94.85 -27.79 15.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -173.35 -40.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HB3' ' HA ' ' A' ' 81' ' ' PRO . 28.5 m-85 -102.01 161.93 21.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 55.6 Cg_endo -73.22 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.757 -0.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 22.5 m-85 -105.45 -58.04 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.763 ' O ' HD11 ' A' ' 77' ' ' LEU . 0.3 OUTLIER 165.57 -53.93 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.967 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 82' ' ' TYR . 91.0 Cg_exo -42.91 119.14 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.803 2.335 . . . . 0.0 112.807 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.746 ' HB3' HD13 ' A' ' 76' ' ' LEU . 31.5 Cg_exo -59.0 164.46 10.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.598 2.199 . . . . 0.0 112.301 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 87' ' ' CYS . 19.8 mm -104.02 159.54 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -136.31 157.11 47.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.083 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG ' ' A' ' 108' ' ' LYS . 37.1 m-85 -146.62 170.24 17.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 107' ' ' GLY . 9.6 m -124.76 77.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.732 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -49.01 105.13 0.47 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.52 -178.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.24 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.29 179.41 8.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.253 0.549 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 p -88.11 6.92 34.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.5 m -95.22 -58.87 2.02 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -178.57 3.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 143' ' ' SER . 10.2 t -109.87 -163.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.727 HD11 ' HA3' ' A' ' 107' ' ' GLY . 0.8 OUTLIER -119.87 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 110.998 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.28 147.47 23.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 104' ' ' ASP . 0.7 OUTLIER -86.48 136.18 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.973 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.4 -166.24 36.04 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.788 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -26.29 48.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.152 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.766 ' CE1' HG23 ' A' ' 109' ' ' ILE . 2.4 t-80 -94.27 -28.17 15.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.083 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.614 HG12 HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -134.34 68.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.058 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 103' ' ' VAL . 1.2 p-10 -47.56 -105.82 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.104 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.45 -54.42 2.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.703 0.287 . . . . 0.0 111.479 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -95.71 38.64 1.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.584 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.84 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 52.14 53.76 29.39 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.533 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.458 ' CG ' ' CE2' ' A' ' 88' ' ' PHE . 3.1 mtmm -102.78 133.72 47.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.815 HD11 HG13 ' A' ' 89' ' ' VAL . 5.3 mp -87.46 106.01 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.97 48.34 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 113' ' ' TYR . 11.8 mt -70.19 121.98 84.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.63 -19.15 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.53 2.153 . . . . 0.0 112.606 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.676 ' CD2' HD22 ' A' ' 111' ' ' LEU . 15.2 m-85 -56.33 -54.33 46.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.0 111.082 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -64.47 -30.86 71.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.012 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.57 -41.47 84.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.18 27.39 7.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -89.55 115.56 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 86.13 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER 68.73 158.53 0.15 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 -179.343 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 119' ' ' HIS . 68.2 Cg_endo -89.8 9.65 63.54 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.999 0.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -140.82 30.23 1.86 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.9 t -66.17 78.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.12 -172.38 2.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.721 HD11 HD21 ' A' ' 74' ' ' LEU . 12.6 tp -57.44 -34.26 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 27' ' ' ASN . 1.7 mm? -62.36 -53.38 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.806 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.42 -38.55 95.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.1 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 114' ' ' LEU . 32.3 tp -54.21 -28.76 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 110.649 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mm -84.33 -29.01 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.802 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.443 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -61.65 -40.51 95.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.838 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.827 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.1 p -59.92 -42.93 91.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.414 . . . . 0.0 110.496 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.42 ' HB3' ' CD2' ' A' ' 135' ' ' PHE . 10.4 mtt -65.98 -34.4 78.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.315 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 129' ' ' GLN . 2.8 mt -60.08 -30.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.514 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.03 -52.81 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 130' ' ' VAL . 44.2 t -52.1 -49.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 131' ' ' MET . 17.6 m-30 -80.38 -27.2 38.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.94 -24.86 68.84 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.512 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.96 -44.45 12.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.991 0.424 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -177.08 123.64 0.28 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.81 144.09 56.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.361 2.041 . . . . 0.0 112.35 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.75 -39.66 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.607 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 m -63.24 117.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.2 t80 176.64 -176.26 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.969 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.651 ' HB3' HG21 ' A' ' 96' ' ' THR . 11.2 p -143.72 24.29 1.71 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.89 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -177.03 80.99 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.999 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.504 2.136 . . . . 0.0 112.384 179.862 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' O ' ' NE2' ' A' ' 7' ' ' GLN . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.656 0.265 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -122.64 70.81 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -72.83 164.03 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.421 . . . . 0.0 110.687 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.1 -31.26 69.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 111.085 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -51.96 51.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.785 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.455 ' NE2' ' O ' ' A' ' 2' ' ' ALA . 5.1 tt0 -59.19 -41.59 88.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.197 0.522 . . . . 0.0 111.312 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.519 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.2 tp -66.01 -28.49 68.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -58.79 -48.43 81.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.966 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -61.85 -35.96 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.75 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mtp -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.765 HG12 ' SD ' ' A' ' 53' ' ' MET . 25.0 m -108.3 19.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.705 0.288 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.3 p -71.89 -29.14 64.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -74.12 -29.08 61.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.045 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.6 m-85 -58.59 127.58 32.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB3' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER -59.29 -31.51 69.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.092 0.473 . . . . 0.0 111.307 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . 5.1 m-85 -90.44 -55.18 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.662 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.4 ttm180 66.67 -68.35 0.14 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.6 t0 -58.67 -53.16 61.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.102 0.477 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 20' ' ' LEU . 1.1 tt -59.32 -30.79 68.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.756 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.635 HG23 ' CD2' ' A' ' 76' ' ' LEU . 7.1 m -74.96 -53.03 9.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.011 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 18' ' ' ARG . 32.8 t -63.5 -36.15 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.304 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -62.8 -52.25 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 28' ' ' VAL . 60.7 mt-10 -63.05 -35.53 80.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.613 HG23 ' CD2' ' A' ' 55' ' ' LEU . 61.8 m -70.1 -35.66 74.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -81.56 -47.12 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -53.23 -30.28 37.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.588 -179.222 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.796 HG21 HD23 ' A' ' 124' ' ' LEU . 35.5 t -84.5 -61.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 26' ' ' VAL . 6.0 pt -53.56 -38.98 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.557 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.0 t -68.55 -36.96 79.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 125' ' ' LEU . 5.1 mp -77.54 -52.7 8.63 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.368 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -76.45 -17.93 59.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.034 0.445 . . . . 0.0 111.815 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 65.92 -61.57 0.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.318 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' OD1' HD22 ' A' ' 35' ' ' LEU . 1.9 p30 -53.73 -37.03 62.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.849 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.531 HD13 ' HA3' ' A' ' 57' ' ' GLY . 2.3 mm? -63.05 129.07 38.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.72 145.28 52.87 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.18 155.45 22.48 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.673 2.249 . . . . 0.0 112.738 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 39' ' ' LEU . 4.9 t -147.74 161.63 7.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 51' ' ' GLU . 2.2 tm? -134.13 102.21 5.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.218 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -117.76 128.61 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.343 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -77.53 145.91 36.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.66 104.25 3.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 49' ' ' SER . 29.4 m -63.11 172.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -124.87 90.3 3.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.692 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.72 -72.59 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.845 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.84 37.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.78 -24.31 6.43 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.62 -167.51 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 0.0 110.788 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.426 ' HA ' HG12 ' A' ' 43' ' ' VAL . 49.3 m -127.47 105.34 8.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.461 ' HB3' HD21 ' A' ' 52' ' ' LEU . 1.6 tpp180 -91.07 126.82 36.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.223 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' HG2' HD11 ' A' ' 39' ' ' LEU . 4.2 mt-10 -88.84 91.08 8.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 110.567 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.1 mm? -87.01 153.94 21.16 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.211 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.765 ' SD ' HG12 ' A' ' 12' ' ' VAL . 2.4 mtp -105.36 145.74 30.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.392 . . . . 0.0 110.574 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 4.4 p30 -136.61 132.78 35.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' CD2' HG23 ' A' ' 25' ' ' THR . 16.1 mt -101.49 116.13 32.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -117.68 143.79 45.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.802 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -179.71 164.09 31.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.444 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.718 HG22 ' CA ' ' A' ' 71' ' ' PRO . 33.5 p -113.97 140.0 48.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.611 ' N ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -121.48 156.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.356 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.44 136.73 60.82 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.839 2.359 . . . . 0.0 112.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 70' ' ' ILE . 62.1 t -152.67 95.67 3.04 Favored Pre-proline 0 C--O 1.223 -0.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.002 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.59 130.43 29.9 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.067 1.845 . . . . 0.0 112.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -127.95 -74.78 0.57 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.07 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -96.5 38.77 1.19 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 -23.3 35.81 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.512 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -112.64 164.89 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 110.786 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -72.88 135.49 45.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.59 -169.01 1.46 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -138.18 94.64 2.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.987 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.722 HG21 ' HD2' ' A' ' 135' ' ' PHE . 24.0 mm -92.39 106.64 18.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 0.0 111.026 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.718 ' CA ' HG22 ' A' ' 58' ' ' THR . 58.3 Cg_endo -71.66 156.93 56.78 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.001 1.801 . . . . 0.0 112.523 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 71' ' ' PRO . 23.3 pt -158.18 178.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -146.0 160.21 42.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 75' ' ' TRP . 0.3 OUTLIER -129.72 162.44 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.774 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.518 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -130.86 145.69 52.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 52' ' ' LEU . 1.4 tp -136.84 160.88 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.11 167.37 16.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.342 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.1 m-20 -93.84 -40.76 10.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 16' ' ' LYS . 18.2 p -159.88 -48.49 0.05 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.748 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.507 ' HB3' ' HA ' ' A' ' 81' ' ' PRO . 5.4 m-85 -115.95 168.12 9.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.777 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 62.7 Cg_endo -91.47 -33.5 0.99 Allowed 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.925 -1.281 . . . . 0.0 113.699 0.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 73.1 m-85 -82.36 -71.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.488 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 7.1 t30 129.79 -48.71 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 123.788 0.68 . . . . 0.0 111.069 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 60.5 Cg_endo -75.51 133.58 16.01 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.173 1.915 . . . . 0.0 112.334 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 138.75 41.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.725 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 87' ' ' CYS . 5.6 mt -99.75 159.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.501 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HB3' HD12 ' A' ' 109' ' ' ILE . 5.3 m -126.36 141.72 51.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.935 0.398 . . . . 0.0 111.281 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.456 ' CE2' ' HG3' ' A' ' 108' ' ' LYS . 10.4 m-85 -142.33 -177.25 5.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.551 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 107' ' ' GLY . 36.0 m -119.77 171.71 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 111.129 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -138.69 99.98 8.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 164.95 31.97 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.525 2.15 . . . . 0.0 112.162 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.79 177.11 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 0.0 110.996 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.4 t -83.75 -31.21 26.1 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -29.55 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.758 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -113.44 -178.47 3.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 5.5 t -125.1 -166.43 1.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.675 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.556 HD11 HG21 ' A' ' 89' ' ' VAL . 4.2 tt -115.39 120.85 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 143' ' ' SER . 6.6 tttt -76.16 127.38 32.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.014 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.688 HG22 ' HA ' ' A' ' 105' ' ' ALA . 67.2 p -98.69 129.86 45.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.63 -123.49 0.73 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.617 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -51.22 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.926 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.737 ' HE1' HD11 ' A' ' 111' ' ' LEU . 3.9 t60 -70.79 -46.3 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.04 77.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.107 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -50.58 175.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.361 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.688 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -58.35 -26.38 63.07 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.406 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -94.25 20.94 7.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.246 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 50.96 43.76 49.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.763 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 88' ' ' PHE . 19.1 mtmt -106.12 124.79 50.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.738 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' CE ' ' A' ' 131' ' ' MET . 59.7 mt -66.02 110.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 111.081 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -123.96 94.34 4.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.737 HD11 ' HE1' ' A' ' 102' ' ' HIS . 9.7 mt -107.77 133.68 20.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.166 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.51 -32.48 96.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.38 2.053 . . . . 0.0 112.038 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.32 -52.39 64.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.484 HD12 ' CE3' ' A' ' 117' ' ' TRP . 8.3 tp -60.68 -32.66 71.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.57 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -61.29 -43.78 98.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.547 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -98.41 25.7 6.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 2.6 t90 -98.56 129.47 45.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.88 103.78 5.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 9.8 p80 -52.37 178.08 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.733 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 58.1 Cg_endo -70.55 4.0 5.1 Favored 'Cis proline' 0 C--N 1.356 0.968 0 N-CA-C 114.517 0.929 . . . . 0.0 114.517 1.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' N ' ' HA ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -71.54 -1.8 14.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 30.1 t -93.49 155.18 17.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.875 0.369 . . . . 0.0 111.097 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.72 162.7 32.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.796 HD23 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -77.71 -37.92 48.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 28' ' ' VAL . 2.4 mp -57.37 -51.75 68.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.753 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.09 -29.61 73.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.0 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.484 HD21 ' SG ' ' A' ' 87' ' ' CYS . 41.6 tp -56.98 -30.79 64.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.615 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mm -82.9 -26.7 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.761 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.1 tp60 -64.82 -45.96 84.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.713 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.2 p -47.45 -45.63 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.872 ' CE ' HD13 ' A' ' 109' ' ' ILE . 1.3 mtt -62.97 -42.9 99.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.3 OUTLIER -53.09 -27.12 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 111.032 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 t -94.21 -52.93 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.58 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 130' ' ' VAL . 43.6 t -54.47 -36.46 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.495 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.722 ' HD2' HG21 ' A' ' 70' ' ' ILE . 5.7 m-85 -81.53 -28.78 33.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.653 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.432 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -68.32 -11.75 62.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.637 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -45.82 7.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.678 0.239 . . . . 0.0 111.055 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.96 109.03 2.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.43 116.47 3.24 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.516 2.144 . . . . 0.0 112.199 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.83 44.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.091 2.527 . . . . 0.0 112.244 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 141' ' ' VAL . 15.1 t -124.95 -7.19 6.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.862 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.39 -61.01 1.77 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.277 -0.264 . . . . 0.0 111.129 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER 73.37 53.37 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.86 0.362 . . . . 0.0 110.856 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.98 88.66 17.68 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.103 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--O 1.248 0.979 0 C-N-CA 122.694 2.263 . . . . 0.0 112.469 179.747 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.764 0.316 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 3' ' ' VAL . 21.6 t -128.5 44.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -59.46 166.05 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 110.799 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -33.32 74.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -36.3 83.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.41 . . . . 0.0 110.529 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.7 -30.82 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.696 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 3' ' ' VAL . 1.1 tt -73.89 -31.07 62.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -72.04 -46.76 55.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -31.27 67.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.479 ' HE2' ' HG ' ' A' ' 39' ' ' LEU . 7.7 ttm -63.49 -48.75 76.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.726 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 22' ' ' VAL . 17.2 m -94.53 19.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.66 -42.96 39.96 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -70.78 -25.28 62.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.652 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.78 121.69 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.305 0.378 . . . . 0.0 111.149 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 tptt -60.13 -36.68 78.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.4 44.55 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.6 ttp-105 -51.04 -52.42 43.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -54.04 -32.22 53.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.75 -29.03 18.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 76' ' ' LEU . 86.3 m -78.05 -47.0 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 12' ' ' VAL . 40.3 t -64.78 -38.16 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -45.67 53.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.875 ' O ' HG23 ' A' ' 28' ' ' VAL . 48.9 mm-40 -62.5 -39.39 93.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.755 HG22 HD11 ' A' ' 29' ' ' ILE . 63.8 m -63.31 -59.15 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.39 -47.43 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.487 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.696 ' HB3' HD13 ' A' ' 125' ' ' LEU . 4.1 t-20 -57.58 -26.2 61.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -85.96 -27.86 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.377 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -91.19 -29.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.88 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.7 m -69.7 -46.45 65.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.505 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -72.19 -40.81 67.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.953 0.406 . . . . 0.0 110.725 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -103.36 116.31 32.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.826 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 31.02 3.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.02 23.12 5.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.62 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.4 mm? -117.07 165.88 12.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.84 121.93 9.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 127.96 16.3 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.393 2.062 . . . . 0.0 112.428 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.6 t -123.76 162.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.771 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HG ' ' HE2' ' A' ' 11' ' ' MET . 2.2 tm? -146.84 110.06 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.56 141.36 52.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.37 116.39 28.94 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.381 0.425 . . . . 0.0 111.18 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.448 ' H ' HD23 ' A' ' 52' ' ' LEU . 10.0 t80 -91.4 135.17 34.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.656 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 48' ' ' SER . 35.8 m -85.58 167.24 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.155 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 48.6 m-85 -136.84 148.77 47.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.255 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.89 -63.44 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.073 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 5.1 p30 176.3 -24.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.679 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.34 23.4 2.54 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.018 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 44' ' ' PHE . 27.7 t -99.71 175.26 5.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 162.72 38.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.797 0.332 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HB3' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -169.62 150.3 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.454 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.561 ' C ' HD22 ' A' ' 52' ' ' LEU . 3.7 tt0 -83.82 111.08 18.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.881 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.6 mm? -122.74 116.21 23.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -81.97 147.56 29.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.427 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 15.3 p-10 -148.11 143.87 27.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 25' ' ' THR . 44.2 mt -108.75 116.51 32.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.6 m -116.38 145.53 43.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.62 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 160.61 175.83 32.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -100.31 147.24 26.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.486 HG22 HG13 ' A' ' 61' ' ' VAL . 23.1 mt -107.34 114.52 60.86 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.046 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.43 70.1 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.301 2.0 . . . . 0.0 112.1 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 59' ' ' ILE . 7.6 m -89.96 144.68 31.8 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 35.9 Cg_endo -65.34 153.89 76.12 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.188 1.925 . . . . 0.0 112.345 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 139' ' ' PRO . 57.7 t80 -154.49 105.69 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 1.3 mpt_? 60.43 29.1 18.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.989 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.05 3.52 67.77 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.784 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 1.5 t-20 -120.75 178.35 4.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.692 0.246 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.54 131.57 44.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.726 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.21 163.08 22.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.829 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.512 ' O ' HD13 ' A' ' 70' ' ' ILE . 7.9 p-10 -121.74 123.5 41.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.722 HG23 ' CG2' ' A' ' 141' ' ' VAL . 18.7 mm -123.07 103.22 36.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' A' ' 91' ' ' PRO . 55.3 Cg_endo -69.93 133.16 24.58 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.092 1.862 . . . . 0.0 112.305 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.473 ' CD1' HD11 ' A' ' 59' ' ' ILE . 2.9 pt -142.95 167.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -131.0 134.62 46.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.447 HD13 HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -107.45 137.85 44.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.979 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.514 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -115.52 144.44 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.777 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 52' ' ' LEU . 6.1 mp -138.51 160.06 40.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.68 163.83 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -43.41 23.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 80' ' ' TYR . 4.4 t 179.97 33.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.434 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 1.8 m-85 -153.91 151.31 24.53 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.649 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 72.5 Cg_endo -76.7 -44.0 0.58 Allowed 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.173 -1.595 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.433 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 72.2 m-85 -103.92 -60.81 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.557 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 5.8 t-20 162.88 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.58 0.55 . . . . 0.0 110.833 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 81.5 Cg_exo -45.34 108.65 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.497 2.132 . . . . 0.0 112.607 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.57 145.08 30.77 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.498 2.132 . . . . 0.0 112.211 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 87' ' ' CYS . 16.5 mt -91.51 160.02 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.48 ' N ' HG22 ' A' ' 86' ' ' ILE . 4.8 p -143.5 137.66 28.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.45 ' CZ ' ' HE2' ' A' ' 108' ' ' LYS . 6.5 m-85 -140.97 143.4 34.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.637 HG22 ' HA3' ' A' ' 107' ' ' GLY . 24.8 m -84.22 146.14 7.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.066 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.08 72.29 76.54 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 71' ' ' PRO . 75.7 Cg_exo -51.34 170.82 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.588 2.192 . . . . 0.0 112.312 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.22 176.99 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -72.77 -27.13 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -5.8 50.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.516 ' HB3' HG12 ' A' ' 141' ' ' VAL . 20.7 mtm -145.81 -174.79 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.65 0.262 . . . . 0.0 110.983 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.872 HG22 ' HB2' ' A' ' 143' ' ' SER . 12.4 t -134.18 -164.68 1.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.266 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.846 HD11 ' HA2' ' A' ' 107' ' ' GLY . 11.3 tt -111.3 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.669 ' O ' HG11 ' A' ' 103' ' ' VAL . 2.7 ttpp -75.29 114.31 13.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 p -72.64 134.98 45.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.34 -118.66 1.26 Allowed Glycine 0 CA--C 1.515 0.083 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.672 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -31.69 11.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -118.26 -29.69 5.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 98' ' ' LYS . 11.8 t -57.23 -27.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.566 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 56.55 -152.94 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.679 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 -40.9 5.97 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -93.46 3.66 55.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.846 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . 91.5 4.85 67.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.134 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HE2' ' CZ ' ' A' ' 88' ' ' PHE . 8.1 tttm -60.18 108.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.768 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 109' ' ' ILE . 4.2 mp -74.65 66.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -92.38 57.57 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 110.856 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.593 HD21 HG11 ' A' ' 134' ' ' VAL . 7.1 mt -53.19 151.71 9.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.417 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.625 ' HA ' ' CD2' ' A' ' 115' ' ' HIS . 32.5 Cg_exo -57.58 -45.83 31.24 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.573 2.182 . . . . 0.0 111.987 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -66.54 -39.58 88.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.99 -52.32 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.625 ' CD2' ' HA ' ' A' ' 112' ' ' PRO . 3.5 p80 -64.87 -35.86 82.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.669 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -95.95 26.0 4.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CE2' ' HA ' ' A' ' 122' ' ' SER . 2.5 t90 -94.79 -71.12 0.68 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 122' ' ' SER . 2.6 tptt 80.29 -165.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.645 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -154.32 -175.9 0.55 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.241 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.71 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 17.0 Cg_endo -57.21 -16.98 1.43 Allowed 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 124.837 -0.901 . . . . 0.0 114.051 1.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.536 ' N ' ' HA ' ' A' ' 119' ' ' HIS . 5.5 mt-30 -32.4 -49.17 0.2 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 117' ' ' TRP . 33.3 t -46.25 158.27 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.067 0.461 . . . . 0.0 111.696 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -177.85 146.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -59.52 -46.48 88.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' A' ' 27' ' ' ASN . 11.6 tp -51.81 -46.13 64.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.91 -31.34 35.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.632 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 130' ' ' VAL . 11.3 tp -56.13 -31.78 63.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.9 mp -86.73 -28.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.56 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.93 -38.65 82.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.9 p -61.65 -42.65 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.518 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.42 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 52.8 mtt -65.37 -42.73 92.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.674 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.2 mp -52.05 -26.77 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.644 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 t -95.03 -54.89 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.668 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 130' ' ' VAL . 38.1 t -55.3 -37.08 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.727 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.714 ' HD2' HG21 ' A' ' 70' ' ' ILE . 3.4 m-85 -83.22 -28.08 29.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.403 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.21 -13.02 61.64 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.716 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -99.85 -45.24 5.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 0.217 . . . . 0.0 111.195 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.3 100.63 4.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 50.7 Cg_exo -55.91 119.73 7.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.386 2.057 . . . . 0.0 112.166 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 88.9 Cg_endo -78.62 -0.64 10.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.449 2.1 . . . . 0.0 112.847 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.722 ' CG2' HG23 ' A' ' 70' ' ' ILE . 22.6 t -93.21 -2.71 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.525 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 143' ' ' SER . 0.5 OUTLIER -39.42 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 111.459 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.872 ' HB2' HG22 ' A' ' 96' ' ' THR . 29.5 t -173.21 31.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.222 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -78.89 110.41 14.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.304 2.003 . . . . 0.0 112.361 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.938 0.399 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 3' ' ' VAL . 26.2 t 66.17 42.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.982 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t 66.04 159.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.482 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.79 -29.31 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.989 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -54.19 -38.24 65.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.439 ' CB ' ' HB ' ' A' ' 3' ' ' VAL . 5.7 tp60 -67.77 -45.83 73.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 12' ' ' VAL . 10.7 tp -59.32 -33.06 70.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.5 -50.95 71.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -32.7 73.94 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.488 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmm -70.14 -36.92 75.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 8' ' ' LEU . 27.2 m -99.51 16.76 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.174 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -69.97 -35.67 74.63 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 111.129 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -29.08 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.644 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.568 ' HD2' HG21 ' A' ' 21' ' ' THR . 4.2 m-30 -57.12 117.84 4.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -44.02 90.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CE1' ' OG1' ' A' ' 21' ' ' THR . 0.7 OUTLIER -95.55 33.93 1.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.9 ttt180 -49.18 -31.0 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.959 0.409 . . . . 0.0 109.996 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.65 -43.56 93.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.181 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -80.81 -25.45 37.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 0.0 110.144 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.568 HG21 ' HD2' ' A' ' 15' ' ' TYR . 18.7 m -74.15 -54.81 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.596 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.6 t -63.15 -30.0 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.054 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -44.67 18.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.076 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.841 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.8 mm-40 -71.17 -40.11 71.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.495 ' O ' HD13 ' A' ' 29' ' ' ILE . 89.8 m -61.44 -47.86 83.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.481 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -60.87 -47.08 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.605 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.7 t-20 -57.53 -25.65 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.8 t -67.08 -58.26 7.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.212 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -71.59 -19.48 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.454 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -64.65 -42.61 95.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.833 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.658 HD12 ' CG ' ' A' ' 32' ' ' TYR . 1.2 pp -88.04 -43.15 11.92 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CG ' HD12 ' A' ' 31' ' ' LEU . 10.6 m-85 -107.93 109.16 20.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -89.71 64.8 6.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.423 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -145.65 -45.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.3 mm? -62.79 140.03 58.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 106.09 37.9 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.87 128.46 17.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.234 1.956 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.3 t -130.24 161.94 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.641 HD11 ' HB3' ' A' ' 51' ' ' GLU . 1.7 tm? -114.89 91.63 3.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.48 117.57 34.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 p -82.04 138.52 34.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -115.35 136.34 53.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 45' ' ' ASN . 12.3 p -90.94 134.62 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.06 30.1 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.737 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.613 ' H ' HG22 ' A' ' 43' ' ' VAL . 1.5 m-80 63.88 -77.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.5 -15.71 16.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 111.805 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 31.01 7.03 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.32 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.25 -170.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.6 p -121.57 130.25 53.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.06 160.32 15.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.805 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.641 ' HB3' HD11 ' A' ' 39' ' ' LEU . 12.4 mt-10 -94.95 99.23 11.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.436 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.714 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.2 mm? -104.43 139.07 39.9 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.7 ttp -89.87 146.12 24.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.832 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -139.29 130.94 27.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.4 92.3 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -95.3 135.25 37.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.68 -148.37 7.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.02 128.59 7.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 pt -107.09 151.13 40.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.53 132.73 27.94 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.432 2.088 . . . . 0.0 112.197 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 136' ' ' GLY . 41.0 t -138.92 106.29 7.44 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.201 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 52.2 Cg_endo -69.11 120.65 7.51 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.66 2.24 . . . . 0.0 112.208 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 139' ' ' PRO . 12.2 t80 -131.28 113.21 13.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.979 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 66.4 11.34 7.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.52 -7.74 34.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.272 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -102.38 -177.44 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.131 0.466 . . . . 0.0 110.912 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.61 111.12 21.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.392 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -110.48 141.97 42.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -99.22 109.36 22.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.768 HG21 ' HD2' ' A' ' 135' ' ' PHE . 20.3 mm -97.77 100.3 8.2 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' O ' HG23 ' A' ' 72' ' ' ILE . 51.5 Cg_endo -69.41 146.68 63.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.282 1.988 . . . . 0.0 112.419 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 71' ' ' PRO . 2.4 pt -157.2 156.39 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.5 m -116.16 145.7 42.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.831 ' CD1' HD11 ' A' ' 128' ' ' ILE . 0.5 OUTLIER -122.58 91.2 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.999 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -66.29 144.73 56.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.8 mm? -115.19 173.44 6.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.705 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.709 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -139.44 -177.61 5.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -107.91 -35.73 6.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.076 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m 178.98 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.579 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' CB ' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -102.69 165.11 14.31 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.507 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 67.4 Cg_endo -73.45 -39.75 1.38 Allowed 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.465 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 26.2 m-85 -103.01 -63.84 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 82' ' ' TYR . 11.3 t-20 165.13 -51.36 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 33.3 Cg_endo -67.69 153.01 77.18 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.204 1.936 . . . . 0.0 112.508 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.487 ' HA ' HD12 ' A' ' 77' ' ' LEU . 54.2 Cg_endo -69.75 162.83 40.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.609 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 86' ' ' ILE . 3.2 mp -104.12 105.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.671 ' SG ' HD11 ' A' ' 127' ' ' LEU . 58.6 m -62.49 149.41 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -153.39 148.38 26.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.639 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.795 HG13 HD11 ' A' ' 109' ' ' ILE . 23.0 m -103.33 127.35 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -107.01 87.4 2.95 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.089 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.448 ' HG3' HD12 ' A' ' 97' ' ' ILE . 64.9 Cg_endo -73.41 -167.83 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.611 2.207 . . . . 0.0 112.296 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -131.8 177.13 7.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -28.66 69.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -30.94 15.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.75 137.02 32.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.754 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.21 -166.97 1.69 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.3 tt -136.96 61.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 111.149 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' O ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -42.68 133.13 3.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.818 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 105' ' ' ALA . 17.0 p -98.31 132.68 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.76 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.4 -118.76 1.74 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.582 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -100.05 -33.21 10.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -117.05 -38.69 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 98' ' ' LYS . 5.6 t -55.09 -24.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 99' ' ' THR . 0.4 OUTLIER 51.02 -155.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.177 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -104.16 -26.36 12.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.062 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.4 -2.06 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.697 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.699 ' HA3' HG22 ' A' ' 89' ' ' VAL . . . 73.27 39.12 52.84 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.613 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 88' ' ' PHE . 3.0 tttt -88.58 2.69 52.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 111.559 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.795 HD11 HG13 ' A' ' 89' ' ' VAL . 3.0 mp 45.7 73.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.839 0.352 . . . . 0.0 111.691 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 63.1 m-85 -85.74 55.53 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 mt -58.01 110.09 2.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.13 -36.17 54.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.396 2.064 . . . . 0.0 112.308 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -60.09 -53.32 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 114' ' ' LEU . 2.6 tm? -66.09 -34.04 77.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.82 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.98 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.777 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 23.84 8.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.008 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.565 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 2.8 t90 -115.82 -76.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.752 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER 37.73 82.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.667 -179.353 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 120' ' ' PRO . 1.6 m-70 62.44 170.56 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.046 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' A' ' 119' ' ' HIS . 73.6 Cg_endo -87.91 3.76 69.46 Favored 'Cis proline' 0 C--N 1.351 0.699 0 C-N-CA 124.044 -1.232 . . . . 0.0 112.948 -0.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -104.58 -16.08 15.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.515 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.469 ' CB ' ' CE2' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -87.4 104.56 16.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.869 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -117.76 -179.51 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.644 HD12 ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -59.92 -36.65 77.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.853 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 27' ' ' ASN . 4.0 mp -63.35 -46.52 86.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.52 -26.81 53.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.339 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.3 tm? -55.35 -29.99 59.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 0.0 110.747 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 74' ' ' LEU . 1.9 mp -91.94 -32.58 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.778 ' HA ' HD12 ' A' ' 132' ' ' ILE . 11.6 tt0 -58.59 -35.01 71.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' MET . 5.0 p -56.03 -46.18 80.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 6.0 mtt -66.77 -40.1 88.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.986 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 129' ' ' GLN . 92.9 mt -54.24 -23.55 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.899 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 129' ' ' GLN . 40.6 t -95.09 -56.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.68 -38.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.768 ' HD2' HG21 ' A' ' 70' ' ' ILE . 5.1 m-85 -85.81 -28.64 24.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.502 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.818 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.83 -24.49 66.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.44 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.69 -39.38 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.655 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.98 128.18 0.52 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 16.0 Cg_endo -58.43 134.21 59.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 112.147 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 82.6 Cg_endo -79.8 -1.4 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.44 2.094 . . . . 0.0 112.49 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 97' ' ' ILE . 3.3 m -105.72 118.29 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -177.51 164.63 2.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.6 t -92.82 62.84 3.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.33 87.85 0.34 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.36 2.04 . . . . 0.0 112.337 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.077 0.465 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 7' ' ' GLN . 11.6 p -110.15 -26.83 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.449 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t 65.39 142.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.219 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.11 -31.22 69.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 110.759 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -38.49 76.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.197 0.522 . . . . 0.0 110.75 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.591 ' HB3' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.13 -42.24 47.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.372 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 8' ' ' LEU . 8.8 tp -59.08 -40.51 85.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.05 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -55.46 -62.44 1.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.38 58.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.999 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -45.97 63.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.77 17.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.454 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.2 t -72.69 -28.76 62.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.054 0.454 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -26.93 68.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -51.97 130.91 30.74 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -56.41 -64.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.897 ' CD2' HD12 ' A' ' 20' ' ' LEU . 40.7 m-85 -60.15 -58.48 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.675 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.609 ' O ' HG23 ' A' ' 22' ' ' VAL . 12.2 ttt180 66.84 -68.43 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.828 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' TYR . 2.6 m-20 -50.23 -47.15 55.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.897 HD12 ' CD2' ' A' ' 17' ' ' TYR . 30.4 mt -71.0 -36.4 72.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 m -70.13 -34.73 73.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.071 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 18' ' ' ARG . 23.8 t -87.57 -28.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.396 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -80.11 -45.44 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.84 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.3 mt-10 -63.49 -37.76 88.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 29' ' ' ILE . 91.7 m -64.56 -59.14 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.92 -47.65 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.563 ' HB3' HD11 ' A' ' 125' ' ' LEU . 1.5 m-20 -59.04 -27.64 65.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 24' ' ' GLU . 42.5 t -85.35 -25.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.407 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.08 -28.64 6.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.077 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -70.0 -43.61 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.021 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD23 ' CE1' ' A' ' 32' ' ' TYR . 4.5 tp -77.07 -31.61 56.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.867 ' HB3' HD23 ' A' ' 35' ' ' LEU . 78.6 m-85 -114.37 116.17 28.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -9.24 58.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.579 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' C ' HD22 ' A' ' 35' ' ' LEU . 11.2 m-20 -97.3 25.0 5.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.605 0.24 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.867 HD23 ' HB3' ' A' ' 32' ' ' TYR . 4.2 mm? -117.98 141.56 48.32 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.99 126.26 12.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.607 ' HA ' HD23 ' A' ' 55' ' ' LEU . 55.4 Cg_endo -70.43 155.34 63.94 Favored 'Trans proline' 0 C--O 1.222 -0.316 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 39' ' ' LEU . 8.8 t -151.09 162.68 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.556 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.5 tm? -136.49 119.87 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.94 162.02 30.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.505 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.2 t -103.66 135.8 44.55 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.168 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -108.76 111.13 22.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.82 143.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.987 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 50' ' ' ARG . 32.8 m-85 -94.04 78.46 4.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.352 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 2.3 p-10 46.33 43.29 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.373 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 65.68 22.72 11.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.084 0.469 . . . . 0.0 111.104 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.59 -13.85 8.51 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.526 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.0 t -178.14 -165.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.737 0.304 . . . . 0.0 111.198 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -158.56 165.76 33.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.593 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.56 ' HE ' HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -157.36 144.85 18.7 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.794 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CG ' HD11 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -70.05 112.03 6.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.736 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.56 HD13 ' HE ' ' A' ' 50' ' ' ARG . 8.0 tp -117.92 128.91 55.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.878 0.371 . . . . 0.0 111.05 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.9 ttp -96.38 150.32 20.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.438 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -145.23 149.27 34.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.866 HD21 HG23 ' A' ' 25' ' ' THR . 35.0 mt -113.56 112.26 23.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.553 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.9 m -109.0 134.86 51.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.729 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.814 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -166.2 -156.25 9.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.489 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.548 HG23 ' N ' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -148.23 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -130.8 136.51 29.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.29 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 97.9 Cg_endo -78.76 80.36 3.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.827 2.351 . . . . 0.0 112.558 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.461 HG21 HG13 ' A' ' 70' ' ' ILE . 14.9 m -99.62 148.2 34.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 128.29 16.01 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.451 2.101 . . . . 0.0 112.432 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 0.5 OUTLIER -131.5 108.46 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 80.18 -10.96 1.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.78 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.16 -17.02 3.4 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.12 172.93 7.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -65.64 150.04 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -150.3 148.89 29.4 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.732 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.76 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.819 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 61' ' ' VAL . 26.0 mm -108.27 104.91 55.43 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.053 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.548 ' N ' HG23 ' A' ' 58' ' ' THR . 41.0 Cg_endo -67.58 140.3 51.51 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.303 2.002 . . . . 0.0 112.505 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 pt -148.86 173.46 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.553 ' SG ' HG23 ' A' ' 56' ' ' THR . 11.0 m -132.54 170.59 14.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.19 145.03 38.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.764 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -123.3 145.72 48.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 111.195 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.764 HD22 ' C ' ' A' ' 75' ' ' TRP . 2.7 mm? -127.28 171.3 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD11 ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -133.72 162.55 31.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.249 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.96 -30.9 10.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.13 -41.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -127.9 106.59 20.31 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.181 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HB3' ' HG2' ' A' ' 84' ' ' PRO . 24.2 Cg_exo -62.85 167.85 33.23 Favored 'Cis proline' 0 C--N 1.351 0.691 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.12 -0.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 25.99 9.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.454 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER 175.15 -61.31 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 17.0 Cg_endo -61.18 109.83 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.6 2.2 . . . . 0.0 112.458 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.755 ' HA ' HD11 ' A' ' 77' ' ' LEU . 87.4 Cg_endo -81.54 143.26 13.48 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.618 2.212 . . . . 0.0 112.701 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.9 mt -84.65 161.39 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.526 ' CB ' HG21 ' A' ' 109' ' ' ILE . 13.7 m -141.59 155.42 45.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 9.3 m-85 -157.89 143.38 16.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.457 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.853 HG21 HD12 ' A' ' 97' ' ' ILE . 29.7 m -59.06 -175.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.547 . . . . 0.0 111.266 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HE2' HG21 ' A' ' 56' ' ' THR . 5.6 tttm -158.42 51.86 0.49 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.474 ' CD ' HG23 ' A' ' 89' ' ' VAL . 56.1 Cg_endo -69.35 -167.16 0.2 Allowed 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.1 p -124.0 151.28 43.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -17.14 62.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.809 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -93.58 -15.09 25.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.869 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.828 ' CG ' HG13 ' A' ' 141' ' ' VAL . 3.6 tmm? -118.57 -8.56 10.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 95' ' ' MET . 13.8 t 46.98 -163.45 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.065 0.46 . . . . 0.0 111.306 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.853 HD12 HG21 ' A' ' 89' ' ' VAL . 10.2 tt -135.54 132.69 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -75.26 133.11 41.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.689 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 105' ' ' ALA . 33.5 p -85.58 131.4 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.966 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.5 -152.98 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -56.8 4.51 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.807 0.337 . . . . 0.0 110.648 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -85.66 -34.28 21.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.454 HG11 ' CB ' ' A' ' 140' ' ' PRO . 13.0 t -95.86 72.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.128 0.489 . . . . 0.0 111.047 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -176.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -63.27 -23.88 67.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.439 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.39 27.06 9.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.97 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA3' ' CG2' ' A' ' 89' ' ' VAL . . . 40.87 55.3 3.38 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.967 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.493 ' O ' HG22 ' A' ' 109' ' ' ILE . 2.6 tttp -81.82 11.48 4.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.851 -0.205 . . . . 0.0 111.51 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER 44.96 45.66 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 108' ' ' LYS . 3.7 m-85 -68.18 72.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.89 HD22 HG21 ' A' ' 134' ' ' VAL . 8.8 mt -88.77 158.83 47.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.48 -36.03 4.29 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.623 2.216 . . . . 0.0 112.43 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' HB2' HG21 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -57.86 -65.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -56.46 -29.6 61.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.699 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.82 -43.15 89.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -96.81 24.08 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.977 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 6.2 t90 -80.91 120.03 24.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -131.97 10.4 4.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.624 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 4.2 p80 53.21 160.24 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 69.0 Cg_endo -98.83 12.43 29.01 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.664 0.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -59.55 -54.96 40.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.763 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.454 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -82.64 144.06 30.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 111.374 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -139.4 175.22 9.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.543 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -57.01 -38.55 73.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 27' ' ' ASN . 3.8 mp -57.8 -47.17 83.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.48 -24.83 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 130' ' ' VAL . 7.5 tt -57.2 -30.54 64.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 110.741 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.4 HG22 ' CD1' ' A' ' 132' ' ' ILE . 3.4 mp -87.74 -30.8 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.61 97.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.7 p -58.09 -43.04 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.459 ' CG ' HD11 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -63.59 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.368 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.4 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.0 OUTLIER -58.3 -27.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.616 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.08 -51.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.677 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.89 HG21 HD22 ' A' ' 111' ' ' LEU . 43.2 t -53.54 -41.91 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.639 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.507 ' HZ ' HD12 ' A' ' 109' ' ' ILE . 21.8 m-30 -81.26 -27.91 34.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.455 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.9 -23.34 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.46 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -30.76 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.039 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -146.27 83.86 8.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.438 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 9.0 Cg_exo -71.27 152.44 61.35 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.78 2.32 . . . . 0.0 112.101 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CB ' HG11 ' A' ' 103' ' ' VAL . 59.2 Cg_endo -71.3 -31.79 13.71 Favored 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.278 1.985 . . . . 0.0 112.154 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.828 HG13 ' CG ' ' A' ' 95' ' ' MET . 84.0 t -59.45 162.35 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.01 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' HG12 ' A' ' 141' ' ' VAL . 11.1 t80 179.85 -80.01 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.654 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 95' ' ' MET . 0.8 OUTLIER 53.46 23.57 3.49 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.436 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 52.68 88.21 0.12 Allowed Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.01 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.246 0.913 0 C-N-CA 122.578 2.185 . . . . 0.0 112.338 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.984 0.421 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.45 66.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.393 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 m -110.73 -170.02 1.56 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.528 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.74 -36.46 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -60.13 -37.79 81.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -71.14 -31.9 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -58.29 -46.39 86.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.972 0.415 . . . . 0.0 111.029 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.06 -51.02 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.841 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -61.33 -30.88 70.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.486 ' HE2' HD23 ' A' ' 39' ' ' LEU . 13.3 mtp -67.74 -30.74 70.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -111.39 20.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.0 p -67.98 -24.59 65.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -58.08 -44.8 87.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' OH ' HD12 ' A' ' 52' ' ' LEU . 9.8 m-30 -61.75 175.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.49 -31.05 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 20' ' ' LEU . 4.3 m-30 -62.99 -69.72 0.25 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.55 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.9 ttt180 66.68 -69.43 0.12 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -44.72 95.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.051 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.625 HD12 ' CD2' ' A' ' 17' ' ' TYR . 46.3 mt -68.0 -36.46 80.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.995 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.66 HG21 HG11 ' A' ' 12' ' ' VAL . 16.5 m -62.89 -31.32 72.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.806 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.1 t -90.56 -27.14 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -45.23 19.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 28' ' ' VAL . 3.1 tt0 -67.68 -43.71 79.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.858 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.8 t -58.43 -48.02 82.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.18 0.514 . . . . 0.0 110.793 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG2' ' A' ' 25' ' ' THR . 0.4 OUTLIER -60.4 -47.08 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.456 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -51.78 -29.96 21.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.338 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 24' ' ' GLU . 21.8 t -85.04 -63.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pt -56.68 -25.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.339 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.7 m -80.29 -31.08 38.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.75 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.4 mt -86.54 -20.11 28.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.045 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -126.91 136.56 52.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.35 27.11 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 111.191 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.47 8.68 3.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.348 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.743 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.9 mm? -118.11 130.41 56.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.532 0.206 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -129.81 146.13 60.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.97 146.63 32.99 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.967 2.445 . . . . 0.0 112.706 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.738 ' CG2' HG22 ' A' ' 56' ' ' THR . 6.7 t -135.54 162.2 37.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD23 ' HE2' ' A' ' 11' ' ' MET . 1.8 tm? -132.16 123.8 27.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' N ' HD13 ' A' ' 39' ' ' LEU . 22.8 t70 -139.21 129.64 25.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 p -91.3 148.2 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.63 147.48 48.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.982 0.42 . . . . 0.0 110.652 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.5 m -106.86 150.08 9.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 111.155 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -93.08 73.99 4.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.97 41.06 21.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.966 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 61.44 24.24 14.38 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.35 8.96 12.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.796 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.46 -170.96 0.14 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.92 131.76 12.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.643 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.28 153.38 47.04 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.93 95.01 7.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.83 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.539 HD23 ' CZ3' ' A' ' 75' ' ' TRP . 6.7 tp -96.67 161.32 13.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.817 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.645 ' HE1' HD21 ' A' ' 55' ' ' LEU . 1.2 ttp -121.11 158.22 28.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.464 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 17.7 t-20 -154.17 150.71 28.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.645 HD21 ' HE1' ' A' ' 53' ' ' MET . 2.6 mt -123.51 134.6 53.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.738 HG22 ' CG2' ' A' ' 38' ' ' VAL . 10.2 t -121.05 156.76 31.51 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.153 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.743 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 165.25 173.28 33.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.487 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 71' ' ' PRO . 13.6 p -133.8 128.0 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -86.75 111.45 40.03 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.399 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.52 96.88 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.662 2.241 . . . . 0.0 112.409 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.45 141.36 27.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.275 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.26 157.34 50.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.294 1.996 . . . . 0.0 112.37 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.436 ' CE2' ' HD2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -157.56 110.07 2.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 58.87 28.22 17.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.227 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.55 5.75 66.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.9 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -116.08 -168.45 1.43 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 110.618 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.02 123.78 50.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 7.6 t80 -121.51 162.75 19.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.711 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -140.18 123.86 17.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.838 HG21 ' CD2' ' A' ' 135' ' ' PHE . 5.2 mm -101.94 100.86 15.98 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HA ' HG22 ' A' ' 58' ' ' THR . 42.7 Cg_endo -68.03 109.55 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.163 1.909 . . . . 0.0 112.105 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 89' ' ' VAL . 2.6 pp -123.35 143.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -107.17 167.87 9.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD22 HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -132.29 137.98 47.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.705 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -114.63 145.95 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.705 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.2 mm? -120.17 158.12 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.803 HD11 ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -128.07 174.67 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 79' ' ' THR . 12.8 p-10 -97.38 39.95 1.17 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.592 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 72.24 10.61 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.97 158.77 58.37 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.775 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.57 -44.28 0.55 Allowed 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.193 -1.586 . . . . 0.0 112.158 0.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 47.2 m-85 -78.78 -71.52 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 23.0 p30 146.13 -30.91 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.639 0.776 . . . . 0.0 112.185 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 48.0 Cg_exo -57.24 135.47 70.54 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.912 1.741 . . . . 0.0 112.243 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.803 ' HA ' HD11 ' A' ' 77' ' ' LEU . 69.2 Cg_endo -73.96 133.76 18.73 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.402 2.068 . . . . 0.0 112.358 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.24 147.68 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.7 t -139.98 131.28 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 20.7 m-30 -116.5 -176.19 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 109' ' ' ILE . 4.6 m -134.16 87.17 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.899 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 109.47 1.73 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.424 ' CG ' HD11 ' A' ' 97' ' ' ILE . 73.8 Cg_endo -75.54 -167.97 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.251 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.5 p -149.05 173.85 12.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.089 0.471 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -67.37 -24.6 65.71 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.035 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -47.63 80.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.184 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -167.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.063 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -126.93 -146.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.588 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.424 HD11 ' CG ' ' A' ' 91' ' ' PRO . 22.1 mm -123.62 123.01 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.875 0.369 . . . . 0.0 110.766 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -85.12 162.29 19.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.768 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 104' ' ' ASP . 12.9 p -141.1 132.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.39 -86.5 0.13 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.942 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -54.29 -71.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CG ' ' HG ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -162.95 63.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.25 0.548 . . . . 0.0 111.021 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -133.57 -7.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.708 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.765 ' O ' HG22 ' A' ' 99' ' ' THR . 0.6 OUTLIER 51.82 -153.86 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.16 -29.51 10.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.463 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -104.95 27.21 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.786 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 70.76 45.35 52.92 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.704 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.436 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -100.38 142.19 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.743 -0.269 . . . . 0.0 110.954 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.011 HD11 HG13 ' A' ' 89' ' ' VAL . 4.5 mp -101.84 98.45 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -99.63 40.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' HD2' ' A' ' 112' ' ' PRO . 3.8 mt -55.63 139.07 68.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.974 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HD2' HD23 ' A' ' 111' ' ' LEU . 73.1 Cg_endo -76.17 -25.01 10.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.49 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -48.69 76.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.96 -31.66 59.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.794 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.7 -35.8 79.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.79 20.02 12.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 122' ' ' SER . 3.5 t90 -117.3 121.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 110.799 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -126.81 126.88 44.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.629 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 6.6 p80 -52.42 160.16 1.4 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.334 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' GLN . 1.2 Cg_endo -83.22 142.08 43.67 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.208 0.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 120' ' ' PRO . 3.1 mt-30 141.92 -31.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 117' ' ' TRP . 1.3 p -76.91 120.84 22.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.984 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -136.31 178.29 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 128' ' ' ILE . 17.1 mt -84.05 -19.47 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mp -67.11 -43.09 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.41 -36.91 8.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 130' ' ' VAL . 5.4 tp -54.93 -27.97 47.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.537 HD13 ' O ' ' A' ' 124' ' ' LEU . 1.3 mp -90.26 -31.04 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.423 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -56.4 -33.15 65.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.647 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.2 p -57.54 -45.53 86.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.446 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 31.2 mtt -67.94 -38.46 82.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.072 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -55.12 -25.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 129' ' ' GLN . 40.4 t -95.07 -53.1 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.676 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 130' ' ' VAL . 38.9 t -57.99 -44.54 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.838 ' CD2' HG21 ' A' ' 70' ' ' ILE . 18.0 m-85 -83.3 -23.16 32.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.268 0.556 . . . . 0.0 110.987 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.12 -28.61 73.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.359 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.96 -38.76 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -176.58 113.09 0.25 Allowed Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.895 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 50.1 Cg_exo -54.08 136.5 67.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.194 1.929 . . . . 0.0 112.135 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 135' ' ' PHE . 84.7 Cg_endo -81.75 -21.71 5.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.63 2.22 . . . . 0.0 112.345 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.653 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 6.4 t -50.52 171.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.653 ' CB ' ' O ' ' A' ' 141' ' ' VAL . 4.5 t80 102.44 176.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.032 0.444 . . . . 0.0 110.375 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -94.12 50.35 1.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 63.8 88.74 0.11 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.67 2.246 . . . . 0.0 112.393 179.802 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.891 0.377 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.89 -63.11 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 63.47 143.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.762 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -31.95 73.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -60.04 -46.94 87.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 0.0 110.815 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.26 -42.54 99.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.239 0.542 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.23 -51.09 60.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.145 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -58.86 -24.24 61.89 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.192 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -21.42 42.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.016 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.0 mtt -73.93 -43.37 58.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 16.5 m -91.99 0.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.701 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -60.14 -31.95 70.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -26.17 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.977 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' A' ' 12' ' ' VAL . 10.9 m-85 -56.75 156.35 6.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -85.53 -54.54 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 23.2 m-30 -90.25 69.03 7.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -50.51 -56.44 11.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.226 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.53 -58.67 7.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 111.048 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -55.58 -26.45 43.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.352 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.848 HG23 HD23 ' A' ' 76' ' ' LEU . 77.6 m -86.0 -55.09 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.243 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.6 t -66.65 -33.54 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.37 -47.49 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.702 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.775 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.7 mp0 -67.33 -29.66 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.856 HG23 HD21 ' A' ' 55' ' ' LEU . 7.1 m -78.37 -30.8 48.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -84.16 -46.65 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.218 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.566 ' CG ' HD11 ' A' ' 125' ' ' LEU . 7.6 t-20 -52.32 -36.52 53.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.378 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 24' ' ' GLU . 28.8 t -74.83 -62.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.192 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -57.5 -43.42 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.8 m -58.99 -42.71 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tt -73.8 -41.66 62.04 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 121.173 0.511 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -104.95 104.91 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.781 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.1 61.86 6.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -142.78 -44.34 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.801 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.656 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.61 168.13 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.828 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 143.23 18.91 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.658 ' HA ' HD23 ' A' ' 55' ' ' LEU . 55.6 Cg_endo -70.63 134.46 26.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.639 2.226 . . . . 0.0 112.18 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' LEU . 6.5 t -127.16 162.45 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.01 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.1 tm? -138.2 128.14 25.5 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -153.4 129.16 10.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.324 0.583 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -74.05 157.6 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.07 103.74 3.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.93 137.24 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -82.89 162.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.537 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -80.42 -1.76 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.42 -28.85 24.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.616 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.41 -35.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -92.96 164.96 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -124.95 -178.1 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.138 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -167.43 135.47 2.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.77 111.69 18.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.8 mm? -110.29 138.23 46.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.315 0.579 . . . . 0.0 110.555 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.49 ' CE ' HG21 ' A' ' 25' ' ' THR . 2.9 tmm? -85.45 142.37 29.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.774 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 38' ' ' VAL . 12.1 p-10 -135.28 148.71 49.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 25' ' ' THR . 8.7 mt -113.32 120.82 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.413 HG23 ' SG ' ' A' ' 73' ' ' CYS . 2.5 m -115.95 158.91 22.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.1 -179.35 28.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.342 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.675 HG22 ' CA ' ' A' ' 71' ' ' PRO . 60.4 p -124.32 152.8 42.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.935 0.397 . . . . 0.0 111.007 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.462 HG23 ' HD2' ' A' ' 60' ' ' PRO . 5.3 mt -123.47 137.02 27.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.072 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 59' ' ' ILE . 19.0 Cg_endo -60.75 104.1 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.22 1.947 . . . . 0.0 112.0 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.648 HG13 ' HA2' ' A' ' 136' ' ' GLY . 42.3 t -132.1 121.65 17.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.94 146.78 55.48 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.368 2.046 . . . . 0.0 112.29 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -106.01 -75.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.087 0.47 . . . . 0.0 110.897 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 26.0 2.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.05 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.28 3.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.79 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -123.1 174.02 7.5 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -91.8 123.67 35.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -120.35 161.77 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -112.34 99.97 8.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.568 HG21 ' HD2' ' A' ' 135' ' ' PHE . 21.0 mm -82.63 110.21 20.93 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.675 ' CA ' HG22 ' A' ' 58' ' ' THR . 59.7 Cg_endo -72.21 145.08 43.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.262 1.975 . . . . 0.0 112.298 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 59' ' ' ILE . 2.9 pt -155.69 153.06 7.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' SG ' HG23 ' A' ' 56' ' ' THR . 87.9 m -113.52 169.18 9.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.624 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.558 HD21 HD21 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -138.89 146.81 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.533 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 HG23 ' A' ' 21' ' ' THR . 1.7 mp -135.2 155.92 49.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -126.07 174.58 8.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.099 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.614 ' O ' HG22 ' A' ' 79' ' ' THR . 10.1 p-10 -96.31 39.55 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 76.63 6.85 3.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.455 ' HD1' HG23 ' A' ' 79' ' ' THR . 1.6 m-85 -152.94 150.81 25.07 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.927 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 87.4 Cg_endo -82.77 -37.74 1.36 Allowed 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.409 0.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.603 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 88.3 m-85 -60.9 -80.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.766 ' O ' HD21 ' A' ' 77' ' ' LEU . 8.7 t-20 135.89 -51.89 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 123.395 0.678 . . . . 0.0 111.052 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 67.9 Cg_endo -75.59 128.54 11.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.395 2.063 . . . . 0.0 112.34 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 135.94 71.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.456 2.104 . . . . 0.0 112.529 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.1 mp -92.73 160.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.493 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -128.09 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 111.296 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 109' ' ' ILE . 6.5 m-85 -130.83 143.33 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.747 HG22 ' HD3' ' A' ' 91' ' ' PRO . 13.1 p -97.67 138.72 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.956 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -130.36 68.94 81.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.747 ' HD3' HG22 ' A' ' 89' ' ' VAL . 32.7 Cg_exo -59.53 -178.68 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.471 2.114 . . . . 0.0 112.256 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -82.81 165.41 19.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -86.28 -13.71 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.461 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -95.07 -27.92 15.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 0.0 110.586 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 13.5 ttm -89.53 -25.07 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.98 149.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.823 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 97' ' ' ILE . 10.2 tt -95.18 109.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.099 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 1.0 OUTLIER -77.05 130.86 37.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.19 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.8 p -75.2 136.56 41.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.981 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 103' ' ' VAL . . . -144.68 -157.37 7.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.562 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -35.48 70.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -105.77 -39.25 6.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 140' ' ' PRO . 1.3 m -84.38 85.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.406 ' OD2' ' CD2' ' A' ' 110' ' ' TYR . 15.3 m-20 -60.76 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.13 5.14 31.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -131.84 30.11 4.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 0.0 111.173 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . 51.53 51.21 38.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.8 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -119.21 93.0 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.033 0.444 . . . . 0.0 110.768 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 109' ' ' ILE . 3.6 mp -59.29 108.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.016 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 1.3 m-85 -101.72 51.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.733 HD13 HG11 ' A' ' 130' ' ' VAL . 19.5 mt -59.49 119.02 36.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 -27.43 27.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.426 2.084 . . . . 0.0 112.296 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -58.83 -29.43 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.486 HD22 HD23 ' A' ' 127' ' ' LEU . 6.8 tp -91.81 -34.32 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -67.21 -37.5 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -98.44 28.32 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.435 ' CE2' ' HA ' ' A' ' 122' ' ' SER . 1.8 t90 -96.71 -80.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 75.6 120.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.201 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.714 ' CB ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -45.75 179.39 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.688 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.714 ' HA ' ' CB ' ' A' ' 119' ' ' HIS . 61.3 Cg_endo -91.0 37.53 5.11 Favored 'Cis proline' 0 C--N 1.357 0.974 0 C-N-CA 125.035 -0.819 . . . . 0.0 113.864 0.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -21.7 12.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.831 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.435 ' HA ' ' CE2' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -64.24 160.49 18.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 111.483 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 179.95 -177.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.587 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.558 HD21 HD21 ' A' ' 74' ' ' LEU . 4.4 mt -84.57 -34.49 23.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.854 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.566 HD11 ' CG ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -50.48 -47.46 57.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.65 -25.77 55.64 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.366 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.663 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.4 tm? -58.37 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 128' ' ' ILE . 3.4 mp -90.48 -27.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.709 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.863 ' O ' HG22 ' A' ' 132' ' ' ILE . 2.5 tt0 -65.17 -33.2 75.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.701 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.81 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.7 p -66.5 -41.86 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 0.0 110.653 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.419 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.3 mmt -67.48 -44.38 78.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.863 HG22 ' O ' ' A' ' 129' ' ' GLN . 1.2 tt -52.77 -26.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.153 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.03 -54.1 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 130' ' ' VAL . 41.6 t -55.53 -38.32 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.568 ' HD2' HG21 ' A' ' 70' ' ' ILE . 6.0 m-85 -83.86 -26.7 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.648 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -65.05 -18.74 65.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.534 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -48.93 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.56 111.19 1.65 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.0 139.07 79.67 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.991 . . . . 0.0 112.192 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.684 ' HB2' HG11 ' A' ' 103' ' ' VAL . 91.8 Cg_endo -84.78 1.62 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.698 2.265 . . . . 0.0 112.658 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 91' ' ' PRO . 25.8 t -84.9 -47.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.409 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 51.35 172.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.274 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 142' ' ' PHE . 1.1 p -173.34 38.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.845 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 43.92 89.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.358 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo . . . . . 0 C--O 1.25 1.089 0 C-N-CA 122.66 2.24 . . . . 0.0 112.291 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 7' ' ' GLN . 11.1 p -95.61 -28.59 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.5 145.34 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.793 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.62 72.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -49.76 75.75 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.524 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.564 ' HB3' HG22 ' A' ' 3' ' ' VAL . 5.1 tt0 -65.95 -49.34 68.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.173 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.1 tp -58.73 -29.67 66.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.927 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -55.2 36.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -70.15 -29.56 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.426 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmm -62.56 -49.18 76.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.044 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 8' ' ' LEU . 17.1 m -101.35 19.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.487 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -67.09 -29.75 69.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.822 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -31.22 68.08 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CE2' HG21 ' A' ' 21' ' ' THR . 3.4 m-30 -56.91 129.73 42.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' HG21 ' A' ' 79' ' ' THR . 1.0 OUTLIER -58.27 -62.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.63 -55.25 25.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.829 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 ttp180 66.97 -67.41 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.38 -49.62 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -48.31 79.89 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.512 0.507 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 15' ' ' TYR . 5.0 m -66.97 -31.93 72.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 18' ' ' ARG . 37.8 t -79.94 -25.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.131 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -79.01 -47.02 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 28' ' ' VAL . 15.5 mt-10 -67.13 -43.46 82.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.7 t -58.44 -47.46 83.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.449 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -62.44 -46.99 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.776 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.447 ' HB3' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -51.72 -32.58 30.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.274 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.938 HG21 HD23 ' A' ' 124' ' ' LEU . 21.4 t -73.85 -66.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -56.9 -28.33 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.0 m -70.25 -33.53 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.62 -34.43 15.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -102.11 122.63 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.88 3.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.6 15.75 2.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.416 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 167.64 11.24 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.832 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -152.4 137.03 10.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.776 ' HA ' HD23 ' A' ' 55' ' ' LEU . 74.4 Cg_endo -75.12 159.7 40.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.601 2.201 . . . . 0.0 112.115 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 6.4 t -150.6 161.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.5 tm? -129.42 122.35 29.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -138.03 161.45 36.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.401 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.09 152.15 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.72 88.44 2.68 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.142 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.47 163.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.947 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.39 76.91 1.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 57.22 54.68 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 44.95 32.14 0.79 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.403 0.62 . . . . 0.0 110.885 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.71 -19.23 7.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.449 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.8 -167.79 0.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.192 0.52 . . . . 0.0 110.477 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -153.41 123.08 6.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -123.53 120.15 32.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -59.73 142.08 53.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 52' ' ' LEU . 3.9 tp -147.01 141.54 26.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.251 0.548 . . . . 0.0 110.997 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.602 ' SD ' HG11 ' A' ' 12' ' ' VAL . 5.7 ttp -107.21 139.57 41.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.492 ' ND2' ' HB ' ' A' ' 38' ' ' VAL . 5.0 p-10 -138.77 157.46 46.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.813 HD12 HD13 ' A' ' 74' ' ' LEU . 4.1 mt -124.58 128.4 48.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.5 m -124.24 134.31 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.15 169.57 37.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.71 139.39 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.733 ' O ' HD12 ' A' ' 59' ' ' ILE . 2.0 pp -117.07 156.43 48.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.763 ' HG2' HD11 ' A' ' 132' ' ' ILE . 39.8 Cg_endo -67.45 134.96 34.87 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.489 2.126 . . . . 0.0 112.211 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.71 HG21 ' CG1' ' A' ' 70' ' ' ILE . 98.1 t -143.27 106.22 5.16 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.74 134.71 41.76 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.794 2.329 . . . . 0.0 112.252 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -167.85 116.27 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER 81.21 -10.24 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.039 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.06 -6.99 7.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.573 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.77 175.13 6.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 114.63 28.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -94.18 148.15 22.47 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.17 104.3 16.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.724 HG21 ' HD2' ' A' ' 135' ' ' PHE . 31.6 mm -102.45 98.88 11.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 72' ' ' ILE . 46.0 Cg_endo -68.44 153.55 73.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.469 2.113 . . . . 0.0 112.189 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.756 ' O ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -159.21 154.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.403 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 43.2 t -105.13 150.01 25.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.813 HD13 HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -124.68 142.67 51.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.544 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -127.62 139.95 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 75' ' ' TRP . 2.6 mm? -128.22 170.4 13.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.15 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.68 165.75 18.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.08 -39.42 75.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.794 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 16' ' ' LYS . 1.5 t 173.37 -34.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.181 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 79' ' ' THR . 11.8 m-85 -166.07 163.39 12.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.771 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 68.1 Cg_endo -92.78 -0.59 54.19 Favored 'Cis proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.237 -1.151 . . . . 0.0 112.647 0.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 12.0 m-85 -87.2 51.7 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.631 0.253 . . . . 0.0 111.062 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.568 ' O ' HD11 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -40.99 -51.63 7.26 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 44.4 Cg_endo -70.68 115.52 4.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.217 1.945 . . . . 0.0 112.105 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 84' ' ' PRO . 34.5 Cg_endo -64.97 167.67 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.0 112.591 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 3.6 mp -104.07 159.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.487 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.6 p -133.53 126.08 30.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.051 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 21.7 m-85 -131.72 161.63 32.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.78 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.546 HG22 ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -133.54 129.78 56.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 80.49 50.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 89' ' ' VAL . 84.3 Cg_exo -46.52 164.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.448 2.098 . . . . 0.0 112.588 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.0 p -87.23 172.57 9.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.824 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -59.83 -20.78 58.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 m -54.42 -58.93 5.53 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.032 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.02 177.03 5.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.048 0.451 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.804 HG23 ' O ' ' A' ' 142' ' ' PHE . 8.2 t -94.19 -137.74 0.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.592 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -152.1 111.25 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.317 0.58 . . . . 0.0 111.382 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' HA ' ' A' ' 140' ' ' PRO . 3.0 ptmt -101.78 133.83 45.89 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.142 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -173.48 -177.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 111.487 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' A' ' 99' ' ' THR . . . 153.63 -17.92 0.67 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.302 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -54.89 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.551 0.215 . . . . 0.0 111.279 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.614 ' ND1' HG23 ' A' ' 103' ' ' VAL . 10.6 p80 -129.96 -34.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.614 HG23 ' ND1' ' A' ' 102' ' ' HIS . 84.7 t -77.46 -16.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.454 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 99' ' ' THR . 2.5 m-20 53.01 170.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.84 0.352 . . . . 0.0 111.455 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.47 -19.09 62.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.609 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.43 24.63 4.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 53.24 23.53 18.19 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.066 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.47 125.7 37.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.546 -0.385 . . . . 0.0 110.481 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.34 108.73 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 111.291 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -104.31 31.66 4.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.115 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.614 HD21 HG21 ' A' ' 134' ' ' VAL . 4.2 mt -51.72 152.01 5.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.599 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CD ' HD23 ' A' ' 111' ' ' LEU . 23.1 Cg_exo -63.82 -32.12 67.32 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.745 ' HB2' HG21 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -57.9 -31.51 66.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.684 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -86.97 -42.71 12.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.13 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.33 -36.26 83.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.059 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.99 37.01 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.422 ' NE1' ' CB ' ' A' ' 122' ' ' SER . 1.6 t90 -80.44 114.96 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.575 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -149.38 111.1 4.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 6.0 p80 -50.69 159.68 0.88 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.023 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 74.8 Cg_endo -87.76 -14.13 31.61 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.9 -1.291 . . . . 0.0 112.874 0.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -26.93 5.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.079 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.422 ' CB ' ' NE1' ' A' ' 117' ' ' TRP . 23.3 p -74.57 156.41 36.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 177.49 153.87 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -56.71 -43.8 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 27' ' ' ASN . 1.6 mp -55.48 -42.37 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.766 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.46 56.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.254 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 130' ' ' VAL . 30.2 tp -56.54 -36.58 69.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.441 HD11 HD11 ' A' ' 74' ' ' LEU . 3.8 mp -90.2 -23.99 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.653 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.922 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.2 tt0 -69.3 -33.41 73.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.676 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 113' ' ' TYR . 3.6 p -63.51 -42.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.428 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 4.6 mtt -64.77 -43.76 92.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.922 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER -53.77 -25.05 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.39 -52.69 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.503 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 130' ' ' VAL . 43.0 t -57.09 -36.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.375 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.724 ' HD2' HG21 ' A' ' 70' ' ' ILE . 4.3 m-85 -83.3 -26.1 30.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.244 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.22 -15.07 72.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.61 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.4 -36.14 11.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.803 0.335 . . . . 0.0 110.642 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -153.39 85.8 4.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.45 111.11 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.652 2.235 . . . . 0.0 112.727 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 98' ' ' LYS . 86.8 Cg_endo -83.9 50.0 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.857 2.371 . . . . 0.0 112.082 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 70' ' ' ILE . 3.8 t -125.15 -7.66 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -78.37 -159.33 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.676 ' HA ' HG21 ' A' ' 96' ' ' THR . 80.3 p -57.07 -125.89 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.472 ' CB ' ' HB2' ' A' ' 98' ' ' LYS . 20.8 tpt85 67.54 61.55 0.78 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.644 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 144' ' ' ARG . 59.9 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.783 2.322 . . . . 0.0 111.922 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.641 0.257 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 m -110.91 66.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.759 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -22.69 11.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -82.36 -34.67 28.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -81.5 -32.92 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.937 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -70.67 -42.07 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.633 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.735 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.6 tp -59.88 -44.57 94.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.457 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.2 66.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.801 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -72.93 -29.01 62.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.97 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -88.62 -35.86 16.61 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.0 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 8' ' ' LEU . 26.9 m -88.54 8.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.632 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 p -79.22 -29.55 42.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.912 0.387 . . . . 0.0 110.809 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -69.81 -17.89 63.43 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.533 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 78' ' ' ASP . 1.8 m-85 -51.17 167.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.821 0.343 . . . . 0.0 111.142 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -47.85 8.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -84.24 -58.08 2.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER 66.54 -68.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -52.78 -29.9 30.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.195 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -84.9 -39.44 18.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -47.73 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 18' ' ' ARG . 22.9 t -61.68 -39.62 83.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -63.31 -50.57 69.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.269 0.557 . . . . 0.0 111.173 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 28' ' ' VAL . 9.4 mt-10 -60.68 -47.04 88.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.944 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.471 HG23 HD21 ' A' ' 55' ' ' LEU . 5.7 m -58.8 -50.65 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -58.78 -47.37 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -53.31 -33.22 52.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.446 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.847 HG21 HD23 ' A' ' 124' ' ' LEU . 21.8 t -80.95 -58.98 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.448 HD11 ' HA ' ' A' ' 26' ' ' VAL . 2.9 pt -59.83 -34.54 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.362 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.5 t -67.52 -38.01 83.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.831 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' CD2' HG23 ' A' ' 30' ' ' THR . 2.5 mm? -86.39 -30.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.35 124.99 50.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.302 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.95 68.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -168.62 -41.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.588 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.7 mm? -62.56 129.39 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.85 101.44 53.49 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.883 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.05 139.71 33.64 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.453 2.102 . . . . 0.0 112.385 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.497 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 5.2 t -132.18 162.08 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.466 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.4 tm? -118.75 124.07 46.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 39' ' ' LEU . 16.2 t70 -149.2 127.33 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.866 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -90.91 159.26 16.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -112.3 104.77 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 110.727 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.61 158.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 50' ' ' ARG . 41.5 m-85 -114.33 74.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 3.2 p-10 44.74 52.09 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.543 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.86 23.5 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.919 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.77 -14.1 14.74 Favored Glycine 0 N--CA 1.459 0.228 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.319 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -177.38 -169.43 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.719 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.4 107.39 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.429 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HG2' ' CE1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -97.45 134.14 41.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.78 123.73 24.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 77' ' ' LEU . 6.5 tp -134.36 155.08 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.527 ' HE2' HD12 ' A' ' 76' ' ' LEU . 15.5 ttp -118.44 149.93 40.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 38' ' ' VAL . 4.4 p-10 -143.41 160.7 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.884 HD12 HD13 ' A' ' 74' ' ' LEU . 11.0 mt -127.08 118.72 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.958 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.41 HG21 ' HD3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -119.9 155.84 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.588 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 161.04 172.0 27.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.481 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.409 HG23 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -110.52 124.82 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.0 111.248 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 pt -104.0 150.91 38.78 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.189 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.83 149.46 66.46 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 112.257 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.772 HG13 ' HA2' ' A' ' 136' ' ' GLY . 97.1 t -155.7 107.57 2.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.199 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 58.2 Cg_exo -52.23 111.78 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.151 1.9 . . . . 0.0 112.293 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -110.45 97.43 6.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 57.49 24.97 10.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.68 -15.97 28.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.815 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -96.94 177.89 5.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -114.14 111.25 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.064 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.12 -173.7 2.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.097 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -146.98 87.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.063 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 70' ' ' ILE . 3.2 mp -89.09 107.51 18.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HG3' HG23 ' A' ' 92' ' ' THR . 49.5 Cg_endo -69.18 160.24 50.66 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.556 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 71' ' ' PRO . 2.7 pp -159.22 163.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 158.88 28.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.737 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.884 HD13 HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -132.83 135.18 45.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.908 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -121.35 134.17 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.908 HD23 ' O ' ' A' ' 75' ' ' TRP . 8.8 mt -133.13 156.75 46.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.06 162.77 24.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 4.8 p-10 -60.3 -44.11 95.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.676 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -177.39 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.56 157.74 55.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HG2' ' CD2' ' A' ' 82' ' ' TYR . 73.5 Cg_endo -77.86 -47.37 0.31 Allowed 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.307 -1.539 . . . . 0.0 112.569 0.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 80.3 m-85 -87.91 -67.66 0.81 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' O ' HD21 ' A' ' 77' ' ' LEU . 4.6 m-20 156.82 -52.44 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.779 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' O ' HD11 ' A' ' 77' ' ' LEU . 87.2 Cg_exo -44.52 143.49 3.87 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.744 2.296 . . . . 0.0 112.774 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.594 ' CB ' HD22 ' A' ' 76' ' ' LEU . 85.8 Cg_endo -82.25 138.56 10.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.0 112.445 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.3 mp -83.38 160.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.493 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.4 t -134.97 141.71 46.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.028 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.477 ' CA ' HD12 ' A' ' 109' ' ' ILE . 2.8 m-85 -138.76 -179.86 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 107' ' ' GLY . 13.6 p -128.25 149.19 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HD3' HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -114.36 87.83 14.41 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.7 148.46 15.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.527 2.152 . . . . 0.0 112.398 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.647 HG23 ' HG3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -105.65 -176.71 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.0 t -77.88 -31.83 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.688 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -73.56 -56.97 4.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.7 mtm -91.54 179.3 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -130.09 -98.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.484 HD11 HG11 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -175.5 126.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.29 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.15 116.08 29.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.636 HG22 ' C ' ' A' ' 104' ' ' ASP . 57.5 p -86.27 134.07 33.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.43 -63.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.43 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -100.03 -71.31 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.577 ' NE2' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -120.71 -15.67 8.37 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' THR . 21.7 t -87.48 70.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.661 0.267 . . . . 0.0 111.583 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.636 ' C ' HG22 ' A' ' 99' ' ' THR . 70.6 m-20 -52.04 -176.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.25 68.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.19 19.64 10.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.796 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 53.99 29.39 43.24 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 88' ' ' PHE . 27.8 tttp -83.87 113.31 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.578 HG22 HD12 ' A' ' 111' ' ' LEU . 2.2 mp -69.78 110.19 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.21 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 102' ' ' HIS . 3.8 p90 -132.92 46.98 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.481 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 109' ' ' ILE . 1.3 mp -44.67 148.95 0.84 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.644 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -30.85 10.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.564 2.176 . . . . 0.0 112.017 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -60.34 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.98 -30.91 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.418 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -58.86 -55.64 32.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.02 31.02 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.608 ' O ' ' CB ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -81.05 -64.37 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.589 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 117' ' ' TRP . 1.0 OUTLIER 109.58 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.915 0.76 . . . . 0.0 110.053 -179.404 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 120' ' ' PRO . 1.4 m80 -175.95 175.77 0.66 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.392 -0.193 . . . . 0.0 110.746 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.583 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 83.5 Cg_endo -84.42 -2.32 57.99 Favored 'Cis proline' 0 C--N 1.354 0.83 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.049 0.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -25.3 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.381 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.415 ' N ' ' NE1' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -70.13 66.21 0.27 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.015 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -93.17 168.89 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 28' ' ' VAL . 4.4 tp -57.76 -39.68 77.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mp -49.28 -43.16 42.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.54 -26.86 49.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.256 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.1 tm? -57.87 -31.74 67.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.6 mp -88.02 -28.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.7 tm0? -61.34 -35.86 78.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 111' ' ' LEU . 2.3 p -65.19 -39.94 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.404 ' HG2' ' CE1' ' A' ' 135' ' ' PHE . 10.0 mtt -68.74 -44.59 73.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.858 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 129' ' ' GLN . 1.2 tt -52.65 -24.53 6.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.204 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 129' ' ' GLN . 42.0 t -92.98 -56.48 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.529 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 130' ' ' VAL . 89.6 t -56.63 -46.95 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.543 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.544 ' CD2' HG21 ' A' ' 70' ' ' ILE . 4.3 m-85 -74.9 -27.79 60.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.772 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -66.53 -15.54 64.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.592 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -89.78 -48.66 7.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -158.81 137.35 7.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.74 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 138' ' ' GLU . 48.5 Cg_exo -55.66 105.97 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 112.338 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 18.3 Cg_exo -66.62 -12.85 37.54 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.227 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 141' ' ' VAL . 42.8 t -84.56 -13.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.605 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -68.42 179.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.98 44.17 1.04 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 61.2 154.84 0.11 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.237 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.252 1.18 0 C-N-CA 122.657 2.238 . . . . 0.0 112.282 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.698 0.285 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.93 31.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -25.65 58.88 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.022 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.27 -34.42 14.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -72.27 -35.35 68.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.73 -32.66 57.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.821 ' O ' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -63.01 -28.39 70.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -29.47 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.292 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -73.65 -28.13 61.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.988 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.66 ' CE ' HD23 ' A' ' 39' ' ' LEU . 5.6 ptm -85.62 -35.22 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.081 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 8' ' ' LEU . 29.4 m -94.87 11.57 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.561 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -23.19 63.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.055 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -26.67 25.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.409 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 8.5 m-85 -54.52 134.19 46.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -67.5 -49.41 63.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -90.7 66.44 6.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.851 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -56.92 -60.73 3.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.325 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -51.45 -53.28 38.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.094 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.03 -41.24 99.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.0 m -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 18' ' ' ARG . 39.4 t -82.31 -31.74 10.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -72.27 -48.42 42.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 28' ' ' VAL . 23.4 mt-10 -64.39 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.697 HG23 ' CD2' ' A' ' 55' ' ' LEU . 85.6 m -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.078 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -85.78 -47.81 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.598 ' O ' HD23 ' A' ' 31' ' ' LEU . 2.4 m-20 -55.42 -28.72 56.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.474 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.5 t -85.82 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.427 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 5.9 pt -57.38 -33.76 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.567 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 26' ' ' VAL . 4.8 t -75.47 -32.69 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 27' ' ' ASN . 2.7 mm? -77.04 -38.91 51.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.858 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' CB ' HD23 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -99.26 -20.56 16.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.512 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 1.1 mttp 67.31 -59.88 0.39 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.639 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -45.69 -35.88 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.885 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.674 HD21 ' CG2' ' A' ' 59' ' ' ILE . 3.6 mm? -63.38 132.52 51.75 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 111.059 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -129.95 117.97 18.4 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.699 ' HB2' HD11 ' A' ' 8' ' ' LEU . 45.4 Cg_exo -56.7 140.68 91.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.401 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 39' ' ' LEU . 8.4 t -131.34 162.81 38.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.66 HD23 ' CE ' ' A' ' 11' ' ' MET . 2.1 tm? -133.4 95.18 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.862 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.24 118.6 35.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.08 145.52 49.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.296 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -117.67 119.93 36.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.596 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 49' ' ' SER . 33.3 m -85.0 152.38 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 111.188 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -121.17 107.95 13.19 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.355 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 46.94 29.69 1.09 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 64.09 15.82 9.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.369 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.6 -13.86 66.69 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.175 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.454 ' CB ' ' CE2' ' A' ' 44' ' ' PHE . 0.5 OUTLIER 173.77 -168.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.569 ' HB3' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -147.08 131.22 17.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.07 127.99 55.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.421 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -74.49 101.09 4.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' O ' HD22 ' A' ' 39' ' ' LEU . 4.6 mm? -108.65 138.99 44.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.556 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 65.8 ttp -84.85 149.2 25.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.442 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 9.0 p-10 -149.98 117.8 6.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.697 ' CD2' HG23 ' A' ' 25' ' ' THR . 3.6 mt -85.37 107.65 17.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.522 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 m -108.5 149.73 28.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.498 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 163.4 165.42 20.5 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.42 HG23 ' HB3' ' A' ' 71' ' ' PRO . 1.4 p -107.29 120.63 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.604 0.24 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.674 ' CG2' HD21 ' A' ' 35' ' ' LEU . 2.2 pt -99.76 126.35 37.35 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.456 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.11 126.61 22.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.417 2.078 . . . . 0.0 111.952 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG11 ' CG1' ' A' ' 70' ' ' ILE . 14.8 p -132.84 136.69 28.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.0 Cg_exo -58.16 150.98 62.28 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.433 2.089 . . . . 0.0 112.094 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -176.76 116.46 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 58.48 25.1 12.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.27 3.18 75.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.75 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -124.74 176.9 6.28 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 133.91 47.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -165.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -143.53 98.04 3.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.995 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.701 HG21 ' CD2' ' A' ' 135' ' ' PHE . 25.0 mm -100.92 101.8 17.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB3' HG23 ' A' ' 58' ' ' THR . 61.3 Cg_endo -73.23 136.25 24.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.486 2.124 . . . . 0.0 112.53 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.409 HD12 ' SG ' ' A' ' 87' ' ' CYS . 11.5 pt -134.81 167.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 108.62 10.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.935 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.894 HD22 HD22 ' A' ' 124' ' ' LEU . 8.3 mt -85.44 98.66 10.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.086 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.778 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -79.66 146.9 32.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.569 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.778 HD22 ' C ' ' A' ' 75' ' ' TRP . 2.8 mm? -126.97 170.87 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.44 166.25 25.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.38 0.61 . . . . 0.0 110.715 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -39.27 24.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.77 163.11 27.14 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.62 -62.58 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.187 -0.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 25.4 m-85 -105.03 -56.09 2.23 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.619 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.572 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.9 p-10 161.83 -34.37 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.369 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 28.5 Cg_exo -62.09 116.99 3.83 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.968 1.778 . . . . 0.0 112.269 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.694 ' HB3' HD13 ' A' ' 76' ' ' LEU . 46.2 Cg_endo -68.17 166.94 23.35 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.39 2.06 . . . . 0.0 112.199 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.802 HG21 ' CE1' ' A' ' 88' ' ' PHE . 1.2 mp -103.95 164.03 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.066 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.774 ' H ' HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -131.67 53.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.814 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.802 ' CE1' HG21 ' A' ' 86' ' ' ILE . 30.6 m-85 -48.73 125.42 10.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.182 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.733 HG13 HG23 ' A' ' 109' ' ' ILE . 33.5 m -81.6 127.0 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.253 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -127.44 89.83 50.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 32.9 Cg_exo -60.33 -158.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.644 2.23 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -128.6 173.95 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 t -68.4 -25.73 65.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -29.22 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.294 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.685 ' HB3' HG12 ' A' ' 141' ' ' VAL . 2.0 mpp? -127.2 -169.17 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 143' ' ' SER . 13.0 t -135.62 -162.7 1.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 97' ' ' ILE . 9.3 tt -122.89 104.29 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -81.43 102.28 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 105' ' ' ALA . 15.5 p -57.56 141.37 48.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.33 -100.44 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.557 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -95.96 -64.53 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.81 ' CE1' HG11 ' A' ' 134' ' ' VAL . 4.8 p-80 -107.53 -24.34 11.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.422 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 140' ' ' PRO . 52.1 t -55.28 -27.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 99' ' ' THR . 1.0 OUTLIER 44.4 -166.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -103.81 -20.57 13.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.513 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.65 22.2 7.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.488 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.41 ' HA2' ' CD1' ' A' ' 97' ' ' ILE . . . 51.52 44.27 53.41 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.781 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 1.5 tttm -124.05 90.82 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.785 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.858 ' O ' HD12 ' A' ' 109' ' ' ILE . 2.0 pp -46.79 108.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.874 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 108' ' ' LYS . 33.5 m-85 -95.61 30.9 2.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.713 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.778 HD13 HG11 ' A' ' 130' ' ' VAL . 9.5 mt -49.17 106.56 0.64 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.35 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.5 -14.73 46.01 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.463 2.109 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -58.56 -71.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.318 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -60.63 -19.64 58.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.151 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.954 ' N ' HD13 ' A' ' 114' ' ' LEU . 24.2 t60 -64.62 -46.55 82.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 110.332 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.02 26.79 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.736 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.508 ' HD1' ' N ' ' A' ' 118' ' ' LYS . 2.2 t90 -97.02 136.89 36.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.508 ' N ' ' HD1' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -124.51 138.19 54.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.773 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.625 ' CB ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -48.98 174.28 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.236 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.625 ' HA ' ' CB ' ' A' ' 119' ' ' HIS . 59.9 Cg_endo -90.43 32.03 9.81 Favored 'Cis proline' 0 C--N 1.355 0.876 0 C-N-CA 124.661 -0.975 . . . . 0.0 113.437 0.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -113.41 -0.38 14.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.748 0.309 . . . . 0.0 111.273 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.497 ' CB ' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -90.72 120.96 32.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -174.27 179.78 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.894 HD22 HD22 ' A' ' 74' ' ' LEU . 59.0 mt -59.68 -31.2 69.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -47.6 81.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -83.94 -40.72 8.54 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 130' ' ' VAL . 9.5 tt -54.02 -27.4 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.749 HD11 HD11 ' A' ' 74' ' ' LEU . 50.0 mt -90.54 -28.54 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.666 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.875 ' HA ' HD12 ' A' ' 132' ' ' ILE . 2.2 tt0 -57.47 -33.06 67.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.778 HG11 HD13 ' A' ' 111' ' ' LEU . 4.3 p -59.79 -45.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.38 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.449 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 12.8 mtm -69.89 -40.58 75.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.087 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 129' ' ' GLN . 63.4 mt -54.6 -26.25 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.741 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 129' ' ' GLN . 39.9 t -91.87 -54.39 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.437 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.81 HG11 ' CE1' ' A' ' 102' ' ' HIS . 39.5 t -56.42 -47.82 80.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.701 ' CD2' HG21 ' A' ' 70' ' ' ILE . 7.3 m-30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.279 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 61' ' ' VAL . . . -67.66 -15.87 67.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.696 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -104.12 -42.83 5.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 28.0 mt-10 -151.0 90.53 4.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.253 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 10.7 Cg_endo -55.99 129.23 33.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.487 2.125 . . . . 0.0 112.306 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.648 ' HB3' HG21 ' A' ' 103' ' ' VAL . 37.0 Cg_exo -59.1 -19.03 46.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.175 1.917 . . . . 0.0 111.871 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 95' ' ' MET . 1.6 t -75.06 152.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.25 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 144' ' ' ARG . 16.7 t80 -174.99 -87.65 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.043 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.827 ' HB3' HG22 ' A' ' 96' ' ' THR . 1.3 p 57.35 33.23 23.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.525 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 23.3 mtm-85 60.45 153.35 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.838 0.351 . . . . 0.0 111.025 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.597 2.198 . . . . 0.0 112.632 179.605 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.633 0.254 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 3' ' ' VAL . 18.9 t -100.04 36.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.6 p -107.28 -23.94 12.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -84.68 -51.31 6.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.074 0.464 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -60.41 -31.76 70.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -84.31 -22.88 30.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.103 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.797 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.2 tp -55.34 -50.72 68.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.219 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -31.8 40.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.924 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.49 68.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.651 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.543 ' HG2' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -86.28 -33.0 20.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 8' ' ' LEU . 26.7 m -100.45 20.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -26.51 68.36 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.561 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -21.86 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.339 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -51.54 134.48 29.28 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -64.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.832 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -86.5 63.73 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 22' ' ' VAL . 12.8 ttp180 -63.76 -53.7 46.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.278 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -35.03 56.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 111.449 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.59 -40.19 16.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.738 HG23 HD23 ' A' ' 76' ' ' LEU . 81.8 m -66.49 -49.82 65.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.086 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.1 t -59.67 -39.59 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -48.4 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.381 0.61 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.4 -43.42 88.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.852 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.757 HG22 HD11 ' A' ' 29' ' ' ILE . 23.4 m -65.02 -59.02 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.94 -48.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.183 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.2 t-20 -55.99 -28.04 55.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -84.08 -27.18 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.757 HD11 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -91.12 -27.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.933 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -68.77 -48.15 64.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -41.89 66.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.35 117.31 34.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -95.7 21.13 8.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.216 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' C ' HD22 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -119.0 17.65 13.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.725 HD13 ' HA3' ' A' ' 57' ' ' GLY . 4.1 mm? -118.04 159.86 22.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -149.35 124.58 4.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.686 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 133.84 21.27 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.252 1.968 . . . . 0.0 112.344 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.543 HG23 HG22 ' A' ' 56' ' ' THR . 6.9 t -130.15 162.15 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.068 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -120.55 114.8 22.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.804 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -134.1 115.46 14.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 110.89 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 p -72.99 141.88 47.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.09 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.48 120.51 41.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.91 156.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -114.24 54.52 0.76 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.166 0.507 . . . . 0.0 110.964 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 55.93 68.58 0.84 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.947 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.94 22.36 12.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.26 38.1 2.67 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.463 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.6 t 69.39 169.2 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.4 p -125.47 173.92 8.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.769 ' NE ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -133.12 138.94 46.84 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.488 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.54 107.08 0.14 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.769 HD13 ' NE ' ' A' ' 50' ' ' ARG . 7.6 tp -117.82 131.03 56.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 110.544 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.76 ' SD ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -92.04 146.08 24.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.211 0.529 . . . . 0.0 110.912 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.434 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 6.6 p-10 -143.86 140.7 29.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.915 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD11 HG23 ' A' ' 25' ' ' THR . 57.5 mt -100.32 101.67 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.543 HG22 HG23 ' A' ' 38' ' ' VAL . 11.7 t -102.55 152.96 20.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.694 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.725 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 154.19 -172.41 32.79 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.411 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.6 p -121.53 156.5 32.73 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.852 HD12 HG13 ' A' ' 61' ' ' VAL . 2.2 pp -131.87 134.28 25.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.036 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 116.18 4.56 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.562 2.175 . . . . 0.0 112.104 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.852 HG13 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -120.15 102.1 46.47 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.522 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 89.4 Cg_exo -42.61 129.7 5.13 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.211 2.607 . . . . 0.0 112.688 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -135.56 87.17 2.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 63.01 42.77 7.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.14 -16.58 55.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.1 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 3.1 t-20 -86.65 -147.47 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.857 -0.202 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 67' ' ' THR . 6.0 t -176.24 41.95 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 121.547 0.689 . . . . 0.0 109.906 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.459 ' O ' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -31.27 148.33 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.524 -179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -105.66 106.11 16.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.682 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.744 HG21 ' CD2' ' A' ' 135' ' ' PHE . 13.2 mm -99.58 108.25 49.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.217 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.16 147.53 93.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.494 2.129 . . . . 0.0 111.853 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 pt -149.57 149.82 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 111.215 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 116.71 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 138.4 32.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.699 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -113.35 145.92 40.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.76 HD22 ' SD ' ' A' ' 53' ' ' MET . 2.3 mp -141.22 146.4 36.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.37 166.24 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.16 0.505 . . . . 0.0 110.85 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.84 -39.57 79.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.723 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t 174.43 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.843 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -125.59 163.54 38.15 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 90.5 Cg_endo -82.65 -31.69 3.89 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.421 -1.491 . . . . 0.0 112.108 0.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 52.0 m-85 -59.55 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.101 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 64.6 t-20 117.67 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 89.5 Cg_endo -84.21 141.25 9.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.433 2.089 . . . . 0.0 112.399 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 84' ' ' PRO . 50.4 Cg_exo -55.36 127.42 26.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.473 2.115 . . . . 0.0 112.248 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.639 ' CD1' HD12 ' A' ' 77' ' ' LEU . 2.5 mp -93.35 160.03 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.637 ' C ' HD12 ' A' ' 109' ' ' ILE . 4.2 t -155.16 123.19 5.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.474 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 19.7 m-85 -134.6 121.64 21.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.581 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.496 HG11 HG12 ' A' ' 103' ' ' VAL . 14.6 p -68.71 130.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 125.86 68.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.04 165.89 22.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.119 . . . . 0.0 112.41 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.41 -176.66 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.914 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.93 -33.96 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 p -93.48 -32.78 14.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.766 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.417 ' SD ' HG21 ' A' ' 141' ' ' VAL . 21.3 ttp -99.01 -12.14 20.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.528 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 143' ' ' SER . 8.9 t 44.59 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -139.39 127.14 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 111.473 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.01 145.61 29.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 104' ' ' ASP . 72.7 p -79.34 131.35 36.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.22 -121.13 1.65 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.635 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 -39.07 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.132 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.74 -48.49 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 140' ' ' PRO . 2.9 m -68.11 67.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 99' ' ' THR . 71.5 m-20 -49.89 -100.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.18 -54.7 2.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -106.94 39.59 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.037 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.461 ' HA3' HG13 ' A' ' 89' ' ' VAL . . . 59.83 51.89 56.24 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.391 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 4.2 mtpt -93.11 90.0 6.7 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.041 0.448 . . . . 0.0 110.406 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 87' ' ' CYS . 4.2 mt -47.89 109.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.089 0.471 . . . . 0.0 111.435 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.38 39.48 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.668 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.3 mt -54.59 118.98 18.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.18 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.75 -35.32 87.5 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.0 112.122 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.97 -29.83 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.801 ' CD1' HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.47 -30.11 17.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -57.35 -37.7 72.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.23 22.75 8.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.47 ' CD1' ' HB3' ' A' ' 122' ' ' SER . 2.8 t90 -95.08 122.72 38.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.652 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -129.53 107.56 9.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 15.1 p80 -56.35 -179.04 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.134 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.668 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 50.4 Cg_exo -57.3 -17.63 1.52 Allowed 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 124.718 -0.951 . . . . 0.0 113.98 0.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.534 ' N ' ' HA ' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -37.86 -59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.686 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -58.58 164.38 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.03 -84.51 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 24' ' ' GLU . 5.4 tp 176.78 -36.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.42 -44.81 95.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.779 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.63 -36.45 92.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.108 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.801 HD13 ' CD1' ' A' ' 114' ' ' LEU . 20.6 tp -57.12 -34.14 68.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.979 0.418 . . . . 0.0 110.513 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.75 -24.32 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.006 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.873 ' O ' HG22 ' A' ' 132' ' ' ILE . 19.7 tt0 -68.9 -40.87 78.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.816 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.9 p -61.76 -41.31 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.472 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.407 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 2.5 mtt -63.81 -40.3 96.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -55.89 -28.34 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.964 0.411 . . . . 0.0 111.022 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.19 -52.22 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 130' ' ' VAL . 40.0 t -54.86 -36.0 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.989 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.744 ' CD2' HG21 ' A' ' 70' ' ' ILE . 5.5 m-85 -92.18 -21.93 20.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -21.53 61.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -28.89 13.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.734 0.302 . . . . 0.0 111.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -161.3 95.79 1.35 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.28 117.83 3.78 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.6 2.2 . . . . 0.0 112.076 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.552 ' O ' HG11 ' A' ' 103' ' ' VAL . 93.5 Cg_endo -88.55 45.84 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.621 2.214 . . . . 0.0 112.737 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.497 ' O ' ' C ' ' A' ' 142' ' ' PHE . 1.4 m -136.9 -40.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.842 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' C ' ' O ' ' A' ' 141' ' ' VAL . 21.8 t80 -0.86 -86.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 113.214 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.494 ' O ' HG21 ' A' ' 96' ' ' THR . 0.2 OUTLIER 41.28 30.45 0.12 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.834 0.454 . . . . 0.0 112.031 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.465 ' O ' ' CZ ' ' A' ' 142' ' ' PHE . 11.9 ttp85 -102.89 100.2 16.04 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.181 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 143' ' ' SER . 80.6 Cg_exo . . . . . 0 C--O 1.252 1.184 0 C-N-CA 122.601 2.201 . . . . 0.0 112.533 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -50.98 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.584 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.11 -31.28 70.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.818 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.4 tp -59.23 -44.37 92.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -57.95 -44.5 87.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.186 0.517 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.38 -30.67 71.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtm -79.28 -31.54 43.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.825 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 8' ' ' LEU . 18.3 m -102.21 20.18 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.027 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -78.54 -31.14 47.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.859 0.362 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -31.35 71.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.49 156.18 8.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -54.17 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.48 66.13 4.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.0 ttm180 -61.83 -52.38 64.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.35 -29.55 48.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.23 -26.94 17.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.887 HG23 HD23 ' A' ' 76' ' ' LEU . 97.7 m -80.71 -30.45 36.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 18' ' ' ARG . 40.3 t -87.18 -28.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -82.1 -33.32 29.79 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.151 0.501 . . . . 0.0 110.848 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.646 ' HB3' HD12 ' A' ' 124' ' ' LEU . 66.4 mt-10 -68.93 -42.29 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.833 ' CG2' HD21 ' A' ' 55' ' ' LEU . 19.0 m -69.03 -55.07 11.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -52.35 -46.89 46.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.779 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 m-80 -51.69 -37.01 48.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.889 HG21 HD22 ' A' ' 124' ' ' LEU . 23.9 t -82.9 -63.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.465 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.588 HD13 HG22 ' A' ' 25' ' ' THR . 5.6 pt -52.27 -26.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -85.54 -26.49 26.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.01 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 27' ' ' ASN . 5.6 mp -89.74 -39.02 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.668 0.271 . . . . 0.0 111.202 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' HE2' HD11 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -93.14 11.46 27.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.659 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 14.33 61.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.38 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD13 ' HA3' ' A' ' 57' ' ' GLY . 4.0 mm? -62.75 121.77 14.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.02 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? -100.13 128.05 31.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.123 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.798 ' HA ' HD23 ' A' ' 55' ' ' LEU . 56.7 Cg_endo -70.53 139.39 37.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.3 2.0 . . . . 0.0 112.608 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.5 t -134.19 162.11 39.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.8 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.697 HD11 ' HG3' ' A' ' 51' ' ' GLU . 2.1 tm? -136.82 103.83 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.797 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -123.78 127.12 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.385 0.612 . . . . 0.0 110.534 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.72 139.64 30.53 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -108.85 160.23 16.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.96 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 179.682 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.396 0.141 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.88 140.23 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.551 0.532 . . . . 0.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.697 ' HG3' HD11 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -74.33 128.51 35.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.085 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 52' ' ' LEU . 4.8 tp -136.11 136.27 39.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.4 ttp -105.26 149.75 25.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.229 0.538 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.444 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -148.17 163.53 36.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.892 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.833 HD21 ' CG2' ' A' ' 25' ' ' THR . 5.1 mt -127.54 123.85 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -119.45 131.12 55.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.553 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -174.65 -174.06 41.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.604 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -121.06 151.61 39.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.714 0.292 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.699 HG12 HD12 ' A' ' 72' ' ' ILE . 1.4 pt -130.97 114.84 16.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.273 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.28 167.37 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.434 2.089 . . . . 0.0 112.141 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 p -173.39 127.01 0.48 Allowed Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.347 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.78 115.83 4.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.255 1.97 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.61 137.18 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 60.13 20.88 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.524 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.56 5.16 82.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.672 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.19 175.51 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.87 0.366 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 100.49 10.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.43 159.56 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.5 m-20 -114.33 125.07 53.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 141' ' ' VAL . 31.0 mm -110.0 95.47 21.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.226 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 69' ' ' ASN . 32.9 Cg_exo -61.11 144.37 99.18 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.156 1.904 . . . . 0.0 112.221 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.699 HD12 HG12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -155.47 138.97 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.9 m -99.6 162.43 13.02 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.787 HD11 HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -130.35 134.88 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.538 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -115.15 148.33 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.774 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.887 HD23 HG23 ' A' ' 21' ' ' THR . 7.6 mp -133.44 155.63 49.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.805 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.741 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -135.11 158.86 43.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 79' ' ' THR . 2.4 t0 -73.8 -30.95 63.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -178.05 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.37 154.02 68.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.76 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HG2' ' CE1' ' A' ' 82' ' ' TYR . 73.7 Cg_endo -76.99 -45.01 0.46 Allowed 'Cis proline' 0 C--N 1.347 0.448 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.433 0.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -105.09 -59.81 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.686 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER 166.45 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.865 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.38 143.52 15.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.677 2.251 . . . . 0.0 112.455 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 149.99 50.3 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.491 2.127 . . . . 0.0 112.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 87' ' ' CYS . 2.9 mp -87.85 154.61 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.419 ' N ' HG22 ' A' ' 86' ' ' ILE . 5.0 p -123.71 142.46 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.454 ' C ' HD11 ' A' ' 109' ' ' ILE . 4.1 m-85 -151.97 154.44 36.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.844 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.791 HG13 HD11 ' A' ' 109' ' ' ILE . 16.7 m -117.19 139.09 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.117 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -135.49 79.4 48.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HB3' HG13 ' A' ' 141' ' ' VAL . 56.3 Cg_endo -69.09 176.52 6.15 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.413 2.075 . . . . 0.0 112.572 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -91.84 170.35 9.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.8 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -58.72 -28.63 66.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -76.33 -29.56 57.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.06 177.03 7.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -139.33 -173.52 3.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.613 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.494 ' H ' HG22 ' A' ' 96' ' ' THR . 12.1 mm -126.13 92.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.444 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 25.5 tptt -66.47 103.72 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.867 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -58.47 134.42 56.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.71 -131.11 1.62 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.557 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 0.5 OUTLIER -99.99 -32.42 10.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.789 0.328 . . . . 0.0 111.014 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.665 ' CG ' HD23 ' A' ' 111' ' ' LEU . 23.1 m-70 -111.44 -34.82 6.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.981 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.868 HG21 ' HG3' ' A' ' 140' ' ' PRO . 22.0 t -91.05 79.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.27 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -69.25 -173.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.39 5.26 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.356 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -112.9 24.9 11.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.708 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 56.49 27.89 54.84 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.99 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.4 160.24 15.57 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.436 -0.449 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.791 HD11 HG13 ' A' ' 89' ' ' VAL . 3.3 mp -131.55 38.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 30.1 p90 -60.77 102.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.989 0.423 . . . . 0.0 110.625 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.665 HD23 ' CG ' ' A' ' 102' ' ' HIS . 2.1 mt -108.74 144.68 30.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.073 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HD3' ' CE1' ' A' ' 102' ' ' HIS . 52.9 Cg_exo -54.72 -40.36 84.97 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.491 2.127 . . . . 0.0 112.04 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.77 -30.33 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.684 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -90.52 -32.51 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.51 -49.55 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.83 33.26 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.779 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.457 ' NE1' ' HB2' ' A' ' 122' ' ' SER . 2.8 t90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.108 0.48 . . . . 0.0 110.747 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.457 ' HB2' ' NE1' ' A' ' 117' ' ' TRP . 39.3 t . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.847 0.356 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.16 -0.93 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER 87.66 -26.45 0.08 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.62 0.368 . . . . 0.0 111.322 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.605 HD21 HD22 ' A' ' 31' ' ' LEU . 1.3 tp -64.92 -38.23 90.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.96 -31.18 54.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.016 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 114' ' ' LEU . 28.1 tp -55.97 -30.5 61.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.593 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.1 mm -88.08 -28.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.037 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.846 ' HA ' HD12 ' A' ' 132' ' ' ILE . 1.8 tt0 -67.9 -41.26 82.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.215 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 134' ' ' VAL . 6.8 p -52.4 -46.58 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.981 0.419 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.48 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.1 mtt -66.94 -35.38 79.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.389 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 129' ' ' GLN . 52.5 mt -61.13 -27.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.771 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 129' ' ' GLN . 23.2 t -91.43 -48.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 130' ' ' VAL . 48.6 t -60.22 -39.94 82.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.48 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 131' ' ' MET . 20.0 m-30 -85.21 -15.89 42.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.075 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.0 -14.77 81.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.434 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -97.98 -38.01 9.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -164.8 89.31 1.02 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.563 ' HB3' HD11 ' A' ' 70' ' ' ILE . 33.5 Cg_exo -57.86 126.54 22.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.569 2.179 . . . . 0.0 112.412 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.868 ' HG3' HG21 ' A' ' 103' ' ' VAL . 92.7 Cg_endo -85.83 -13.42 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.71 2.273 . . . . 0.0 112.561 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.865 HG21 HG23 ' A' ' 70' ' ' ILE . 36.9 t -72.45 -3.72 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.148 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.055 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.701 0.286 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -46.68 17.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -40.01 80.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.709 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.0 tt -59.85 -37.53 79.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -62.47 -50.23 72.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.727 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -63.54 -31.12 72.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.56 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.423 ' HE3' HD23 ' A' ' 39' ' ' LEU . 11.1 mtp -74.65 -30.6 61.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 8' ' ' LEU . 32.7 m -105.02 19.45 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.805 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -65.35 -29.86 70.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.21 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -27.24 58.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.872 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 21.2 m-85 -56.06 130.64 44.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -66.98 -42.54 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' CG2' ' A' ' 79' ' ' THR . 16.0 m-85 -103.62 60.77 0.75 Allowed 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.787 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.0 ptm180 -59.02 -35.4 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.785 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.73 -51.12 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -33.31 63.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.672 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -66.47 -39.08 88.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.3 t -82.02 -30.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -46.79 35.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.863 ' O ' HG23 ' A' ' 28' ' ' VAL . 21.1 mt-10 -59.29 -42.33 91.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.979 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.931 HG23 HD21 ' A' ' 55' ' ' LEU . 9.3 m -63.71 -59.57 4.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -47.4 -47.59 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.069 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.455 ' HB3' HD13 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -58.02 -29.48 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -83.33 -37.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.256 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 25' ' ' THR . 0.6 OUTLIER -74.37 -27.97 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.954 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.8 m -80.55 -29.06 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.693 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 31' ' ' LEU . 11.2 tp -88.73 -30.24 19.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.895 0.379 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -106.92 127.2 53.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 35.24 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.98 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -152.06 24.75 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.026 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.861 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.8 mm? -118.07 160.74 21.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -149.28 130.14 7.03 Favored Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.32 131.74 15.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.365 2.043 . . . . 0.0 112.316 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.2 t -127.47 161.79 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.64 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 51' ' ' GLU . 1.1 tm? -130.9 115.06 16.03 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.076 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.58 120.75 18.91 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.3 p -82.16 146.07 29.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -139.35 134.67 32.82 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.352 179.753 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -117.26 132.31 56.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.501 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.669 ' HB2' HD11 ' A' ' 39' ' ' LEU . 3.5 pm0 -75.32 110.4 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.8 mm? -106.09 134.93 48.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.462 ' HA ' HD22 ' A' ' 39' ' ' LEU . 2.6 tmm? -86.31 146.82 26.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 0.0 110.776 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.455 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 12.1 p-10 -147.3 143.86 28.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.985 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.931 HD21 HG23 ' A' ' 25' ' ' THR . 16.1 mt -98.91 105.07 17.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -94.72 132.82 39.07 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.861 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 179.78 -155.23 15.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.503 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 p -150.72 150.75 31.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.569 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.675 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -124.43 149.44 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.677 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.04 116.73 4.63 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.331 2.021 . . . . 0.0 112.503 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' HA2' ' A' ' 136' ' ' GLY . 61.6 t -123.45 84.52 52.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 32.0 Cg_exo -59.51 165.07 10.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.285 1.99 . . . . 0.0 112.351 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -69.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.246 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.29 46.77 1.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.089 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.06 -16.73 59.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.579 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 1.2 t-20 -99.97 -168.22 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 110.447 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -155.96 128.71 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.757 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.24 -170.62 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.666 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.41 67.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.56 HG21 ' CD2' ' A' ' 135' ' ' PHE . 13.2 mm -57.65 108.09 1.15 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.239 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 155.61 65.23 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.447 2.098 . . . . 0.0 112.226 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -155.88 153.82 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.0 m -122.17 103.32 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.853 HD11 HD13 ' A' ' 76' ' ' LEU . 1.4 tm? -82.11 129.09 34.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.711 ' N ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -106.92 147.52 29.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.934 0.397 . . . . 0.0 111.108 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.853 HD13 HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -134.67 142.29 46.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.33 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.85 HD21 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -112.8 -178.87 3.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 111.481 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.31 39.42 1.5 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.605 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 17' ' ' TYR . 4.9 m 75.04 25.69 1.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.5 OUTLIER 178.0 142.18 0.27 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.043 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 90.3 Cg_endo -83.83 -40.11 0.82 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.467 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -82.85 65.96 8.23 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.85 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -32.8 -55.42 0.57 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 122.95 0.5 . . . . 0.0 111.377 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 73.0 Cg_exo -48.65 131.48 24.19 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.404 2.069 . . . . 0.0 112.166 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 84' ' ' PRO . 57.1 Cg_exo -51.81 134.1 46.99 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.459 2.106 . . . . 0.0 112.329 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.515 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 29.1 mt -104.13 148.56 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.486 ' HB3' HD21 ' A' ' 127' ' ' LEU . 26.2 p -134.95 125.25 26.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' HA ' HD12 ' A' ' 109' ' ' ILE . 22.6 m-85 -133.48 142.08 48.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 107' ' ' GLY . 10.8 p -95.57 145.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.781 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.0 123.95 31.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.1 -172.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.477 2.118 . . . . 0.0 112.237 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -170.63 2.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.1 -37.79 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.91 -29.37 14.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.073 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -94.72 -168.4 1.82 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.911 0.386 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.4 t -146.33 -156.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.563 HD11 ' HA2' ' A' ' 107' ' ' GLY . 1.0 OUTLIER -134.85 142.85 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 110.897 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.818 ' HD2' HG21 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -111.83 145.52 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 105' ' ' ALA . 3.8 p -114.89 134.48 55.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.82 -115.78 0.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.472 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -71.43 0.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.628 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -142.23 62.88 1.42 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 111.532 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.818 HG21 ' HD2' ' A' ' 98' ' ' LYS . 6.0 t -135.17 -7.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.867 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 99' ' ' THR . 16.6 m-20 45.7 -167.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.286 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.689 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -94.09 -46.81 6.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.129 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.69 -17.23 60.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.184 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.778 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 114.84 20.87 5.56 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.762 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG2' ' CE1' ' A' ' 88' ' ' PHE . 2.4 mptt -83.07 115.49 21.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.759 -0.259 . . . . 0.0 111.04 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.787 HG21 HD12 ' A' ' 111' ' ' LEU . 5.3 mp -73.46 107.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.661 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -95.73 41.58 1.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.787 HD12 HG21 ' A' ' 109' ' ' ILE . 4.0 mt -60.42 119.74 45.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.14 -21.13 27.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.438 2.092 . . . . 0.0 112.225 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' TRP . 87.5 m-85 -56.64 -62.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.834 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.4 tp -46.56 -39.47 11.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -59.21 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.532 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.1 35.07 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.91 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 113' ' ' TYR . 7.2 t90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.932 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.423 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 39.8 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.54 -173.41 3.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 24' ' ' GLU . 7.2 tp -62.41 -40.4 96.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 27' ' ' ASN . 4.5 tp -56.57 -53.78 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.89 -29.66 74.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.21 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 87' ' ' CYS . 7.9 tt -56.44 -31.87 64.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.648 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -82.81 -25.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.978 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.745 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -73.59 -51.48 16.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.998 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' MET . 5.8 p -47.11 -45.62 8.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 3.6 mtm -60.35 -38.71 84.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -56.15 -25.78 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.04 -53.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.409 HG11 ' CE1' ' A' ' 102' ' ' HIS . 56.7 t -54.67 -29.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.49 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.56 ' CD2' HG21 ' A' ' 70' ' ' ILE . 2.8 m-85 -86.41 -27.86 23.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.541 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -74.2 -14.55 80.51 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.802 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -96.47 -30.57 13.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.382 . . . . 0.0 110.958 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.59 109.19 1.48 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.65 123.16 12.69 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 135' ' ' PHE . 94.2 Cg_endo -89.63 25.67 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.3 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.83 -12.94 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.74 0.305 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -40.93 82.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -36.9 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.909 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.67 -55.49 34.37 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.569 0.543 . . . . 0.0 110.831 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -58.21 -30.33 66.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.89 -41.04 75.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.5 mtp -58.22 -36.32 72.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.588 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.64 HG11 ' SD ' ' A' ' 53' ' ' MET . 22.6 m -112.27 19.65 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.186 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -67.99 -29.13 68.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.908 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -28.44 65.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 5.2 m-85 -55.73 124.07 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HD2' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -51.77 -67.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.0 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.861 ' HB3' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -64.47 -49.19 72.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.832 ' NH1' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER 64.63 -65.97 0.13 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.33 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 17' ' ' TYR . 36.7 t0 -48.05 -43.91 30.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.052 0.453 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.876 HD13 ' H ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -53.03 -36.18 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.876 ' H ' HD13 ' A' ' 20' ' ' LEU . 95.6 m -83.66 -35.58 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.843 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.832 HG22 ' NH1' ' A' ' 18' ' ' ARG . 60.7 t -52.08 -35.11 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.761 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -83.52 -40.64 18.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.845 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.752 ' O ' HG23 ' A' ' 28' ' ' VAL . 19.7 mt-10 -66.54 -32.65 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.907 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 t -73.6 -41.63 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -72.16 -47.43 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.021 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.7 m-80 -50.15 -46.52 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.27 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.855 ' CG2' HD23 ' A' ' 124' ' ' LEU . 23.6 t -64.57 -61.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.28 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 26' ' ' VAL . 3.4 pt -59.32 -23.5 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.403 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.7 m -82.58 -28.75 30.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -18.84 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CE2' HG23 ' A' ' 59' ' ' ILE . 7.1 m-85 -125.93 164.28 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 0.0 110.602 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -18.52 8.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -96.87 28.63 3.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.718 0.294 . . . . 0.0 111.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.835 HD22 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -117.7 154.51 31.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.44 104.43 2.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' A' ' 55' ' ' LEU . 58.3 Cg_exo -51.02 140.9 38.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.22 1.947 . . . . 0.0 112.588 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.4 t -127.61 161.82 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.109 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.3 tm? -118.48 122.93 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.728 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' N ' HD13 ' A' ' 39' ' ' LEU . 20.6 t0 -157.05 138.9 14.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -87.07 154.02 21.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.24 124.91 28.21 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG12 ' CA ' ' A' ' 49' ' ' SER . 35.4 m . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.22 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.702 ' CA ' HG12 ' A' ' 43' ' ' VAL . 15.1 t . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.31 134.89 12.59 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.88 115.75 3.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.043 0.449 . . . . 0.0 110.797 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.02 158.36 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.008 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.64 ' SD ' HG11 ' A' ' 12' ' ' VAL . 35.9 ttp -130.71 147.23 52.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.912 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 13.4 p-10 -136.61 177.31 7.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.7 mt -139.6 104.01 4.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.641 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.4 m -99.96 157.41 16.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.879 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.62 -149.4 14.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.42 142.0 31.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 61' ' ' VAL . 37.5 mt -112.21 123.76 33.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.83 112.63 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.3 2.0 . . . . 0.0 112.219 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 59' ' ' ILE . 23.8 t -134.74 94.86 16.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.058 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 55.6 Cg_endo -69.75 152.96 69.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.565 2.177 . . . . 0.0 112.325 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -179.14 -36.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -97.53 45.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.451 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 17.34 79.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.368 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 12.5 t-20 -177.43 165.21 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.509 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.29 129.23 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 -165.57 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.776 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -147.32 86.44 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.013 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.7 mm -79.51 129.29 72.19 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.957 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.506 ' O ' HG23 ' A' ' 72' ' ' ILE . 70.9 Cg_endo -74.63 145.95 33.67 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.664 2.243 . . . . 0.0 112.286 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 71' ' ' PRO . 1.7 pp -158.13 171.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.449 . . . . 0.0 111.042 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 56' ' ' THR . 73.7 m -148.36 161.83 40.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.987 HD21 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -131.92 144.86 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.509 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -120.47 147.28 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.466 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.8 mm? -118.77 -178.7 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.025 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.61 146.21 34.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.192 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -62.94 -35.56 80.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.87 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.517 HG21 ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 166.54 -26.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.151 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 79' ' ' THR . 39.6 m-85 -160.62 161.76 24.32 Favored Pre-proline 0 C--N 1.334 -0.086 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.789 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -88.52 -26.22 5.68 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.512 0.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.883 ' CD1' HD11 ' A' ' 86' ' ' ILE . 6.9 p90 -76.68 60.67 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.3 m120 -41.21 -52.77 7.14 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 54.2 Cg_exo -51.14 146.1 24.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 112.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.23 127.1 14.52 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.883 HD11 ' CD1' ' A' ' 82' ' ' TYR . 2.7 mt -89.22 151.34 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.011 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.749 ' SG ' HD11 ' A' ' 127' ' ' LEU . 14.4 m -122.9 161.82 23.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.495 ' N ' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -162.13 159.64 26.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.679 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 107' ' ' GLY . 11.4 p -128.37 137.65 56.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.161 0.505 . . . . 0.0 111.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.04 92.79 28.49 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.79 158.26 58.06 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.446 2.097 . . . . 0.0 112.187 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -84.68 176.49 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.25 0.547 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 m -65.37 -25.15 67.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -57.44 -59.03 5.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.057 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -111.25 -179.01 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -115.01 -157.27 0.63 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.519 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -115.84 121.67 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.159 0.504 . . . . 0.0 110.797 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -81.72 133.69 35.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 105' ' ' ALA . 34.8 p -102.45 131.21 49.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.75 -120.31 0.72 Allowed Glycine 0 C--N 1.322 -0.227 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.671 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -99.79 -57.93 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.861 0.363 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.774 ' HB3' HD23 ' A' ' 111' ' ' LEU . 8.7 m-70 -80.79 -41.01 24.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.711 HG21 ' HB2' ' A' ' 140' ' ' PRO . 25.9 t -92.1 75.39 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.087 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -52.98 -178.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -79.39 -13.98 59.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.815 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.15 23.75 5.48 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.417 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 51.01 30.19 22.34 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.705 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -111.26 115.37 29.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.634 0.254 . . . . 0.0 110.99 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.728 HG22 ' HG ' ' A' ' 111' ' ' LEU . 2.2 mp -60.94 94.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.46 75.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.784 HD13 HG11 ' A' ' 130' ' ' VAL . 1.6 mt -84.02 136.0 41.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.804 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.39 -28.31 18.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 0.0 112.246 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -79.61 -54.29 6.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.804 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.781 ' HG ' HD12 ' A' ' 127' ' ' LEU . 1.9 tm? -62.99 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.73 -35.82 71.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.1 25.59 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 t90 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.865 0.364 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.62 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.987 HD11 HD21 ' A' ' 74' ' ' LEU . 3.4 tp -66.59 -33.98 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.48 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -29.49 75.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.781 HD12 ' HG ' ' A' ' 114' ' ' LEU . 6.5 tp -56.2 -31.53 63.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.9 mm -78.98 -29.61 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.767 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -62.43 -26.73 68.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.784 HG11 HD13 ' A' ' 111' ' ' LEU . 1.3 p -76.27 -36.81 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.552 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.421 ' HG2' ' CZ ' ' A' ' 135' ' ' PHE . 37.0 mtt -77.86 -42.63 32.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.997 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 129' ' ' GLN . 13.1 tt -58.25 -26.5 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 129' ' ' GLN . 28.6 t -91.2 -58.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.56 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 130' ' ' VAL . 88.0 t -53.55 -50.8 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.48 ' O ' HG11 ' A' ' 61' ' ' VAL . 6.8 m-30 -71.83 -27.3 62.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.66 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.04 -12.93 69.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.608 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.06 -47.71 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.55 126.95 2.45 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.83 107.6 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.451 2.101 . . . . 0.0 112.808 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.711 ' HB2' HG21 ' A' ' 103' ' ' VAL . 97.6 Cg_endo -88.64 23.85 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.663 2.242 . . . . 0.0 111.956 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 141' ' ' VAL . 22.9 t -121.99 -4.27 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.928 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.739 -179.301 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -60.71 -44.88 96.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -32.59 73.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.4 tp -72.95 -25.22 60.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.136 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.44 -24.52 50.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.391 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -22.61 33.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.167 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.427 ' HE1' ' HB2' ' A' ' 39' ' ' LEU . 15.9 ptp -89.98 -34.05 16.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 8' ' ' LEU . 28.3 m -91.31 -1.84 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -69.65 -31.4 69.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.181 0.515 . . . . 0.0 111.105 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -72.35 -26.37 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.16 169.02 0.43 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.994 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -91.87 -38.7 12.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -122.35 68.33 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.1 0.476 . . . . 0.0 110.937 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.83 -34.81 71.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.859 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.52 -46.45 90.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -33.09 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -70.96 -48.18 54.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 18' ' ' ARG . 42.4 t -71.25 -27.32 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.362 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -48.4 24.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -58.68 -42.48 88.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.973 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.885 HG22 HD11 ' A' ' 29' ' ' ILE . 26.8 m -59.81 -58.97 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.82 -46.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.658 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.1 t-20 -58.46 -22.37 54.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.224 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.018 HG21 HD23 ' A' ' 124' ' ' LEU . 27.2 t -93.19 -22.52 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.48 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.885 HD11 HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER -91.03 -28.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.148 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -80.42 -42.62 22.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 31' ' ' LEU . 7.4 tt -70.98 -23.64 62.24 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.683 ' HE2' HG21 ' A' ' 128' ' ' ILE . 35.1 m-85 -116.97 161.61 19.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 80.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.956 0.408 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 174.99 -33.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.524 HD22 HG12 ' A' ' 28' ' ' VAL . 1.7 mp -62.46 134.77 56.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.796 0.331 . . . . 0.0 110.925 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 106.03 21.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.936 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.785 ' HA ' HD23 ' A' ' 55' ' ' LEU . 76.1 Cg_exo -50.5 150.37 11.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.384 2.056 . . . . 0.0 112.594 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.5 t -151.51 161.85 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.605 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.488 ' C ' HD13 ' A' ' 39' ' ' LEU . 2.5 tm? -129.85 116.97 19.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -149.54 132.88 16.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.964 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -84.38 158.04 21.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.43 149.21 49.54 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.163 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.71 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.626 ' HB2' HD21 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -175.87 128.86 0.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.087 0.47 . . . . 0.0 110.546 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.713 ' C ' HD22 ' A' ' 52' ' ' LEU . 5.7 mt-10 -86.88 108.14 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.696 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.713 HD22 ' C ' ' A' ' 51' ' ' GLU . 3.0 mm? -123.2 178.95 4.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.012 0.434 . . . . 0.0 111.061 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.83 145.68 46.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -130.5 153.1 49.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 111.078 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.5 mt -108.87 101.89 10.95 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.857 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.5 m -85.49 132.95 34.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.56 -177.44 42.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.505 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.694 HG22 ' CA ' ' A' ' 71' ' ' PRO . 16.8 p -143.8 130.33 20.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 pt -115.53 154.35 47.79 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HB3' HG22 ' A' ' 67' ' ' THR . 51.0 Cg_exo -54.53 163.07 4.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.616 2.211 . . . . 0.0 112.568 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.742 HG21 ' CG1' ' A' ' 70' ' ' ILE . 25.4 t -158.24 106.16 1.7 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.684 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.67 92.43 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.335 2.024 . . . . 0.0 112.19 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.443 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 55.3 t80 -132.72 140.34 48.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 mtp85 61.09 18.55 9.12 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 20.45 61.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.566 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.02 176.97 8.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.338 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -96.24 104.8 16.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.752 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -91.12 167.33 12.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.744 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -123.48 111.75 16.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.742 ' CG1' HG21 ' A' ' 61' ' ' VAL . 37.0 mm -108.93 109.5 61.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.694 ' CA ' HG22 ' A' ' 58' ' ' THR . 49.9 Cg_endo -68.92 141.83 49.9 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.361 2.041 . . . . 0.0 112.251 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -147.43 136.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.036 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 118.26 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.699 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.663 HD22 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -84.59 149.68 25.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.482 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -123.57 142.99 50.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.832 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 52' ' ' LEU . 2.6 mm? -121.92 167.4 13.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.608 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.804 HD22 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -149.5 150.91 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.469 0.652 . . . . 0.0 111.065 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.28 -38.4 90.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.3 t 179.57 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 0.8 OUTLIER -87.47 159.54 49.84 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 7.5 Cg_exo -73.46 -45.55 0.45 Allowed 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.588 -1.422 . . . . 0.0 111.977 0.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.92 -59.92 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.628 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.9 OUTLIER 166.03 -53.75 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.78 145.14 4.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.733 2.289 . . . . 0.0 112.632 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.58 ' CG ' HD12 ' A' ' 124' ' ' LEU . 72.0 Cg_endo -76.94 143.06 22.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.668 2.245 . . . . 0.0 112.427 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 87' ' ' CYS . 2.9 mp -90.1 160.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.477 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -134.51 141.41 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 9.7 m-85 -147.73 144.33 28.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 107' ' ' GLY . 33.8 m -95.08 117.69 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.035 0.445 . . . . 0.0 111.365 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -81.08 121.25 80.44 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.77 137.87 67.81 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.463 2.108 . . . . 0.0 112.219 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 95' ' ' MET . 8.8 t -115.2 -167.11 1.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.642 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m -86.98 -56.2 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.81 -29.7 67.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.765 ' H ' HG23 ' A' ' 92' ' ' THR . 2.3 mpp? -135.88 -169.47 2.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.4 p -150.0 -80.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.782 HD11 HG23 ' A' ' 89' ' ' VAL . 0.4 OUTLIER 179.69 109.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.66 116.71 28.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 104' ' ' ASP . 27.8 p -53.25 131.82 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.53 -96.46 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -60.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 111.032 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.739 ' CD2' HG21 ' A' ' 134' ' ' VAL . 22.5 m-70 -127.47 48.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.31 -17.88 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.799 ' O ' HG22 ' A' ' 99' ' ' THR . 7.9 p-10 40.56 -158.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.335 0.254 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 5.27 48.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -131.26 28.62 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 51.07 25.36 10.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.013 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.452 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -85.96 136.6 33.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.881 ' CG2' HD12 ' A' ' 111' ' ' LEU . 1.4 mp -68.99 88.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 110.523 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.09 62.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.847 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.881 HD12 ' CG2' ' A' ' 109' ' ' ILE . 9.8 mt -95.23 109.25 43.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.83 -29.44 82.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.457 2.105 . . . . 0.0 112.131 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -54.08 50.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.009 HD22 HD13 ' A' ' 127' ' ' LEU . 55.5 tp -60.41 -33.34 72.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.48 -44.44 89.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.602 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.87 24.53 6.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.4 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 3.8 t90 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.4 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 6.0 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.882 0.372 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.37 -164.25 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.018 HD23 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -51.76 -28.12 14.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 125' ' ' LEU . 3.2 mm? -68.97 -55.0 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.07 -35.99 92.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.345 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 1.009 HD13 HD22 ' A' ' 114' ' ' LEU . 66.7 tp -55.72 -31.7 62.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.683 HG21 ' HE2' ' A' ' 32' ' ' TYR . 24.7 mm -79.7 -21.74 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.809 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -82.54 -33.67 28.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.26 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 131' ' ' MET . 11.3 p -72.75 -47.37 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.528 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.6 mtm -66.8 -42.82 85.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.14 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 129' ' ' GLN . 4.0 tt -53.84 -30.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 129' ' ' GLN . 30.0 t -85.81 -51.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.464 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.739 HG21 ' CD2' ' A' ' 102' ' ' HIS . 1.2 p -54.76 -51.14 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.865 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.536 ' CD1' HG22 ' A' ' 61' ' ' VAL . 2.1 p90 -87.31 -9.15 55.69 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.38 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.439 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -72.82 -24.67 75.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.77 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.18 -30.69 15.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.541 0.21 . . . . 0.0 110.601 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -162.84 118.99 1.21 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.565 ' HB3' HD11 ' A' ' 70' ' ' ILE . 24.3 Cg_exo -61.93 110.93 1.08 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.537 2.158 . . . . 0.0 112.155 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.06 -15.97 7.66 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.418 2.079 . . . . 0.0 112.561 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.468 HG21 HG23 ' A' ' 70' ' ' ILE . 98.1 t -57.04 -19.34 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -36.87 71.22 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.531 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -24.99 38.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.12 -50.92 71.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.01 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.91 -31.68 68.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.114 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -65.26 -28.06 69.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.615 ' HG2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -80.77 -31.2 35.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 111.063 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.656 HG21 ' CG2' ' A' ' 22' ' ' VAL . 29.3 m -103.15 20.22 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.735 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.8 -29.65 45.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.8 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -99.06 -18.89 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.428 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' HD2' HG21 ' A' ' 21' ' ' THR . 2.3 m-30 -55.58 146.11 21.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 79' ' ' THR . 9.7 tttm -56.09 -24.73 42.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -140.32 128.44 22.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.699 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.699 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.5 ttp85 -101.09 -64.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -50.59 63.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 20' ' ' LEU . 2.5 tm? -63.43 -50.79 68.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.222 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.483 HG21 ' HD2' ' A' ' 15' ' ' TYR . 99.1 m -62.25 -34.5 76.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.5 t -83.67 -23.47 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -30.36 21.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 0.0 111.001 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.806 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.89 -31.44 64.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.2 t -69.65 -47.43 63.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.498 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 22' ' ' VAL . 1.4 t -61.13 -55.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -46.28 -40.27 11.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.74 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 24' ' ' GLU . 35.2 t -76.47 -63.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.714 HG22 ' HB3' ' A' ' 35' ' ' LEU . 4.7 pt -51.9 -34.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.306 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -73.17 -29.09 62.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.63 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -76.08 -33.56 59.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.011 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB2' HD23 ' A' ' 35' ' ' LEU . 4.2 m-85 -93.73 -0.27 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.794 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.85 37.15 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.224 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -169.34 47.88 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.714 ' HB3' HG22 ' A' ' 29' ' ' ILE . 3.9 mm? -117.9 151.1 38.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.25 96.08 25.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.06 129.05 17.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.435 2.09 . . . . 0.0 111.992 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.8 t -125.27 162.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.287 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.846 HD11 ' HG3' ' A' ' 51' ' ' GLU . 2.6 tm? -128.36 98.93 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.731 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.67 126.97 48.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -84.62 128.45 34.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -97.16 104.22 16.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.602 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.455 HG12 ' OG ' ' A' ' 49' ' ' SER . 30.3 m . . . . . 0 C--O 1.234 0.281 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.289 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.455 ' OG ' HG12 ' A' ' 43' ' ' VAL . 19.0 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.058 0.456 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -96.67 118.52 33.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.846 ' HG3' HD11 ' A' ' 39' ' ' LEU . 5.0 tt0 -64.67 106.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.3 mm? -118.71 131.99 56.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.154 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.416 ' HA ' HD22 ' A' ' 39' ' ' LEU . 6.1 tmm? -92.91 147.39 22.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 15.2 p-10 -141.71 159.61 41.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.937 0.399 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.007 HD12 HD13 ' A' ' 74' ' ' LEU . 4.7 mt -126.7 103.92 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -101.34 140.67 35.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 176.4 169.18 37.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -116.28 144.48 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 110.935 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -109.43 139.9 21.56 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 59' ' ' ILE . 70.3 Cg_endo -74.9 60.52 5.38 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.535 2.157 . . . . 0.0 112.21 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 59' ' ' ILE . 92.7 t -90.56 133.39 32.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.9 143.56 33.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.144 1.896 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -83.46 -77.01 0.26 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -110.82 -61.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.92 14.15 3.1 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.449 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -175.27 3.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.81 143.2 27.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.7 174.37 10.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -128.66 103.02 6.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.72 102.68 10.78 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.98 154.4 70.85 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.313 2.009 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 pt -155.78 156.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.238 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 130.19 53.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.007 HD13 HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -106.42 137.84 43.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.766 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -125.79 145.95 50.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.686 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.766 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.4 mm? -125.49 165.26 18.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -125.64 165.55 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.98 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -94.85 -27.79 15.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -173.35 -40.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HB3' ' HA ' ' A' ' 81' ' ' PRO . 28.5 m-85 -102.01 161.93 21.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 55.6 Cg_endo -73.22 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.757 -0.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 22.5 m-85 -105.45 -58.04 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.763 ' O ' HD11 ' A' ' 77' ' ' LEU . 0.3 OUTLIER 165.57 -53.93 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.967 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 82' ' ' TYR . 91.0 Cg_exo -42.91 119.14 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.803 2.335 . . . . 0.0 112.807 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.746 ' HB3' HD13 ' A' ' 76' ' ' LEU . 31.5 Cg_exo -59.0 164.46 10.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.598 2.199 . . . . 0.0 112.301 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 87' ' ' CYS . 19.8 mm -104.02 159.54 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -136.31 157.11 47.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.083 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG ' ' A' ' 108' ' ' LYS . 37.1 m-85 -146.62 170.24 17.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 107' ' ' GLY . 9.6 m -124.76 77.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.732 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -49.01 105.13 0.47 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.52 -178.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.24 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.29 179.41 8.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.253 0.549 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 p -88.11 6.92 34.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.5 m -95.22 -58.87 2.02 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -178.57 3.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.2 t -109.87 -163.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.727 HD11 ' HA3' ' A' ' 107' ' ' GLY . 0.8 OUTLIER -119.87 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 110.998 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.28 147.47 23.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 104' ' ' ASP . 0.7 OUTLIER -86.48 136.18 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.973 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.4 -166.24 36.04 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.788 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -26.29 48.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.152 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.766 ' CE1' HG23 ' A' ' 109' ' ' ILE . 2.4 t-80 -94.27 -28.17 15.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.083 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.614 HG12 HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -134.34 68.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.058 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 103' ' ' VAL . 1.2 p-10 -47.56 -105.82 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.104 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.45 -54.42 2.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.703 0.287 . . . . 0.0 111.479 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -95.71 38.64 1.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.584 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.84 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 52.14 53.76 29.39 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.533 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.458 ' CG ' ' CE2' ' A' ' 88' ' ' PHE . 3.1 mtmm -102.78 133.72 47.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.815 HD11 HG13 ' A' ' 89' ' ' VAL . 5.3 mp -87.46 106.01 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.97 48.34 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 113' ' ' TYR . 11.8 mt -70.19 121.98 84.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.63 -19.15 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.53 2.153 . . . . 0.0 112.606 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.676 ' CD2' HD22 ' A' ' 111' ' ' LEU . 15.2 m-85 -56.33 -54.33 46.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.0 111.082 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -64.47 -30.86 71.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.012 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.57 -41.47 84.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.18 27.39 7.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.073 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.12 -172.38 2.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.721 HD11 HD21 ' A' ' 74' ' ' LEU . 12.6 tp -57.44 -34.26 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 27' ' ' ASN . 1.7 mm? -62.36 -53.38 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.806 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.42 -38.55 95.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.1 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 114' ' ' LEU . 32.3 tp -54.21 -28.76 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 110.649 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mm -84.33 -29.01 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.802 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.443 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -61.65 -40.51 95.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.838 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.827 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.1 p -59.92 -42.93 91.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.414 . . . . 0.0 110.496 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.42 ' HB3' ' CD2' ' A' ' 135' ' ' PHE . 10.4 mtt -65.98 -34.4 78.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.315 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 129' ' ' GLN . 2.8 mt -60.08 -30.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.514 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.03 -52.81 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 130' ' ' VAL . 44.2 t -52.1 -49.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 131' ' ' MET . 17.6 m-30 -80.38 -27.2 38.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.94 -24.86 68.84 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.512 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.96 -44.45 12.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.991 0.424 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -177.08 123.64 0.28 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.81 144.09 56.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.361 2.041 . . . . 0.0 112.35 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.75 -39.66 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.607 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 m -63.24 117.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.969 -179.881 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 121.352 0.596 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -51.96 51.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.785 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -59.19 -41.59 88.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.197 0.522 . . . . 0.0 111.312 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.519 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.2 tp -66.01 -28.49 68.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -58.79 -48.43 81.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.966 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -61.85 -35.96 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.75 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mtp -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.765 HG12 ' SD ' ' A' ' 53' ' ' MET . 25.0 m -108.3 19.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.705 0.288 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.3 p -71.89 -29.14 64.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -74.12 -29.08 61.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.045 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.6 m-85 -58.59 127.58 32.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB3' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER -59.29 -31.51 69.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.092 0.473 . . . . 0.0 111.307 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . 5.1 m-85 -90.44 -55.18 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.662 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.4 ttm180 66.67 -68.35 0.14 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.6 t0 -58.67 -53.16 61.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.102 0.477 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 20' ' ' LEU . 1.1 tt -59.32 -30.79 68.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.756 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.635 HG23 ' CD2' ' A' ' 76' ' ' LEU . 7.1 m -74.96 -53.03 9.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.011 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 18' ' ' ARG . 32.8 t -63.5 -36.15 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.304 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -62.8 -52.25 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 28' ' ' VAL . 60.7 mt-10 -63.05 -35.53 80.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.613 HG23 ' CD2' ' A' ' 55' ' ' LEU . 61.8 m -70.1 -35.66 74.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -81.56 -47.12 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.425 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.5 m-80 -53.23 -30.28 37.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.588 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.796 HG21 HD23 ' A' ' 124' ' ' LEU . 35.5 t -84.5 -61.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 26' ' ' VAL . 6.0 pt -53.56 -38.98 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.557 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.0 t -68.55 -36.96 79.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 125' ' ' LEU . 5.1 mp -77.54 -52.7 8.63 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.368 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -76.45 -17.93 59.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.034 0.445 . . . . 0.0 111.815 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 65.92 -61.57 0.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.318 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' OD1' HD22 ' A' ' 35' ' ' LEU . 1.9 p30 -53.73 -37.03 62.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.849 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.531 HD13 ' HA3' ' A' ' 57' ' ' GLY . 2.3 mm? -63.05 129.07 38.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.72 145.28 52.87 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.18 155.45 22.48 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.673 2.249 . . . . 0.0 112.738 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 39' ' ' LEU . 4.9 t -147.74 161.63 7.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 51' ' ' GLU . 2.2 tm? -134.13 102.21 5.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.218 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -117.76 128.61 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.343 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -77.53 145.91 36.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.66 104.25 3.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 49' ' ' SER . 29.4 m . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.426 ' HA ' HG12 ' A' ' 43' ' ' VAL . 49.3 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.506 0.193 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.461 ' HB3' HD21 ' A' ' 52' ' ' LEU . 1.6 tpp180 -91.07 126.82 36.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.223 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' HG2' HD11 ' A' ' 39' ' ' LEU . 4.2 mt-10 -88.84 91.08 8.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 110.567 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.1 mm? -87.01 153.94 21.16 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.211 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.765 ' SD ' HG12 ' A' ' 12' ' ' VAL . 2.4 mtp -105.36 145.74 30.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.392 . . . . 0.0 110.574 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 4.4 p30 -136.61 132.78 35.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' CD2' HG23 ' A' ' 25' ' ' THR . 16.1 mt -101.49 116.13 32.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -117.68 143.79 45.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.802 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -179.71 164.09 31.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.444 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.718 HG22 ' CA ' ' A' ' 71' ' ' PRO . 33.5 p -113.97 140.0 48.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.611 ' N ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -121.48 156.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.356 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.44 136.73 60.82 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.839 2.359 . . . . 0.0 112.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 70' ' ' ILE . 62.1 t -152.67 95.67 3.04 Favored Pre-proline 0 C--O 1.223 -0.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.002 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.59 130.43 29.9 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.067 1.845 . . . . 0.0 112.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -127.95 -74.78 0.57 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.07 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -96.5 38.77 1.19 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 -23.3 35.81 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.512 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -112.64 164.89 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 110.786 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -72.88 135.49 45.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.59 -169.01 1.46 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -138.18 94.64 2.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.987 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.722 HG21 ' HD2' ' A' ' 135' ' ' PHE . 24.0 mm -92.39 106.64 18.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 0.0 111.026 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.718 ' CA ' HG22 ' A' ' 58' ' ' THR . 58.3 Cg_endo -71.66 156.93 56.78 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.001 1.801 . . . . 0.0 112.523 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 71' ' ' PRO . 23.3 pt -158.18 178.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -146.0 160.21 42.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 75' ' ' TRP . 0.3 OUTLIER -129.72 162.44 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.774 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.518 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -130.86 145.69 52.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 52' ' ' LEU . 1.4 tp -136.84 160.88 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.11 167.37 16.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.342 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.1 m-20 -93.84 -40.76 10.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 16' ' ' LYS . 18.2 p -159.88 -48.49 0.05 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.748 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.507 ' HB3' ' HA ' ' A' ' 81' ' ' PRO . 5.4 m-85 -115.95 168.12 9.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.777 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 62.7 Cg_endo -91.47 -33.5 0.99 Allowed 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.925 -1.281 . . . . 0.0 113.699 0.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 73.1 m-85 -82.36 -71.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.488 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 7.1 t30 129.79 -48.71 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 123.788 0.68 . . . . 0.0 111.069 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 60.5 Cg_endo -75.51 133.58 16.01 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.173 1.915 . . . . 0.0 112.334 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 138.75 41.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.725 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 87' ' ' CYS . 5.6 mt -99.75 159.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.501 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HB3' HD12 ' A' ' 109' ' ' ILE . 5.3 m -126.36 141.72 51.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.935 0.398 . . . . 0.0 111.281 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.456 ' CE2' ' HG3' ' A' ' 108' ' ' LYS . 10.4 m-85 -142.33 -177.25 5.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.551 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 107' ' ' GLY . 36.0 m -119.77 171.71 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 111.129 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -138.69 99.98 8.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 164.95 31.97 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.525 2.15 . . . . 0.0 112.162 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.79 177.11 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 0.0 110.996 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.4 t -83.75 -31.21 26.1 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -29.55 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.758 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -113.44 -178.47 3.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 5.5 t -125.1 -166.43 1.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.675 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.556 HD11 HG21 ' A' ' 89' ' ' VAL . 4.2 tt -115.39 120.85 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -76.16 127.38 32.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.014 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.688 HG22 ' HA ' ' A' ' 105' ' ' ALA . 67.2 p -98.69 129.86 45.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.63 -123.49 0.73 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.617 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -51.22 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.926 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.851 ' CE1' HG23 ' A' ' 109' ' ' ILE . 17.8 t-80 -70.79 -46.3 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.04 77.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.107 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -50.58 175.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.361 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.688 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -58.35 -26.38 63.07 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.406 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -94.25 20.94 7.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.246 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 50.96 43.76 49.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.763 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 88' ' ' PHE . 19.1 mtmt -106.12 124.79 50.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.738 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' CE ' ' A' ' 131' ' ' MET . 59.7 mt -66.02 110.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 111.081 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -123.96 94.34 4.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.582 HD21 HG21 ' A' ' 134' ' ' VAL . 9.7 mt -107.77 133.68 20.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.166 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.51 -32.48 96.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.38 2.053 . . . . 0.0 112.038 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.32 -52.39 64.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.484 HD12 ' CE3' ' A' ' 117' ' ' TRP . 8.3 tp -60.68 -32.66 71.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.57 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -61.29 -43.78 98.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.547 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -98.41 25.7 6.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 2.6 t90 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 30.1 t . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.875 0.369 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.72 162.7 32.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.796 HD23 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -77.71 -37.92 48.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 28' ' ' VAL . 2.4 mp -57.37 -51.75 68.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.753 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.09 -29.61 73.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.0 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.484 HD21 ' SG ' ' A' ' 87' ' ' CYS . 41.6 tp -56.98 -30.79 64.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.615 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mm -82.9 -26.7 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.761 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.1 tp60 -64.82 -45.96 84.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.713 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.2 p -47.45 -45.63 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.872 ' CE ' HD13 ' A' ' 109' ' ' ILE . 1.3 mtt -62.97 -42.9 99.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.3 OUTLIER -53.09 -27.12 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 111.032 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 t -94.21 -52.93 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.58 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.746 HG11 ' HD2' ' A' ' 102' ' ' HIS . 43.6 t -54.47 -36.46 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.495 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.722 ' HD2' HG21 ' A' ' 70' ' ' ILE . 5.7 m-85 -81.53 -28.78 33.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.653 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.432 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -68.32 -11.75 62.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.637 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -45.82 7.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.678 0.239 . . . . 0.0 111.055 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.96 109.03 2.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.43 116.47 3.24 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.516 2.144 . . . . 0.0 112.199 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.83 44.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.091 2.527 . . . . 0.0 112.244 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 141' ' ' VAL . 15.1 t -124.95 -7.19 6.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.862 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.345 0 O-C-N 122.277 -0.264 . . . . 0.0 111.129 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -36.3 83.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.41 . . . . 0.0 110.529 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.7 -30.82 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.696 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.89 -31.07 62.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -72.04 -46.76 55.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -31.27 67.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.479 ' HE2' ' HG ' ' A' ' 39' ' ' LEU . 7.7 ttm -63.49 -48.75 76.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.726 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 22' ' ' VAL . 17.2 m -94.53 19.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.66 -42.96 39.96 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -70.78 -25.28 62.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.652 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.78 121.69 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.305 0.378 . . . . 0.0 111.149 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 tptt -60.13 -36.68 78.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.4 44.55 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.6 ttp-105 -51.04 -52.42 43.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -54.04 -32.22 53.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.75 -29.03 18.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 76' ' ' LEU . 86.3 m -78.05 -47.0 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 12' ' ' VAL . 40.3 t -64.78 -38.16 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -45.67 53.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.875 ' O ' HG23 ' A' ' 28' ' ' VAL . 48.9 mm-40 -62.5 -39.39 93.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.755 HG22 HD11 ' A' ' 29' ' ' ILE . 63.8 m -63.31 -59.15 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.39 -47.43 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.487 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.696 ' HB3' HD13 ' A' ' 125' ' ' LEU . 4.1 t-20 -57.58 -26.2 61.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -85.96 -27.86 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.377 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -91.19 -29.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.88 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.7 m -69.7 -46.45 65.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.505 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -72.19 -40.81 67.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.953 0.406 . . . . 0.0 110.725 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -103.36 116.31 32.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.826 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 31.02 3.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.02 23.12 5.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.62 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.4 mm? -117.07 165.88 12.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.84 121.93 9.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 127.96 16.3 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.393 2.062 . . . . 0.0 112.428 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.6 t -123.76 162.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.771 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HG ' ' HE2' ' A' ' 11' ' ' MET . 2.2 tm? -146.84 110.06 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.56 141.36 52.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.37 116.39 28.94 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.381 0.425 . . . . 0.0 111.18 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.448 ' H ' HD23 ' A' ' 52' ' ' LEU . 10.0 t80 -91.4 135.17 34.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.656 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.155 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.797 0.332 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HB3' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -169.62 150.3 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.454 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.561 ' C ' HD22 ' A' ' 52' ' ' LEU . 3.7 tt0 -83.82 111.08 18.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.881 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.6 mm? -122.74 116.21 23.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -81.97 147.56 29.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.427 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 15.3 p-10 -148.11 143.87 27.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 25' ' ' THR . 44.2 mt -108.75 116.51 32.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.6 m -116.38 145.53 43.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.62 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 160.61 175.83 32.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -100.31 147.24 26.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.486 HG22 HG13 ' A' ' 61' ' ' VAL . 23.1 mt -107.34 114.52 60.86 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.046 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.43 70.1 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.301 2.0 . . . . 0.0 112.1 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 59' ' ' ILE . 7.6 m -89.96 144.68 31.8 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 35.9 Cg_endo -65.34 153.89 76.12 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.188 1.925 . . . . 0.0 112.345 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 139' ' ' PRO . 57.7 t80 -154.49 105.69 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 1.3 mpt_? 60.43 29.1 18.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.989 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.05 3.52 67.77 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.784 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 1.5 t-20 -120.75 178.35 4.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.692 0.246 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.54 131.57 44.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.726 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.21 163.08 22.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.829 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.512 ' O ' HD13 ' A' ' 70' ' ' ILE . 7.9 p-10 -121.74 123.5 41.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.722 HG23 ' CG2' ' A' ' 141' ' ' VAL . 18.7 mm -123.07 103.22 36.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' A' ' 91' ' ' PRO . 55.3 Cg_endo -69.93 133.16 24.58 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.092 1.862 . . . . 0.0 112.305 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.473 ' CD1' HD11 ' A' ' 59' ' ' ILE . 2.9 pt -142.95 167.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -131.0 134.62 46.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.447 HD13 HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -107.45 137.85 44.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.979 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.514 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -115.52 144.44 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.777 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 52' ' ' LEU . 6.1 mp -138.51 160.06 40.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.68 163.83 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -43.41 23.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 80' ' ' TYR . 4.4 t 179.97 33.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.434 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 1.8 m-85 -153.91 151.31 24.53 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.649 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 72.5 Cg_endo -76.7 -44.0 0.58 Allowed 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.173 -1.595 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.433 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 72.2 m-85 -103.92 -60.81 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.557 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 5.8 t-20 162.88 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.58 0.55 . . . . 0.0 110.833 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 81.5 Cg_exo -45.34 108.65 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.497 2.132 . . . . 0.0 112.607 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.57 145.08 30.77 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.498 2.132 . . . . 0.0 112.211 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 87' ' ' CYS . 16.5 mt -91.51 160.02 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.48 ' N ' HG22 ' A' ' 86' ' ' ILE . 4.8 p -143.5 137.66 28.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.45 ' CZ ' ' HE2' ' A' ' 108' ' ' LYS . 6.5 m-85 -140.97 143.4 34.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.637 HG22 ' HA3' ' A' ' 107' ' ' GLY . 24.8 m -84.22 146.14 7.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.066 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.08 72.29 76.54 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 71' ' ' PRO . 75.7 Cg_exo -51.34 170.82 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.588 2.192 . . . . 0.0 112.312 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.22 176.99 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -72.77 -27.13 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -5.8 50.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.516 ' HB3' HG12 ' A' ' 141' ' ' VAL . 20.7 mtm -145.81 -174.79 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.65 0.262 . . . . 0.0 110.983 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.4 t -134.18 -164.68 1.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.266 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.846 HD11 ' HA2' ' A' ' 107' ' ' GLY . 11.3 tt -111.3 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.669 ' O ' HG11 ' A' ' 103' ' ' VAL . 2.7 ttpp -75.29 114.31 13.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 p -72.64 134.98 45.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.34 -118.66 1.26 Allowed Glycine 0 CA--C 1.515 0.083 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.672 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -31.69 11.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -118.26 -29.69 5.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 98' ' ' LYS . 11.8 t -57.23 -27.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.566 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 56.55 -152.94 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.679 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 -40.9 5.97 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -93.46 3.66 55.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.846 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . 91.5 4.85 67.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.134 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HE2' ' CZ ' ' A' ' 88' ' ' PHE . 8.1 tttm -60.18 108.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.768 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 109' ' ' ILE . 4.2 mp -74.65 66.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -92.38 57.57 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 110.856 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.593 HD21 HG11 ' A' ' 134' ' ' VAL . 7.1 mt -53.19 151.71 9.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.417 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.483 ' HA ' ' CE1' ' A' ' 115' ' ' HIS . 32.5 Cg_exo -57.58 -45.83 31.24 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.573 2.182 . . . . 0.0 111.987 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -66.54 -39.58 88.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.99 -52.32 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.483 ' CE1' ' HA ' ' A' ' 112' ' ' PRO . 2.8 p-80 -64.87 -35.86 82.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.669 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.453 ' N ' ' CD2' ' A' ' 115' ' ' HIS . 1.4 tt0 -95.95 26.0 4.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CE2' ' HA ' ' A' ' 122' ' ' SER . 2.5 t90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 117' ' ' TRP . 33.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.067 0.461 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -177.85 146.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -59.52 -46.48 88.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' A' ' 27' ' ' ASN . 11.6 tp -51.81 -46.13 64.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.91 -31.34 35.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.632 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 130' ' ' VAL . 11.3 tp -56.13 -31.78 63.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.9 mp -86.73 -28.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.56 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.93 -38.65 82.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.9 p -61.65 -42.65 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.518 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.42 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 52.8 mtt -65.37 -42.73 92.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.674 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.2 mp -52.05 -26.77 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.644 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 t -95.03 -54.89 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.668 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 130' ' ' VAL . 38.1 t -55.3 -37.08 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.727 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.714 ' HD2' HG21 ' A' ' 70' ' ' ILE . 3.4 m-85 -83.22 -28.08 29.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.403 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.21 -13.02 61.64 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.716 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -99.85 -45.24 5.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 0.217 . . . . 0.0 111.195 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.3 100.63 4.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 50.7 Cg_exo -55.91 119.73 7.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.386 2.057 . . . . 0.0 112.166 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 88.9 Cg_endo -78.62 -0.64 10.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.449 2.1 . . . . 0.0 112.847 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.722 ' CG2' HG23 ' A' ' 70' ' ' ILE . 22.6 t -93.21 -2.71 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.525 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 111.459 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.907 0.384 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -54.19 -38.24 65.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.77 -45.83 73.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 12' ' ' VAL . 10.7 tp -59.32 -33.06 70.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.5 -50.95 71.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -32.7 73.94 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.488 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmm -70.14 -36.92 75.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 8' ' ' LEU . 27.2 m -99.51 16.76 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.174 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -69.97 -35.67 74.63 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 111.129 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -29.08 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.644 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.568 ' HD2' HG21 ' A' ' 21' ' ' THR . 4.2 m-30 -57.12 117.84 4.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -44.02 90.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CE1' ' OG1' ' A' ' 21' ' ' THR . 0.7 OUTLIER -95.55 33.93 1.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.9 ttt180 -49.18 -31.0 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.959 0.409 . . . . 0.0 109.996 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.65 -43.56 93.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.181 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -80.81 -25.45 37.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 0.0 110.144 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.568 HG21 ' HD2' ' A' ' 15' ' ' TYR . 18.7 m -74.15 -54.81 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.596 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.6 t -63.15 -30.0 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.054 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -44.67 18.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.076 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.841 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.8 mm-40 -71.17 -40.11 71.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.495 ' O ' HD13 ' A' ' 29' ' ' ILE . 89.8 m -61.44 -47.86 83.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.481 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -60.87 -47.08 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.605 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.7 t-20 -57.53 -25.65 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.8 t -67.08 -58.26 7.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.212 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -71.59 -19.48 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.454 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -64.65 -42.61 95.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.833 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.658 HD12 ' CG ' ' A' ' 32' ' ' TYR . 1.2 pp -88.04 -43.15 11.92 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CG ' HD12 ' A' ' 31' ' ' LEU . 10.6 m-85 -107.93 109.16 20.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -89.71 64.8 6.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.423 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -145.65 -45.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.3 mm? -62.79 140.03 58.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 106.09 37.9 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.87 128.46 17.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.234 1.956 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.3 t -130.24 161.94 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.641 HD11 ' HB3' ' A' ' 51' ' ' GLU . 1.7 tm? -114.89 91.63 3.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.48 117.57 34.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 p -82.04 138.52 34.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -115.35 136.34 53.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.927 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.428 0.156 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.06 160.32 15.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.805 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.641 ' HB3' HD11 ' A' ' 39' ' ' LEU . 12.4 mt-10 -94.95 99.23 11.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.436 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.714 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.2 mm? -104.43 139.07 39.9 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.7 ttp -89.87 146.12 24.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.832 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -139.29 130.94 27.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.4 92.3 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -95.3 135.25 37.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.68 -148.37 7.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.02 128.59 7.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 pt -107.09 151.13 40.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.53 132.73 27.94 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.432 2.088 . . . . 0.0 112.197 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 136' ' ' GLY . 41.0 t -138.92 106.29 7.44 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.201 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 52.2 Cg_endo -69.11 120.65 7.51 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.66 2.24 . . . . 0.0 112.208 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 139' ' ' PRO . 12.2 t80 -131.28 113.21 13.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.979 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 66.4 11.34 7.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.52 -7.74 34.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.272 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -102.38 -177.44 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.131 0.466 . . . . 0.0 110.912 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.61 111.12 21.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.392 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -110.48 141.97 42.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -99.22 109.36 22.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.768 HG21 ' HD2' ' A' ' 135' ' ' PHE . 20.3 mm -97.77 100.3 8.2 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' O ' HG23 ' A' ' 72' ' ' ILE . 51.5 Cg_endo -69.41 146.68 63.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.282 1.988 . . . . 0.0 112.419 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 71' ' ' PRO . 2.4 pt -157.2 156.39 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.5 m -116.16 145.7 42.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.831 ' CD1' HD11 ' A' ' 128' ' ' ILE . 0.5 OUTLIER -122.58 91.2 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.999 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -66.29 144.73 56.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.8 mm? -115.19 173.44 6.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.705 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.709 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -139.44 -177.61 5.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -107.91 -35.73 6.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.076 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m 178.98 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.579 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' CB ' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -102.69 165.11 14.31 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.507 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 67.4 Cg_endo -73.45 -39.75 1.38 Allowed 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.465 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 26.2 m-85 -103.01 -63.84 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 82' ' ' TYR . 11.3 t-20 165.13 -51.36 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 33.3 Cg_endo -67.69 153.01 77.18 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.204 1.936 . . . . 0.0 112.508 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.487 ' HA ' HD12 ' A' ' 77' ' ' LEU . 54.2 Cg_endo -69.75 162.83 40.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.609 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 86' ' ' ILE . 3.2 mp -104.12 105.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.671 ' SG ' HD11 ' A' ' 127' ' ' LEU . 58.6 m -62.49 149.41 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -153.39 148.38 26.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.639 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.795 HG13 HD11 ' A' ' 109' ' ' ILE . 23.0 m -103.33 127.35 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -107.01 87.4 2.95 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.089 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.448 ' HG3' HD12 ' A' ' 97' ' ' ILE . 64.9 Cg_endo -73.41 -167.83 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.611 2.207 . . . . 0.0 112.296 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -131.8 177.13 7.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -28.66 69.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -30.94 15.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.75 137.02 32.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.754 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.21 -166.97 1.69 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.3 tt -136.96 61.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 111.149 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' O ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -42.68 133.13 3.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.818 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 105' ' ' ALA . 17.0 p -98.31 132.68 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.76 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.4 -118.76 1.74 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.582 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -100.05 -33.21 10.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -117.05 -38.69 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 98' ' ' LYS . 5.6 t -55.09 -24.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 99' ' ' THR . 0.4 OUTLIER 51.02 -155.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.177 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -104.16 -26.36 12.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.062 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.4 -2.06 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.697 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.699 ' HA3' HG22 ' A' ' 89' ' ' VAL . . . 73.27 39.12 52.84 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.613 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 88' ' ' PHE . 3.0 tttt -88.58 2.69 52.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 111.559 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.795 HD11 HG13 ' A' ' 89' ' ' VAL . 3.0 mp 45.7 73.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.839 0.352 . . . . 0.0 111.691 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 63.1 m-85 -85.74 55.53 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 mt -58.01 110.09 2.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.13 -36.17 54.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.396 2.064 . . . . 0.0 112.308 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -60.09 -53.32 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 114' ' ' LEU . 2.6 tm? -66.09 -34.04 77.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.82 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.98 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.777 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 23.84 8.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.008 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.469 ' CE2' ' CB ' ' A' ' 122' ' ' SER . 2.8 t90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.752 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.469 ' CB ' ' CE2' ' A' ' 117' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.928 0.394 . . . . 0.0 110.869 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -117.76 -179.51 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.644 HD12 ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -59.92 -36.65 77.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.853 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 27' ' ' ASN . 4.0 mp -63.35 -46.52 86.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.52 -26.81 53.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.339 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.3 tm? -55.35 -29.99 59.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 0.0 110.747 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 74' ' ' LEU . 1.9 mp -91.94 -32.58 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.778 ' HA ' HD12 ' A' ' 132' ' ' ILE . 11.6 tt0 -58.59 -35.01 71.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' MET . 5.0 p -56.03 -46.18 80.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 6.0 mtt -66.77 -40.1 88.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.986 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 129' ' ' GLN . 92.9 mt -54.24 -23.55 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.899 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 129' ' ' GLN . 40.6 t -95.09 -56.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.68 -38.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.768 ' HD2' HG21 ' A' ' 70' ' ' ILE . 5.1 m-85 -85.81 -28.64 24.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.502 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.818 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.83 -24.49 66.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.44 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.69 -39.38 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.655 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.98 128.18 0.52 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 16.0 Cg_endo -58.43 134.21 59.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 112.147 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 82.6 Cg_endo -79.8 -1.4 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.44 2.094 . . . . 0.0 112.49 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 97' ' ' ILE . 3.3 m -105.72 118.29 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.2 t80 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.992 -179.818 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -38.49 76.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.197 0.522 . . . . 0.0 110.75 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -42.24 47.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.372 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 8' ' ' LEU . 8.8 tp -59.08 -40.51 85.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.05 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -55.46 -62.44 1.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.38 58.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.999 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -45.97 63.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.77 17.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.454 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.2 t -72.69 -28.76 62.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.054 0.454 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -26.93 68.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -51.97 130.91 30.74 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -56.41 -64.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.897 ' CD2' HD12 ' A' ' 20' ' ' LEU . 40.7 m-85 -60.15 -58.48 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.675 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.609 ' O ' HG23 ' A' ' 22' ' ' VAL . 12.2 ttt180 66.84 -68.43 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.828 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' TYR . 2.6 m-20 -50.23 -47.15 55.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.897 HD12 ' CD2' ' A' ' 17' ' ' TYR . 30.4 mt -71.0 -36.4 72.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 m -70.13 -34.73 73.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.071 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 18' ' ' ARG . 23.8 t -87.57 -28.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.396 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -80.11 -45.44 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.84 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.3 mt-10 -63.49 -37.76 88.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 29' ' ' ILE . 91.7 m -64.56 -59.14 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.92 -47.65 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.563 ' HB3' HD11 ' A' ' 125' ' ' LEU . 1.5 m-20 -59.04 -27.64 65.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 24' ' ' GLU . 42.5 t -85.35 -25.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.407 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.08 -28.64 6.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.077 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -70.0 -43.61 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.021 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD23 ' CE1' ' A' ' 32' ' ' TYR . 4.5 tp -77.07 -31.61 56.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.867 ' HB3' HD23 ' A' ' 35' ' ' LEU . 78.6 m-85 -114.37 116.17 28.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -9.24 58.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.579 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' C ' HD22 ' A' ' 35' ' ' LEU . 11.2 m-20 -97.3 25.0 5.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.605 0.24 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.867 HD23 ' HB3' ' A' ' 32' ' ' TYR . 4.2 mm? -117.98 141.56 48.32 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.99 126.26 12.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.607 ' HA ' HD23 ' A' ' 55' ' ' LEU . 55.4 Cg_endo -70.43 155.34 63.94 Favored 'Trans proline' 0 C--O 1.222 -0.316 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 39' ' ' LEU . 8.8 t -151.09 162.68 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.556 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.5 tm? -136.49 119.87 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.94 162.02 30.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.505 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.2 t -103.66 135.8 44.55 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.168 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -108.76 111.13 22.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.987 -179.743 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.56 ' HE ' HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -157.36 144.85 18.7 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.794 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CG ' HD11 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -70.05 112.03 6.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.736 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.56 HD13 ' HE ' ' A' ' 50' ' ' ARG . 8.0 tp -117.92 128.91 55.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.878 0.371 . . . . 0.0 111.05 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.9 ttp -96.38 150.32 20.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.438 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -145.23 149.27 34.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.866 HD21 HG23 ' A' ' 25' ' ' THR . 35.0 mt -113.56 112.26 23.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.553 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.9 m -109.0 134.86 51.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.729 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.814 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -166.2 -156.25 9.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.489 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.548 HG23 ' N ' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -148.23 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -130.8 136.51 29.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.29 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 97.9 Cg_endo -78.76 80.36 3.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.827 2.351 . . . . 0.0 112.558 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.461 HG21 HG13 ' A' ' 70' ' ' ILE . 14.9 m -99.62 148.2 34.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 128.29 16.01 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.451 2.101 . . . . 0.0 112.432 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 0.5 OUTLIER -131.5 108.46 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 80.18 -10.96 1.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.78 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.16 -17.02 3.4 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.12 172.93 7.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -65.64 150.04 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -150.3 148.89 29.4 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.732 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.76 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.819 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 61' ' ' VAL . 26.0 mm -108.27 104.91 55.43 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.053 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.548 ' N ' HG23 ' A' ' 58' ' ' THR . 41.0 Cg_endo -67.58 140.3 51.51 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.303 2.002 . . . . 0.0 112.505 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 pt -148.86 173.46 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.553 ' SG ' HG23 ' A' ' 56' ' ' THR . 11.0 m -132.54 170.59 14.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.19 145.03 38.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.764 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -123.3 145.72 48.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 111.195 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.764 HD22 ' C ' ' A' ' 75' ' ' TRP . 2.7 mm? -127.28 171.3 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.755 HD11 ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -133.72 162.55 31.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.249 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.96 -30.9 10.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.13 -41.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -127.9 106.59 20.31 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.181 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HB3' ' HG2' ' A' ' 84' ' ' PRO . 24.2 Cg_exo -62.85 167.85 33.23 Favored 'Cis proline' 0 C--N 1.351 0.691 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.12 -0.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 25.99 9.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.454 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER 175.15 -61.31 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 17.0 Cg_endo -61.18 109.83 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.6 2.2 . . . . 0.0 112.458 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.755 ' HA ' HD11 ' A' ' 77' ' ' LEU . 87.4 Cg_endo -81.54 143.26 13.48 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.618 2.212 . . . . 0.0 112.701 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.9 mt -84.65 161.39 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.526 ' CB ' HG21 ' A' ' 109' ' ' ILE . 13.7 m -141.59 155.42 45.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 9.3 m-85 -157.89 143.38 16.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.457 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.853 HG21 HD12 ' A' ' 97' ' ' ILE . 29.7 m -59.06 -175.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.547 . . . . 0.0 111.266 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HE2' HG21 ' A' ' 56' ' ' THR . 5.6 tttm -158.42 51.86 0.49 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.474 ' CD ' HG23 ' A' ' 89' ' ' VAL . 56.1 Cg_endo -69.35 -167.16 0.2 Allowed 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.1 p -124.0 151.28 43.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -17.14 62.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.809 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -93.58 -15.09 25.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.869 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.828 ' CG ' HG13 ' A' ' 141' ' ' VAL . 3.6 tmm? -118.57 -8.56 10.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 95' ' ' MET . 13.8 t 46.98 -163.45 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.065 0.46 . . . . 0.0 111.306 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.853 HD12 HG21 ' A' ' 89' ' ' VAL . 10.2 tt -135.54 132.69 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -75.26 133.11 41.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.689 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 105' ' ' ALA . 33.5 p -85.58 131.4 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.966 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.5 -152.98 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -56.8 4.51 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.807 0.337 . . . . 0.0 110.648 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -85.66 -34.28 21.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.454 HG11 ' CB ' ' A' ' 140' ' ' PRO . 13.0 t -95.86 72.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.128 0.489 . . . . 0.0 111.047 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -176.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -63.27 -23.88 67.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.439 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.39 27.06 9.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.97 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA3' ' CG2' ' A' ' 89' ' ' VAL . . . 40.87 55.3 3.38 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.967 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.493 ' O ' HG22 ' A' ' 109' ' ' ILE . 2.6 tttp -81.82 11.48 4.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.851 -0.205 . . . . 0.0 111.51 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER 44.96 45.66 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 108' ' ' LYS . 3.7 m-85 -68.18 72.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.89 HD22 HG21 ' A' ' 134' ' ' VAL . 8.8 mt -88.77 158.83 47.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.48 -36.03 4.29 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.623 2.216 . . . . 0.0 112.43 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.55 ' HB2' HG21 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -57.86 -65.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -56.46 -29.6 61.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.699 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.82 -43.15 89.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -96.81 24.08 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.977 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 6.2 t90 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.454 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.024 0.44 . . . . 0.0 111.374 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -139.4 175.22 9.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.543 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -57.01 -38.55 73.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 27' ' ' ASN . 3.8 mp -57.8 -47.17 83.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.48 -24.83 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 130' ' ' VAL . 7.5 tt -57.2 -30.54 64.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 110.741 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.4 HG22 ' CD1' ' A' ' 132' ' ' ILE . 3.4 mp -87.74 -30.8 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.61 97.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.7 p -58.09 -43.04 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.459 ' CG ' HD11 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -63.59 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.368 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.4 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.0 OUTLIER -58.3 -27.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.616 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.08 -51.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.677 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.89 HG21 HD22 ' A' ' 111' ' ' LEU . 43.2 t -53.54 -41.91 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.639 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.507 ' HZ ' HD12 ' A' ' 109' ' ' ILE . 21.8 m-30 -81.26 -27.91 34.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.455 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.9 -23.34 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.46 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -30.76 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.039 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -146.27 83.86 8.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.438 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 9.0 Cg_exo -71.27 152.44 61.35 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.78 2.32 . . . . 0.0 112.101 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CB ' HG11 ' A' ' 103' ' ' VAL . 59.2 Cg_endo -71.3 -31.79 13.71 Favored 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.278 1.985 . . . . 0.0 112.154 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.828 HG13 ' CG ' ' A' ' 95' ' ' MET . 84.0 t -59.45 162.35 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.01 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' HG12 ' A' ' 141' ' ' VAL . 11.1 t80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.654 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.606 0.241 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -60.13 -37.79 81.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -71.14 -31.9 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -58.29 -46.39 86.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.972 0.415 . . . . 0.0 111.029 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.06 -51.02 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.841 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -61.33 -30.88 70.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.486 ' HE2' HD23 ' A' ' 39' ' ' LEU . 13.3 mtp -67.74 -30.74 70.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -111.39 20.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.0 p -67.98 -24.59 65.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -58.08 -44.8 87.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' OH ' HD12 ' A' ' 52' ' ' LEU . 9.8 m-30 -61.75 175.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.49 -31.05 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 20' ' ' LEU . 4.3 m-30 -62.99 -69.72 0.25 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.55 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.9 ttt180 66.68 -69.43 0.12 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -44.72 95.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.051 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.625 HD12 ' CD2' ' A' ' 17' ' ' TYR . 46.3 mt -68.0 -36.46 80.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.995 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.66 HG21 HG11 ' A' ' 12' ' ' VAL . 16.5 m -62.89 -31.32 72.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.806 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.1 t -90.56 -27.14 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -45.23 19.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 28' ' ' VAL . 3.1 tt0 -67.68 -43.71 79.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.858 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.8 t -58.43 -48.02 82.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.18 0.514 . . . . 0.0 110.793 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG2' ' A' ' 25' ' ' THR . 0.4 OUTLIER -60.4 -47.08 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.456 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -51.78 -29.96 21.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.338 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 24' ' ' GLU . 21.8 t -85.04 -63.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pt -56.68 -25.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.339 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.7 m -80.29 -31.08 38.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.75 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.4 mt -86.54 -20.11 28.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.045 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -126.91 136.56 52.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.35 27.11 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 111.191 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.47 8.68 3.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.348 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.743 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.9 mm? -118.11 130.41 56.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.532 0.206 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -129.81 146.13 60.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.97 146.63 32.99 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.967 2.445 . . . . 0.0 112.706 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.738 ' CG2' HG22 ' A' ' 56' ' ' THR . 6.7 t -135.54 162.2 37.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD23 ' HE2' ' A' ' 11' ' ' MET . 1.8 tm? -132.16 123.8 27.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.461 ' N ' HD13 ' A' ' 39' ' ' LEU . 22.8 t70 -139.21 129.64 25.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 p -91.3 148.2 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.63 147.48 48.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.982 0.42 . . . . 0.0 110.652 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 111.155 179.722 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.28 153.38 47.04 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.93 95.01 7.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.83 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.539 HD23 ' CZ3' ' A' ' 75' ' ' TRP . 6.7 tp -96.67 161.32 13.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.817 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.645 ' HE1' HD21 ' A' ' 55' ' ' LEU . 1.2 ttp -121.11 158.22 28.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.464 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 17.7 t-20 -154.17 150.71 28.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.645 HD21 ' HE1' ' A' ' 53' ' ' MET . 2.6 mt -123.51 134.6 53.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.738 HG22 ' CG2' ' A' ' 38' ' ' VAL . 10.2 t -121.05 156.76 31.51 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.153 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.743 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 165.25 173.28 33.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.487 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 71' ' ' PRO . 13.6 p -133.8 128.0 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -86.75 111.45 40.03 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.399 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.52 96.88 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.662 2.241 . . . . 0.0 112.409 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.45 141.36 27.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.275 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.26 157.34 50.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.294 1.996 . . . . 0.0 112.37 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.436 ' CE2' ' HD2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -157.56 110.07 2.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 58.87 28.22 17.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.227 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.55 5.75 66.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.9 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -116.08 -168.45 1.43 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 110.618 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.02 123.78 50.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 7.6 t80 -121.51 162.75 19.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.711 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -140.18 123.86 17.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.838 HG21 ' CD2' ' A' ' 135' ' ' PHE . 5.2 mm -101.94 100.86 15.98 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HA ' HG22 ' A' ' 58' ' ' THR . 42.7 Cg_endo -68.03 109.55 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.163 1.909 . . . . 0.0 112.105 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 89' ' ' VAL . 2.6 pp -123.35 143.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -107.17 167.87 9.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.493 HD22 HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -132.29 137.98 47.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.705 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -114.63 145.95 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.705 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.2 mm? -120.17 158.12 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.803 HD11 ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -128.07 174.67 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 79' ' ' THR . 12.8 p-10 -97.38 39.95 1.17 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.592 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 72.24 10.61 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.97 158.77 58.37 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.775 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.57 -44.28 0.55 Allowed 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.193 -1.586 . . . . 0.0 112.158 0.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 47.2 m-85 -78.78 -71.52 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 23.0 p30 146.13 -30.91 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.639 0.776 . . . . 0.0 112.185 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 48.0 Cg_exo -57.24 135.47 70.54 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.912 1.741 . . . . 0.0 112.243 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.803 ' HA ' HD11 ' A' ' 77' ' ' LEU . 69.2 Cg_endo -73.96 133.76 18.73 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.402 2.068 . . . . 0.0 112.358 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.24 147.68 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.7 t -139.98 131.28 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 20.7 m-30 -116.5 -176.19 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 109' ' ' ILE . 4.6 m -134.16 87.17 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.899 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 109.47 1.73 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.424 ' CG ' HD11 ' A' ' 97' ' ' ILE . 73.8 Cg_endo -75.54 -167.97 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.251 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.5 p -149.05 173.85 12.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.089 0.471 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -67.37 -24.6 65.71 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.035 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -47.63 80.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.184 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -167.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.063 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -126.93 -146.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.588 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.424 HD11 ' CG ' ' A' ' 91' ' ' PRO . 22.1 mm -123.62 123.01 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.875 0.369 . . . . 0.0 110.766 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -85.12 162.29 19.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.768 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 104' ' ' ASP . 12.9 p -141.1 132.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.39 -86.5 0.13 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.942 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -54.29 -71.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CG ' ' HG ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -162.95 63.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.25 0.548 . . . . 0.0 111.021 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -133.57 -7.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.708 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.765 ' O ' HG22 ' A' ' 99' ' ' THR . 0.6 OUTLIER 51.82 -153.86 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.16 -29.51 10.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.463 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -104.95 27.21 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.786 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 70.76 45.35 52.92 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.704 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.436 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -100.38 142.19 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.743 -0.269 . . . . 0.0 110.954 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.011 HD11 HG13 ' A' ' 89' ' ' VAL . 4.5 mp -101.84 98.45 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -99.63 40.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' HD2' ' A' ' 112' ' ' PRO . 3.8 mt -55.63 139.07 68.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.974 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HD2' HD23 ' A' ' 111' ' ' LEU . 73.1 Cg_endo -76.17 -25.01 10.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.49 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -48.69 76.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.96 -31.66 59.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.794 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.7 -35.8 79.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.79 20.02 12.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 122' ' ' SER . 3.5 t90 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 110.799 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 117' ' ' TRP . 1.3 p . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.794 0.331 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -136.31 178.29 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 128' ' ' ILE . 17.1 mt -84.05 -19.47 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mp -67.11 -43.09 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.41 -36.91 8.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 130' ' ' VAL . 5.4 tp -54.93 -27.97 47.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.537 HD13 ' O ' ' A' ' 124' ' ' LEU . 1.3 mp -90.26 -31.04 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.423 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -56.4 -33.15 65.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.647 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.2 p -57.54 -45.53 86.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.446 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 31.2 mtt -67.94 -38.46 82.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.072 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -55.12 -25.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 129' ' ' GLN . 40.4 t -95.07 -53.1 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.676 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 130' ' ' VAL . 38.9 t -57.99 -44.54 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.838 ' CD2' HG21 ' A' ' 70' ' ' ILE . 18.0 m-85 -83.3 -23.16 32.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.268 0.556 . . . . 0.0 110.987 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.12 -28.61 73.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.359 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.96 -38.76 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -176.58 113.09 0.25 Allowed Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.895 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 50.1 Cg_exo -54.08 136.5 67.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.194 1.929 . . . . 0.0 112.135 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 135' ' ' PHE . 84.7 Cg_endo -81.75 -21.71 5.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.63 2.22 . . . . 0.0 112.345 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.653 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 6.4 t -50.52 171.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.653 ' CB ' ' O ' ' A' ' 141' ' ' VAL . 4.5 t80 . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.032 0.444 . . . . 0.0 110.375 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.834 0.35 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -60.04 -46.94 87.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 0.0 110.815 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.26 -42.54 99.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.239 0.542 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.23 -51.09 60.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.145 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -58.86 -24.24 61.89 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.192 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -21.42 42.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.016 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.0 mtt -73.93 -43.37 58.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.438 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 16.5 m -91.99 0.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.701 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -60.14 -31.95 70.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -26.17 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.977 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' A' ' 12' ' ' VAL . 10.9 m-85 -56.75 156.35 6.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -85.53 -54.54 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 23.2 m-30 -90.25 69.03 7.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -50.51 -56.44 11.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.226 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.53 -58.67 7.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 111.048 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -55.58 -26.45 43.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.352 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.848 HG23 HD23 ' A' ' 76' ' ' LEU . 77.6 m -86.0 -55.09 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.243 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.6 t -66.65 -33.54 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.37 -47.49 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.702 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.775 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.7 mp0 -67.33 -29.66 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.856 HG23 HD21 ' A' ' 55' ' ' LEU . 7.1 m -78.37 -30.8 48.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -84.16 -46.65 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.218 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.566 ' CG ' HD11 ' A' ' 125' ' ' LEU . 7.6 t-20 -52.32 -36.52 53.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.378 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 24' ' ' GLU . 28.8 t -74.83 -62.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.192 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -57.5 -43.42 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.8 m -58.99 -42.71 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tt -73.8 -41.66 62.04 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 121.173 0.511 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -104.95 104.91 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.781 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.1 61.86 6.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -142.78 -44.34 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.801 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.656 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.61 168.13 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.828 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 143.23 18.91 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.658 ' HA ' HD23 ' A' ' 55' ' ' LEU . 55.6 Cg_endo -70.63 134.46 26.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.639 2.226 . . . . 0.0 112.18 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' LEU . 6.5 t -127.16 162.45 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.01 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.1 tm? -138.2 128.14 25.5 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -153.4 129.16 10.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.324 0.583 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -74.05 157.6 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.07 103.74 3.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.587 0.232 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -167.43 135.47 2.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.77 111.69 18.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.8 mm? -110.29 138.23 46.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.315 0.579 . . . . 0.0 110.555 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.49 ' CE ' HG21 ' A' ' 25' ' ' THR . 2.9 tmm? -85.45 142.37 29.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.774 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.414 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 1.4 p30 -135.28 148.71 49.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 25' ' ' THR . 8.7 mt -113.32 120.82 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.413 HG23 ' SG ' ' A' ' 73' ' ' CYS . 2.5 m -115.95 158.91 22.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.1 -179.35 28.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.342 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.675 HG22 ' CA ' ' A' ' 71' ' ' PRO . 60.4 p -124.32 152.8 42.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.935 0.397 . . . . 0.0 111.007 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.462 HG23 ' HD2' ' A' ' 60' ' ' PRO . 5.3 mt -123.47 137.02 27.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.072 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 59' ' ' ILE . 19.0 Cg_endo -60.75 104.1 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.22 1.947 . . . . 0.0 112.0 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.648 HG13 ' HA2' ' A' ' 136' ' ' GLY . 42.3 t -132.1 121.65 17.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.94 146.78 55.48 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.368 2.046 . . . . 0.0 112.29 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -106.01 -75.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.087 0.47 . . . . 0.0 110.897 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 26.0 2.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.05 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.28 3.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.79 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -123.1 174.02 7.5 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -91.8 123.67 35.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -120.35 161.77 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -112.34 99.97 8.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.568 HG21 ' HD2' ' A' ' 135' ' ' PHE . 21.0 mm -82.63 110.21 20.93 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.675 ' CA ' HG22 ' A' ' 58' ' ' THR . 59.7 Cg_endo -72.21 145.08 43.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.262 1.975 . . . . 0.0 112.298 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 59' ' ' ILE . 2.9 pt -155.69 153.06 7.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' SG ' HG23 ' A' ' 56' ' ' THR . 87.9 m -113.52 169.18 9.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.624 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.558 HD21 HD21 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -138.89 146.81 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.533 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 HG23 ' A' ' 21' ' ' THR . 1.7 mp -135.2 155.92 49.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -126.07 174.58 8.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.099 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.614 ' O ' HG22 ' A' ' 79' ' ' THR . 10.1 p-10 -96.31 39.55 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 76.63 6.85 3.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.455 ' HD1' HG23 ' A' ' 79' ' ' THR . 1.6 m-85 -152.94 150.81 25.07 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.927 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 87.4 Cg_endo -82.77 -37.74 1.36 Allowed 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.409 0.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.603 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 88.3 m-85 -60.9 -80.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.766 ' O ' HD21 ' A' ' 77' ' ' LEU . 8.7 t-20 135.89 -51.89 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 123.395 0.678 . . . . 0.0 111.052 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 67.9 Cg_endo -75.59 128.54 11.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.395 2.063 . . . . 0.0 112.34 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 135.94 71.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.456 2.104 . . . . 0.0 112.529 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.1 mp -92.73 160.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.493 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -128.09 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 111.296 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 109' ' ' ILE . 6.5 m-85 -130.83 143.33 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.747 HG22 ' HD3' ' A' ' 91' ' ' PRO . 13.1 p -97.67 138.72 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.956 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -130.36 68.94 81.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.747 ' HD3' HG22 ' A' ' 89' ' ' VAL . 32.7 Cg_exo -59.53 -178.68 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.471 2.114 . . . . 0.0 112.256 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -82.81 165.41 19.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -86.28 -13.71 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.461 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -95.07 -27.92 15.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 0.0 110.586 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 13.5 ttm -89.53 -25.07 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.98 149.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.823 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 97' ' ' ILE . 10.2 tt -95.18 109.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.099 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 1.0 OUTLIER -77.05 130.86 37.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.19 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.8 p -75.2 136.56 41.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.981 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 103' ' ' VAL . . . -144.68 -157.37 7.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.562 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -35.48 70.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -105.77 -39.25 6.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 140' ' ' PRO . 1.3 m -84.38 85.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.406 ' OD2' ' CD2' ' A' ' 110' ' ' TYR . 15.3 m-20 -60.76 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.13 5.14 31.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -131.84 30.11 4.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 0.0 111.173 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . 51.53 51.21 38.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.8 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.454 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -119.21 93.0 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.033 0.444 . . . . 0.0 110.768 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 109' ' ' ILE . 3.6 mp -59.29 108.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.016 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 1.3 m-85 -101.72 51.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.733 HD13 HG11 ' A' ' 130' ' ' VAL . 19.5 mt -59.49 119.02 36.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 -27.43 27.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.426 2.084 . . . . 0.0 112.296 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -58.83 -29.43 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.486 HD22 HD23 ' A' ' 127' ' ' LEU . 6.8 tp -91.81 -34.32 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -67.21 -37.5 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -98.44 28.32 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.435 ' CE2' ' HA ' ' A' ' 122' ' ' SER . 1.8 t90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.435 ' HA ' ' CE2' ' A' ' 117' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.047 0.451 . . . . 0.0 111.483 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 179.95 -177.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.587 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.558 HD21 HD21 ' A' ' 74' ' ' LEU . 4.4 mt -84.57 -34.49 23.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.854 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.566 HD11 ' CG ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -50.48 -47.46 57.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.65 -25.77 55.64 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.366 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.663 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.4 tm? -58.37 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 128' ' ' ILE . 3.4 mp -90.48 -27.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.709 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.863 ' O ' HG22 ' A' ' 132' ' ' ILE . 2.5 tt0 -65.17 -33.2 75.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.701 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.81 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.7 p -66.5 -41.86 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 0.0 110.653 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.419 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.3 mmt -67.48 -44.38 78.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.863 HG22 ' O ' ' A' ' 129' ' ' GLN . 1.2 tt -52.77 -26.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.153 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.03 -54.1 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 130' ' ' VAL . 41.6 t -55.53 -38.32 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.568 ' HD2' HG21 ' A' ' 70' ' ' ILE . 6.0 m-85 -83.86 -26.7 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.648 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -65.05 -18.74 65.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.534 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -48.93 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.56 111.19 1.65 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.0 139.07 79.67 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.991 . . . . 0.0 112.192 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.684 ' HB2' HG11 ' A' ' 103' ' ' VAL . 91.8 Cg_endo -84.78 1.62 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.698 2.265 . . . . 0.0 112.658 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 91' ' ' PRO . 25.8 t -84.9 -47.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.409 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.274 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -49.76 75.75 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.524 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.95 -49.34 68.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.1 tp -58.73 -29.67 66.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.927 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -55.2 36.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -70.15 -29.56 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.426 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmm -62.56 -49.18 76.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.044 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 8' ' ' LEU . 17.1 m -101.35 19.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.487 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -67.09 -29.75 69.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.822 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -31.22 68.08 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CE2' HG21 ' A' ' 21' ' ' THR . 3.4 m-30 -56.91 129.73 42.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' HG21 ' A' ' 79' ' ' THR . 1.0 OUTLIER -58.27 -62.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.63 -55.25 25.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.829 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 ttp180 66.97 -67.41 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.38 -49.62 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -48.31 79.89 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.512 0.507 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 15' ' ' TYR . 5.0 m -66.97 -31.93 72.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 18' ' ' ARG . 37.8 t -79.94 -25.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.131 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -79.01 -47.02 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 28' ' ' VAL . 15.5 mt-10 -67.13 -43.46 82.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.7 t -58.44 -47.46 83.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.449 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -62.44 -46.99 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.776 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.447 ' HB3' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -51.72 -32.58 30.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.274 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.938 HG21 HD23 ' A' ' 124' ' ' LEU . 21.4 t -73.85 -66.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -56.9 -28.33 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.0 m -70.25 -33.53 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.62 -34.43 15.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -102.11 122.63 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.88 3.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.6 15.75 2.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.416 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 167.64 11.24 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.832 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -152.4 137.03 10.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.776 ' HA ' HD23 ' A' ' 55' ' ' LEU . 74.4 Cg_endo -75.12 159.7 40.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.601 2.201 . . . . 0.0 112.115 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 39' ' ' LEU . 6.4 t -150.6 161.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.5 tm? -129.42 122.35 29.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -138.03 161.45 36.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.401 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.09 152.15 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.72 88.44 2.68 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.142 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.947 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.053 0.454 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -123.53 120.15 32.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -59.73 142.08 53.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 52' ' ' LEU . 3.9 tp -147.01 141.54 26.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.251 0.548 . . . . 0.0 110.997 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.602 ' SD ' HG11 ' A' ' 12' ' ' VAL . 5.7 ttp -107.21 139.57 41.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.459 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -138.77 157.46 46.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.813 HD12 HD13 ' A' ' 74' ' ' LEU . 4.1 mt -124.58 128.4 48.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.5 m -124.24 134.31 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.15 169.57 37.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.71 139.39 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.733 ' O ' HD12 ' A' ' 59' ' ' ILE . 2.0 pp -117.07 156.43 48.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.763 ' HG2' HD11 ' A' ' 132' ' ' ILE . 39.8 Cg_endo -67.45 134.96 34.87 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.489 2.126 . . . . 0.0 112.211 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.71 HG21 ' CG1' ' A' ' 70' ' ' ILE . 98.1 t -143.27 106.22 5.16 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.74 134.71 41.76 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.794 2.329 . . . . 0.0 112.252 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -167.85 116.27 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER 81.21 -10.24 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.039 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.06 -6.99 7.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.573 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.77 175.13 6.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 114.63 28.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -94.18 148.15 22.47 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.17 104.3 16.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.724 HG21 ' HD2' ' A' ' 135' ' ' PHE . 31.6 mm -102.45 98.88 11.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 72' ' ' ILE . 46.0 Cg_endo -68.44 153.55 73.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.469 2.113 . . . . 0.0 112.189 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.756 ' O ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -159.21 154.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.403 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 43.2 t -105.13 150.01 25.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.813 HD13 HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -124.68 142.67 51.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.544 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -127.62 139.95 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 75' ' ' TRP . 2.6 mm? -128.22 170.4 13.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.15 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.68 165.75 18.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.08 -39.42 75.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.794 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 16' ' ' LYS . 1.5 t 173.37 -34.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.181 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 79' ' ' THR . 11.8 m-85 -166.07 163.39 12.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.771 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 68.1 Cg_endo -92.78 -0.59 54.19 Favored 'Cis proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.237 -1.151 . . . . 0.0 112.647 0.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 12.0 m-85 -87.2 51.7 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.631 0.253 . . . . 0.0 111.062 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.568 ' O ' HD11 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -40.99 -51.63 7.26 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 44.4 Cg_endo -70.68 115.52 4.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.217 1.945 . . . . 0.0 112.105 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 84' ' ' PRO . 34.5 Cg_endo -64.97 167.67 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.0 112.591 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 3.6 mp -104.07 159.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.487 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.6 p -133.53 126.08 30.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.051 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 21.7 m-85 -131.72 161.63 32.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.78 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.546 HG22 ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -133.54 129.78 56.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 80.49 50.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 89' ' ' VAL . 84.3 Cg_exo -46.52 164.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.448 2.098 . . . . 0.0 112.588 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.0 p -87.23 172.57 9.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.824 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -59.83 -20.78 58.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 m -54.42 -58.93 5.53 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.032 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.02 177.03 5.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.048 0.451 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.804 HG23 ' O ' ' A' ' 142' ' ' PHE . 8.2 t -94.19 -137.74 0.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.592 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -152.1 111.25 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.317 0.58 . . . . 0.0 111.382 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' HA ' ' A' ' 140' ' ' PRO . 3.0 ptmt -101.78 133.83 45.89 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.142 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -173.48 -177.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 111.487 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' A' ' 99' ' ' THR . . . 153.63 -17.92 0.67 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.302 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -54.89 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.551 0.215 . . . . 0.0 111.279 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.614 ' ND1' HG23 ' A' ' 103' ' ' VAL . 10.6 p80 -129.96 -34.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.614 HG23 ' ND1' ' A' ' 102' ' ' HIS . 84.7 t -77.46 -16.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.454 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 99' ' ' THR . 2.5 m-20 53.01 170.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.84 0.352 . . . . 0.0 111.455 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.47 -19.09 62.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.609 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.43 24.63 4.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 53.24 23.53 18.19 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.066 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.47 125.7 37.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.546 -0.385 . . . . 0.0 110.481 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.34 108.73 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 111.291 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -104.31 31.66 4.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.115 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.614 HD21 HG21 ' A' ' 134' ' ' VAL . 4.2 mt -51.72 152.01 5.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.599 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CD ' HD23 ' A' ' 111' ' ' LEU . 23.1 Cg_exo -63.82 -32.12 67.32 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.745 ' HB2' HG21 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -57.9 -31.51 66.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.684 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -86.97 -42.71 12.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.13 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.33 -36.26 83.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.059 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.99 37.01 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.422 ' NE1' ' CB ' ' A' ' 122' ' ' SER . 1.6 t90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.575 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.422 ' CB ' ' NE1' ' A' ' 117' ' ' TRP . 23.3 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.879 0.371 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 177.49 153.87 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -56.71 -43.8 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 27' ' ' ASN . 1.6 mp -55.48 -42.37 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.766 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.46 56.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.254 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 130' ' ' VAL . 30.2 tp -56.54 -36.58 69.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.441 HD11 HD11 ' A' ' 74' ' ' LEU . 3.8 mp -90.2 -23.99 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.653 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.922 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.2 tt0 -69.3 -33.41 73.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.676 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 113' ' ' TYR . 3.6 p -63.51 -42.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.428 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 4.6 mtt -64.77 -43.76 92.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.922 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER -53.77 -25.05 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.39 -52.69 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.503 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 130' ' ' VAL . 43.0 t -57.09 -36.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.375 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.724 ' HD2' HG21 ' A' ' 70' ' ' ILE . 4.3 m-85 -83.3 -26.1 30.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.244 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.22 -15.07 72.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.61 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.4 -36.14 11.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.803 0.335 . . . . 0.0 110.642 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -153.39 85.8 4.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.45 111.11 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.652 2.235 . . . . 0.0 112.727 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 98' ' ' LYS . 86.8 Cg_endo -83.9 50.0 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.857 2.371 . . . . 0.0 112.082 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 70' ' ' ILE . 3.8 t -125.15 -7.66 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.404 0.145 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -81.5 -32.92 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.937 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -70.67 -42.07 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.633 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.735 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.6 tp -59.88 -44.57 94.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.457 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.2 66.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.801 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -72.93 -29.01 62.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.97 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -88.62 -35.86 16.61 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.0 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 8' ' ' LEU . 26.9 m -88.54 8.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.632 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 p -79.22 -29.55 42.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.912 0.387 . . . . 0.0 110.809 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -69.81 -17.89 63.43 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.533 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 78' ' ' ASP . 1.8 m-85 -51.17 167.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.821 0.343 . . . . 0.0 111.142 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -47.85 8.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -84.24 -58.08 2.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER 66.54 -68.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -52.78 -29.9 30.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.195 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -84.9 -39.44 18.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -47.73 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 18' ' ' ARG . 22.9 t -61.68 -39.62 83.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -63.31 -50.57 69.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.269 0.557 . . . . 0.0 111.173 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 28' ' ' VAL . 9.4 mt-10 -60.68 -47.04 88.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.944 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.471 HG23 HD21 ' A' ' 55' ' ' LEU . 5.7 m -58.8 -50.65 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -58.78 -47.37 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.423 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -53.31 -33.22 52.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.446 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.847 HG21 HD23 ' A' ' 124' ' ' LEU . 21.8 t -80.95 -58.98 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.448 HD11 ' HA ' ' A' ' 26' ' ' VAL . 2.9 pt -59.83 -34.54 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.362 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.5 t -67.52 -38.01 83.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.831 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' CD2' HG23 ' A' ' 30' ' ' THR . 2.5 mm? -86.39 -30.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.35 124.99 50.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.302 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.95 68.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -168.62 -41.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.588 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.7 mm? -62.56 129.39 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.85 101.44 53.49 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.883 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.05 139.71 33.64 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.453 2.102 . . . . 0.0 112.385 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.2 t -132.18 162.08 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.466 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.4 tm? -118.75 124.07 46.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 39' ' ' LEU . 16.2 t70 -149.2 127.33 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.866 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -90.91 159.26 16.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -112.3 104.77 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 110.727 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -179.843 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.733 0.302 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 134.14 41.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.78 123.73 24.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 77' ' ' LEU . 6.5 tp -134.36 155.08 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.527 ' HE2' HD12 ' A' ' 76' ' ' LEU . 15.5 ttp -118.44 149.93 40.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.442 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 0.4 OUTLIER -143.41 160.7 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.884 HD12 HD13 ' A' ' 74' ' ' LEU . 11.0 mt -127.08 118.72 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.958 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.41 HG21 ' HD3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -119.9 155.84 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.588 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 161.04 172.0 27.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.481 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.409 HG23 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -110.52 124.82 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.0 111.248 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 pt -104.0 150.91 38.78 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.189 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.83 149.46 66.46 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 112.257 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.772 HG13 ' HA2' ' A' ' 136' ' ' GLY . 97.1 t -155.7 107.57 2.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.199 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 58.2 Cg_exo -52.23 111.78 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.151 1.9 . . . . 0.0 112.293 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -110.45 97.43 6.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 57.49 24.97 10.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.68 -15.97 28.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.815 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -96.94 177.89 5.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -114.14 111.25 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.064 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.12 -173.7 2.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.097 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -146.98 87.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.063 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 70' ' ' ILE . 3.2 mp -89.09 107.51 18.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HG3' HG23 ' A' ' 92' ' ' THR . 49.5 Cg_endo -69.18 160.24 50.66 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.556 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 71' ' ' PRO . 2.7 pp -159.22 163.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 158.88 28.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.737 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.884 HD13 HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -132.83 135.18 45.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.908 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -121.35 134.17 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.908 HD23 ' O ' ' A' ' 75' ' ' TRP . 8.8 mt -133.13 156.75 46.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.06 162.77 24.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 4.8 p-10 -60.3 -44.11 95.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.676 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -177.39 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.56 157.74 55.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HG2' ' CD2' ' A' ' 82' ' ' TYR . 73.5 Cg_endo -77.86 -47.37 0.31 Allowed 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.307 -1.539 . . . . 0.0 112.569 0.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 80.3 m-85 -87.91 -67.66 0.81 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' O ' HD21 ' A' ' 77' ' ' LEU . 4.6 m-20 156.82 -52.44 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.779 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' O ' HD11 ' A' ' 77' ' ' LEU . 87.2 Cg_exo -44.52 143.49 3.87 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.744 2.296 . . . . 0.0 112.774 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.594 ' CB ' HD22 ' A' ' 76' ' ' LEU . 85.8 Cg_endo -82.25 138.56 10.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.0 112.445 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.3 mp -83.38 160.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.493 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.4 t -134.97 141.71 46.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.028 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.477 ' CA ' HD12 ' A' ' 109' ' ' ILE . 2.8 m-85 -138.76 -179.86 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 107' ' ' GLY . 13.6 p -128.25 149.19 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HD3' HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -114.36 87.83 14.41 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.7 148.46 15.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.527 2.152 . . . . 0.0 112.398 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.647 HG23 ' HG3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -105.65 -176.71 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.0 t -77.88 -31.83 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.688 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -73.56 -56.97 4.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.7 mtm -91.54 179.3 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -130.09 -98.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.484 HD11 HG11 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -175.5 126.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.29 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.15 116.08 29.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.636 HG22 ' C ' ' A' ' 104' ' ' ASP . 57.5 p -86.27 134.07 33.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.43 -63.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.43 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -100.03 -71.31 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.577 ' NE2' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -120.71 -15.67 8.37 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' THR . 21.7 t -87.48 70.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.661 0.267 . . . . 0.0 111.583 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.636 ' C ' HG22 ' A' ' 99' ' ' THR . 70.6 m-20 -52.04 -176.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.25 68.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.19 19.64 10.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.796 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 53.99 29.39 43.24 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 88' ' ' PHE . 27.8 tttp -83.87 113.31 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.578 HG22 HD12 ' A' ' 111' ' ' LEU . 2.2 mp -69.78 110.19 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.21 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 102' ' ' HIS . 3.8 p90 -132.92 46.98 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.481 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 109' ' ' ILE . 1.3 mp -44.67 148.95 0.84 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.644 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -30.85 10.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.564 2.176 . . . . 0.0 112.017 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -60.34 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.98 -30.91 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.418 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -58.86 -55.64 32.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.02 31.02 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.495 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.589 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.415 ' N ' ' NE1' ' A' ' 117' ' ' TRP . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.042 0.449 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -93.17 168.89 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 28' ' ' VAL . 4.4 tp -57.76 -39.68 77.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mp -49.28 -43.16 42.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.54 -26.86 49.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.256 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.1 tm? -57.87 -31.74 67.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.6 mp -88.02 -28.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.7 tm0? -61.34 -35.86 78.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 111' ' ' LEU . 2.3 p -65.19 -39.94 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.404 ' HG2' ' CE1' ' A' ' 135' ' ' PHE . 10.0 mtt -68.74 -44.59 73.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.858 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 129' ' ' GLN . 1.2 tt -52.65 -24.53 6.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.204 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 129' ' ' GLN . 42.0 t -92.98 -56.48 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.529 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 130' ' ' VAL . 89.6 t -56.63 -46.95 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.543 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.544 ' CD2' HG21 ' A' ' 70' ' ' ILE . 4.3 m-85 -74.9 -27.79 60.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.772 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -66.53 -15.54 64.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.592 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -89.78 -48.66 7.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -158.81 137.35 7.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.74 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 138' ' ' GLU . 48.5 Cg_exo -55.66 105.97 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 112.338 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 18.3 Cg_exo -66.62 -12.85 37.54 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.227 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 141' ' ' VAL . 42.8 t -84.56 -13.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.605 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.68 0.276 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -72.27 -35.35 68.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.73 -32.66 57.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.821 ' O ' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -63.01 -28.39 70.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -29.47 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.292 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -73.65 -28.13 61.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.988 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.66 ' CE ' HD23 ' A' ' 39' ' ' LEU . 5.6 ptm -85.62 -35.22 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.081 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 8' ' ' LEU . 29.4 m -94.87 11.57 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.561 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -23.19 63.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.055 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -26.67 25.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.409 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 8.5 m-85 -54.52 134.19 46.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -67.5 -49.41 63.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -90.7 66.44 6.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.851 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -56.92 -60.73 3.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.325 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -51.45 -53.28 38.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.094 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.03 -41.24 99.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.0 m -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 18' ' ' ARG . 39.4 t -82.31 -31.74 10.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -72.27 -48.42 42.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 28' ' ' VAL . 23.4 mt-10 -64.39 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.697 HG23 ' CD2' ' A' ' 55' ' ' LEU . 85.6 m -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.078 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -85.78 -47.81 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.598 ' O ' HD23 ' A' ' 31' ' ' LEU . 2.4 m-20 -55.42 -28.72 56.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.474 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.5 t -85.82 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.427 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 5.9 pt -57.38 -33.76 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.567 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 26' ' ' VAL . 4.8 t -75.47 -32.69 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 27' ' ' ASN . 2.7 mm? -77.04 -38.91 51.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.858 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' CB ' HD23 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -99.26 -20.56 16.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.512 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 1.1 mttp 67.31 -59.88 0.39 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.639 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -45.69 -35.88 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.885 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.674 HD21 ' CG2' ' A' ' 59' ' ' ILE . 3.6 mm? -63.38 132.52 51.75 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 111.059 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -129.95 117.97 18.4 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.699 ' HB2' HD11 ' A' ' 8' ' ' LEU . 45.4 Cg_exo -56.7 140.68 91.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.401 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 39' ' ' LEU . 8.4 t -131.34 162.81 38.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.66 HD23 ' CE ' ' A' ' 11' ' ' MET . 2.1 tm? -133.4 95.18 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.862 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.24 118.6 35.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.08 145.52 49.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.296 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -117.67 119.93 36.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.596 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 49' ' ' SER . 33.3 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 111.188 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.569 ' HB3' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.662 0.267 . . . . 0.0 111.275 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.07 127.99 55.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.421 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -74.49 101.09 4.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' O ' HD22 ' A' ' 39' ' ' LEU . 4.6 mm? -108.65 138.99 44.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.556 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 65.8 ttp -84.85 149.2 25.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.442 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 9.0 p-10 -149.98 117.8 6.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.697 ' CD2' HG23 ' A' ' 25' ' ' THR . 3.6 mt -85.37 107.65 17.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.522 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 m -108.5 149.73 28.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.498 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 163.4 165.42 20.5 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.42 HG23 ' HB3' ' A' ' 71' ' ' PRO . 1.4 p -107.29 120.63 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.604 0.24 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.674 ' CG2' HD21 ' A' ' 35' ' ' LEU . 2.2 pt -99.76 126.35 37.35 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.456 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.11 126.61 22.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.417 2.078 . . . . 0.0 111.952 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG11 ' CG1' ' A' ' 70' ' ' ILE . 14.8 p -132.84 136.69 28.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.0 Cg_exo -58.16 150.98 62.28 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.433 2.089 . . . . 0.0 112.094 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -176.76 116.46 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 58.48 25.1 12.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.27 3.18 75.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.75 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -124.74 176.9 6.28 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 133.91 47.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -165.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -143.53 98.04 3.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.995 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.701 HG21 ' CD2' ' A' ' 135' ' ' PHE . 25.0 mm -100.92 101.8 17.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB3' HG23 ' A' ' 58' ' ' THR . 61.3 Cg_endo -73.23 136.25 24.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.486 2.124 . . . . 0.0 112.53 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.409 HD12 ' SG ' ' A' ' 87' ' ' CYS . 11.5 pt -134.81 167.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 108.62 10.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.935 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.894 HD22 HD22 ' A' ' 124' ' ' LEU . 8.3 mt -85.44 98.66 10.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.086 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.778 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -79.66 146.9 32.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.569 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.778 HD22 ' C ' ' A' ' 75' ' ' TRP . 2.8 mm? -126.97 170.87 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.44 166.25 25.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.38 0.61 . . . . 0.0 110.715 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -39.27 24.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.77 163.11 27.14 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.62 -62.58 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.187 -0.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 25.4 m-85 -105.03 -56.09 2.23 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.619 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.572 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.9 p-10 161.83 -34.37 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.369 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 28.5 Cg_exo -62.09 116.99 3.83 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.968 1.778 . . . . 0.0 112.269 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.694 ' HB3' HD13 ' A' ' 76' ' ' LEU . 46.2 Cg_endo -68.17 166.94 23.35 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.39 2.06 . . . . 0.0 112.199 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.802 HG21 ' CE1' ' A' ' 88' ' ' PHE . 1.2 mp -103.95 164.03 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.066 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.774 ' H ' HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -131.67 53.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.814 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.802 ' CE1' HG21 ' A' ' 86' ' ' ILE . 30.6 m-85 -48.73 125.42 10.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.182 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.733 HG13 HG23 ' A' ' 109' ' ' ILE . 33.5 m -81.6 127.0 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.253 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -127.44 89.83 50.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 32.9 Cg_exo -60.33 -158.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.644 2.23 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -128.6 173.95 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 t -68.4 -25.73 65.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -29.22 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.294 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.685 ' HB3' HG12 ' A' ' 141' ' ' VAL . 2.0 mpp? -127.2 -169.17 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.0 t -135.62 -162.7 1.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 97' ' ' ILE . 9.3 tt -122.89 104.29 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -81.43 102.28 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 105' ' ' ALA . 15.5 p -57.56 141.37 48.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.33 -100.44 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.557 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -95.96 -64.53 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.81 ' CE1' HG11 ' A' ' 134' ' ' VAL . 4.8 p-80 -107.53 -24.34 11.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.422 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 140' ' ' PRO . 52.1 t -55.28 -27.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 99' ' ' THR . 1.0 OUTLIER 44.4 -166.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -103.81 -20.57 13.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.513 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.65 22.2 7.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.488 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.41 ' HA2' ' CD1' ' A' ' 97' ' ' ILE . . . 51.52 44.27 53.41 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.781 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 1.5 tttm -124.05 90.82 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.785 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.858 ' O ' HD12 ' A' ' 109' ' ' ILE . 2.0 pp -46.79 108.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.874 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 108' ' ' LYS . 33.5 m-85 -95.61 30.9 2.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.713 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.778 HD13 HG11 ' A' ' 130' ' ' VAL . 9.5 mt -49.17 106.56 0.64 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.35 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.5 -14.73 46.01 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.463 2.109 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -58.56 -71.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.318 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -60.63 -19.64 58.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.151 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.954 ' N ' HD13 ' A' ' 114' ' ' LEU . 24.2 t60 -64.62 -46.55 82.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 110.332 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.02 26.79 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.736 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.497 ' CD1' ' CB ' ' A' ' 122' ' ' SER . 2.2 t90 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.497 ' CB ' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -174.27 179.78 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.894 HD22 HD22 ' A' ' 74' ' ' LEU . 59.0 mt -59.68 -31.2 69.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -47.6 81.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -83.94 -40.72 8.54 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 130' ' ' VAL . 9.5 tt -54.02 -27.4 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.749 HD11 HD11 ' A' ' 74' ' ' LEU . 50.0 mt -90.54 -28.54 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.666 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.875 ' HA ' HD12 ' A' ' 132' ' ' ILE . 2.2 tt0 -57.47 -33.06 67.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.778 HG11 HD13 ' A' ' 111' ' ' LEU . 4.3 p -59.79 -45.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.38 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.449 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 12.8 mtm -69.89 -40.58 75.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.087 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 129' ' ' GLN . 63.4 mt -54.6 -26.25 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.741 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 129' ' ' GLN . 39.9 t -91.87 -54.39 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.437 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.81 HG11 ' CE1' ' A' ' 102' ' ' HIS . 39.5 t -56.42 -47.82 80.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.701 ' CD2' HG21 ' A' ' 70' ' ' ILE . 7.3 m-30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.279 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 61' ' ' VAL . . . -67.66 -15.87 67.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.696 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -104.12 -42.83 5.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 28.0 mt-10 -151.0 90.53 4.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.253 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 10.7 Cg_endo -55.99 129.23 33.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.487 2.125 . . . . 0.0 112.306 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.648 ' HB3' HG21 ' A' ' 103' ' ' VAL . 37.0 Cg_exo -59.1 -19.03 46.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.175 1.917 . . . . 0.0 111.871 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 95' ' ' MET . 1.6 t -75.06 152.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.25 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 t80 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.043 -179.346 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.074 0.464 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -60.41 -31.76 70.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -84.31 -22.88 30.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.103 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.797 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.2 tp -55.34 -50.72 68.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.219 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -31.8 40.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.924 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.49 68.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.651 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.543 ' HG2' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -86.28 -33.0 20.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 8' ' ' LEU . 26.7 m -100.45 20.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -26.51 68.36 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.561 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -21.86 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.339 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -51.54 134.48 29.28 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -64.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.832 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -86.5 63.73 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 22' ' ' VAL . 12.8 ttp180 -63.76 -53.7 46.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.278 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -35.03 56.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 111.449 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.59 -40.19 16.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.738 HG23 HD23 ' A' ' 76' ' ' LEU . 81.8 m -66.49 -49.82 65.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.086 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.1 t -59.67 -39.59 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -48.4 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.381 0.61 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.4 -43.42 88.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.852 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.757 HG22 HD11 ' A' ' 29' ' ' ILE . 23.4 m -65.02 -59.02 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.94 -48.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.183 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.2 t-20 -55.99 -28.04 55.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -84.08 -27.18 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.757 HD11 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -91.12 -27.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.933 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -68.77 -48.15 64.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -41.89 66.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.35 117.31 34.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -95.7 21.13 8.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.216 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.469 ' C ' HD22 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -119.0 17.65 13.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.725 HD13 ' HA3' ' A' ' 57' ' ' GLY . 4.1 mm? -118.04 159.86 22.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -149.35 124.58 4.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.686 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 133.84 21.27 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.252 1.968 . . . . 0.0 112.344 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.543 HG23 HG22 ' A' ' 56' ' ' THR . 6.9 t -130.15 162.15 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.068 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -120.55 114.8 22.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.804 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -134.1 115.46 14.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 110.89 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 p -72.99 141.88 47.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.09 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.48 120.51 41.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.495 179.766 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.769 ' NE ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -133.12 138.94 46.84 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.488 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.54 107.08 0.14 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.769 HD13 ' NE ' ' A' ' 50' ' ' ARG . 7.6 tp -117.82 131.03 56.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 110.544 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.76 ' SD ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -92.04 146.08 24.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.211 0.529 . . . . 0.0 110.912 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.434 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 6.6 p-10 -143.86 140.7 29.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.915 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD11 HG23 ' A' ' 25' ' ' THR . 57.5 mt -100.32 101.67 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.543 HG22 HG23 ' A' ' 38' ' ' VAL . 11.7 t -102.55 152.96 20.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.694 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.725 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 154.19 -172.41 32.79 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.411 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.6 p -121.53 156.5 32.73 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.852 HD12 HG13 ' A' ' 61' ' ' VAL . 2.2 pp -131.87 134.28 25.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.036 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 116.18 4.56 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.562 2.175 . . . . 0.0 112.104 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.852 HG13 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -120.15 102.1 46.47 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.522 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 89.4 Cg_exo -42.61 129.7 5.13 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.211 2.607 . . . . 0.0 112.688 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -135.56 87.17 2.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 63.01 42.77 7.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.14 -16.58 55.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.1 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -86.65 -147.47 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.857 -0.202 . . . . 0.0 110.731 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 67' ' ' THR . 6.0 t -176.24 41.95 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 121.547 0.689 . . . . 0.0 109.906 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.459 ' O ' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -31.27 148.33 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.524 -179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -105.66 106.11 16.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.682 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.744 HG21 ' CD2' ' A' ' 135' ' ' PHE . 13.2 mm -99.58 108.25 49.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.217 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.16 147.53 93.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.494 2.129 . . . . 0.0 111.853 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 pt -149.57 149.82 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 111.215 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 116.71 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 138.4 32.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.699 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -113.35 145.92 40.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.76 HD22 ' SD ' ' A' ' 53' ' ' MET . 2.3 mp -141.22 146.4 36.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.37 166.24 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.16 0.505 . . . . 0.0 110.85 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.84 -39.57 79.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.723 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t 174.43 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.843 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -125.59 163.54 38.15 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 90.5 Cg_endo -82.65 -31.69 3.89 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.421 -1.491 . . . . 0.0 112.108 0.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 52.0 m-85 -59.55 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.101 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 64.6 t-20 117.67 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 89.5 Cg_endo -84.21 141.25 9.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.433 2.089 . . . . 0.0 112.399 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 84' ' ' PRO . 50.4 Cg_exo -55.36 127.42 26.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.473 2.115 . . . . 0.0 112.248 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.639 ' CD1' HD12 ' A' ' 77' ' ' LEU . 2.5 mp -93.35 160.03 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.637 ' C ' HD12 ' A' ' 109' ' ' ILE . 4.2 t -155.16 123.19 5.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.474 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 19.7 m-85 -134.6 121.64 21.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.581 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.496 HG11 HG12 ' A' ' 103' ' ' VAL . 14.6 p -68.71 130.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 125.86 68.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.04 165.89 22.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.119 . . . . 0.0 112.41 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.41 -176.66 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.914 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.93 -33.96 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 p -93.48 -32.78 14.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.766 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.417 ' SD ' HG21 ' A' ' 141' ' ' VAL . 21.3 ttp -99.01 -12.14 20.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.528 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 142' ' ' PHE . 8.9 t 44.59 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -139.39 127.14 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 111.473 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.01 145.61 29.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 104' ' ' ASP . 72.7 p -79.34 131.35 36.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.22 -121.13 1.65 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.635 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 -39.07 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.132 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.74 -48.49 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 140' ' ' PRO . 2.9 m -68.11 67.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 99' ' ' THR . 71.5 m-20 -49.89 -100.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.18 -54.7 2.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -106.94 39.59 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.037 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.461 ' HA3' HG13 ' A' ' 89' ' ' VAL . . . 59.83 51.89 56.24 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.391 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 4.2 mtpt -93.11 90.0 6.7 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.041 0.448 . . . . 0.0 110.406 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 87' ' ' CYS . 4.2 mt -47.89 109.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.089 0.471 . . . . 0.0 111.435 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.38 39.48 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.668 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.3 mt -54.59 118.98 18.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.18 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.75 -35.32 87.5 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.0 112.122 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.97 -29.83 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.801 ' CD1' HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.47 -30.11 17.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -57.35 -37.7 72.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.23 22.75 8.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.47 ' CD1' ' HB3' ' A' ' 122' ' ' SER . 2.8 t90 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.652 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' A' ' 117' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.867 0.365 . . . . 0.0 111.028 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.03 -84.51 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 24' ' ' GLU . 5.4 tp 176.78 -36.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.42 -44.81 95.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.779 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.63 -36.45 92.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.108 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.801 HD13 ' CD1' ' A' ' 114' ' ' LEU . 20.6 tp -57.12 -34.14 68.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.979 0.418 . . . . 0.0 110.513 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.75 -24.32 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.006 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.873 ' O ' HG22 ' A' ' 132' ' ' ILE . 19.7 tt0 -68.9 -40.87 78.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.816 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.9 p -61.76 -41.31 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.472 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.407 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 2.5 mtt -63.81 -40.3 96.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -55.89 -28.34 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.964 0.411 . . . . 0.0 111.022 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.19 -52.22 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 130' ' ' VAL . 40.0 t -54.86 -36.0 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.989 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.744 ' CD2' HG21 ' A' ' 70' ' ' ILE . 5.5 m-85 -92.18 -21.93 20.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -21.53 61.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -28.89 13.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.734 0.302 . . . . 0.0 111.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -161.3 95.79 1.35 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.28 117.83 3.78 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.6 2.2 . . . . 0.0 112.076 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.552 ' O ' HG11 ' A' ' 103' ' ' VAL . 93.5 Cg_endo -88.55 45.84 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.621 2.214 . . . . 0.0 112.737 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.497 ' O ' ' C ' ' A' ' 142' ' ' PHE . 1.4 m -136.9 -40.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.842 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' C ' ' O ' ' A' ' 141' ' ' VAL . 21.8 t80 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 113.214 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.725 0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 3' ' ' VAL . 31.6 m -133.81 66.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.349 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -73.34 -175.88 2.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.137 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -59.38 -38.29 80.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.033 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -61.01 -50.98 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.584 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.11 -31.28 70.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.818 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.4 tp -59.23 -44.37 92.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -57.95 -44.5 87.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.186 0.517 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.38 -30.67 71.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtm -79.28 -31.54 43.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.825 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 8' ' ' LEU . 18.3 m -102.21 20.18 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.027 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -78.54 -31.14 47.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.859 0.362 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -31.35 71.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.49 156.18 8.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -54.17 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.48 66.13 4.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.0 ttm180 -61.83 -52.38 64.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.35 -29.55 48.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.23 -26.94 17.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.887 HG23 HD23 ' A' ' 76' ' ' LEU . 97.7 m -80.71 -30.45 36.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.988 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 18' ' ' ARG . 40.3 t -87.18 -28.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -82.1 -33.32 29.79 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.151 0.501 . . . . 0.0 110.848 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.646 ' HB3' HD12 ' A' ' 124' ' ' LEU . 66.4 mt-10 -68.93 -42.29 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.833 ' CG2' HD21 ' A' ' 55' ' ' LEU . 19.0 m -69.03 -55.07 11.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -52.35 -46.89 46.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.779 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 m-80 -51.69 -37.01 48.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.568 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.889 HG21 HD22 ' A' ' 124' ' ' LEU . 23.9 t -82.9 -63.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.465 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.588 HD13 HG22 ' A' ' 25' ' ' THR . 5.6 pt -52.27 -26.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.4 m -85.54 -26.49 26.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.01 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 27' ' ' ASN . 5.6 mp -89.74 -39.02 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.668 0.271 . . . . 0.0 111.202 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' HE2' HD11 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -93.14 11.46 27.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.659 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 14.33 61.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -165.38 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD13 ' HA3' ' A' ' 57' ' ' GLY . 4.0 mm? -62.75 121.77 14.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.02 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? -100.13 128.05 31.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.123 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.798 ' HA ' HD23 ' A' ' 55' ' ' LEU . 56.7 Cg_endo -70.53 139.39 37.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.3 2.0 . . . . 0.0 112.608 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.5 t -134.19 162.11 39.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-O 121.098 0.475 . . . . 0.0 110.8 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.697 HD11 ' HG3' ' A' ' 51' ' ' GLU . 2.1 tm? -136.82 103.83 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.797 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -123.78 127.12 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.385 0.612 . . . . 0.0 110.534 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.72 139.64 30.53 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -108.85 160.23 16.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.96 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.74 151.18 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -98.9 80.04 2.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 60.78 37.65 18.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.4 21.49 12.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.061 0.458 . . . . 0.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.01 -17.47 16.2 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.361 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.64 133.18 0.77 Allowed 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.687 -0.302 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m -100.26 177.75 4.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.88 140.23 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.551 0.532 . . . . 0.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.697 ' HG3' HD11 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -74.33 128.51 35.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.085 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 52' ' ' LEU . 4.8 tp -136.11 136.27 39.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.4 ttp -105.26 149.75 25.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.229 0.538 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.444 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -148.17 163.53 36.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.892 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.833 HD21 ' CG2' ' A' ' 25' ' ' THR . 5.1 mt -127.54 123.85 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -119.45 131.12 55.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.553 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -174.65 -174.06 41.06 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.604 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -121.06 151.61 39.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.714 0.292 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.699 HG12 HD12 ' A' ' 72' ' ' ILE . 1.4 pt -130.97 114.84 16.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.273 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.28 167.37 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.434 2.089 . . . . 0.0 112.141 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 p -173.39 127.01 0.48 Allowed Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.347 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.78 115.83 4.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.255 1.97 . . . . 0.0 112.317 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.61 137.18 18.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 60.13 20.88 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.524 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.56 5.16 82.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.672 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.19 175.51 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.87 0.366 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 100.49 10.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.43 159.56 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.5 m-20 -114.33 125.07 53.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 141' ' ' VAL . 31.0 mm -110.0 95.47 21.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.226 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 69' ' ' ASN . 32.9 Cg_exo -61.11 144.37 99.18 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.156 1.904 . . . . 0.0 112.221 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.699 HD12 HG12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -155.47 138.97 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.9 m -99.6 162.43 13.02 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.787 HD11 HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -130.35 134.88 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.538 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -115.15 148.33 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.774 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.887 HD23 HG23 ' A' ' 21' ' ' THR . 7.6 mp -133.44 155.63 49.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.805 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.741 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -135.11 158.86 43.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 79' ' ' THR . 2.4 t0 -73.8 -30.95 63.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -178.05 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.37 154.02 68.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.76 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HG2' ' CE1' ' A' ' 82' ' ' TYR . 73.7 Cg_endo -76.99 -45.01 0.46 Allowed 'Cis proline' 0 C--N 1.347 0.448 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.433 0.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -105.09 -59.81 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.686 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER 166.45 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.865 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.38 143.52 15.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.677 2.251 . . . . 0.0 112.455 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 149.99 50.3 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.491 2.127 . . . . 0.0 112.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 87' ' ' CYS . 2.9 mp -87.85 154.61 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.419 ' N ' HG22 ' A' ' 86' ' ' ILE . 5.0 p -123.71 142.46 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.454 ' C ' HD11 ' A' ' 109' ' ' ILE . 4.1 m-85 -151.97 154.44 36.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.844 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.791 HG13 HD11 ' A' ' 109' ' ' ILE . 16.7 m -117.19 139.09 45.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.117 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -135.49 79.4 48.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HB3' HG13 ' A' ' 141' ' ' VAL . 56.3 Cg_endo -69.09 176.52 6.15 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 122.413 2.075 . . . . 0.0 112.572 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -91.84 170.35 9.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.8 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -58.72 -28.63 66.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -76.33 -29.56 57.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.06 177.03 7.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -139.33 -173.52 3.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.613 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.494 ' H ' HG22 ' A' ' 96' ' ' THR . 12.1 mm -126.13 92.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.444 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 25.5 tptt -66.47 103.72 1.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.867 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 p -58.47 134.42 56.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.715 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.71 -131.11 1.62 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.557 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 0.5 OUTLIER -99.99 -32.42 10.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.789 0.328 . . . . 0.0 111.014 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.665 ' CG ' HD23 ' A' ' 111' ' ' LEU . 23.1 m-70 -111.44 -34.82 6.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.981 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.868 HG21 ' HG3' ' A' ' 140' ' ' PRO . 22.0 t -91.05 79.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.27 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -69.25 -173.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.39 5.26 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.356 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -112.9 24.9 11.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.708 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 56.49 27.89 54.84 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.99 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.4 160.24 15.57 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.436 -0.449 . . . . 0.0 110.67 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.791 HD11 HG13 ' A' ' 89' ' ' VAL . 3.3 mp -131.55 38.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 30.1 p90 -60.77 102.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.989 0.423 . . . . 0.0 110.625 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.665 HD23 ' CG ' ' A' ' 102' ' ' HIS . 2.1 mt -108.74 144.68 30.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.073 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HD3' ' CE1' ' A' ' 102' ' ' HIS . 52.9 Cg_exo -54.72 -40.36 84.97 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.491 2.127 . . . . 0.0 112.04 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.77 -30.33 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.684 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -90.52 -32.51 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.51 -49.55 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.83 33.26 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.779 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.532 ' HD1' ' N ' ' A' ' 118' ' ' LYS . 2.8 t90 -90.93 136.59 32.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.108 0.48 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.532 ' N ' ' HD1' ' A' ' 117' ' ' TRP . 16.6 pttt -149.4 133.34 17.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.888 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.648 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 3.8 p80 -45.99 169.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.304 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.648 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 1.9 Cg_endo -83.16 6.81 50.4 Favored 'Cis proline' 0 C--N 1.354 0.84 0 C-N-CA 124.95 -0.854 . . . . 0.0 113.435 0.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -6.83 45.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.457 ' HB2' ' NE1' ' A' ' 117' ' ' TRP . 39.3 t -92.98 103.65 15.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.847 0.356 . . . . 0.0 111.258 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.16 -0.93 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER 87.66 -26.45 0.08 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.62 0.368 . . . . 0.0 111.322 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.605 HD21 HD22 ' A' ' 31' ' ' LEU . 1.3 tp -64.92 -38.23 90.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.96 -31.18 54.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.016 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 114' ' ' LEU . 28.1 tp -55.97 -30.5 61.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.593 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.1 mm -88.08 -28.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.037 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.846 ' HA ' HD12 ' A' ' 132' ' ' ILE . 1.8 tt0 -67.9 -41.26 82.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.215 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 134' ' ' VAL . 6.8 p -52.4 -46.58 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.981 0.419 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.48 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.1 mtt -66.94 -35.38 79.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.389 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 129' ' ' GLN . 52.5 mt -61.13 -27.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.771 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 129' ' ' GLN . 23.2 t -91.43 -48.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 110.505 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 130' ' ' VAL . 48.6 t -60.22 -39.94 82.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.48 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 131' ' ' MET . 20.0 m-30 -85.21 -15.89 42.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.075 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.0 -14.77 81.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.434 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -97.98 -38.01 9.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.959 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -164.8 89.31 1.02 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.563 ' HB3' HD11 ' A' ' 70' ' ' ILE . 33.5 Cg_exo -57.86 126.54 22.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.569 2.179 . . . . 0.0 112.412 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.868 ' HG3' HG21 ' A' ' 103' ' ' VAL . 92.7 Cg_endo -85.83 -13.42 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.71 2.273 . . . . 0.0 112.561 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.865 HG21 HG23 ' A' ' 70' ' ' ILE . 36.9 t -72.45 -3.72 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.148 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -45.19 173.96 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.055 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 p -140.64 21.71 2.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.091 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 46.0 76.77 0.51 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.132 1.888 . . . . 0.0 112.436 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.643 HG13 ' CE ' ' A' ' 11' ' ' MET . 21.6 t 59.98 64.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.164 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.2 p -84.8 -177.08 6.49 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.659 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -59.71 -30.94 69.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.927 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -46.68 17.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -40.01 80.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.709 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.0 tt -59.85 -37.53 79.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.268 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -62.47 -50.23 72.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.727 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -63.54 -31.12 72.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.56 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.643 ' CE ' HG13 ' A' ' 3' ' ' VAL . 11.1 mtp -74.65 -30.6 61.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 8' ' ' LEU . 32.7 m -105.02 19.45 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.805 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -65.35 -29.86 70.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.21 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -27.24 58.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.872 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 21.2 m-85 -56.06 130.64 44.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -66.98 -42.54 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' CG2' ' A' ' 79' ' ' THR . 16.0 m-85 -103.62 60.77 0.75 Allowed 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.787 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.0 ptm180 -59.02 -35.4 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.785 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -57.73 -51.12 70.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -33.31 63.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.672 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.4 m -66.47 -39.08 88.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.3 t -82.02 -30.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -46.79 35.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.863 ' O ' HG23 ' A' ' 28' ' ' VAL . 21.1 mt-10 -59.29 -42.33 91.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.979 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.931 HG23 HD21 ' A' ' 55' ' ' LEU . 9.3 m -63.71 -59.57 4.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -47.4 -47.59 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.069 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.455 ' HB3' HD13 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -58.02 -29.48 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -83.33 -37.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.256 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 25' ' ' THR . 0.6 OUTLIER -74.37 -27.97 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.954 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.8 m -80.55 -29.06 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.693 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 31' ' ' LEU . 11.2 tp -88.73 -30.24 19.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.895 0.379 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -106.92 127.2 53.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 35.24 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.98 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -152.06 24.75 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.026 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.861 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.8 mm? -118.07 160.74 21.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -149.28 130.14 7.03 Favored Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.32 131.74 15.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.365 2.043 . . . . 0.0 112.316 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.2 t -127.47 161.79 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.64 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 51' ' ' GLU . 1.1 tm? -130.9 115.06 16.03 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.076 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.58 120.75 18.91 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.3 p -82.16 146.07 29.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -139.35 134.67 32.82 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.5 158.58 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.352 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -106.59 -175.02 2.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.218 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.21 -23.97 64.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.255 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -85.85 -28.53 24.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.296 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.15 -27.98 4.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.657 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -58.42 162.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -115.59 122.95 47.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.205 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -117.26 132.31 56.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.501 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.669 ' HB2' HD11 ' A' ' 39' ' ' LEU . 3.5 pm0 -75.32 110.4 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.8 mm? -106.09 134.93 48.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.462 ' HA ' HD22 ' A' ' 39' ' ' LEU . 2.6 tmm? -86.31 146.82 26.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 0.0 110.776 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.455 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 12.1 p-10 -147.3 143.86 28.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.985 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.931 HD21 HG23 ' A' ' 25' ' ' THR . 16.1 mt -98.91 105.07 17.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.769 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -94.72 132.82 39.07 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.861 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 179.78 -155.23 15.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.503 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 p -150.72 150.75 31.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.569 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.675 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -124.43 149.44 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.677 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.04 116.73 4.63 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.331 2.021 . . . . 0.0 112.503 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' HA2' ' A' ' 136' ' ' GLY . 61.6 t -123.45 84.52 52.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 32.0 Cg_exo -59.51 165.07 10.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.285 1.99 . . . . 0.0 112.351 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -69.15 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.246 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.29 46.77 1.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.089 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.06 -16.73 59.73 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.579 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 1.2 t-20 -99.97 -168.22 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 110.447 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -155.96 128.71 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.757 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.24 -170.62 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.666 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.41 67.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.56 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.56 HG21 ' CD2' ' A' ' 135' ' ' PHE . 13.2 mm -57.65 108.09 1.15 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.239 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 155.61 65.23 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.447 2.098 . . . . 0.0 112.226 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -155.88 153.82 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.0 m -122.17 103.32 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.853 HD11 HD13 ' A' ' 76' ' ' LEU . 1.4 tm? -82.11 129.09 34.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.711 ' N ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -106.92 147.52 29.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.934 0.397 . . . . 0.0 111.108 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.853 HD13 HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -134.67 142.29 46.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.33 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.85 HD21 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -112.8 -178.87 3.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 111.481 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.31 39.42 1.5 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.605 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.443 ' CG2' ' CE2' ' A' ' 17' ' ' TYR . 4.9 m 75.04 25.69 1.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.5 OUTLIER 178.0 142.18 0.27 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.043 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 90.3 Cg_endo -83.83 -40.11 0.82 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.467 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -82.85 65.96 8.23 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.486 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.85 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -32.8 -55.42 0.57 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 122.95 0.5 . . . . 0.0 111.377 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 73.0 Cg_exo -48.65 131.48 24.19 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.404 2.069 . . . . 0.0 112.166 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 84' ' ' PRO . 57.1 Cg_exo -51.81 134.1 46.99 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.459 2.106 . . . . 0.0 112.329 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.515 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 29.1 mt -104.13 148.56 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.486 ' HB3' HD21 ' A' ' 127' ' ' LEU . 26.2 p -134.95 125.25 26.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' HA ' HD12 ' A' ' 109' ' ' ILE . 22.6 m-85 -133.48 142.08 48.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 107' ' ' GLY . 10.8 p -95.57 145.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.781 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.0 123.95 31.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.1 -172.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.477 2.118 . . . . 0.0 112.237 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -170.63 2.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.1 -37.79 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.91 -29.37 14.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.073 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -94.72 -168.4 1.82 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.911 0.386 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.4 t -146.33 -156.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.563 HD11 ' HA2' ' A' ' 107' ' ' GLY . 1.0 OUTLIER -134.85 142.85 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 110.897 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.818 ' HD2' HG21 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -111.83 145.52 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 105' ' ' ALA . 3.8 p -114.89 134.48 55.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.82 -115.78 0.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.472 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -71.43 0.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.628 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -142.23 62.88 1.42 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 111.532 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.818 HG21 ' HD2' ' A' ' 98' ' ' LYS . 6.0 t -135.17 -7.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.867 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 99' ' ' THR . 16.6 m-20 45.7 -167.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.74 0.305 . . . . 0.0 111.286 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.689 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -94.09 -46.81 6.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.129 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.69 -17.23 60.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.184 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.778 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 114.84 20.87 5.56 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.762 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG2' ' CE1' ' A' ' 88' ' ' PHE . 2.4 mptt -83.07 115.49 21.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.759 -0.259 . . . . 0.0 111.04 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.787 HG21 HD12 ' A' ' 111' ' ' LEU . 5.3 mp -73.46 107.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.661 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -95.73 41.58 1.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.787 HD12 HG21 ' A' ' 109' ' ' ILE . 4.0 mt -60.42 119.74 45.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.14 -21.13 27.66 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.438 2.092 . . . . 0.0 112.225 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' TRP . 87.5 m-85 -56.64 -62.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.834 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.4 tp -46.56 -39.47 11.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -59.21 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.532 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.1 35.07 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.91 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 113' ' ' TYR . 7.2 t90 -101.94 122.98 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.932 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -140.55 9.87 2.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.457 ' HB3' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER 174.57 160.42 0.36 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.73 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 1.7 Cg_endo -82.15 -19.24 22.9 Favored 'Cis proline' 0 C--N 1.345 0.358 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.691 0.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -131.09 54.76 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.423 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 39.8 t -70.5 68.61 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.903 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.54 -173.41 3.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 24' ' ' GLU . 7.2 tp -62.41 -40.4 96.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 27' ' ' ASN . 4.5 tp -56.57 -53.78 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.89 -29.66 74.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.21 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 87' ' ' CYS . 7.9 tt -56.44 -31.87 64.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.648 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -82.81 -25.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.978 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.745 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -73.59 -51.48 16.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.998 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' MET . 5.8 p -47.11 -45.62 8.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 3.6 mtm -60.35 -38.71 84.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -56.15 -25.78 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.04 -53.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.409 HG11 ' CE1' ' A' ' 102' ' ' HIS . 56.7 t -54.67 -29.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.49 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.56 ' CD2' HG21 ' A' ' 70' ' ' ILE . 2.8 m-85 -86.41 -27.86 23.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.541 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -74.2 -14.55 80.51 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.802 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -96.47 -30.57 13.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.382 . . . . 0.0 110.958 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.59 109.19 1.48 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.65 123.16 12.69 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 135' ' ' PHE . 94.2 Cg_endo -89.63 25.67 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.3 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.83 -12.94 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -162.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.7 57.84 0.96 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.24 86.17 0.15 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.789 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 122.788 2.325 . . . . 0.0 112.416 179.811 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 p -97.88 -39.59 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.51 143.08 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.787 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -59.44 -35.16 73.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -40.93 82.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -36.9 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.909 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.67 -55.49 34.37 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.569 0.543 . . . . 0.0 110.831 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -58.21 -30.33 66.39 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.89 -41.04 75.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.922 0.392 . . . . 0.0 111.076 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.5 mtp -58.22 -36.32 72.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.588 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.64 HG11 ' SD ' ' A' ' 53' ' ' MET . 22.6 m -112.27 19.65 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.186 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -67.99 -29.13 68.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.908 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -28.44 65.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 5.2 m-85 -55.73 124.07 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HD2' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -51.77 -67.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.0 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.861 ' HB3' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -64.47 -49.19 72.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.832 ' NH1' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER 64.63 -65.97 0.13 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.33 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 17' ' ' TYR . 36.7 t0 -48.05 -43.91 30.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.052 0.453 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.876 HD13 ' H ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -53.03 -36.18 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.876 ' H ' HD13 ' A' ' 20' ' ' LEU . 95.6 m -83.66 -35.58 24.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.843 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.832 HG22 ' NH1' ' A' ' 18' ' ' ARG . 60.7 t -52.08 -35.11 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.761 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -83.52 -40.64 18.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.845 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.752 ' O ' HG23 ' A' ' 28' ' ' VAL . 19.7 mt-10 -66.54 -32.65 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.907 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 t -73.6 -41.63 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -72.16 -47.43 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.021 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.7 m-80 -50.15 -46.52 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.27 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.855 ' CG2' HD23 ' A' ' 124' ' ' LEU . 23.6 t -64.57 -61.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.28 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 26' ' ' VAL . 3.4 pt -59.32 -23.5 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.403 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.7 m -82.58 -28.75 30.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -18.84 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CE2' HG23 ' A' ' 59' ' ' ILE . 7.1 m-85 -125.93 164.28 21.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 0.0 110.602 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -18.52 8.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -96.87 28.63 3.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.718 0.294 . . . . 0.0 111.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.835 HD22 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -117.7 154.51 31.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.44 104.43 2.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' A' ' 55' ' ' LEU . 58.3 Cg_exo -51.02 140.9 38.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.22 1.947 . . . . 0.0 112.588 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.4 t -127.61 161.82 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.109 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.3 tm? -118.48 122.93 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.728 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' N ' HD13 ' A' ' 39' ' ' LEU . 20.6 t0 -157.05 138.9 14.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -87.07 154.02 21.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.24 124.91 28.21 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG12 ' CA ' ' A' ' 49' ' ' SER . 35.4 m -91.18 151.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.22 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.41 ' HZ ' ' HH ' ' A' ' 82' ' ' TYR . 19.9 m-85 -97.19 38.36 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.25 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 69.31 -64.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -125.66 18.51 8.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.56 22.11 12.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.168 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 p 64.07 175.95 0.18 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.744 0.307 . . . . 0.0 111.384 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.702 ' CA ' HG12 ' A' ' 43' ' ' VAL . 15.1 t -80.27 168.73 18.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.09 0.471 . . . . 0.0 111.285 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.31 134.89 12.59 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.88 115.75 3.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.043 0.449 . . . . 0.0 110.797 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.02 158.36 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.008 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.64 ' SD ' HG11 ' A' ' 12' ' ' VAL . 35.9 ttp -130.71 147.23 52.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.912 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 13.4 p-10 -136.61 177.31 7.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.055 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.7 mt -139.6 104.01 4.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.641 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.4 m -99.96 157.41 16.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.879 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.62 -149.4 14.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.42 142.0 31.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 61' ' ' VAL . 37.5 mt -112.21 123.76 33.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.83 112.63 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.3 2.0 . . . . 0.0 112.219 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 59' ' ' ILE . 23.8 t -134.74 94.86 16.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.058 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 55.6 Cg_endo -69.75 152.96 69.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.565 2.177 . . . . 0.0 112.325 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -179.14 -36.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -97.53 45.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.451 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 17.34 79.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.368 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 12.5 t-20 -177.43 165.21 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.509 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.29 129.23 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 -165.57 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.776 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -147.32 86.44 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.013 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.7 mm -79.51 129.29 72.19 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.957 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.506 ' O ' HG23 ' A' ' 72' ' ' ILE . 70.9 Cg_endo -74.63 145.95 33.67 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.664 2.243 . . . . 0.0 112.286 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 71' ' ' PRO . 1.7 pp -158.13 171.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.449 . . . . 0.0 111.042 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 56' ' ' THR . 73.7 m -148.36 161.83 40.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.987 HD21 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -131.92 144.86 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.509 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -120.47 147.28 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.466 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.8 mm? -118.77 -178.7 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.025 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.61 146.21 34.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.192 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -62.94 -35.56 80.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.87 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.517 HG21 ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER 166.54 -26.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.151 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 79' ' ' THR . 39.6 m-85 -160.62 161.76 24.32 Favored Pre-proline 0 C--N 1.334 -0.086 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.789 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -88.52 -26.22 5.68 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.512 0.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.883 ' CD1' HD11 ' A' ' 86' ' ' ILE . 6.9 p90 -76.68 60.67 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.3 m120 -41.21 -52.77 7.14 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 54.2 Cg_exo -51.14 146.1 24.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 112.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.23 127.1 14.52 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.883 HD11 ' CD1' ' A' ' 82' ' ' TYR . 2.7 mt -89.22 151.34 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.011 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.749 ' SG ' HD11 ' A' ' 127' ' ' LEU . 14.4 m -122.9 161.82 23.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.495 ' N ' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -162.13 159.64 26.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.679 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 107' ' ' GLY . 11.4 p -128.37 137.65 56.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.161 0.505 . . . . 0.0 111.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.04 92.79 28.49 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.79 158.26 58.06 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.446 2.097 . . . . 0.0 112.187 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.8 p -84.68 176.49 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.25 0.547 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.0 m -65.37 -25.15 67.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -57.44 -59.03 5.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.057 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -111.25 -179.01 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 143' ' ' SER . 8.9 t -115.01 -157.27 0.63 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.519 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -115.84 121.67 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.159 0.504 . . . . 0.0 110.797 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -81.72 133.69 35.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 105' ' ' ALA . 34.8 p -102.45 131.21 49.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.75 -120.31 0.72 Allowed Glycine 0 C--N 1.322 -0.227 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.671 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -99.79 -57.93 2.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.861 0.363 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.774 ' HB3' HD23 ' A' ' 111' ' ' LEU . 8.7 m-70 -80.79 -41.01 24.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.711 HG21 ' HB2' ' A' ' 140' ' ' PRO . 25.9 t -92.1 75.39 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.087 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -52.98 -178.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.897 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -79.39 -13.98 59.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.815 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.15 23.75 5.48 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.417 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 51.01 30.19 22.34 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.705 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -111.26 115.37 29.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.634 0.254 . . . . 0.0 110.99 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.728 HG22 ' HG ' ' A' ' 111' ' ' LEU . 2.2 mp -60.94 94.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.46 75.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.784 HD13 HG11 ' A' ' 130' ' ' VAL . 1.6 mt -84.02 136.0 41.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.804 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.39 -28.31 18.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 0.0 112.246 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -79.61 -54.29 6.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.804 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.781 ' HG ' HD12 ' A' ' 127' ' ' LEU . 1.9 tm? -62.99 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.73 -35.82 71.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -103.1 25.59 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.418 ' NE1' ' O ' ' A' ' 119' ' ' HIS . 6.4 t90 -107.47 120.61 42.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 24.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.191 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' O ' ' NE1' ' A' ' 117' ' ' TRP . 0.3 OUTLIER 178.37 151.26 0.44 Allowed Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.064 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.77 -30.33 4.02 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.378 -1.509 . . . . 0.0 112.485 -0.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -120.42 57.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.129 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.2 p -76.18 62.98 1.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.751 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.62 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.987 HD11 HD21 ' A' ' 74' ' ' LEU . 3.4 tp -66.59 -33.98 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.48 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -29.49 75.18 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.781 HD12 ' HG ' ' A' ' 114' ' ' LEU . 6.5 tp -56.2 -31.53 63.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.9 mm -78.98 -29.61 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.767 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -62.43 -26.73 68.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.784 HG11 HD13 ' A' ' 111' ' ' LEU . 1.3 p -76.27 -36.81 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.552 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.421 ' HG2' ' CZ ' ' A' ' 135' ' ' PHE . 37.0 mtt -77.86 -42.63 32.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.997 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 129' ' ' GLN . 13.1 tt -58.25 -26.5 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 129' ' ' GLN . 28.6 t -91.2 -58.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.56 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 130' ' ' VAL . 88.0 t -53.55 -50.8 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.48 ' O ' HG11 ' A' ' 61' ' ' VAL . 6.8 m-30 -71.83 -27.3 62.81 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.66 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.04 -12.93 69.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.608 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.06 -47.71 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.55 126.95 2.45 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.83 107.6 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.451 2.101 . . . . 0.0 112.808 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.711 ' HB2' HG21 ' A' ' 103' ' ' VAL . 97.6 Cg_endo -88.64 23.85 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.663 2.242 . . . . 0.0 111.956 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 141' ' ' VAL . 22.9 t -121.99 -4.27 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.928 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' N ' ' A' ' 143' ' ' SER . 17.3 t80 -46.13 -92.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.739 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.582 ' HB2' HG22 ' A' ' 96' ' ' THR . 42.0 t -175.92 35.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.996 0.426 . . . . 0.0 111.601 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.401 ' CG ' ' HD2' ' A' ' 145' ' ' PRO . 23.5 ttp180 63.18 143.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.992 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 144' ' ' ARG . 53.8 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 m -76.5 68.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.41 -175.56 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.12 -35.97 74.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -60.71 -44.88 96.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -32.59 73.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.4 tp -72.95 -25.22 60.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.136 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.44 -24.52 50.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.391 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -22.61 33.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.167 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.427 ' HE1' ' HB2' ' A' ' 39' ' ' LEU . 15.9 ptp -89.98 -34.05 16.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 8' ' ' LEU . 28.3 m -91.31 -1.84 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -69.65 -31.4 69.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.181 0.515 . . . . 0.0 111.105 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -72.35 -26.37 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.16 169.02 0.43 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.994 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -91.87 -38.7 12.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.692 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -122.35 68.33 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.1 0.476 . . . . 0.0 110.937 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.83 -34.81 71.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.859 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.52 -46.45 90.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -33.09 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -70.96 -48.18 54.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 18' ' ' ARG . 42.4 t -71.25 -27.32 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.362 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -48.4 24.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -58.68 -42.48 88.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.973 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.885 HG22 HD11 ' A' ' 29' ' ' ILE . 26.8 m -59.81 -58.97 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.82 -46.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.658 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.1 t-20 -58.46 -22.37 54.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.224 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.018 HG21 HD23 ' A' ' 124' ' ' LEU . 27.2 t -93.19 -22.52 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.48 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.885 HD11 HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER -91.03 -28.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.148 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -80.42 -42.62 22.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 31' ' ' LEU . 7.4 tt -70.98 -23.64 62.24 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.683 ' HE2' HG21 ' A' ' 128' ' ' ILE . 35.1 m-85 -116.97 161.61 19.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 80.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.956 0.408 . . . . 0.0 110.517 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 174.99 -33.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.524 HD22 HG12 ' A' ' 28' ' ' VAL . 1.7 mp -62.46 134.77 56.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.796 0.331 . . . . 0.0 110.925 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 106.03 21.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.936 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.785 ' HA ' HD23 ' A' ' 55' ' ' LEU . 76.1 Cg_exo -50.5 150.37 11.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.384 2.056 . . . . 0.0 112.594 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.5 t -151.51 161.85 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.605 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.488 ' C ' HD13 ' A' ' 39' ' ' LEU . 2.5 tm? -129.85 116.97 19.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -149.54 132.88 16.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.964 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -84.38 158.04 21.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.43 149.21 49.54 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.163 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -126.52 140.12 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.71 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -91.63 170.45 9.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.969 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.26 -3.16 44.61 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.111 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.65 -30.12 22.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.974 0.416 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.9 -27.12 4.67 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.613 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.63 126.37 33.3 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.963 0.411 . . . . 0.0 110.717 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.9 p -101.81 -168.01 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.626 ' HB2' HD21 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -175.87 128.86 0.24 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.087 0.47 . . . . 0.0 110.546 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.713 ' C ' HD22 ' A' ' 52' ' ' LEU . 5.7 mt-10 -86.88 108.14 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.696 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.713 HD22 ' C ' ' A' ' 51' ' ' GLU . 3.0 mm? -123.2 178.95 4.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.012 0.434 . . . . 0.0 111.061 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.83 145.68 46.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -130.5 153.1 49.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 111.078 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 37' ' ' PRO . 2.5 mt -108.87 101.89 10.95 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.857 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.5 m -85.49 132.95 34.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.56 -177.44 42.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.505 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.694 HG22 ' CA ' ' A' ' 71' ' ' PRO . 16.8 p -143.8 130.33 20.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 pt -115.53 154.35 47.79 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.066 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HB3' HG22 ' A' ' 67' ' ' THR . 51.0 Cg_exo -54.53 163.07 4.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.616 2.211 . . . . 0.0 112.568 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.742 HG21 ' CG1' ' A' ' 70' ' ' ILE . 25.4 t -158.24 106.16 1.7 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.684 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.67 92.43 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.335 2.024 . . . . 0.0 112.19 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.443 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 55.3 t80 -132.72 140.34 48.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 mtp85 61.09 18.55 9.12 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 20.45 61.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.566 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.02 176.97 8.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.338 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -96.24 104.8 16.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.752 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -91.12 167.33 12.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.744 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -123.48 111.75 16.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.742 ' CG1' HG21 ' A' ' 61' ' ' VAL . 37.0 mm -108.93 109.5 61.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.694 ' CA ' HG22 ' A' ' 58' ' ' THR . 49.9 Cg_endo -68.92 141.83 49.9 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.361 2.041 . . . . 0.0 112.251 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -147.43 136.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.036 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 118.26 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.699 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.663 HD22 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -84.59 149.68 25.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.482 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -123.57 142.99 50.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.832 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 52' ' ' LEU . 2.6 mm? -121.92 167.4 13.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.608 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.804 HD22 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -149.5 150.91 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.469 0.652 . . . . 0.0 111.065 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.28 -38.4 90.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.3 t 179.57 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.147 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 0.8 OUTLIER -87.47 159.54 49.84 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.739 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 7.5 Cg_exo -73.46 -45.55 0.45 Allowed 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.588 -1.422 . . . . 0.0 111.977 0.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.92 -59.92 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.628 ' O ' HD21 ' A' ' 77' ' ' LEU . 0.9 OUTLIER 166.03 -53.75 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.78 145.14 4.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.733 2.289 . . . . 0.0 112.632 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.58 ' CG ' HD12 ' A' ' 124' ' ' LEU . 72.0 Cg_endo -76.94 143.06 22.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.668 2.245 . . . . 0.0 112.427 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 87' ' ' CYS . 2.9 mp -90.1 160.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.877 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.477 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -134.51 141.41 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.452 ' CZ ' ' CG ' ' A' ' 108' ' ' LYS . 9.7 m-85 -147.73 144.33 28.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 107' ' ' GLY . 33.8 m -95.08 117.69 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.035 0.445 . . . . 0.0 111.365 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -81.08 121.25 80.44 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.77 137.87 67.81 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.463 2.108 . . . . 0.0 112.219 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 95' ' ' MET . 8.8 t -115.2 -167.11 1.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.642 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m -86.98 -56.2 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.81 -29.7 67.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.765 ' H ' HG23 ' A' ' 92' ' ' THR . 2.3 mpp? -135.88 -169.47 2.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.4 p -150.0 -80.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.782 HD11 HG23 ' A' ' 89' ' ' VAL . 0.4 OUTLIER 179.69 109.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.404 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.66 116.71 28.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 104' ' ' ASP . 27.8 p -53.25 131.82 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.53 -96.46 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -60.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 111.032 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.739 ' CD2' HG21 ' A' ' 134' ' ' VAL . 22.5 m-70 -127.47 48.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.31 -17.88 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.799 ' O ' HG22 ' A' ' 99' ' ' THR . 7.9 p-10 40.56 -158.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.335 0.254 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 5.27 48.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -131.26 28.62 4.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 51.07 25.36 10.2 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.013 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -85.96 136.6 33.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.881 ' CG2' HD12 ' A' ' 111' ' ' LEU . 1.4 mp -68.99 88.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 110.523 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.09 62.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.847 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.881 HD12 ' CG2' ' A' ' 109' ' ' ILE . 9.8 mt -95.23 109.25 43.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.83 -29.44 82.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.457 2.105 . . . . 0.0 112.131 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -54.08 50.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.009 HD22 HD13 ' A' ' 127' ' ' LEU . 55.5 tp -60.41 -33.34 72.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.48 -44.44 89.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.602 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.87 24.53 6.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.4 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 3.8 t90 -112.99 121.84 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.944 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.9 27.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.448 ' CG ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER 175.11 158.33 0.37 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.448 ' HA ' ' CG ' ' A' ' 119' ' ' HIS . 93.0 Cg_endo -85.95 4.49 65.8 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 123.342 -1.524 . . . . 0.0 112.73 0.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 28.66 0.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.872 0.368 . . . . 0.0 111.073 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.4 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 6.0 t -54.43 117.95 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.37 -164.25 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.018 HD23 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -51.76 -28.12 14.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 125' ' ' LEU . 3.2 mm? -68.97 -55.0 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.07 -35.99 92.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.345 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 1.009 HD13 HD22 ' A' ' 114' ' ' LEU . 66.7 tp -55.72 -31.7 62.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.683 HG21 ' HE2' ' A' ' 32' ' ' TYR . 24.7 mm -79.7 -21.74 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.809 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -82.54 -33.67 28.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.26 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 131' ' ' MET . 11.3 p -72.75 -47.37 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.528 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.6 mtm -66.8 -42.82 85.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.14 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 129' ' ' GLN . 4.0 tt -53.84 -30.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.97 0.414 . . . . 0.0 110.863 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 129' ' ' GLN . 30.0 t -85.81 -51.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.464 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.739 HG21 ' CD2' ' A' ' 102' ' ' HIS . 1.2 p -54.76 -51.14 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.865 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.536 ' CD1' HG22 ' A' ' 61' ' ' VAL . 2.1 p90 -87.31 -9.15 55.69 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.38 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.439 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -72.82 -24.67 75.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.77 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.18 -30.69 15.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.541 0.21 . . . . 0.0 110.601 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -162.84 118.99 1.21 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.565 ' HB3' HD11 ' A' ' 70' ' ' ILE . 24.3 Cg_exo -61.93 110.93 1.08 Allowed 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.537 2.158 . . . . 0.0 112.155 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.06 -15.97 7.66 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.418 2.079 . . . . 0.0 112.561 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.468 HG21 HG23 ' A' ' 70' ' ' ILE . 98.1 t -57.04 -19.34 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -41.37 2.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t 65.79 57.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.621 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -109.43 97.09 25.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.81 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 122.313 2.009 . . . . 0.0 112.424 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.045 0.45 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 3' ' ' VAL . 14.6 t -120.76 37.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.477 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -163.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.817 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -27.44 6.52 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.567 0.542 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -36.87 71.22 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.531 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -24.99 38.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.12 -50.92 71.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.01 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.91 -31.68 68.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.114 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -65.26 -28.06 69.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.615 ' HG2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -80.77 -31.2 35.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 111.063 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.656 HG21 ' CG2' ' A' ' 22' ' ' VAL . 29.3 m -103.15 20.22 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.735 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.8 -29.65 45.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.8 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -99.06 -18.89 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.428 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' HD2' HG21 ' A' ' 21' ' ' THR . 2.3 m-30 -55.58 146.11 21.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 79' ' ' THR . 9.7 tttm -56.09 -24.73 42.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -140.32 128.44 22.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.699 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.699 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.5 ttp85 -101.09 -64.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -50.59 63.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 20' ' ' LEU . 2.5 tm? -63.43 -50.79 68.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.222 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.483 HG21 ' HD2' ' A' ' 15' ' ' TYR . 99.1 m -62.25 -34.5 76.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 18' ' ' ARG . 59.5 t -83.67 -23.47 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -30.36 21.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 0.0 111.001 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.806 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.89 -31.44 64.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.2 t -69.65 -47.43 63.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.498 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 22' ' ' VAL . 1.4 t -61.13 -55.76 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.282 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HB3' HD21 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -46.28 -40.27 11.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.74 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 24' ' ' GLU . 35.2 t -76.47 -63.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.714 HG22 ' HB3' ' A' ' 35' ' ' LEU . 4.7 pt -51.9 -34.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.306 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -73.17 -29.09 62.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.63 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -76.08 -33.56 59.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.011 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB2' HD23 ' A' ' 35' ' ' LEU . 4.2 m-85 -93.73 -0.27 56.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.794 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.85 37.15 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.224 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -169.34 47.88 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.845 0.355 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.714 ' HB3' HG22 ' A' ' 29' ' ' ILE . 3.9 mm? -117.9 151.1 38.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.928 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.25 96.08 25.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.06 129.05 17.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.435 2.09 . . . . 0.0 111.992 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.8 t -125.27 162.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.287 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.846 HD11 ' HG3' ' A' ' 51' ' ' GLU . 2.6 tm? -128.36 98.93 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.731 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.67 126.97 48.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.6 p -84.62 128.45 34.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.295 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -97.16 104.22 16.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.602 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.455 HG12 ' OG ' ' A' ' 49' ' ' SER . 30.3 m -60.06 137.03 23.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.289 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -84.23 -175.97 6.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 110.96 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.59 -11.83 60.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -85.88 -30.93 22.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.572 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.5 -30.5 4.01 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.271 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.24 165.99 1.8 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.158 0.504 . . . . 0.0 110.632 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.455 ' OG ' HG12 ' A' ' 43' ' ' VAL . 19.0 m -122.68 120.07 32.6 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.058 0.456 . . . . 0.0 111.026 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -96.67 118.52 33.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.846 ' HG3' HD11 ' A' ' 39' ' ' LEU . 5.0 tt0 -64.67 106.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.3 mm? -118.71 131.99 56.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.154 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.416 ' HA ' HD22 ' A' ' 39' ' ' LEU . 6.1 tmm? -92.91 147.39 22.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 15.2 p-10 -141.71 159.61 41.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.937 0.399 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.007 HD12 HD13 ' A' ' 74' ' ' LEU . 4.7 mt -126.7 103.92 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -101.34 140.67 35.31 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 176.4 169.18 37.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -116.28 144.48 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 110.935 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -109.43 139.9 21.56 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 59' ' ' ILE . 70.3 Cg_endo -74.9 60.52 5.38 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.535 2.157 . . . . 0.0 112.21 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 59' ' ' ILE . 92.7 t -90.56 133.39 32.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.9 143.56 33.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.144 1.896 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -83.46 -77.01 0.26 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -110.82 -61.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.92 14.15 3.1 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.449 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -175.27 3.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.81 143.2 27.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.7 174.37 10.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -128.66 103.02 6.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.72 102.68 10.78 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.98 154.4 70.85 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.313 2.009 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 pt -155.78 156.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.238 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 130.19 53.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.007 HD13 HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -106.42 137.84 43.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.766 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -125.79 145.95 50.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.686 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.766 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.4 mm? -125.49 165.26 18.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -125.64 165.55 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.98 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -94.85 -27.79 15.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -173.35 -40.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HB3' ' HA ' ' A' ' 81' ' ' PRO . 28.5 m-85 -102.01 161.93 21.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 55.6 Cg_endo -73.22 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.757 -0.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 22.5 m-85 -105.45 -58.04 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.763 ' O ' HD11 ' A' ' 77' ' ' LEU . 0.3 OUTLIER 165.57 -53.93 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.967 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 82' ' ' TYR . 91.0 Cg_exo -42.91 119.14 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.803 2.335 . . . . 0.0 112.807 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.746 ' HB3' HD13 ' A' ' 76' ' ' LEU . 31.5 Cg_exo -59.0 164.46 10.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.598 2.199 . . . . 0.0 112.301 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 87' ' ' CYS . 19.8 mm -104.02 159.54 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -136.31 157.11 47.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.083 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CE2' ' CG ' ' A' ' 108' ' ' LYS . 37.1 m-85 -146.62 170.24 17.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 107' ' ' GLY . 9.6 m -124.76 77.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.732 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -49.01 105.13 0.47 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.52 -178.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.345 2.03 . . . . 0.0 112.24 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.29 179.41 8.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.253 0.549 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 p -88.11 6.92 34.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.5 m -95.22 -58.87 2.02 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -178.57 3.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 143' ' ' SER . 10.2 t -109.87 -163.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.727 HD11 ' HA3' ' A' ' 107' ' ' GLY . 0.8 OUTLIER -119.87 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 110.998 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.28 147.47 23.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 104' ' ' ASP . 0.7 OUTLIER -86.48 136.18 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.973 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.4 -166.24 36.04 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.788 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -26.29 48.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.784 0.326 . . . . 0.0 111.152 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.766 ' CE1' HG23 ' A' ' 109' ' ' ILE . 2.4 t-80 -94.27 -28.17 15.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.083 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.614 HG12 HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -134.34 68.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.058 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 103' ' ' VAL . 1.2 p-10 -47.56 -105.82 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.104 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.45 -54.42 2.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.703 0.287 . . . . 0.0 111.479 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -95.71 38.64 1.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.584 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.84 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 52.14 53.76 29.39 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.533 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.458 ' CG ' ' CE2' ' A' ' 88' ' ' PHE . 3.1 mtmm -102.78 133.72 47.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.815 HD11 HG13 ' A' ' 89' ' ' VAL . 5.3 mp -87.46 106.01 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.97 48.34 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 113' ' ' TYR . 11.8 mt -70.19 121.98 84.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.63 -19.15 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.53 2.153 . . . . 0.0 112.606 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.676 ' CD2' HD22 ' A' ' 111' ' ' LEU . 15.2 m-85 -56.33 -54.33 46.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.0 111.082 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -64.47 -30.86 71.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.012 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.57 -41.47 84.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.18 27.39 7.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -89.55 115.56 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 86.13 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER 68.73 158.53 0.15 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 -179.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 119' ' ' HIS . 68.2 Cg_endo -89.8 9.65 63.54 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.999 0.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.82 30.23 1.86 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.9 t -66.17 78.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.12 -172.38 2.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.721 HD11 HD21 ' A' ' 74' ' ' LEU . 12.6 tp -57.44 -34.26 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 27' ' ' ASN . 1.7 mm? -62.36 -53.38 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.806 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.42 -38.55 95.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.1 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 114' ' ' LEU . 32.3 tp -54.21 -28.76 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 110.649 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mm -84.33 -29.01 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.802 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.443 ' HA ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -61.65 -40.51 95.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.838 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.827 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.1 p -59.92 -42.93 91.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.414 . . . . 0.0 110.496 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.42 ' HB3' ' CD2' ' A' ' 135' ' ' PHE . 10.4 mtt -65.98 -34.4 78.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.315 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 129' ' ' GLN . 2.8 mt -60.08 -30.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.514 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.03 -52.81 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 130' ' ' VAL . 44.2 t -52.1 -49.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 131' ' ' MET . 17.6 m-30 -80.38 -27.2 38.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.94 -24.86 68.84 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.512 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.96 -44.45 12.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.991 0.424 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -177.08 123.64 0.28 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.81 144.09 56.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.361 2.041 . . . . 0.0 112.35 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.75 -39.66 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.607 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 m -63.24 117.67 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.2 t80 176.64 -176.26 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.969 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.651 ' HB3' HG21 ' A' ' 96' ' ' THR . 11.2 p -143.72 24.29 1.71 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.89 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -177.03 80.99 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.999 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.504 2.136 . . . . 0.0 112.384 179.862 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.656 0.265 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -122.64 70.81 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.91 0.386 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t -72.83 164.03 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.421 . . . . 0.0 110.687 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.1 -31.26 69.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 111.085 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -51.96 51.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.785 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -59.19 -41.59 88.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.197 0.522 . . . . 0.0 111.312 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.519 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.2 tp -66.01 -28.49 68.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -58.79 -48.43 81.28 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.966 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -61.85 -35.96 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.75 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mtp -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.765 HG12 ' SD ' ' A' ' 53' ' ' MET . 25.0 m -108.3 19.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.705 0.288 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.3 p -71.89 -29.14 64.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -74.12 -29.08 61.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.045 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 21' ' ' THR . 4.6 m-85 -58.59 127.58 32.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.043 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB3' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER -59.29 -31.51 69.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.092 0.473 . . . . 0.0 111.307 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' ASP . 5.1 m-85 -90.44 -55.18 3.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.662 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.4 ttm180 66.67 -68.35 0.14 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.6 t0 -58.67 -53.16 61.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.102 0.477 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 20' ' ' LEU . 1.1 tt -59.32 -30.79 68.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.756 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.635 HG23 ' CD2' ' A' ' 76' ' ' LEU . 7.1 m -74.96 -53.03 9.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.011 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 18' ' ' ARG . 32.8 t -63.5 -36.15 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.304 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -62.8 -52.25 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 28' ' ' VAL . 60.7 mt-10 -63.05 -35.53 80.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.613 HG23 ' CD2' ' A' ' 55' ' ' LEU . 61.8 m -70.1 -35.66 74.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -81.56 -47.12 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.5 m-80 -53.23 -30.28 37.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.588 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.796 HG21 HD23 ' A' ' 124' ' ' LEU . 35.5 t -84.5 -61.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 26' ' ' VAL . 6.0 pt -53.56 -38.98 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.557 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.0 t -68.55 -36.96 79.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 125' ' ' LEU . 5.1 mp -77.54 -52.7 8.63 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.368 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -76.45 -17.93 59.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.034 0.445 . . . . 0.0 111.815 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 65.92 -61.57 0.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.318 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' OD1' HD22 ' A' ' 35' ' ' LEU . 1.9 p30 -53.73 -37.03 62.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.849 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.531 HD13 ' HA3' ' A' ' 57' ' ' GLY . 2.3 mm? -63.05 129.07 38.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.72 145.28 52.87 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.18 155.45 22.48 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.673 2.249 . . . . 0.0 112.738 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 39' ' ' LEU . 4.9 t -147.74 161.63 7.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 51' ' ' GLU . 2.2 tm? -134.13 102.21 5.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.218 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -117.76 128.61 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.343 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -77.53 145.91 36.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.66 104.25 3.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 49' ' ' SER . 29.4 m -63.11 172.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -124.87 90.3 3.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.692 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.72 -72.59 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.845 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.84 37.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.098 0.475 . . . . 0.0 111.217 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.78 -24.31 6.43 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.62 -167.51 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 0.0 110.788 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.426 ' HA ' HG12 ' A' ' 43' ' ' VAL . 49.3 m -127.47 105.34 8.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.461 ' HB3' HD21 ' A' ' 52' ' ' LEU . 1.6 tpp180 -91.07 126.82 36.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.223 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' HG2' HD11 ' A' ' 39' ' ' LEU . 4.2 mt-10 -88.84 91.08 8.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 110.567 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.1 mm? -87.01 153.94 21.16 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.211 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.765 ' SD ' HG12 ' A' ' 12' ' ' VAL . 2.4 mtp -105.36 145.74 30.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.392 . . . . 0.0 110.574 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 4.4 p30 -136.61 132.78 35.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' CD2' HG23 ' A' ' 25' ' ' THR . 16.1 mt -101.49 116.13 32.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -117.68 143.79 45.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.802 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -179.71 164.09 31.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.444 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.718 HG22 ' CA ' ' A' ' 71' ' ' PRO . 33.5 p -113.97 140.0 48.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.611 ' N ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -121.48 156.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.356 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.44 136.73 60.82 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.839 2.359 . . . . 0.0 112.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 70' ' ' ILE . 62.1 t -152.67 95.67 3.04 Favored Pre-proline 0 C--O 1.223 -0.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.002 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.59 130.43 29.9 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.067 1.845 . . . . 0.0 112.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -127.95 -74.78 0.57 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.07 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -96.5 38.77 1.19 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 -23.3 35.81 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.512 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -112.64 164.89 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 110.786 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 m -72.88 135.49 45.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.59 -169.01 1.46 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -138.18 94.64 2.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.987 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.722 HG21 ' HD2' ' A' ' 135' ' ' PHE . 24.0 mm -92.39 106.64 18.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 0.0 111.026 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.718 ' CA ' HG22 ' A' ' 58' ' ' THR . 58.3 Cg_endo -71.66 156.93 56.78 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.001 1.801 . . . . 0.0 112.523 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 71' ' ' PRO . 23.3 pt -158.18 178.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -146.0 160.21 42.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 75' ' ' TRP . 0.3 OUTLIER -129.72 162.44 28.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.774 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.518 ' H ' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -130.86 145.69 52.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 52' ' ' LEU . 1.4 tp -136.84 160.88 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.11 167.37 16.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.342 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.1 m-20 -93.84 -40.76 10.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 16' ' ' LYS . 18.2 p -159.88 -48.49 0.05 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.748 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.507 ' HB3' ' HA ' ' A' ' 81' ' ' PRO . 5.4 m-85 -115.95 168.12 9.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.777 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 62.7 Cg_endo -91.47 -33.5 0.99 Allowed 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.925 -1.281 . . . . 0.0 113.699 0.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 73.1 m-85 -82.36 -71.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.488 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 7.1 t30 129.79 -48.71 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 O-C-N 123.788 0.68 . . . . 0.0 111.069 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 60.5 Cg_endo -75.51 133.58 16.01 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.173 1.915 . . . . 0.0 112.334 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 138.75 41.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.725 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 87' ' ' CYS . 5.6 mt -99.75 159.42 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.501 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HB3' HD12 ' A' ' 109' ' ' ILE . 5.3 m -126.36 141.72 51.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.935 0.398 . . . . 0.0 111.281 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.456 ' CE2' ' HG3' ' A' ' 108' ' ' LYS . 10.4 m-85 -142.33 -177.25 5.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.551 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 107' ' ' GLY . 36.0 m -119.77 171.71 7.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 111.129 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -138.69 99.98 8.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 164.95 31.97 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.525 2.15 . . . . 0.0 112.162 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.79 177.11 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.168 0.508 . . . . 0.0 110.996 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.4 t -83.75 -31.21 26.1 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.657 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -29.55 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.758 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -113.44 -178.47 3.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 5.5 t -125.1 -166.43 1.53 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.675 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.556 HD11 HG21 ' A' ' 89' ' ' VAL . 4.2 tt -115.39 120.85 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 143' ' ' SER . 6.6 tttt -76.16 127.38 32.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.014 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.688 HG22 ' HA ' ' A' ' 105' ' ' ALA . 67.2 p -98.69 129.86 45.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.63 -123.49 0.73 Allowed Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.617 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -51.22 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.926 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.851 ' CE1' HG23 ' A' ' 109' ' ' ILE . 17.8 t-80 -70.79 -46.3 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.04 77.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.107 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -50.58 175.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.361 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.688 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -58.35 -26.38 63.07 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.036 0.446 . . . . 0.0 111.406 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -94.25 20.94 7.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.246 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 50.96 43.76 49.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.763 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 88' ' ' PHE . 19.1 mtmt -106.12 124.79 50.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.738 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' CE ' ' A' ' 131' ' ' MET . 59.7 mt -66.02 110.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 111.081 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -123.96 94.34 4.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.582 HD21 HG21 ' A' ' 134' ' ' VAL . 9.7 mt -107.77 133.68 20.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.166 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.51 -32.48 96.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.38 2.053 . . . . 0.0 112.038 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.32 -52.39 64.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.484 HD12 ' CE3' ' A' ' 117' ' ' TRP . 8.3 tp -60.68 -32.66 71.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.57 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -61.29 -43.78 98.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.547 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -98.41 25.7 6.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 2.6 t90 -98.56 129.47 45.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.88 103.78 5.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 9.8 p80 -52.37 178.08 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.572 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.733 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 58.1 Cg_endo -70.55 4.0 5.1 Favored 'Cis proline' 0 C--N 1.356 0.968 0 N-CA-C 114.517 0.929 . . . . 0.0 114.517 1.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' N ' ' HA ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -71.54 -1.8 14.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 30.1 t -93.49 155.18 17.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.875 0.369 . . . . 0.0 111.097 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.72 162.7 32.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.796 HD23 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -77.71 -37.92 48.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 28' ' ' VAL . 2.4 mp -57.37 -51.75 68.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.753 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.09 -29.61 73.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.0 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.484 HD21 ' SG ' ' A' ' 87' ' ' CYS . 41.6 tp -56.98 -30.79 64.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.615 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mm -82.9 -26.7 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.761 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.1 tp60 -64.82 -45.96 84.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.713 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.2 p -47.45 -45.63 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.872 ' CE ' HD13 ' A' ' 109' ' ' ILE . 1.3 mtt -62.97 -42.9 99.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.3 OUTLIER -53.09 -27.12 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 111.032 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 t -94.21 -52.93 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.58 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.746 HG11 ' HD2' ' A' ' 102' ' ' HIS . 43.6 t -54.47 -36.46 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.495 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.722 ' HD2' HG21 ' A' ' 70' ' ' ILE . 5.7 m-85 -81.53 -28.78 33.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.653 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.432 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -68.32 -11.75 62.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.637 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -45.82 7.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.678 0.239 . . . . 0.0 111.055 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -153.96 109.03 2.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.43 116.47 3.24 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.516 2.144 . . . . 0.0 112.199 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.83 44.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.091 2.527 . . . . 0.0 112.244 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 141' ' ' VAL . 15.1 t -124.95 -7.19 6.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.862 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.39 -61.01 1.77 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.277 -0.264 . . . . 0.0 111.129 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER 73.37 53.37 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.86 0.362 . . . . 0.0 110.856 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.98 88.66 17.68 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.103 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--O 1.248 0.979 0 C-N-CA 122.694 2.263 . . . . 0.0 112.469 179.747 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.764 0.316 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 3' ' ' VAL . 21.6 t -128.5 44.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -59.46 166.05 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 110.799 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -33.32 74.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -36.3 83.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.41 . . . . 0.0 110.529 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.7 -30.82 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.696 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 3' ' ' VAL . 1.1 tt -73.89 -31.07 62.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -72.04 -46.76 55.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -31.27 67.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.479 ' HE2' ' HG ' ' A' ' 39' ' ' LEU . 7.7 ttm -63.49 -48.75 76.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.726 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 22' ' ' VAL . 17.2 m -94.53 19.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.66 -42.96 39.96 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -70.78 -25.28 62.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.652 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.78 121.69 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.305 0.378 . . . . 0.0 111.149 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 tptt -60.13 -36.68 78.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -108.4 44.55 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.6 ttp-105 -51.04 -52.42 43.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -54.04 -32.22 53.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.75 -29.03 18.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 76' ' ' LEU . 86.3 m -78.05 -47.0 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 12' ' ' VAL . 40.3 t -64.78 -38.16 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -45.67 53.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.875 ' O ' HG23 ' A' ' 28' ' ' VAL . 48.9 mm-40 -62.5 -39.39 93.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.767 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.755 HG22 HD11 ' A' ' 29' ' ' ILE . 63.8 m -63.31 -59.15 5.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.39 -47.43 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.487 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.696 ' HB3' HD13 ' A' ' 125' ' ' LEU . 4.1 t-20 -57.58 -26.2 61.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -85.96 -27.86 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.377 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -91.19 -29.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.88 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.7 m -69.7 -46.45 65.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.505 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -72.19 -40.81 67.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.953 0.406 . . . . 0.0 110.725 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -103.36 116.31 32.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.826 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.86 31.02 3.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.02 23.12 5.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.62 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.4 mm? -117.07 165.88 12.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.84 121.93 9.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 127.96 16.3 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.393 2.062 . . . . 0.0 112.428 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.6 t -123.76 162.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.771 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HG ' ' HE2' ' A' ' 11' ' ' MET . 2.2 tm? -146.84 110.06 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.56 141.36 52.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.37 116.39 28.94 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.381 0.425 . . . . 0.0 111.18 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.448 ' H ' HD23 ' A' ' 52' ' ' LEU . 10.0 t80 -91.4 135.17 34.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.656 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 48' ' ' SER . 35.8 m -85.58 167.24 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.155 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 48.6 m-85 -136.84 148.77 47.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.255 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.89 -63.44 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.073 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 5.1 p30 176.3 -24.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.679 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.34 23.4 2.54 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.018 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 44' ' ' PHE . 27.7 t -99.71 175.26 5.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 162.72 38.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.797 0.332 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' HB3' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -169.62 150.3 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.454 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.561 ' C ' HD22 ' A' ' 52' ' ' LEU . 3.7 tt0 -83.82 111.08 18.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.881 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.6 mm? -122.74 116.21 23.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.151 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -81.97 147.56 29.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.427 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 15.3 p-10 -148.11 143.87 27.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 25' ' ' THR . 44.2 mt -108.75 116.51 32.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.6 m -116.38 145.53 43.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.62 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 160.61 175.83 32.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -100.31 147.24 26.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.486 HG22 HG13 ' A' ' 61' ' ' VAL . 23.1 mt -107.34 114.52 60.86 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.046 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.43 70.1 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.301 2.0 . . . . 0.0 112.1 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 59' ' ' ILE . 7.6 m -89.96 144.68 31.8 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 35.9 Cg_endo -65.34 153.89 76.12 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.188 1.925 . . . . 0.0 112.345 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 139' ' ' PRO . 57.7 t80 -154.49 105.69 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 1.3 mpt_? 60.43 29.1 18.75 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.989 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.05 3.52 67.77 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.784 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 1.5 t-20 -120.75 178.35 4.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.692 0.246 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.54 131.57 44.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.726 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.21 163.08 22.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.829 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.512 ' O ' HD13 ' A' ' 70' ' ' ILE . 7.9 p-10 -121.74 123.5 41.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.722 HG23 ' CG2' ' A' ' 141' ' ' VAL . 18.7 mm -123.07 103.22 36.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' A' ' 91' ' ' PRO . 55.3 Cg_endo -69.93 133.16 24.58 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.092 1.862 . . . . 0.0 112.305 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.473 ' CD1' HD11 ' A' ' 59' ' ' ILE . 2.9 pt -142.95 167.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -131.0 134.62 46.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.447 HD13 HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -107.45 137.85 44.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.979 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.514 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -115.52 144.44 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.777 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 52' ' ' LEU . 6.1 mp -138.51 160.06 40.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.68 163.83 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.3 -43.41 23.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 80' ' ' TYR . 4.4 t 179.97 33.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.434 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 1.8 m-85 -153.91 151.31 24.53 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.649 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 72.5 Cg_endo -76.7 -44.0 0.58 Allowed 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.173 -1.595 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.433 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 72.2 m-85 -103.92 -60.81 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.557 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 5.8 t-20 162.88 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 O-C-N 123.58 0.55 . . . . 0.0 110.833 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 81.5 Cg_exo -45.34 108.65 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.497 2.132 . . . . 0.0 112.607 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.57 145.08 30.77 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.498 2.132 . . . . 0.0 112.211 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 87' ' ' CYS . 16.5 mt -91.51 160.02 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.48 ' N ' HG22 ' A' ' 86' ' ' ILE . 4.8 p -143.5 137.66 28.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.04 0.448 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.45 ' CZ ' ' HE2' ' A' ' 108' ' ' LYS . 6.5 m-85 -140.97 143.4 34.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.637 HG22 ' HA3' ' A' ' 107' ' ' GLY . 24.8 m -84.22 146.14 7.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.066 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.08 72.29 76.54 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 71' ' ' PRO . 75.7 Cg_exo -51.34 170.82 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.588 2.192 . . . . 0.0 112.312 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.22 176.99 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -72.77 -27.13 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -5.8 50.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.516 ' HB3' HG12 ' A' ' 141' ' ' VAL . 20.7 mtm -145.81 -174.79 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.65 0.262 . . . . 0.0 110.983 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.872 HG22 ' HB2' ' A' ' 143' ' ' SER . 12.4 t -134.18 -164.68 1.54 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.266 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.846 HD11 ' HA2' ' A' ' 107' ' ' GLY . 11.3 tt -111.3 99.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.669 ' O ' HG11 ' A' ' 103' ' ' VAL . 2.7 ttpp -75.29 114.31 13.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 p -72.64 134.98 45.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.34 -118.66 1.26 Allowed Glycine 0 CA--C 1.515 0.083 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.672 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -31.69 11.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -118.26 -29.69 5.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 98' ' ' LYS . 11.8 t -57.23 -27.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.566 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 56.55 -152.94 0.37 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.679 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 -40.9 5.97 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -93.46 3.66 55.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.846 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . 91.5 4.85 67.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.134 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HE2' ' CZ ' ' A' ' 88' ' ' PHE . 8.1 tttm -60.18 108.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.768 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 109' ' ' ILE . 4.2 mp -74.65 66.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -92.38 57.57 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 110.856 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.593 HD21 HG11 ' A' ' 134' ' ' VAL . 7.1 mt -53.19 151.71 9.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.417 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.483 ' HA ' ' CE1' ' A' ' 115' ' ' HIS . 32.5 Cg_exo -57.58 -45.83 31.24 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.573 2.182 . . . . 0.0 111.987 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -66.54 -39.58 88.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.99 -52.32 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.483 ' CE1' ' HA ' ' A' ' 112' ' ' PRO . 2.8 p-80 -64.87 -35.86 82.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.669 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.453 ' N ' ' CD2' ' A' ' 115' ' ' HIS . 1.4 tt0 -95.95 26.0 4.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CE2' ' HA ' ' A' ' 122' ' ' SER . 2.5 t90 -94.79 -71.12 0.68 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 122' ' ' SER . 2.6 tptt 80.29 -165.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.645 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -154.32 -175.9 0.55 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.241 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.71 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 17.0 Cg_endo -57.21 -16.98 1.43 Allowed 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 124.837 -0.901 . . . . 0.0 114.051 1.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.536 ' N ' ' HA ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -32.4 -49.17 0.2 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 117' ' ' TRP . 33.3 t -46.25 158.27 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.067 0.461 . . . . 0.0 111.696 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -177.85 146.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -59.52 -46.48 88.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' A' ' 27' ' ' ASN . 11.6 tp -51.81 -46.13 64.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.91 -31.34 35.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.632 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 130' ' ' VAL . 11.3 tp -56.13 -31.78 63.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 124' ' ' LEU . 2.9 mp -86.73 -28.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.56 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -59.93 -38.65 82.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.9 p -61.65 -42.65 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.518 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.42 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 52.8 mtt -65.37 -42.73 92.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.674 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.2 mp -52.05 -26.77 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.644 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 t -95.03 -54.89 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.668 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 130' ' ' VAL . 38.1 t -55.3 -37.08 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.727 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.714 ' HD2' HG21 ' A' ' 70' ' ' ILE . 3.4 m-85 -83.22 -28.08 29.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.403 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.21 -13.02 61.64 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.716 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -99.85 -45.24 5.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 0.217 . . . . 0.0 111.195 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.3 100.63 4.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.118 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 50.7 Cg_exo -55.91 119.73 7.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.386 2.057 . . . . 0.0 112.166 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 88.9 Cg_endo -78.62 -0.64 10.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.449 2.1 . . . . 0.0 112.847 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.722 ' CG2' HG23 ' A' ' 70' ' ' ILE . 22.6 t -93.21 -2.71 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.525 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 143' ' ' SER . 0.5 OUTLIER -39.42 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 111.459 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.872 ' HB2' HG22 ' A' ' 96' ' ' THR . 29.5 t -173.21 31.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.222 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -78.89 110.41 14.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.304 2.003 . . . . 0.0 112.361 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.938 0.399 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 3' ' ' VAL . 26.2 t 66.17 42.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.982 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t 66.04 159.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.482 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.79 -29.31 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.989 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -54.19 -38.24 65.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.439 ' CB ' ' HB ' ' A' ' 3' ' ' VAL . 5.7 tp60 -67.77 -45.83 73.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 12' ' ' VAL . 10.7 tp -59.32 -33.06 70.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.5 -50.95 71.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -32.7 73.94 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.488 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmm -70.14 -36.92 75.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 8' ' ' LEU . 27.2 m -99.51 16.76 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.174 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -69.97 -35.67 74.63 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 111.129 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -29.08 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.644 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.568 ' HD2' HG21 ' A' ' 21' ' ' THR . 4.2 m-30 -57.12 117.84 4.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -44.02 90.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CE1' ' OG1' ' A' ' 21' ' ' THR . 0.7 OUTLIER -95.55 33.93 1.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.9 ttt180 -49.18 -31.0 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.959 0.409 . . . . 0.0 109.996 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.65 -43.56 93.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.181 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -80.81 -25.45 37.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.951 0.405 . . . . 0.0 110.144 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.568 HG21 ' HD2' ' A' ' 15' ' ' TYR . 18.7 m -74.15 -54.81 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.596 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.6 t -63.15 -30.0 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.054 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -44.67 18.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.076 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.841 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.8 mm-40 -71.17 -40.11 71.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.495 ' O ' HD13 ' A' ' 29' ' ' ILE . 89.8 m -61.44 -47.86 83.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.111 0.481 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -60.87 -47.08 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.605 ' HB3' HD11 ' A' ' 125' ' ' LEU . 4.7 t-20 -57.53 -25.65 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 24' ' ' GLU . 39.8 t -67.08 -58.26 7.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.212 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -71.59 -19.48 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.454 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -64.65 -42.61 95.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.833 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.658 HD12 ' CG ' ' A' ' 32' ' ' TYR . 1.2 pp -88.04 -43.15 11.92 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CG ' HD12 ' A' ' 31' ' ' LEU . 10.6 m-85 -107.93 109.16 20.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -89.71 64.8 6.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.423 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -145.65 -45.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.3 mm? -62.79 140.03 58.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 106.09 37.9 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.87 128.46 17.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.234 1.956 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.3 t -130.24 161.94 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.174 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.641 HD11 ' HB3' ' A' ' 51' ' ' GLU . 1.7 tm? -114.89 91.63 3.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.48 117.57 34.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 p -82.04 138.52 34.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -115.35 136.34 53.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 45' ' ' ASN . 12.3 p -90.94 134.62 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -99.06 30.1 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.737 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.613 ' H ' HG22 ' A' ' 43' ' ' VAL . 1.5 m-80 63.88 -77.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.5 -15.71 16.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 111.805 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 31.01 7.03 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.32 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.25 -170.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.6 p -121.57 130.25 53.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.06 160.32 15.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.805 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.641 ' HB3' HD11 ' A' ' 39' ' ' LEU . 12.4 mt-10 -94.95 99.23 11.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.436 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.714 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.2 mm? -104.43 139.07 39.9 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.7 ttp -89.87 146.12 24.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.832 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -139.29 130.94 27.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.4 92.3 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.089 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -95.3 135.25 37.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.68 -148.37 7.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.02 128.59 7.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 pt -107.09 151.13 40.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.53 132.73 27.94 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.432 2.088 . . . . 0.0 112.197 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 136' ' ' GLY . 41.0 t -138.92 106.29 7.44 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.201 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 52.2 Cg_endo -69.11 120.65 7.51 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.66 2.24 . . . . 0.0 112.208 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 139' ' ' PRO . 12.2 t80 -131.28 113.21 13.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.979 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 66.4 11.34 7.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.52 -7.74 34.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.272 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -102.38 -177.44 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.131 0.466 . . . . 0.0 110.912 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.61 111.12 21.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.392 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -110.48 141.97 42.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -99.22 109.36 22.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.768 HG21 ' HD2' ' A' ' 135' ' ' PHE . 20.3 mm -97.77 100.3 8.2 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' O ' HG23 ' A' ' 72' ' ' ILE . 51.5 Cg_endo -69.41 146.68 63.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.282 1.988 . . . . 0.0 112.419 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 71' ' ' PRO . 2.4 pt -157.2 156.39 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.5 m -116.16 145.7 42.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.831 ' CD1' HD11 ' A' ' 128' ' ' ILE . 0.5 OUTLIER -122.58 91.2 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.999 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -66.29 144.73 56.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.8 mm? -115.19 173.44 6.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.705 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.709 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -139.44 -177.61 5.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -107.91 -35.73 6.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.076 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m 178.98 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.579 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' CB ' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -102.69 165.11 14.31 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.507 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 67.4 Cg_endo -73.45 -39.75 1.38 Allowed 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.465 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 26.2 m-85 -103.01 -63.84 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 82' ' ' TYR . 11.3 t-20 165.13 -51.36 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 33.3 Cg_endo -67.69 153.01 77.18 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.204 1.936 . . . . 0.0 112.508 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.487 ' HA ' HD12 ' A' ' 77' ' ' LEU . 54.2 Cg_endo -69.75 162.83 40.55 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.609 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 86' ' ' ILE . 3.2 mp -104.12 105.95 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.671 ' SG ' HD11 ' A' ' 127' ' ' LEU . 58.6 m -62.49 149.41 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -153.39 148.38 26.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.639 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.795 HG13 HD11 ' A' ' 109' ' ' ILE . 23.0 m -103.33 127.35 57.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -107.01 87.4 2.95 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.089 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.448 ' HG3' HD12 ' A' ' 97' ' ' ILE . 64.9 Cg_endo -73.41 -167.83 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.611 2.207 . . . . 0.0 112.296 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -131.8 177.13 7.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -28.66 69.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -30.94 15.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.75 137.02 32.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.754 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.21 -166.97 1.69 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.3 tt -136.96 61.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 111.149 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' O ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -42.68 133.13 3.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.818 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 105' ' ' ALA . 17.0 p -98.31 132.68 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.76 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.4 -118.76 1.74 Allowed Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.582 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -100.05 -33.21 10.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.916 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -117.05 -38.69 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 98' ' ' LYS . 5.6 t -55.09 -24.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 99' ' ' THR . 0.4 OUTLIER 51.02 -155.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.177 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -104.16 -26.36 12.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.062 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.4 -2.06 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.697 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.699 ' HA3' HG22 ' A' ' 89' ' ' VAL . . . 73.27 39.12 52.84 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.613 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 88' ' ' PHE . 3.0 tttt -88.58 2.69 52.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.547 0.213 . . . . 0.0 111.559 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.795 HD11 HG13 ' A' ' 89' ' ' VAL . 3.0 mp 45.7 73.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.839 0.352 . . . . 0.0 111.691 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 108' ' ' LYS . 63.1 m-85 -85.74 55.53 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 mt -58.01 110.09 2.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.13 -36.17 54.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.396 2.064 . . . . 0.0 112.308 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -60.09 -53.32 59.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 114' ' ' LEU . 2.6 tm? -66.09 -34.04 77.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.82 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.98 -39.84 95.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.777 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 23.84 8.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.008 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.565 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 2.8 t90 -115.82 -76.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.752 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER 37.73 82.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.667 -179.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 120' ' ' PRO . 2.2 m80 62.44 170.56 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.046 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' A' ' 119' ' ' HIS . 73.6 Cg_endo -87.91 3.76 69.46 Favored 'Cis proline' 0 C--N 1.351 0.699 0 C-N-CA 124.044 -1.232 . . . . 0.0 112.948 -0.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -104.58 -16.08 15.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.515 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.469 ' CB ' ' CE2' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -87.4 104.56 16.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.869 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -117.76 -179.51 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.644 HD12 ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -59.92 -36.65 77.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.853 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 27' ' ' ASN . 4.0 mp -63.35 -46.52 86.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.52 -26.81 53.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.339 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.3 tm? -55.35 -29.99 59.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 0.0 110.747 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 74' ' ' LEU . 1.9 mp -91.94 -32.58 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.778 ' HA ' HD12 ' A' ' 132' ' ' ILE . 11.6 tt0 -58.59 -35.01 71.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' MET . 5.0 p -56.03 -46.18 80.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.562 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 6.0 mtt -66.77 -40.1 88.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.986 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 129' ' ' GLN . 92.9 mt -54.24 -23.55 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.899 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 129' ' ' GLN . 40.6 t -95.09 -56.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.68 -38.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.768 ' HD2' HG21 ' A' ' 70' ' ' ILE . 5.1 m-85 -85.81 -28.64 24.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.502 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.818 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -62.83 -24.49 66.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.44 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.69 -39.38 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.655 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.98 128.18 0.52 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 16.0 Cg_endo -58.43 134.21 59.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 112.147 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 82.6 Cg_endo -79.8 -1.4 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.44 2.094 . . . . 0.0 112.49 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 97' ' ' ILE . 3.3 m -105.72 118.29 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -177.51 164.63 2.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.6 t -92.82 62.84 3.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.33 87.85 0.34 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.36 2.04 . . . . 0.0 112.337 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.077 0.465 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 7' ' ' GLN . 11.6 p -110.15 -26.83 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.449 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t 65.39 142.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.219 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.11 -31.22 69.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 110.759 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -38.49 76.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.197 0.522 . . . . 0.0 110.75 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.591 ' HB3' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.13 -42.24 47.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.372 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 8' ' ' LEU . 8.8 tp -59.08 -40.51 85.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.05 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -55.46 -62.44 1.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.38 58.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.999 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -45.97 63.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.77 17.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.454 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.2 t -72.69 -28.76 62.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.054 0.454 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -26.93 68.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -51.97 130.91 30.74 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -56.41 -64.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.897 ' CD2' HD12 ' A' ' 20' ' ' LEU . 40.7 m-85 -60.15 -58.48 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.675 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.609 ' O ' HG23 ' A' ' 22' ' ' VAL . 12.2 ttt180 66.84 -68.43 0.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.828 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' TYR . 2.6 m-20 -50.23 -47.15 55.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.897 HD12 ' CD2' ' A' ' 17' ' ' TYR . 30.4 mt -71.0 -36.4 72.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 m -70.13 -34.73 73.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.071 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 18' ' ' ARG . 23.8 t -87.57 -28.02 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.396 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -80.11 -45.44 18.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.84 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.3 mt-10 -63.49 -37.76 88.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 29' ' ' ILE . 91.7 m -64.56 -59.14 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -46.92 -47.65 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.563 ' HB3' HD11 ' A' ' 125' ' ' LEU . 1.5 m-20 -59.04 -27.64 65.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 24' ' ' GLU . 42.5 t -85.35 -25.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.407 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.08 -28.64 6.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.077 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -70.0 -43.61 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.021 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD23 ' CE1' ' A' ' 32' ' ' TYR . 4.5 tp -77.07 -31.61 56.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.867 ' HB3' HD23 ' A' ' 35' ' ' LEU . 78.6 m-85 -114.37 116.17 28.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -9.24 58.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.579 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' C ' HD22 ' A' ' 35' ' ' LEU . 11.2 m-20 -97.3 25.0 5.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.605 0.24 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.867 HD23 ' HB3' ' A' ' 32' ' ' TYR . 4.2 mm? -117.98 141.56 48.32 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.99 126.26 12.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.607 ' HA ' HD23 ' A' ' 55' ' ' LEU . 55.4 Cg_endo -70.43 155.34 63.94 Favored 'Trans proline' 0 C--O 1.222 -0.316 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 39' ' ' LEU . 8.8 t -151.09 162.68 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.556 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.5 tm? -136.49 119.87 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.94 162.02 30.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.505 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.2 t -103.66 135.8 44.55 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.168 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -108.76 111.13 22.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.82 143.34 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.987 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 50' ' ' ARG . 32.8 m-85 -94.04 78.46 4.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.352 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 p30 46.33 43.29 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.373 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 65.68 22.72 11.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.084 0.469 . . . . 0.0 111.104 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.59 -13.85 8.51 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.526 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.0 t -178.14 -165.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.737 0.304 . . . . 0.0 111.198 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -158.56 165.76 33.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.593 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.56 ' HE ' HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -157.36 144.85 18.7 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.794 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CG ' HD11 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -70.05 112.03 6.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.736 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.56 HD13 ' HE ' ' A' ' 50' ' ' ARG . 8.0 tp -117.92 128.91 55.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.878 0.371 . . . . 0.0 111.05 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.9 ttp -96.38 150.32 20.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.438 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -145.23 149.27 34.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.866 HD21 HG23 ' A' ' 25' ' ' THR . 35.0 mt -113.56 112.26 23.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.553 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.9 m -109.0 134.86 51.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.729 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.814 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . -166.2 -156.25 9.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.489 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.548 HG23 ' N ' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -148.23 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -130.8 136.51 29.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.29 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 97.9 Cg_endo -78.76 80.36 3.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.827 2.351 . . . . 0.0 112.558 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.461 HG21 HG13 ' A' ' 70' ' ' ILE . 14.9 m -99.62 148.2 34.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 128.29 16.01 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.451 2.101 . . . . 0.0 112.432 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 0.5 OUTLIER -131.5 108.46 9.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 80.18 -10.96 1.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.78 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.16 -17.02 3.4 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.12 172.93 7.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.918 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -65.64 150.04 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -150.3 148.89 29.4 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.732 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.76 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.819 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 61' ' ' VAL . 26.0 mm -108.27 104.91 55.43 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.053 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.548 ' N ' HG23 ' A' ' 58' ' ' THR . 41.0 Cg_endo -67.58 140.3 51.51 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.303 2.002 . . . . 0.0 112.505 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 pt -148.86 173.46 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.553 ' SG ' HG23 ' A' ' 56' ' ' THR . 11.0 m -132.54 170.59 14.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.19 145.03 38.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.764 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -123.3 145.72 48.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 111.195 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.764 HD22 ' C ' ' A' ' 75' ' ' TRP . 2.7 mm? -127.28 171.3 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD11 ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -133.72 162.55 31.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.249 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.96 -30.9 10.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.13 -41.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -127.9 106.59 20.31 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.181 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HB3' ' HG2' ' A' ' 84' ' ' PRO . 24.2 Cg_exo -62.85 167.85 33.23 Favored 'Cis proline' 0 C--N 1.351 0.691 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.12 -0.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 25.99 9.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.454 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER 175.15 -61.31 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 17.0 Cg_endo -61.18 109.83 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.6 2.2 . . . . 0.0 112.458 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.755 ' HA ' HD11 ' A' ' 77' ' ' LEU . 87.4 Cg_endo -81.54 143.26 13.48 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.618 2.212 . . . . 0.0 112.701 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.9 mt -84.65 161.39 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.587 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.526 ' CB ' HG21 ' A' ' 109' ' ' ILE . 13.7 m -141.59 155.42 45.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.218 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 9.3 m-85 -157.89 143.38 16.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.457 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.853 HG21 HD12 ' A' ' 97' ' ' ILE . 29.7 m -59.06 -175.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.547 . . . . 0.0 111.266 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HE2' HG21 ' A' ' 56' ' ' THR . 5.6 tttm -158.42 51.86 0.49 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.474 ' CD ' HG23 ' A' ' 89' ' ' VAL . 56.1 Cg_endo -69.35 -167.16 0.2 Allowed 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.1 p -124.0 151.28 43.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -17.14 62.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.809 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -93.58 -15.09 25.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.869 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.828 ' CG ' HG13 ' A' ' 141' ' ' VAL . 3.6 tmm? -118.57 -8.56 10.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 95' ' ' MET . 13.8 t 46.98 -163.45 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.065 0.46 . . . . 0.0 111.306 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.853 HD12 HG21 ' A' ' 89' ' ' VAL . 10.2 tt -135.54 132.69 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -75.26 133.11 41.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.689 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 105' ' ' ALA . 33.5 p -85.58 131.4 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.966 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.5 -152.98 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.521 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -56.8 4.51 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.807 0.337 . . . . 0.0 110.648 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -85.66 -34.28 21.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.454 HG11 ' CB ' ' A' ' 140' ' ' PRO . 13.0 t -95.86 72.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.128 0.489 . . . . 0.0 111.047 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -176.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -63.27 -23.88 67.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.439 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.39 27.06 9.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.97 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA3' ' CG2' ' A' ' 89' ' ' VAL . . . 40.87 55.3 3.38 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.967 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.493 ' O ' HG22 ' A' ' 109' ' ' ILE . 2.6 tttp -81.82 11.48 4.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.851 -0.205 . . . . 0.0 111.51 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 87' ' ' CYS . 0.6 OUTLIER 44.96 45.66 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 108' ' ' LYS . 3.7 m-85 -68.18 72.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.89 HD22 HG21 ' A' ' 134' ' ' VAL . 8.8 mt -88.77 158.83 47.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.48 -36.03 4.29 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.623 2.216 . . . . 0.0 112.43 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' HB2' HG21 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -57.86 -65.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -56.46 -29.6 61.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.699 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.82 -43.15 89.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -96.81 24.08 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.977 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 122' ' ' SER . 6.2 t90 -80.91 120.03 24.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -131.97 10.4 4.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.624 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 4.2 p80 53.21 160.24 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 69.0 Cg_endo -98.83 12.43 29.01 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.387 -1.089 . . . . 0.0 112.664 0.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -59.55 -54.96 40.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.763 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.454 ' HB2' ' CD1' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -82.64 144.06 30.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 111.374 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -139.4 175.22 9.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.543 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -57.01 -38.55 73.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 27' ' ' ASN . 3.8 mp -57.8 -47.17 83.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.48 -24.83 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 130' ' ' VAL . 7.5 tt -57.2 -30.54 64.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 110.741 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.4 HG22 ' CD1' ' A' ' 132' ' ' ILE . 3.4 mp -87.74 -30.8 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.61 97.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.7 p -58.09 -43.04 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.459 ' CG ' HD11 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -63.59 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.368 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.4 ' CD1' HG22 ' A' ' 128' ' ' ILE . 1.0 OUTLIER -58.3 -27.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.616 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.08 -51.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.677 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.89 HG21 HD22 ' A' ' 111' ' ' LEU . 43.2 t -53.54 -41.91 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.639 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.507 ' HZ ' HD12 ' A' ' 109' ' ' ILE . 21.8 m-30 -81.26 -27.91 34.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.455 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.9 -23.34 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.46 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -30.76 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.039 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -146.27 83.86 8.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.438 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 9.0 Cg_exo -71.27 152.44 61.35 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.78 2.32 . . . . 0.0 112.101 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CB ' HG11 ' A' ' 103' ' ' VAL . 59.2 Cg_endo -71.3 -31.79 13.71 Favored 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.278 1.985 . . . . 0.0 112.154 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.828 HG13 ' CG ' ' A' ' 95' ' ' MET . 84.0 t -59.45 162.35 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.01 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' HG12 ' A' ' 141' ' ' VAL . 11.1 t80 179.85 -80.01 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.654 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 95' ' ' MET . 0.8 OUTLIER 53.46 23.57 3.49 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.436 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 52.68 88.21 0.12 Allowed Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.01 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.246 0.913 0 C-N-CA 122.578 2.185 . . . . 0.0 112.338 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.984 0.421 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.45 66.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.393 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 m -110.73 -170.02 1.56 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.528 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.74 -36.46 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 m -60.13 -37.79 81.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.795 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -71.14 -31.9 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -58.29 -46.39 86.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.972 0.415 . . . . 0.0 111.029 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.06 -51.02 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.841 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -61.33 -30.88 70.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.486 ' HE2' HD23 ' A' ' 39' ' ' LEU . 13.3 mtp -67.74 -30.74 70.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -111.39 20.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.0 p -67.98 -24.59 65.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.919 0.39 . . . . 0.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -58.08 -44.8 87.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' OH ' HD12 ' A' ' 52' ' ' LEU . 9.8 m-30 -61.75 175.86 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.49 -31.05 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 20' ' ' LEU . 4.3 m-30 -62.99 -69.72 0.25 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.55 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.9 ttt180 66.68 -69.43 0.12 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -44.72 95.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.051 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.625 HD12 ' CD2' ' A' ' 17' ' ' TYR . 46.3 mt -68.0 -36.46 80.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.995 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.66 HG21 HG11 ' A' ' 12' ' ' VAL . 16.5 m -62.89 -31.32 72.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.806 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.1 t -90.56 -27.14 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -45.23 19.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 28' ' ' VAL . 3.1 tt0 -67.68 -43.71 79.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.858 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.8 t -58.43 -48.02 82.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.18 0.514 . . . . 0.0 110.793 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG2' ' A' ' 25' ' ' THR . 0.4 OUTLIER -60.4 -47.08 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.456 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -51.78 -29.96 21.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.338 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 24' ' ' GLU . 21.8 t -85.04 -63.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pt -56.68 -25.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.339 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.7 m -80.29 -31.08 38.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.75 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.4 mt -86.54 -20.11 28.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.045 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -126.91 136.56 52.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.35 27.11 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 111.191 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.47 8.68 3.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.348 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.743 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.9 mm? -118.11 130.41 56.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.532 0.206 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -129.81 146.13 60.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.97 146.63 32.99 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.967 2.445 . . . . 0.0 112.706 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.738 ' CG2' HG22 ' A' ' 56' ' ' THR . 6.7 t -135.54 162.2 37.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD23 ' HE2' ' A' ' 11' ' ' MET . 1.8 tm? -132.16 123.8 27.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.091 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' N ' HD13 ' A' ' 39' ' ' LEU . 22.8 t70 -139.21 129.64 25.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 p -91.3 148.2 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.63 147.48 48.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.982 0.42 . . . . 0.0 110.652 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.5 m -106.86 150.08 9.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 111.155 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -93.08 73.99 4.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.97 41.06 21.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.966 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 61.44 24.24 14.38 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.35 8.96 12.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.796 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.46 -170.96 0.14 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.92 131.76 12.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.643 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.28 153.38 47.04 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 121.3 0.571 . . . . 0.0 110.428 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.93 95.01 7.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.83 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.539 HD23 ' CZ3' ' A' ' 75' ' ' TRP . 6.7 tp -96.67 161.32 13.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.817 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.645 ' HE1' HD21 ' A' ' 55' ' ' LEU . 1.2 ttp -121.11 158.22 28.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.464 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 17.7 t-20 -154.17 150.71 28.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.645 HD21 ' HE1' ' A' ' 53' ' ' MET . 2.6 mt -123.51 134.6 53.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.738 HG22 ' CG2' ' A' ' 38' ' ' VAL . 10.2 t -121.05 156.76 31.51 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.153 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.743 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 165.25 173.28 33.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.487 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 71' ' ' PRO . 13.6 p -133.8 128.0 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.628 0.252 . . . . 0.0 110.684 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -86.75 111.45 40.03 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.399 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.52 96.88 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.662 2.241 . . . . 0.0 112.409 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.45 141.36 27.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.275 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.26 157.34 50.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.294 1.996 . . . . 0.0 112.37 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.436 ' CE2' ' HD2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -157.56 110.07 2.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 58.87 28.22 17.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.227 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.55 5.75 66.64 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.9 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -116.08 -168.45 1.43 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.679 0.276 . . . . 0.0 110.618 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.02 123.78 50.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 70' ' ' ILE . 7.6 t80 -121.51 162.75 19.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.711 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -140.18 123.86 17.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.838 HG21 ' CD2' ' A' ' 135' ' ' PHE . 5.2 mm -101.94 100.86 15.98 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HA ' HG22 ' A' ' 58' ' ' THR . 42.7 Cg_endo -68.03 109.55 1.97 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.163 1.909 . . . . 0.0 112.105 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 89' ' ' VAL . 2.6 pp -123.35 143.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 39.3 m -107.17 167.87 9.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD22 HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -132.29 137.98 47.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.705 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -114.63 145.95 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.705 HD22 ' C ' ' A' ' 75' ' ' TRP . 3.2 mm? -120.17 158.12 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.803 HD11 ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -128.07 174.67 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 79' ' ' THR . 12.8 p-10 -97.38 39.95 1.17 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.592 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 72.24 10.61 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.97 158.77 58.37 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.775 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.57 -44.28 0.55 Allowed 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.193 -1.586 . . . . 0.0 112.158 0.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 47.2 m-85 -78.78 -71.52 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 23.0 p30 146.13 -30.91 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.639 0.776 . . . . 0.0 112.185 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 48.0 Cg_exo -57.24 135.47 70.54 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.912 1.741 . . . . 0.0 112.243 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.803 ' HA ' HD11 ' A' ' 77' ' ' LEU . 69.2 Cg_endo -73.96 133.76 18.73 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.402 2.068 . . . . 0.0 112.358 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.24 147.68 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.7 t -139.98 131.28 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' CE1' ' HG3' ' A' ' 108' ' ' LYS . 20.7 m-30 -116.5 -176.19 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 109' ' ' ILE . 4.6 m -134.16 87.17 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.899 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 109.47 1.73 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.424 ' CG ' HD11 ' A' ' 97' ' ' ILE . 73.8 Cg_endo -75.54 -167.97 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.251 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.5 p -149.05 173.85 12.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.089 0.471 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -67.37 -24.6 65.71 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.035 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -47.63 80.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.184 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -167.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.063 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -126.93 -146.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.588 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.424 HD11 ' CG ' ' A' ' 91' ' ' PRO . 22.1 mm -123.62 123.01 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.875 0.369 . . . . 0.0 110.766 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -85.12 162.29 19.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.768 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 104' ' ' ASP . 12.9 p -141.1 132.21 26.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.39 -86.5 0.13 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.942 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -54.29 -71.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CG ' ' HG ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -162.95 63.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.25 0.548 . . . . 0.0 111.021 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -133.57 -7.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.708 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.765 ' O ' HG22 ' A' ' 99' ' ' THR . 0.6 OUTLIER 51.82 -153.86 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.16 -29.51 10.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.463 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -104.95 27.21 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.786 ' O ' HG22 ' A' ' 89' ' ' VAL . . . 70.76 45.35 52.92 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.704 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.436 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -100.38 142.19 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.743 -0.269 . . . . 0.0 110.954 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.011 HD11 HG13 ' A' ' 89' ' ' VAL . 4.5 mp -101.84 98.45 6.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -99.63 40.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' HD2' ' A' ' 112' ' ' PRO . 3.8 mt -55.63 139.07 68.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.974 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HD2' HD23 ' A' ' 111' ' ' LEU . 73.1 Cg_endo -76.17 -25.01 10.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.49 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -48.69 76.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.96 -31.66 59.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.794 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.7 -35.8 79.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.79 20.02 12.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 122' ' ' SER . 3.5 t90 -117.3 121.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 110.799 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -126.81 126.88 44.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.629 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 6.6 p80 -52.42 160.16 1.4 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.334 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' GLN . 1.2 Cg_endo -83.22 142.08 43.67 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.208 0.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 120' ' ' PRO . 3.1 mt-30 141.92 -31.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.781 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 117' ' ' TRP . 1.3 p -76.91 120.84 22.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.984 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -136.31 178.29 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 128' ' ' ILE . 17.1 mt -84.05 -19.47 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mp -67.11 -43.09 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.41 -36.91 8.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 130' ' ' VAL . 5.4 tp -54.93 -27.97 47.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.537 HD13 ' O ' ' A' ' 124' ' ' LEU . 1.3 mp -90.26 -31.04 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.423 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -56.4 -33.15 65.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.647 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.2 p -57.54 -45.53 86.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.568 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.446 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 31.2 mtt -67.94 -38.46 82.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.072 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -55.12 -25.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 129' ' ' GLN . 40.4 t -95.07 -53.1 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.676 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 130' ' ' VAL . 38.9 t -57.99 -44.54 87.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.838 ' CD2' HG21 ' A' ' 70' ' ' ILE . 18.0 m-85 -83.3 -23.16 32.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.268 0.556 . . . . 0.0 110.987 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.12 -28.61 73.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.359 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -88.96 -38.76 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -176.58 113.09 0.25 Allowed Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.895 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 50.1 Cg_exo -54.08 136.5 67.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.194 1.929 . . . . 0.0 112.135 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 135' ' ' PHE . 84.7 Cg_endo -81.75 -21.71 5.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.63 2.22 . . . . 0.0 112.345 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.653 ' O ' ' CB ' ' A' ' 142' ' ' PHE . 6.4 t -50.52 171.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.653 ' CB ' ' O ' ' A' ' 141' ' ' VAL . 4.5 t80 102.44 176.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.032 0.444 . . . . 0.0 110.375 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -94.12 50.35 1.39 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 63.8 88.74 0.11 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.67 2.246 . . . . 0.0 112.393 179.802 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.891 0.377 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.89 -63.11 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 63.47 143.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.762 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -31.95 73.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -60.04 -46.94 87.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 0.0 110.815 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.26 -42.54 99.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.239 0.542 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.23 -51.09 60.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.145 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -58.86 -24.24 61.89 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.192 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -21.42 42.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.016 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.0 mtt -73.93 -43.37 58.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 16.5 m -91.99 0.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.701 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -60.14 -31.95 70.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -26.17 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.977 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' A' ' 12' ' ' VAL . 10.9 m-85 -56.75 156.35 6.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -85.53 -54.54 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 23.2 m-30 -90.25 69.03 7.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -50.51 -56.44 11.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.226 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.53 -58.67 7.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 111.048 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -55.58 -26.45 43.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.352 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.848 HG23 HD23 ' A' ' 76' ' ' LEU . 77.6 m -86.0 -55.09 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.243 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 18' ' ' ARG . 38.6 t -66.65 -33.54 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.37 -47.49 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.702 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.775 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.7 mp0 -67.33 -29.66 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.856 HG23 HD21 ' A' ' 55' ' ' LEU . 7.1 m -78.37 -30.8 48.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -84.16 -46.65 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.218 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.566 ' CG ' HD11 ' A' ' 125' ' ' LEU . 7.6 t-20 -52.32 -36.52 53.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.378 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 24' ' ' GLU . 28.8 t -74.83 -62.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.192 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -57.5 -43.42 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.8 m -58.99 -42.71 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tt -73.8 -41.66 62.04 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 121.173 0.511 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -104.95 104.91 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.781 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.1 61.86 6.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -142.78 -44.34 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.801 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.656 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.61 168.13 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.828 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 143.23 18.91 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.658 ' HA ' HD23 ' A' ' 55' ' ' LEU . 55.6 Cg_endo -70.63 134.46 26.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.639 2.226 . . . . 0.0 112.18 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' LEU . 6.5 t -127.16 162.45 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.01 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.1 tm? -138.2 128.14 25.5 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -153.4 129.16 10.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.324 0.583 . . . . 0.0 110.682 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -74.05 157.6 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.798 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.07 103.74 3.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.93 137.24 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -82.89 162.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.537 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -80.42 -1.76 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.42 -28.85 24.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.616 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.41 -35.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -92.96 164.96 13.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -124.95 -178.1 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.138 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -167.43 135.47 2.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.77 111.69 18.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 76' ' ' LEU . 3.8 mm? -110.29 138.23 46.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.315 0.579 . . . . 0.0 110.555 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.49 ' CE ' HG21 ' A' ' 25' ' ' THR . 2.9 tmm? -85.45 142.37 29.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.774 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.414 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 1.4 p30 -135.28 148.71 49.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 25' ' ' THR . 8.7 mt -113.32 120.82 42.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.413 HG23 ' SG ' ' A' ' 73' ' ' CYS . 2.5 m -115.95 158.91 22.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.1 -179.35 28.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.342 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.675 HG22 ' CA ' ' A' ' 71' ' ' PRO . 60.4 p -124.32 152.8 42.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.935 0.397 . . . . 0.0 111.007 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.462 HG23 ' HD2' ' A' ' 60' ' ' PRO . 5.3 mt -123.47 137.02 27.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.072 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 59' ' ' ILE . 19.0 Cg_endo -60.75 104.1 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.22 1.947 . . . . 0.0 112.0 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.648 HG13 ' HA2' ' A' ' 136' ' ' GLY . 42.3 t -132.1 121.65 17.87 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.94 146.78 55.48 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.368 2.046 . . . . 0.0 112.29 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -106.01 -75.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.087 0.47 . . . . 0.0 110.897 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 26.0 2.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.05 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.28 3.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.79 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -123.1 174.02 7.5 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -91.8 123.67 35.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -120.35 161.77 20.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.212 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -112.34 99.97 8.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.568 HG21 ' HD2' ' A' ' 135' ' ' PHE . 21.0 mm -82.63 110.21 20.93 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.084 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.675 ' CA ' HG22 ' A' ' 58' ' ' THR . 59.7 Cg_endo -72.21 145.08 43.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.262 1.975 . . . . 0.0 112.298 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 59' ' ' ILE . 2.9 pt -155.69 153.06 7.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' SG ' HG23 ' A' ' 56' ' ' THR . 87.9 m -113.52 169.18 9.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.624 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.558 HD21 HD21 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -138.89 146.81 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.533 ' HA ' ' CE3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 HG23 ' A' ' 21' ' ' THR . 1.7 mp -135.2 155.92 49.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -126.07 174.58 8.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.099 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.614 ' O ' HG22 ' A' ' 79' ' ' THR . 10.1 p-10 -96.31 39.55 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 76.63 6.85 3.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.455 ' HD1' HG23 ' A' ' 79' ' ' THR . 1.6 m-85 -152.94 150.81 25.07 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.927 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . 87.4 Cg_endo -82.77 -37.74 1.36 Allowed 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.409 0.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.603 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 88.3 m-85 -60.9 -80.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.766 ' O ' HD21 ' A' ' 77' ' ' LEU . 8.7 t-20 135.89 -51.89 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 123.395 0.678 . . . . 0.0 111.052 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 67.9 Cg_endo -75.59 128.54 11.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.395 2.063 . . . . 0.0 112.34 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 135.94 71.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.456 2.104 . . . . 0.0 112.529 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.1 mp -92.73 160.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.493 ' N ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -128.09 137.4 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 111.296 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 109' ' ' ILE . 6.5 m-85 -130.83 143.33 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.747 HG22 ' HD3' ' A' ' 91' ' ' PRO . 13.1 p -97.67 138.72 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.956 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -130.36 68.94 81.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.747 ' HD3' HG22 ' A' ' 89' ' ' VAL . 32.7 Cg_exo -59.53 -178.68 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.471 2.114 . . . . 0.0 112.256 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -82.81 165.41 19.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -86.28 -13.71 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.461 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -95.07 -27.92 15.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 0.0 110.586 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 13.5 ttm -89.53 -25.07 21.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.98 149.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.823 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 97' ' ' ILE . 10.2 tt -95.18 109.23 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.099 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 1.0 OUTLIER -77.05 130.86 37.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.19 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.8 p -75.2 136.56 41.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.981 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 103' ' ' VAL . . . -144.68 -157.37 7.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.562 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -35.48 70.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -105.77 -39.25 6.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 140' ' ' PRO . 1.3 m -84.38 85.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.406 ' OD2' ' CD2' ' A' ' 110' ' ' TYR . 15.3 m-20 -60.76 -165.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.13 5.14 31.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -131.84 30.11 4.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 0.0 111.173 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . 51.53 51.21 38.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.8 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -119.21 93.0 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.033 0.444 . . . . 0.0 110.768 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 109' ' ' ILE . 3.6 mp -59.29 108.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.016 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CD2' ' OD2' ' A' ' 104' ' ' ASP . 1.3 m-85 -101.72 51.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.733 HD13 HG11 ' A' ' 130' ' ' VAL . 19.5 mt -59.49 119.02 36.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.54 -27.43 27.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.426 2.084 . . . . 0.0 112.296 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -58.83 -29.43 66.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.486 HD22 HD23 ' A' ' 127' ' ' LEU . 6.8 tp -91.81 -34.32 14.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -67.21 -37.5 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -98.44 28.32 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.435 ' CE2' ' HA ' ' A' ' 122' ' ' SER . 1.8 t90 -96.71 -80.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER 75.6 120.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.201 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.714 ' CB ' ' HA ' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -45.75 179.39 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.688 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.714 ' HA ' ' CB ' ' A' ' 119' ' ' HIS . 61.3 Cg_endo -91.0 37.53 5.11 Favored 'Cis proline' 0 C--N 1.357 0.974 0 C-N-CA 125.035 -0.819 . . . . 0.0 113.864 0.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -21.7 12.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.831 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.435 ' HA ' ' CE2' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -64.24 160.49 18.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 111.483 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 179.95 -177.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.587 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.558 HD21 HD21 ' A' ' 74' ' ' LEU . 4.4 mt -84.57 -34.49 23.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.854 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.566 HD11 ' CG ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -50.48 -47.46 57.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.65 -25.77 55.64 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.366 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.663 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.4 tm? -58.37 -30.61 66.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 128' ' ' ILE . 3.4 mp -90.48 -27.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.709 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.863 ' O ' HG22 ' A' ' 132' ' ' ILE . 2.5 tt0 -65.17 -33.2 75.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.701 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.81 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.7 p -66.5 -41.86 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 0.0 110.653 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.419 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 1.3 mmt -67.48 -44.38 78.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.863 HG22 ' O ' ' A' ' 129' ' ' GLN . 1.2 tt -52.77 -26.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.153 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.3 t -95.03 -54.1 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 130' ' ' VAL . 41.6 t -55.53 -38.32 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.568 ' HD2' HG21 ' A' ' 70' ' ' ILE . 6.0 m-85 -83.86 -26.7 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.648 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -65.05 -18.74 65.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.534 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -48.93 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.56 111.19 1.65 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.0 139.07 79.67 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.991 . . . . 0.0 112.192 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.684 ' HB2' HG11 ' A' ' 103' ' ' VAL . 91.8 Cg_endo -84.78 1.62 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.698 2.265 . . . . 0.0 112.658 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 91' ' ' PRO . 25.8 t -84.9 -47.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.409 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 51.35 172.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.274 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 142' ' ' PHE . 1.1 p -173.34 38.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.845 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 43.92 89.58 0.08 OUTLIER Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.358 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo . . . . . 0 C--O 1.25 1.089 0 C-N-CA 122.66 2.24 . . . . 0.0 112.291 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 7' ' ' GLN . 11.1 p -95.61 -28.59 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.5 145.34 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.793 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.62 72.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -49.76 75.75 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.524 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.564 ' HB3' HG22 ' A' ' 3' ' ' VAL . 5.1 tt0 -65.95 -49.34 68.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.173 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 12' ' ' VAL . 6.1 tp -58.73 -29.67 66.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.927 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -55.2 36.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -70.15 -29.56 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.426 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmm -62.56 -49.18 76.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.044 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 8' ' ' LEU . 17.1 m -101.35 19.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.487 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -67.09 -29.75 69.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.822 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -31.22 68.08 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CE2' HG21 ' A' ' 21' ' ' THR . 3.4 m-30 -56.91 129.73 42.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' HG21 ' A' ' 79' ' ' THR . 1.0 OUTLIER -58.27 -62.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.63 -55.25 25.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.829 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 ttp180 66.97 -67.41 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.38 -49.62 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -48.31 79.89 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.512 0.507 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 15' ' ' TYR . 5.0 m -66.97 -31.93 72.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 18' ' ' ARG . 37.8 t -79.94 -25.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.131 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -79.01 -47.02 17.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 28' ' ' VAL . 15.5 mt-10 -67.13 -43.46 82.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 26' ' ' VAL . 4.7 t -58.44 -47.46 83.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.449 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -62.44 -46.99 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.776 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.447 ' HB3' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -51.72 -32.58 30.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.274 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.938 HG21 HD23 ' A' ' 124' ' ' LEU . 21.4 t -73.85 -66.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -56.9 -28.33 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.0 m -70.25 -33.53 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.62 -34.43 15.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -102.11 122.63 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.88 3.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.6 15.75 2.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.416 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 167.64 11.24 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.832 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -152.4 137.03 10.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.776 ' HA ' HD23 ' A' ' 55' ' ' LEU . 74.4 Cg_endo -75.12 159.7 40.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.601 2.201 . . . . 0.0 112.115 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 39' ' ' LEU . 6.4 t -150.6 161.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 39' ' ' LEU . 3.5 tm? -129.42 122.35 29.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -138.03 161.45 36.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.401 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.09 152.15 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.72 88.44 2.68 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.142 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.47 163.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.947 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -118.39 76.91 1.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 57.22 54.68 6.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 44.95 32.14 0.79 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.403 0.62 . . . . 0.0 110.885 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.71 -19.23 7.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.449 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.8 -167.79 0.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.192 0.52 . . . . 0.0 110.477 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -153.41 123.08 6.76 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -123.53 120.15 32.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -59.73 142.08 53.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 52' ' ' LEU . 3.9 tp -147.01 141.54 26.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.251 0.548 . . . . 0.0 110.997 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.602 ' SD ' HG11 ' A' ' 12' ' ' VAL . 5.7 ttp -107.21 139.57 41.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.459 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -138.77 157.46 46.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.813 HD12 HD13 ' A' ' 74' ' ' LEU . 4.1 mt -124.58 128.4 48.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.5 m -124.24 134.31 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.15 169.57 37.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.71 139.39 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.733 ' O ' HD12 ' A' ' 59' ' ' ILE . 2.0 pp -117.07 156.43 48.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.763 ' HG2' HD11 ' A' ' 132' ' ' ILE . 39.8 Cg_endo -67.45 134.96 34.87 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.489 2.126 . . . . 0.0 112.211 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.71 HG21 ' CG1' ' A' ' 70' ' ' ILE . 98.1 t -143.27 106.22 5.16 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.74 134.71 41.76 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.794 2.329 . . . . 0.0 112.252 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -167.85 116.27 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER 81.21 -10.24 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.039 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.06 -6.99 7.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.573 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.77 175.13 6.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 114.63 28.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -94.18 148.15 22.47 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.17 104.3 16.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.724 HG21 ' HD2' ' A' ' 135' ' ' PHE . 31.6 mm -102.45 98.88 11.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 72' ' ' ILE . 46.0 Cg_endo -68.44 153.55 73.72 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.469 2.113 . . . . 0.0 112.189 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.756 ' O ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -159.21 154.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.403 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 43.2 t -105.13 150.01 25.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.813 HD13 HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -124.68 142.67 51.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.544 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -127.62 139.95 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.583 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 75' ' ' TRP . 2.6 mm? -128.22 170.4 13.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.15 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.68 165.75 18.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.9 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.08 -39.42 75.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.794 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 16' ' ' LYS . 1.5 t 173.37 -34.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.181 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 79' ' ' THR . 11.8 m-85 -166.07 163.39 12.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.771 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 80' ' ' TYR . 68.1 Cg_endo -92.78 -0.59 54.19 Favored 'Cis proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.237 -1.151 . . . . 0.0 112.647 0.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 12.0 m-85 -87.2 51.7 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.631 0.253 . . . . 0.0 111.062 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.568 ' O ' HD11 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -40.99 -51.63 7.26 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 83' ' ' ASN . 44.4 Cg_endo -70.68 115.52 4.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.217 1.945 . . . . 0.0 112.105 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 84' ' ' PRO . 34.5 Cg_endo -64.97 167.67 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.0 112.591 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 3.6 mp -104.07 159.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.487 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.6 p -133.53 126.08 30.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.051 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 21.7 m-85 -131.72 161.63 32.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.78 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.546 HG22 ' HD3' ' A' ' 91' ' ' PRO . 10.7 p -133.54 129.78 56.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.6 80.49 50.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 89' ' ' VAL . 84.3 Cg_exo -46.52 164.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.448 2.098 . . . . 0.0 112.588 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.0 p -87.23 172.57 9.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.824 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -59.83 -20.78 58.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 m -54.42 -58.93 5.53 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.032 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.02 177.03 5.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.048 0.451 . . . . 0.0 111.092 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.804 HG23 ' O ' ' A' ' 142' ' ' PHE . 8.2 t -94.19 -137.74 0.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.592 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -152.1 111.25 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.317 0.58 . . . . 0.0 111.382 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' HA ' ' A' ' 140' ' ' PRO . 3.0 ptmt -101.78 133.83 45.89 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.142 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -173.48 -177.76 1.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 111.487 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' A' ' 99' ' ' THR . . . 153.63 -17.92 0.67 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.302 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -54.89 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.551 0.215 . . . . 0.0 111.279 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.614 ' ND1' HG23 ' A' ' 103' ' ' VAL . 10.6 p80 -129.96 -34.09 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.614 HG23 ' ND1' ' A' ' 102' ' ' HIS . 84.7 t -77.46 -16.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.454 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 99' ' ' THR . 2.5 m-20 53.01 170.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.84 0.352 . . . . 0.0 111.455 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.47 -19.09 62.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.609 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.43 24.63 4.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 53.24 23.53 18.19 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.066 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.47 125.7 37.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.546 -0.385 . . . . 0.0 110.481 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.34 108.73 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 111.291 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -104.31 31.66 4.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.115 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.614 HD21 HG21 ' A' ' 134' ' ' VAL . 4.2 mt -51.72 152.01 5.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.599 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CD ' HD23 ' A' ' 111' ' ' LEU . 23.1 Cg_exo -63.82 -32.12 67.32 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.745 ' HB2' HG21 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -57.9 -31.51 66.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.684 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -86.97 -42.71 12.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.13 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.33 -36.26 83.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.059 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.99 37.01 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.221 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.422 ' NE1' ' CB ' ' A' ' 122' ' ' SER . 1.6 t90 -80.44 114.96 19.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.575 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -149.38 111.1 4.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 6.0 p80 -50.69 159.68 0.88 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.023 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 74.8 Cg_endo -87.76 -14.13 31.61 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.9 -1.291 . . . . 0.0 112.874 0.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -26.93 5.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.079 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.422 ' CB ' ' NE1' ' A' ' 117' ' ' TRP . 23.3 p -74.57 156.41 36.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 177.49 153.87 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -56.71 -43.8 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 27' ' ' ASN . 1.6 mp -55.48 -42.37 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.766 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.46 56.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.254 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 130' ' ' VAL . 30.2 tp -56.54 -36.58 69.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.441 HD11 HD11 ' A' ' 74' ' ' LEU . 3.8 mp -90.2 -23.99 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.653 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.922 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.2 tt0 -69.3 -33.41 73.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.676 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 113' ' ' TYR . 3.6 p -63.51 -42.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.428 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 4.6 mtt -64.77 -43.76 92.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.922 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER -53.77 -25.05 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.39 -52.69 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.503 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 130' ' ' VAL . 43.0 t -57.09 -36.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.375 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.724 ' HD2' HG21 ' A' ' 70' ' ' ILE . 4.3 m-85 -83.3 -26.1 30.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.244 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -70.22 -15.07 72.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.61 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.4 -36.14 11.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.803 0.335 . . . . 0.0 110.642 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -153.39 85.8 4.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.45 111.11 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.652 2.235 . . . . 0.0 112.727 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 98' ' ' LYS . 86.8 Cg_endo -83.9 50.0 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.857 2.371 . . . . 0.0 112.082 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 70' ' ' ILE . 3.8 t -125.15 -7.66 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -78.37 -159.33 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.676 ' HA ' HG21 ' A' ' 96' ' ' THR . 80.3 p -57.07 -125.89 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.472 ' CB ' ' HB2' ' A' ' 98' ' ' LYS . 20.8 tpt85 67.54 61.55 0.78 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.644 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 144' ' ' ARG . 59.9 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.783 2.322 . . . . 0.0 111.922 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.641 0.257 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 m -110.91 66.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.759 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -22.69 11.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -82.36 -34.67 28.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -81.5 -32.92 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.937 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -70.67 -42.07 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.633 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.735 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.6 tp -59.88 -44.57 94.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.457 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.2 66.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.801 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -72.93 -29.01 62.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.97 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -88.62 -35.86 16.61 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.0 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 8' ' ' LEU . 26.9 m -88.54 8.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.632 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 p -79.22 -29.55 42.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.912 0.387 . . . . 0.0 110.809 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -69.81 -17.89 63.43 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.533 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 78' ' ' ASP . 1.8 m-85 -51.17 167.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.821 0.343 . . . . 0.0 111.142 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -47.85 8.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -84.24 -58.08 2.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER 66.54 -68.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -52.78 -29.9 30.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.195 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -84.9 -39.44 18.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -47.73 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 18' ' ' ARG . 22.9 t -61.68 -39.62 83.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -63.31 -50.57 69.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.269 0.557 . . . . 0.0 111.173 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 28' ' ' VAL . 9.4 mt-10 -60.68 -47.04 88.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.944 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.471 HG23 HD21 ' A' ' 55' ' ' LEU . 5.7 m -58.8 -50.65 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -58.78 -47.37 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.338 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -53.31 -33.22 52.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.446 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.847 HG21 HD23 ' A' ' 124' ' ' LEU . 21.8 t -80.95 -58.98 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.448 HD11 ' HA ' ' A' ' 26' ' ' VAL . 2.9 pt -59.83 -34.54 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.362 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.5 t -67.52 -38.01 83.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.831 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' CD2' HG23 ' A' ' 30' ' ' THR . 2.5 mm? -86.39 -30.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.35 124.99 50.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.302 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.95 68.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -168.62 -41.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.588 HD13 ' HA3' ' A' ' 57' ' ' GLY . 3.7 mm? -62.56 129.39 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.85 101.44 53.49 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.883 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.05 139.71 33.64 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.453 2.102 . . . . 0.0 112.385 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 39' ' ' LEU . 5.2 t -132.18 162.08 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.466 ' N ' HG12 ' A' ' 38' ' ' VAL . 1.4 tm? -118.75 124.07 46.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 39' ' ' LEU . 16.2 t70 -149.2 127.33 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.866 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -90.91 159.26 16.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -112.3 104.77 12.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.419 . . . . 0.0 110.727 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.61 158.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 50' ' ' ARG . 41.5 m-85 -114.33 74.38 0.87 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.4 p30 44.74 52.09 8.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.543 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.86 23.5 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.919 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.77 -14.1 14.74 Favored Glycine 0 N--CA 1.459 0.228 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.319 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -177.38 -169.43 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.719 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.4 107.39 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.429 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HG2' ' CE1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -97.45 134.14 41.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.78 123.73 24.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 77' ' ' LEU . 6.5 tp -134.36 155.08 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.527 ' HE2' HD12 ' A' ' 76' ' ' LEU . 15.5 ttp -118.44 149.93 40.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.442 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 0.4 OUTLIER -143.41 160.7 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.884 HD12 HD13 ' A' ' 74' ' ' LEU . 11.0 mt -127.08 118.72 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.958 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.41 HG21 ' HD3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -119.9 155.84 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.588 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 161.04 172.0 27.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.481 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.409 HG23 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -110.52 124.82 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.0 111.248 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 pt -104.0 150.91 38.78 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.189 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.83 149.46 66.46 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 112.257 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.772 HG13 ' HA2' ' A' ' 136' ' ' GLY . 97.1 t -155.7 107.57 2.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.199 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 66' ' ' ASN . 58.2 Cg_exo -52.23 111.78 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.151 1.9 . . . . 0.0 112.293 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -110.45 97.43 6.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 57.49 24.97 10.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.68 -15.97 28.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.815 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -96.94 177.89 5.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -114.14 111.25 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.064 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.12 -173.7 2.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.097 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -146.98 87.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.063 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 70' ' ' ILE . 3.2 mp -89.09 107.51 18.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HG3' HG23 ' A' ' 92' ' ' THR . 49.5 Cg_endo -69.18 160.24 50.66 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.556 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 71' ' ' PRO . 2.7 pp -159.22 163.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 158.88 28.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.737 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.884 HD13 HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -132.83 135.18 45.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.908 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -121.35 134.17 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.908 HD23 ' O ' ' A' ' 75' ' ' TRP . 8.8 mt -133.13 156.75 46.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.06 162.77 24.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' HA ' ' CD1' ' A' ' 15' ' ' TYR . 4.8 p-10 -60.3 -44.11 95.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.676 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -177.39 -36.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -86.56 157.74 55.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HG2' ' CD2' ' A' ' 82' ' ' TYR . 73.5 Cg_endo -77.86 -47.37 0.31 Allowed 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.307 -1.539 . . . . 0.0 112.569 0.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 80.3 m-85 -87.91 -67.66 0.81 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' O ' HD21 ' A' ' 77' ' ' LEU . 4.6 m-20 156.82 -52.44 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.779 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' O ' HD11 ' A' ' 77' ' ' LEU . 87.2 Cg_exo -44.52 143.49 3.87 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.744 2.296 . . . . 0.0 112.774 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.594 ' CB ' HD22 ' A' ' 76' ' ' LEU . 85.8 Cg_endo -82.25 138.56 10.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.0 112.445 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 87' ' ' CYS . 3.3 mp -83.38 160.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.493 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.4 t -134.97 141.71 46.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.028 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.477 ' CA ' HD12 ' A' ' 109' ' ' ILE . 2.8 m-85 -138.76 -179.86 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 107' ' ' GLY . 13.6 p -128.25 149.19 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HD3' HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -114.36 87.83 14.41 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.7 148.46 15.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.527 2.152 . . . . 0.0 112.398 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.647 HG23 ' HG3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -105.65 -176.71 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.0 t -77.88 -31.83 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.688 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -73.56 -56.97 4.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.7 mtm -91.54 179.3 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -130.09 -98.45 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.484 HD11 HG11 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -175.5 126.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.29 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.15 116.08 29.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.636 HG22 ' C ' ' A' ' 104' ' ' ASP . 57.5 p -86.27 134.07 33.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.43 -63.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.43 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -100.03 -71.31 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.577 ' NE2' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -120.71 -15.67 8.37 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' THR . 21.7 t -87.48 70.63 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.661 0.267 . . . . 0.0 111.583 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.636 ' C ' HG22 ' A' ' 99' ' ' THR . 70.6 m-20 -52.04 -176.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.25 68.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.408 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.19 19.64 10.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.796 ' O ' HG12 ' A' ' 89' ' ' VAL . . . 53.99 29.39 43.24 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 88' ' ' PHE . 27.8 tttp -83.87 113.31 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.578 HG22 HD12 ' A' ' 111' ' ' LEU . 2.2 mp -69.78 110.19 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.21 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 102' ' ' HIS . 3.8 p90 -132.92 46.98 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.481 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 109' ' ' ILE . 1.3 mp -44.67 148.95 0.84 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.644 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -30.85 10.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.564 2.176 . . . . 0.0 112.017 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -60.34 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.98 -30.91 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.418 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -58.86 -55.64 32.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.02 31.02 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.608 ' O ' ' CB ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -81.05 -64.37 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.589 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' CB ' ' O ' ' A' ' 117' ' ' TRP . 1.0 OUTLIER 109.58 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.915 0.76 . . . . 0.0 110.053 -179.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 120' ' ' PRO . 1.4 m80 -175.95 175.77 0.66 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.392 -0.193 . . . . 0.0 110.746 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.583 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 83.5 Cg_endo -84.42 -2.32 57.99 Favored 'Cis proline' 0 C--N 1.354 0.83 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.049 0.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -25.3 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.381 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.415 ' N ' ' NE1' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -70.13 66.21 0.27 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.015 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -93.17 168.89 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 28' ' ' VAL . 4.4 tp -57.76 -39.68 77.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.0 mp -49.28 -43.16 42.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.54 -26.86 49.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.256 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.1 tm? -57.87 -31.74 67.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 124' ' ' LEU . 4.6 mp -88.02 -28.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.564 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.7 tm0? -61.34 -35.86 78.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 111' ' ' LEU . 2.3 p -65.19 -39.94 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.551 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.404 ' HG2' ' CE1' ' A' ' 135' ' ' PHE . 10.0 mtt -68.74 -44.59 73.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.858 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 129' ' ' GLN . 1.2 tt -52.65 -24.53 6.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.204 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 129' ' ' GLN . 42.0 t -92.98 -56.48 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.529 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 130' ' ' VAL . 89.6 t -56.63 -46.95 82.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.543 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.544 ' CD2' HG21 ' A' ' 70' ' ' ILE . 4.3 m-85 -74.9 -27.79 60.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.772 ' HA2' HG13 ' A' ' 61' ' ' VAL . . . -66.53 -15.54 64.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.592 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -89.78 -48.66 7.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -158.81 137.35 7.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.74 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 138' ' ' GLU . 48.5 Cg_exo -55.66 105.97 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 112.338 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HG2' ' CE2' ' A' ' 135' ' ' PHE . 18.3 Cg_exo -66.62 -12.85 37.54 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.227 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 141' ' ' VAL . 42.8 t -84.56 -13.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.605 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -68.42 179.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.98 44.17 1.04 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 61.2 154.84 0.11 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.237 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.252 1.18 0 C-N-CA 122.657 2.238 . . . . 0.0 112.282 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.698 0.285 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.93 31.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -25.65 58.88 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.022 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.27 -34.42 14.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -72.27 -35.35 68.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.73 -32.66 57.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.821 ' O ' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -63.01 -28.39 70.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -29.47 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.292 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -73.65 -28.13 61.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.988 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.66 ' CE ' HD23 ' A' ' 39' ' ' LEU . 5.6 ptm -85.62 -35.22 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.081 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 8' ' ' LEU . 29.4 m -94.87 11.57 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.561 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.81 -23.19 63.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.055 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -26.67 25.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.409 ' CE2' ' O ' ' A' ' 77' ' ' LEU . 8.5 m-85 -54.52 134.19 46.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -67.5 -49.41 63.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.977 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -90.7 66.44 6.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.851 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -56.92 -60.73 3.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.325 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -51.45 -53.28 38.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.094 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mt -63.03 -41.24 99.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.0 m -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 18' ' ' ARG . 39.4 t -82.31 -31.74 10.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -72.27 -48.42 42.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 28' ' ' VAL . 23.4 mt-10 -64.39 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.697 HG23 ' CD2' ' A' ' 55' ' ' LEU . 85.6 m -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.078 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 30' ' ' THR . 0.5 OUTLIER -85.78 -47.81 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.598 ' O ' HD23 ' A' ' 31' ' ' LEU . 2.4 m-20 -55.42 -28.72 56.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.474 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 24' ' ' GLU . 38.5 t -85.82 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.427 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 5.9 pt -57.38 -33.76 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.567 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 26' ' ' VAL . 4.8 t -75.47 -32.69 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 27' ' ' ASN . 2.7 mm? -77.04 -38.91 51.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.858 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' CB ' HD23 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -99.26 -20.56 16.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.512 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 1.1 mttp 67.31 -59.88 0.39 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.639 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -45.69 -35.88 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.885 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.674 HD21 ' CG2' ' A' ' 59' ' ' ILE . 3.6 mm? -63.38 132.52 51.75 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 111.059 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -129.95 117.97 18.4 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.699 ' HB2' HD11 ' A' ' 8' ' ' LEU . 45.4 Cg_exo -56.7 140.68 91.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.401 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 39' ' ' LEU . 8.4 t -131.34 162.81 38.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.66 HD23 ' CE ' ' A' ' 11' ' ' MET . 2.1 tm? -133.4 95.18 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.862 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.24 118.6 35.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.08 145.52 49.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.296 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -117.67 119.93 36.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.596 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 49' ' ' SER . 33.3 m -85.0 152.38 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 111.188 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -121.17 107.95 13.19 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.355 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 46.94 29.69 1.09 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 64.09 15.82 9.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.369 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.6 -13.86 66.69 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.175 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.454 ' CB ' ' CE2' ' A' ' 44' ' ' PHE . 0.5 OUTLIER 173.77 -168.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.569 ' HB3' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -147.08 131.22 17.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.07 127.99 55.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.421 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -74.49 101.09 4.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' O ' HD22 ' A' ' 39' ' ' LEU . 4.6 mm? -108.65 138.99 44.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.556 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 65.8 ttp -84.85 149.2 25.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.442 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 9.0 p-10 -149.98 117.8 6.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.697 ' CD2' HG23 ' A' ' 25' ' ' THR . 3.6 mt -85.37 107.65 17.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.522 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 m -108.5 149.73 28.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.498 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 163.4 165.42 20.5 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.461 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.42 HG23 ' HB3' ' A' ' 71' ' ' PRO . 1.4 p -107.29 120.63 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.604 0.24 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.674 ' CG2' HD21 ' A' ' 35' ' ' LEU . 2.2 pt -99.76 126.35 37.35 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.456 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.11 126.61 22.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.417 2.078 . . . . 0.0 111.952 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG11 ' CG1' ' A' ' 70' ' ' ILE . 14.8 p -132.84 136.69 28.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.0 Cg_exo -58.16 150.98 62.28 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.433 2.089 . . . . 0.0 112.094 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -176.76 116.46 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.4 mtp85 58.48 25.1 12.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.27 3.18 75.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.75 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -124.74 176.9 6.28 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 133.91 47.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -165.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -143.53 98.04 3.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.995 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.701 HG21 ' CD2' ' A' ' 135' ' ' PHE . 25.0 mm -100.92 101.8 17.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB3' HG23 ' A' ' 58' ' ' THR . 61.3 Cg_endo -73.23 136.25 24.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.486 2.124 . . . . 0.0 112.53 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.409 HD12 ' SG ' ' A' ' 87' ' ' CYS . 11.5 pt -134.81 167.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 108.62 10.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.935 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.894 HD22 HD22 ' A' ' 124' ' ' LEU . 8.3 mt -85.44 98.66 10.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.086 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.778 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -79.66 146.9 32.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.569 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.778 HD22 ' C ' ' A' ' 75' ' ' TRP . 2.8 mm? -126.97 170.87 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.44 166.25 25.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.38 0.61 . . . . 0.0 110.715 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -39.27 24.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.77 163.11 27.14 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.62 -62.58 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.187 -0.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.425 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 25.4 m-85 -105.03 -56.09 2.23 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.619 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.572 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.9 p-10 161.83 -34.37 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.369 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 83' ' ' ASN . 28.5 Cg_exo -62.09 116.99 3.83 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.968 1.778 . . . . 0.0 112.269 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.694 ' HB3' HD13 ' A' ' 76' ' ' LEU . 46.2 Cg_endo -68.17 166.94 23.35 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.39 2.06 . . . . 0.0 112.199 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.802 HG21 ' CE1' ' A' ' 88' ' ' PHE . 1.2 mp -103.95 164.03 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.066 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.774 ' H ' HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -131.67 53.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.814 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.802 ' CE1' HG21 ' A' ' 86' ' ' ILE . 30.6 m-85 -48.73 125.42 10.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.182 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.733 HG13 HG23 ' A' ' 109' ' ' ILE . 33.5 m -81.6 127.0 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.253 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -127.44 89.83 50.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 32.9 Cg_exo -60.33 -158.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.644 2.23 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -128.6 173.95 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 t -68.4 -25.73 65.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -29.22 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.294 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.685 ' HB3' HG12 ' A' ' 141' ' ' VAL . 2.0 mpp? -127.2 -169.17 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 143' ' ' SER . 13.0 t -135.62 -162.7 1.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 97' ' ' ILE . 9.3 tt -122.89 104.29 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -81.43 102.28 10.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 105' ' ' ALA . 15.5 p -57.56 141.37 48.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.33 -100.44 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.557 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -95.96 -64.53 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.81 ' CE1' HG11 ' A' ' 134' ' ' VAL . 4.8 p-80 -107.53 -24.34 11.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.422 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 140' ' ' PRO . 52.1 t -55.28 -27.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 99' ' ' THR . 1.0 OUTLIER 44.4 -166.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 99' ' ' THR . . . -103.81 -20.57 13.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.513 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.65 22.2 7.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.488 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.41 ' HA2' ' CD1' ' A' ' 97' ' ' ILE . . . 51.52 44.27 53.41 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.781 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 1.5 tttm -124.05 90.82 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.785 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.858 ' O ' HD12 ' A' ' 109' ' ' ILE . 2.0 pp -46.79 108.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.874 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 108' ' ' LYS . 33.5 m-85 -95.61 30.9 2.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.713 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.778 HD13 HG11 ' A' ' 130' ' ' VAL . 9.5 mt -49.17 106.56 0.64 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.35 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.5 -14.73 46.01 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.463 2.109 . . . . 0.0 112.418 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -58.56 -71.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.318 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -60.63 -19.64 58.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.151 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.954 ' N ' HD13 ' A' ' 114' ' ' LEU . 24.2 t60 -64.62 -46.55 82.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 110.332 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.02 26.79 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.736 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.508 ' HD1' ' N ' ' A' ' 118' ' ' LYS . 2.2 t90 -97.02 136.89 36.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.508 ' N ' ' HD1' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -124.51 138.19 54.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.773 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.625 ' CB ' ' HA ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -48.98 174.28 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.236 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.625 ' HA ' ' CB ' ' A' ' 119' ' ' HIS . 59.9 Cg_endo -90.43 32.03 9.81 Favored 'Cis proline' 0 C--N 1.355 0.876 0 C-N-CA 124.661 -0.975 . . . . 0.0 113.437 0.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -113.41 -0.38 14.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.748 0.309 . . . . 0.0 111.273 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.497 ' CB ' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -90.72 120.96 32.2 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -174.27 179.78 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.894 HD22 HD22 ' A' ' 74' ' ' LEU . 59.0 mt -59.68 -31.2 69.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -47.6 81.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -83.94 -40.72 8.54 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 130' ' ' VAL . 9.5 tt -54.02 -27.4 31.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.791 0.329 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.749 HD11 HD11 ' A' ' 74' ' ' LEU . 50.0 mt -90.54 -28.54 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.666 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.875 ' HA ' HD12 ' A' ' 132' ' ' ILE . 2.2 tt0 -57.47 -33.06 67.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.332 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.778 HG11 HD13 ' A' ' 111' ' ' LEU . 4.3 p -59.79 -45.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.38 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.449 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 12.8 mtm -69.89 -40.58 75.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.087 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 129' ' ' GLN . 63.4 mt -54.6 -26.25 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.741 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 129' ' ' GLN . 39.9 t -91.87 -54.39 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.437 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.81 HG11 ' CE1' ' A' ' 102' ' ' HIS . 39.5 t -56.42 -47.82 80.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.701 ' CD2' HG21 ' A' ' 70' ' ' ILE . 7.3 m-30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.279 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 61' ' ' VAL . . . -67.66 -15.87 67.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.696 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -104.12 -42.83 5.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 28.0 mt-10 -151.0 90.53 4.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.253 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 138' ' ' GLU . 10.7 Cg_endo -55.99 129.23 33.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.487 2.125 . . . . 0.0 112.306 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.648 ' HB3' HG21 ' A' ' 103' ' ' VAL . 37.0 Cg_exo -59.1 -19.03 46.96 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.175 1.917 . . . . 0.0 111.871 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 95' ' ' MET . 1.6 t -75.06 152.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.25 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 144' ' ' ARG . 16.7 t80 -174.99 -87.65 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.043 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.827 ' HB3' HG22 ' A' ' 96' ' ' THR . 1.3 p 57.35 33.23 23.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.525 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 23.3 mtm-85 60.45 153.35 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.838 0.351 . . . . 0.0 111.025 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.597 2.198 . . . . 0.0 112.632 179.605 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.633 0.254 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 3' ' ' VAL . 18.9 t -100.04 36.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.6 p -107.28 -23.94 12.06 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -84.68 -51.31 6.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.074 0.464 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -60.41 -31.76 70.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -84.31 -22.88 30.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.103 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.797 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.2 tp -55.34 -50.72 68.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.219 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -31.8 40.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.924 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.49 68.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.651 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.543 ' HG2' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -86.28 -33.0 20.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 8' ' ' LEU . 26.7 m -100.45 20.35 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -26.51 68.36 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.561 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -21.86 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.339 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -51.54 134.48 29.28 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.037 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -64.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.832 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -86.5 63.73 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.765 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 22' ' ' VAL . 12.8 ttp180 -63.76 -53.7 46.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.278 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.85 -35.03 56.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 111.449 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.59 -40.19 16.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.738 HG23 HD23 ' A' ' 76' ' ' LEU . 81.8 m -66.49 -49.82 65.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.086 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.1 t -59.67 -39.59 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -48.4 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.381 0.61 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.4 -43.42 88.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.852 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.757 HG22 HD11 ' A' ' 29' ' ' ILE . 23.4 m -65.02 -59.02 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -48.94 -48.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.183 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 1.2 t-20 -55.99 -28.04 55.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 24' ' ' GLU . 31.5 t -84.08 -27.18 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.757 HD11 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -91.12 -27.37 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.933 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -68.77 -48.15 64.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -41.89 66.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.35 117.31 34.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -95.7 21.13 8.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.216 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' C ' HD22 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -119.0 17.65 13.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.725 HD13 ' HA3' ' A' ' 57' ' ' GLY . 4.1 mm? -118.04 159.86 22.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -149.35 124.58 4.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.686 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 133.84 21.27 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.252 1.968 . . . . 0.0 112.344 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.543 HG23 HG22 ' A' ' 56' ' ' THR . 6.9 t -130.15 162.15 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.068 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -120.55 114.8 22.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.804 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -134.1 115.46 14.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 110.89 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 p -72.99 141.88 47.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.09 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.48 120.51 41.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.91 156.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -114.24 54.52 0.76 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.166 0.507 . . . . 0.0 110.964 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 55.93 68.58 0.84 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.947 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.94 22.36 12.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.26 38.1 2.67 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.463 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.6 t 69.39 169.2 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.4 p -125.47 173.92 8.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.769 ' NE ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -133.12 138.94 46.84 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.488 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.54 107.08 0.14 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.513 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.769 HD13 ' NE ' ' A' ' 50' ' ' ARG . 7.6 tp -117.82 131.03 56.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.776 0.322 . . . . 0.0 110.544 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.76 ' SD ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -92.04 146.08 24.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.211 0.529 . . . . 0.0 110.912 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.434 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 6.6 p-10 -143.86 140.7 29.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.915 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD11 HG23 ' A' ' 25' ' ' THR . 57.5 mt -100.32 101.67 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.543 HG22 HG23 ' A' ' 38' ' ' VAL . 11.7 t -102.55 152.96 20.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.694 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.725 ' HA3' HD13 ' A' ' 35' ' ' LEU . . . 154.19 -172.41 32.79 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.411 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.6 p -121.53 156.5 32.73 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.852 HD12 HG13 ' A' ' 61' ' ' VAL . 2.2 pp -131.87 134.28 25.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.036 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 116.18 4.56 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.562 2.175 . . . . 0.0 112.104 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.852 HG13 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -120.15 102.1 46.47 Favored Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.522 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 89.4 Cg_exo -42.61 129.7 5.13 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.211 2.607 . . . . 0.0 112.688 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -135.56 87.17 2.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 63.01 42.77 7.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.14 -16.58 55.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.1 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -86.65 -147.47 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.857 -0.202 . . . . 0.0 110.731 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 67' ' ' THR . 6.0 t -176.24 41.95 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 121.547 0.689 . . . . 0.0 109.906 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.459 ' O ' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -31.27 148.33 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.524 -179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -105.66 106.11 16.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.682 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.744 HG21 ' CD2' ' A' ' 135' ' ' PHE . 13.2 mm -99.58 108.25 49.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.217 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.16 147.53 93.04 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.494 2.129 . . . . 0.0 111.853 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 pt -149.57 149.82 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.0 111.215 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 116.71 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 138.4 32.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.699 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -113.35 145.92 40.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.76 HD22 ' SD ' ' A' ' 53' ' ' MET . 2.3 mp -141.22 146.4 36.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.763 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.37 166.24 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.16 0.505 . . . . 0.0 110.85 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.84 -39.57 79.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.723 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t 174.43 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.843 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -125.59 163.54 38.15 Favored Pre-proline 0 C--O 1.232 0.137 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 90.5 Cg_endo -82.65 -31.69 3.89 Favored 'Cis proline' 0 C--N 1.346 0.432 0 C-N-CA 123.421 -1.491 . . . . 0.0 112.108 0.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.629 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 52.0 m-85 -59.55 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.101 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 82' ' ' TYR . 64.6 t-20 117.67 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 111.561 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 83' ' ' ASN . 89.5 Cg_endo -84.21 141.25 9.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.433 2.089 . . . . 0.0 112.399 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 84' ' ' PRO . 50.4 Cg_exo -55.36 127.42 26.18 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.473 2.115 . . . . 0.0 112.248 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.639 ' CD1' HD12 ' A' ' 77' ' ' LEU . 2.5 mp -93.35 160.03 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.637 ' C ' HD12 ' A' ' 109' ' ' ILE . 4.2 t -155.16 123.19 5.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.474 ' CZ ' ' CG2' ' A' ' 86' ' ' ILE . 19.7 m-85 -134.6 121.64 21.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.581 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.496 HG11 HG12 ' A' ' 103' ' ' VAL . 14.6 p -68.71 130.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 125.86 68.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.04 165.89 22.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.119 . . . . 0.0 112.41 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.41 -176.66 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.914 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.93 -33.96 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 p -93.48 -32.78 14.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.766 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.417 ' SD ' HG21 ' A' ' 141' ' ' VAL . 21.3 ttp -99.01 -12.14 20.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.528 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 143' ' ' SER . 8.9 t 44.59 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -139.39 127.14 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 111.473 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.01 145.61 29.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 104' ' ' ASP . 72.7 p -79.34 131.35 36.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.22 -121.13 1.65 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.635 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 -39.07 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.132 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.74 -48.49 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 140' ' ' PRO . 2.9 m -68.11 67.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.573 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 99' ' ' THR . 71.5 m-20 -49.89 -100.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.564 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.18 -54.7 2.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -106.94 39.59 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.037 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.461 ' HA3' HG13 ' A' ' 89' ' ' VAL . . . 59.83 51.89 56.24 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.391 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 4.2 mtpt -93.11 90.0 6.7 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.041 0.448 . . . . 0.0 110.406 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 87' ' ' CYS . 4.2 mt -47.89 109.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.089 0.471 . . . . 0.0 111.435 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.38 39.48 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.668 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.3 mt -54.59 118.98 18.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.18 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.75 -35.32 87.5 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.0 112.122 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.97 -29.83 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.801 ' CD1' HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.47 -30.11 17.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -57.35 -37.7 72.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.23 22.75 8.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.47 ' CD1' ' HB3' ' A' ' 122' ' ' SER . 2.8 t90 -95.08 122.72 38.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.652 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -129.53 107.56 9.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 15.1 p80 -56.35 -179.04 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.134 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.668 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 50.4 Cg_exo -57.3 -17.63 1.52 Allowed 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 124.718 -0.951 . . . . 0.0 113.98 0.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.534 ' N ' ' HA ' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -37.86 -59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.686 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -58.58 164.38 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.03 -84.51 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 24' ' ' GLU . 5.4 tp 176.78 -36.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.42 -44.81 95.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.779 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.63 -36.45 92.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.108 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.801 HD13 ' CD1' ' A' ' 114' ' ' LEU . 20.6 tp -57.12 -34.14 68.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.979 0.418 . . . . 0.0 110.513 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.75 -24.32 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.006 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.873 ' O ' HG22 ' A' ' 132' ' ' ILE . 19.7 tt0 -68.9 -40.87 78.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.816 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.9 p -61.76 -41.31 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.472 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.407 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 2.5 mtt -63.81 -40.3 96.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -55.89 -28.34 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.964 0.411 . . . . 0.0 111.022 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.19 -52.22 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 130' ' ' VAL . 40.0 t -54.86 -36.0 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.989 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.744 ' CD2' HG21 ' A' ' 70' ' ' ILE . 5.5 m-85 -92.18 -21.93 20.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -21.53 61.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.6 -28.89 13.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.734 0.302 . . . . 0.0 111.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -161.3 95.79 1.35 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.28 117.83 3.78 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.6 2.2 . . . . 0.0 112.076 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.552 ' O ' HG11 ' A' ' 103' ' ' VAL . 93.5 Cg_endo -88.55 45.84 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.621 2.214 . . . . 0.0 112.737 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.497 ' O ' ' C ' ' A' ' 142' ' ' PHE . 1.4 m -136.9 -40.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.842 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' C ' ' O ' ' A' ' 141' ' ' VAL . 21.8 t80 -0.86 -86.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 113.214 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.494 ' O ' HG21 ' A' ' 96' ' ' THR . 0.2 OUTLIER 41.28 30.45 0.12 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.834 0.454 . . . . 0.0 112.031 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.465 ' O ' ' CZ ' ' A' ' 142' ' ' PHE . 11.9 ttp85 -102.89 100.2 16.04 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.181 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 143' ' ' SER . 80.6 Cg_exo . . . . . 0 C--O 1.252 1.184 0 C-N-CA 122.601 2.201 . . . . 0.0 112.533 179.378 . . . . . . . . 1 1 . 1 stop_ save_